0001162194-20-000093.txt : 20200807 0001162194-20-000093.hdr.sgml : 20200807 20200807162854 ACCESSION NUMBER: 0001162194-20-000093 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200807 DATE AS OF CHANGE: 20200807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FLUIDIGM CORP CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 201085382 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 10-Q 1 fldm-20200630.htm 10-Q fldm-20200630
false2020Q20001162194--12-31us-gaap:AccountingStandardsUpdate201613MemberP1YP1Yus-gaap:AccountingStandardsUpdate201613Member6110.12694380.344827600011621942020-01-012020-06-30xbrli:shares00011621942020-07-31iso4217:USD00011621942020-06-3000011621942019-12-31iso4217:USDxbrli:shares0001162194us-gaap:ProductMember2020-04-012020-06-300001162194us-gaap:ProductMember2019-04-012019-06-300001162194us-gaap:ProductMember2020-01-012020-06-300001162194us-gaap:ProductMember2019-01-012019-06-300001162194us-gaap:ServiceMember2020-04-012020-06-300001162194us-gaap:ServiceMember2019-04-012019-06-300001162194us-gaap:ServiceMember2020-01-012020-06-300001162194us-gaap:ServiceMember2019-01-012019-06-300001162194fldm:CollaborationRevenueMember2020-04-012020-06-300001162194fldm:CollaborationRevenueMember2019-04-012019-06-300001162194fldm:CollaborationRevenueMember2020-01-012020-06-300001162194fldm:CollaborationRevenueMember2019-01-012019-06-300001162194us-gaap:ProductAndServiceOtherMember2020-04-012020-06-300001162194us-gaap:ProductAndServiceOtherMember2019-04-012019-06-300001162194us-gaap:ProductAndServiceOtherMember2020-01-012020-06-300001162194us-gaap:ProductAndServiceOtherMember2019-01-012019-06-3000011621942020-04-012020-06-3000011621942019-04-012019-06-3000011621942019-01-012019-06-300001162194us-gaap:CommonStockMember2019-12-310001162194us-gaap:AdditionalPaidInCapitalMember2019-12-310001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001162194us-gaap:RetainedEarningsMember2019-12-310001162194us-gaap:CommonStockMember2020-01-012020-03-310001162194us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-3100011621942020-01-012020-03-310001162194us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001162194srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001162194us-gaap:RetainedEarningsMember2020-01-012020-03-310001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001162194us-gaap:CommonStockMember2020-03-310001162194us-gaap:AdditionalPaidInCapitalMember2020-03-310001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001162194us-gaap:RetainedEarningsMember2020-03-3100011621942020-03-310001162194us-gaap:CommonStockMember2020-04-012020-06-300001162194us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001162194us-gaap:RetainedEarningsMember2020-04-012020-06-300001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001162194us-gaap:CommonStockMember2020-06-300001162194us-gaap:AdditionalPaidInCapitalMember2020-06-300001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001162194us-gaap:RetainedEarningsMember2020-06-300001162194us-gaap:CommonStockMember2018-12-310001162194us-gaap:AdditionalPaidInCapitalMember2018-12-310001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001162194us-gaap:RetainedEarningsMember2018-12-3100011621942018-12-310001162194us-gaap:CommonStockMember2019-01-012019-03-310001162194us-gaap:AdditionalPaidInCapitalMember2019-01-012019-03-3100011621942019-01-012019-03-310001162194us-gaap:RetainedEarningsMember2019-01-012019-03-310001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310001162194us-gaap:CommonStockMember2019-03-310001162194us-gaap:AdditionalPaidInCapitalMember2019-03-310001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001162194us-gaap:RetainedEarningsMember2019-03-3100011621942019-03-310001162194us-gaap:CommonStockMember2019-04-012019-06-300001162194us-gaap:AdditionalPaidInCapitalMember2019-04-012019-06-300001162194us-gaap:RetainedEarningsMember2019-04-012019-06-300001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-300001162194us-gaap:CommonStockMember2019-06-300001162194us-gaap:AdditionalPaidInCapitalMember2019-06-300001162194us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300001162194us-gaap:RetainedEarningsMember2019-06-3000011621942019-06-300001162194us-gaap:ProductMembersrt:MinimumMember2020-01-012020-06-300001162194us-gaap:ProductMembersrt:MaximumMember2020-01-012020-06-300001162194srt:MinimumMemberus-gaap:ServiceMember2020-01-012020-06-300001162194us-gaap:ServiceMembersrt:MaximumMember2020-01-012020-06-300001162194fldm:IntellectualPropertyInfringementClaimsMember2020-03-012020-03-310001162194us-gaap:LicenseMember2020-03-012020-03-3100011621942020-03-012020-03-310001162194srt:MinimumMemberfldm:CommissionCostsMember2020-01-012020-06-300001162194fldm:CommissionCostsMembersrt:MaximumMember2020-01-012020-06-30xbrli:pure0001162194fldm:FiveLargestCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-04-012020-06-300001162194fldm:FiveLargestCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2019-04-012019-06-300001162194fldm:FiveLargestCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-06-300001162194fldm:FiveLargestCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2019-01-012019-06-300001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2014-02-280001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2018-03-310001162194us-gaap:CommonStockMemberus-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2019-01-012019-03-310001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-01-012019-03-310001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesDue2024Member2019-11-300001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2019-11-012019-11-300001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2019-11-300001162194us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001162194us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001162194us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310001162194us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-03-310001162194us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001162194us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-310001162194us-gaap:AccumulatedTranslationAdjustmentMember2020-04-012020-06-300001162194us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-04-012020-06-300001162194us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300001162194us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-06-300001162194us-gaap:EmployeeStockOptionMember2020-01-012020-06-300001162194us-gaap:EmployeeStockOptionMember2019-01-012019-06-300001162194fldm:TwoThousandAndNineteenConvertibleNotesMemberus-gaap:ConvertibleDebtSecuritiesMember2020-01-012020-06-300001162194fldm:TwoThousandAndNineteenConvertibleNotesMemberus-gaap:ConvertibleDebtSecuritiesMember2019-01-012019-06-300001162194fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMemberus-gaap:ConvertibleDebtSecuritiesMember2020-01-012020-06-300001162194fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMemberus-gaap:ConvertibleDebtSecuritiesMember2019-01-012019-06-300001162194fldm:TwoThousandAndFourteenConvertibleNotesMemberus-gaap:ConvertibleDebtSecuritiesMember2020-01-012020-06-300001162194fldm:TwoThousandAndFourteenConvertibleNotesMemberus-gaap:ConvertibleDebtSecuritiesMember2019-01-012019-06-300001162194fldm:InstruNorASMember2020-01-172020-01-1700011621942020-01-170001162194fldm:InstruNorASMember2020-01-170001162194srt:AmericasMember2020-04-012020-06-300001162194srt:AmericasMember2019-04-012019-06-300001162194srt:AmericasMember2020-01-012020-06-300001162194srt:AmericasMember2019-01-012019-06-300001162194us-gaap:EMEAMember2020-04-012020-06-300001162194us-gaap:EMEAMember2019-04-012019-06-300001162194us-gaap:EMEAMember2020-01-012020-06-300001162194us-gaap:EMEAMember2019-01-012019-06-300001162194srt:AsiaPacificMember2020-04-012020-06-300001162194srt:AsiaPacificMember2019-04-012019-06-300001162194srt:AsiaPacificMember2020-01-012020-06-300001162194srt:AsiaPacificMember2019-01-012019-06-300001162194fldm:InstrumentsMember2020-04-012020-06-300001162194fldm:InstrumentsMember2019-04-012019-06-300001162194fldm:InstrumentsMember2020-01-012020-06-300001162194fldm:InstrumentsMember2019-01-012019-06-300001162194fldm:ConsumablesMember2020-04-012020-06-300001162194fldm:ConsumablesMember2019-04-012019-06-300001162194fldm:ConsumablesMember2020-01-012020-06-300001162194fldm:ConsumablesMember2019-01-012019-06-300001162194us-gaap:LicenseMember2020-04-012020-06-300001162194us-gaap:LicenseMember2019-04-012019-06-300001162194us-gaap:LicenseMember2020-01-012020-06-300001162194us-gaap:LicenseMember2019-01-012019-06-300001162194us-gaap:GrantMember2020-04-012020-06-300001162194us-gaap:GrantMember2019-04-012019-06-300001162194us-gaap:GrantMember2020-01-012020-06-300001162194us-gaap:GrantMember2019-01-012019-06-3000011621942020-07-012020-06-3000011621942021-01-012020-06-3000011621942022-01-012020-06-3000011621942023-01-012020-06-300001162194fldm:DVSSciencesInc.Member2014-02-280001162194us-gaap:DevelopedTechnologyRightsMemberfldm:DVSSciencesInc.Member2014-02-012014-02-280001162194fldm:InstruNorASMember2020-03-310001162194us-gaap:DevelopedTechnologyRightsMemberfldm:InstruNorASMember2020-01-012020-03-310001162194us-gaap:DevelopedTechnologyRightsMember2020-06-300001162194us-gaap:DevelopedTechnologyRightsMember2020-01-012020-06-300001162194fldm:PatentsandLicenseAgreementsMember2020-06-300001162194fldm:PatentsandLicenseAgreementsMember2020-01-012020-06-300001162194us-gaap:DevelopedTechnologyRightsMember2019-12-310001162194us-gaap:DevelopedTechnologyRightsMember2019-01-012019-12-310001162194fldm:PatentsandLicenseAgreementsMember2019-12-310001162194fldm:PatentsandLicenseAgreementsMember2019-01-012019-12-310001162194us-gaap:DevelopedTechnologyRightsMember2020-04-012020-06-300001162194us-gaap:DevelopedTechnologyRightsMember2019-04-012019-06-300001162194us-gaap:DevelopedTechnologyRightsMember2019-01-012019-06-300001162194fldm:ComputerEquipmentAndSoftwareMember2020-06-300001162194fldm:ComputerEquipmentAndSoftwareMember2019-12-310001162194fldm:LaboratoryAndManufacturingEquipmentMember2020-06-300001162194fldm:LaboratoryAndManufacturingEquipmentMember2019-12-310001162194us-gaap:LeaseholdImprovementsMember2020-06-300001162194us-gaap:LeaseholdImprovementsMember2019-12-310001162194us-gaap:OfficeEquipmentMember2020-06-300001162194us-gaap:OfficeEquipmentMember2019-12-310001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2014-02-012014-02-280001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2020-06-300001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2018-03-310001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2018-03-12utr:Rate00011621942018-03-012018-03-310001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2018-03-012018-03-310001162194fldm:TrusteeMemberfldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-03-310001162194fldm:TrusteeMemberfldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-02-280001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-02-280001162194us-gaap:CommonStockMemberfldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-02-012019-02-280001162194fldm:TrusteeMemberfldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-02-012019-02-280001162194us-gaap:CommonStockMemberus-gaap:ConvertibleDebtMember2019-01-012019-03-310001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesDue2024Member2019-11-012019-11-300001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-10-012019-12-3100011621942019-11-012019-11-300001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-11-300001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2019-11-012019-11-300001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2019-11-012019-11-300001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Member2019-12-310001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesDue2024Member2020-06-300001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesDue2024Member2019-12-310001162194us-gaap:ConvertibleDebtMember2020-06-300001162194us-gaap:ConvertibleDebtMember2019-12-310001162194us-gaap:RevolvingCreditFacilityMember2018-08-310001162194us-gaap:RevolvingCreditFacilityMember2018-08-012018-08-310001162194us-gaap:RevolvingCreditFacilityMember2020-06-300001162194srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:PrimeRateMember2018-08-012018-08-310001162194us-gaap:RevolvingCreditFacilityMemberus-gaap:PrimeRateMembersrt:MaximumMember2018-08-012018-08-3100011621942018-08-012018-08-3100011621942020-04-212020-04-210001162194us-gaap:RevolvingCreditFacilityMember2020-01-012020-06-300001162194fldm:ExchangeConvertibleSeniorNotesDue2034Memberus-gaap:ConvertibleDebtMember2019-11-012019-11-300001162194srt:MinimumMember2020-01-012020-06-300001162194srt:MaximumMember2020-01-012020-06-300001162194us-gaap:BuildingMember2020-06-300001162194us-gaap:BuildingMember2019-12-310001162194us-gaap:EquipmentMember2020-06-300001162194us-gaap:EquipmentMember2019-12-310001162194us-gaap:VehiclesMember2020-06-300001162194us-gaap:VehiclesMember2019-12-310001162194stpr:CA2020-03-310001162194us-gaap:CashAndCashEquivalentsMember2020-06-300001162194fldm:RestrictedCashAndCashEquivalentsDomain2020-06-300001162194us-gaap:CashMember2020-06-300001162194us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2020-06-300001162194us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2020-06-300001162194us-gaap:FairValueInputsLevel1Member2020-06-300001162194us-gaap:CashAndCashEquivalentsMember2019-12-310001162194fldm:RestrictedCashAndCashEquivalentsDomain2019-12-310001162194us-gaap:CashMember2019-12-310001162194us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2019-12-310001162194us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2019-12-310001162194us-gaap:FairValueInputsLevel1Member2019-12-31fldm:investment0001162194us-gaap:ConvertibleDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberfldm:SeniorConvertibleNotesdue2034Member2020-06-300001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-300001162194us-gaap:ConvertibleDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberfldm:SeniorConvertibleNotesdue2034Member2019-12-310001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesdue2034Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesDue2024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-300001162194us-gaap:ConvertibleDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberfldm:SeniorConvertibleNotesDue2024Member2019-12-310001162194us-gaap:ConvertibleDebtMemberfldm:SeniorConvertibleNotesDue2024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001162194us-gaap:ConvertibleDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-06-300001162194us-gaap:ConvertibleDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-06-300001162194us-gaap:ConvertibleDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001162194us-gaap:ConvertibleDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001162194fldm:TwoThousandAndNineEquityIncentivePlanMemberus-gaap:EmployeeStockOptionMember2020-06-300001162194fldm:TwoThousandAndNineEquityIncentivePlanMemberfldm:RestrictedStockAndPerformanceShareUnitsMember2020-06-300001162194fldm:TwoThousandAndNineEquityIncentivePlanMember2020-06-300001162194us-gaap:EmployeeStockOptionMemberfldm:TwoThousandAndElevenEquityIncentivePlanMember2020-06-300001162194fldm:TwoThousandAndElevenEquityIncentivePlanMemberfldm:RestrictedStockAndPerformanceShareUnitsMember2020-06-300001162194fldm:TwoThousandAndElevenEquityIncentivePlanMember2020-06-300001162194us-gaap:EmployeeStockOptionMemberfldm:TwoThousandAndTenEquityIncentivePlanMember2020-06-300001162194fldm:RestrictedStockAndPerformanceShareUnitsMemberfldm:TwoThousandAndTenEquityIncentivePlanMember2020-06-300001162194fldm:TwoThousandAndTenEquityIncentivePlanMember2020-06-300001162194us-gaap:EmployeeStockOptionMemberfldm:TwoThousandAndSeventeenInducementAwardPlanMember2020-06-300001162194fldm:RestrictedStockAndPerformanceShareUnitsMemberfldm:TwoThousandAndSeventeenInducementAwardPlanMember2020-06-300001162194fldm:TwoThousandAndSeventeenInducementAwardPlanMember2020-06-300001162194us-gaap:EmployeeStockOptionMemberfldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2020-06-300001162194fldm:RestrictedStockAndPerformanceShareUnitsMemberfldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2020-06-300001162194fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2020-06-300001162194us-gaap:EmployeeStockOptionMember2020-06-300001162194fldm:RestrictedStockAndPerformanceShareUnitsMember2020-06-300001162194us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-06-300001162194us-gaap:RestrictedStockUnitsRSUMember2020-05-310001162194us-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-012020-06-300001162194us-gaap:ShareBasedCompensationAwardTrancheOneMember2020-05-012020-05-310001162194us-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-01-012020-06-300001162194us-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-05-012020-05-310001162194us-gaap:StockCompensationPlanMember2020-01-012020-06-300001162194fldm:AwardsHeldByOwnersOfMoreThan10OfCommonStockMember2020-01-012020-06-300001162194us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-012020-06-300001162194fldm:EquityIncentivePlanTwentyElevenMember2019-06-300001162194fldm:EquityIncentivePlanTwentyElevenMember2020-06-300001162194fldm:A2017InducementAwardPlanMember2017-01-310001162194us-gaap:RestrictedStockUnitsRSUMember2019-12-310001162194us-gaap:RestrictedStockUnitsRSUMember2020-06-3000011621942019-01-012019-12-310001162194fldm:EquityIncentivePlanMember2020-06-300001162194fldm:EquityIncentivePlanMember2020-01-012020-06-300001162194us-gaap:PerformanceSharesMember2020-01-012020-06-300001162194srt:MinimumMemberus-gaap:PerformanceSharesMember2020-01-012020-06-300001162194us-gaap:PerformanceSharesMembersrt:MaximumMember2020-01-012020-06-300001162194us-gaap:PerformanceSharesMember2019-12-310001162194us-gaap:PerformanceSharesMember2020-06-300001162194us-gaap:PerformanceSharesMemberfldm:CertainEmployeeMember2019-12-310001162194us-gaap:PerformanceSharesMemberfldm:CertainEmployeeMember2020-01-012020-06-300001162194us-gaap:PerformanceSharesMemberfldm:CertainEmployeeMember2020-06-3000011621942019-05-312019-05-310001162194us-gaap:EmployeeStockMemberfldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2019-05-3100011621942019-06-012019-06-01fldm:numberOfOfferingPeriods00011621942020-05-310001162194us-gaap:EmployeeStockMemberfldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2019-06-010001162194us-gaap:EmployeeStockMemberfldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2019-06-012019-06-010001162194fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2020-01-012020-06-300001162194fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2020-06-012020-06-3000011621942020-06-012020-06-010001162194us-gaap:EmployeeStockMemberfldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember2020-06-300001162194fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember2020-04-012020-06-300001162194fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember2019-04-012019-06-300001162194fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember2020-01-012020-06-300001162194fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember2019-01-012019-06-300001162194us-gaap:EmployeeStockMember2020-04-012020-06-300001162194us-gaap:EmployeeStockMember2019-04-012019-06-300001162194us-gaap:EmployeeStockMember2020-01-012020-06-300001162194us-gaap:EmployeeStockMember2019-01-012019-06-30fldm:segment0001162194us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2020-04-012020-06-300001162194us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2020-01-012020-06-300001162194us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2019-04-012019-06-300001162194us-gaap:GeographicConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMembercountry:US2019-01-012019-06-300001162194us-gaap:GeographicConcentrationRiskMembercountry:CNus-gaap:RevenueFromContractWithCustomerMember2020-04-012020-06-300001162194us-gaap:GeographicConcentrationRiskMembercountry:CNus-gaap:RevenueFromContractWithCustomerMember2019-04-012019-06-300001162194us-gaap:GeographicConcentrationRiskMembercountry:CNus-gaap:RevenueFromContractWithCustomerMember2019-01-012019-06-300001162194us-gaap:SubsequentEventMember2020-07-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to
_____________________________________________
Commission file number: 001-34180

fldm-20200630_g1.jpg
FLUIDIGM CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 77-0513190
State or other jurisdiction of incorporation or organization I.R.S. Employer Identification No.
2 Tower Place, Ste 2000
South San Francisco,
CA
94080
Address of principal executive officesZip Code
Registrant’s telephone number, including area code: (650) 266-6000
_____________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareFLDMThe Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes      No  
As of July 31, 2020, there were 71,316,370 shares of the registrant’s common stock, $0.001 par value per share, outstanding.



FLUIDIGM CORPORATION
TABLE OF CONTENTS
  Page
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
Notes to Condensed Consolidated Financial Statements
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Item 4.
Controls and Procedures
PART II.
OTHER INFORMATION
Item 1.
Legal Proceedings
Item 1A.
Risk Factors
Item 5.
Other Information
Item 6.
Exhibits
SIGNATURES
EXHIBIT LIST


i


PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

FLUIDIGM CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands) 
(Unaudited)
June 30,December 31,
20202019
ASSETS
Current assets:
Cash and cash equivalents$42,965  $21,661  
Short-term investments2,431  36,978  
Accounts receivable (net of allowances of $101 and $6, at June 30, 2020 and December 31, 2019, respectively)
9,983  18,981  
Inventories18,900  13,884  
Prepaid expenses and other current assets4,171  4,592  
Total current assets78,450  96,096  
Property and equipment, net7,865  8,056  
Operating lease right-of-use asset, net39,027  4,860  
Other non-current assets5,034  5,492  
Developed technology, net45,644  46,200  
Goodwill106,328  104,108  
Total assets$282,348  $264,812  
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$9,384  $6,510  
Accrued compensation and related benefits6,757  5,160  
Operating lease liabilities, current2,170  1,833  
Other accrued liabilities5,758  7,515  
Deferred revenue, current14,279  11,803  
Total current liabilities38,348  32,821  
Convertible notes, net54,013  53,821  
Deferred tax liability9,655  11,494  
Operating lease liabilities, non-current39,139  4,323  
Deferred revenue, non-current7,936  8,168  
Other non-current liabilities538  573  
Total liabilities149,629  111,200  
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either June 30, 2020 or December 31, 2019
    
Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2020 and December 31, 2019; 71,283 and 69,956 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively
71  70  
Additional paid-in capital786,193  777,765  
Accumulated other comprehensive loss(809) (582) 
Accumulated deficit(652,736) (623,641) 
Total stockholders’ equity132,719  153,612  
Total liabilities and stockholders’ equity$282,348  $264,812  
See accompanying notes
1



FLUIDIGM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)

 
 Three Months Ended June 30,Six Months Ended June 30,
 2020201920202019
Revenue:
Product revenue$17,405  $23,235  $36,386  $48,062  
Service revenue5,140  4,961  10,326  10,245  
        Development revenue3,000    3,000    
 Other revenue513    3,963    
Total revenue26,058  28,196  53,675  58,307  
Costs and expenses:
Cost of product revenue9,483  11,100  19,123  22,489  
Cost of service revenue1,237  1,733  2,762  3,465  
Research and development8,448  7,865  17,147  16,237  
Selling, general and administrative20,616  22,134  43,311  44,958  
Total costs and expenses39,784  42,832  82,343  87,149  
Loss from operations(13,726) (14,636) (28,668) (28,842) 
Interest expense(897) (491) (1,797) (3,192) 
Loss from extinguishment of debt      (9,000) 
Other income (expense), net463  231  (355) 715  
Loss before income taxes(14,160) (14,896) (30,820) (40,319) 
Income tax benefit1,145  1,143  1,825  1,101  
Net loss$(13,015) $(13,753) $(28,995) $(39,218) 
Net loss per share, basic and diluted$(0.18) $(0.20) $(0.41) $(0.61) 
Shares used in computing net loss per share, basic and diluted70,916  69,158  70,691  63,923  


See accompanying notes
2


FLUIDIGM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
(Unaudited)

 
 Three Months Ended June 30,Six Months Ended June 30,
 2020201920202019
Net loss$(13,015) $(13,753) $(28,995) $(39,218) 
Other comprehensive income (loss), net of tax
Foreign currency translation adjustment109  (9) (194) (1) 
Net change in unrealized gain (loss) on investments(33) 63  (33) 65  
Other comprehensive income (loss), net of tax76  54  (227) 64  
Comprehensive loss$(12,939) $(13,699) $(29,222) $(39,154) 


See accompanying notes
3


FLUIDIGM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands)
(Unaudited)

 Common StockAdditional
Paid-in
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Accumulated
Deficit
Total
Stockholders’
Equity
 SharesAmount
Balance as of December 31, 201969,956  $70  $777,765  $(582) $(623,641) $153,612  
Issuance of restricted stock, net of shares withheld for taxes, and other255  —  (146) —  —  (146) 
Cumulative-effect of new accounting standard for Topic 326 Credit Losses
—  —  —  —  (100) (100) 
Stock-based compensation expense—  —  2,364  —  —  2,364  
Acquisition of InstruNor AS485  1  2,048  —  —  2,049  
Net loss—  —  —  —  (15,980) (15,980) 
Other comprehensive loss, net of tax—  —  —  (303) —  (303) 
Balance as of March 31, 202070,696  $71  $782,031  $(885) $(639,721) $141,496  
Issuance of restricted stock, net of shares withheld for taxes, and other286  —  (116) —  —  (116) 
Issuance of common stock under ESPP301  —  645  —  —  645  
Stock-based compensation expense—  —  3,633  —  —  3,633  
Net loss—  —  —  —  (13,015) (13,015) 
Other comprehensive income, net of tax—  —  —  76  —  76  
Balance as of June 30, 202071,283  $71  $786,193  $(809) $(652,736) $132,719  
 Common StockAdditional
Paid-in
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Accumulated
Deficit
Total
Stockholders’
Equity
 SharesAmount
Balance as of December 31, 201849,338  $49  $631,605  $(687) $(558,851) $72,116  
Issuance of common stock on bond conversion19,460  19  133,279  —  —  133,298  
Issuance of restricted stock, net of shares withheld for taxes, and other140  1  (177) —  —  (176) 
Issuance of common stock from option exercises53  —  255  —  —  255  
Stock-based compensation expense—  —  2,207  —  —  2,207  
Net loss—  —  —  —  (25,465) (25,465) 
Other comprehensive income, net of tax—  —  —  10  —  10  
Balance as of March 31, 201968,991  $69  $767,169  $(677) $(584,316) $182,245  
Issuance of restricted stock, net of shares withheld for taxes, and other183  —  (325) —  —  (325) 
Issuance of common stock from option exercises130  —  793  —  —  793  
Issuance of common stock under ESPP96  —  641  —  —  641  
Stock-based compensation expense—  —  2,985  —  —  2,985  
Net loss—  —  —  —  (13,753) (13,753) 
Other comprehensive income, net of tax—  —  —  54  —  54  
Balance as of June 30, 201969,400  $69  $771,263  $(623) $(598,069) $172,640  
See accompanying notes
4


FLUIDIGM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Six Months Ended June 30,
 20202019
Operating activities
Net loss$(28,995) $(39,218) 
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization2,016  2,351  
Stock-based compensation expense6,000  5,263  
Amortization of developed technology5,936  5,600  
Amortization of debt discounts, premiums and issuance costs 275  2,037  
Lease amortization1,331  (250) 
Loss on extinguishment of debt  9,000  
Provision for excess and obsolete inventory306  555  
Loss on disposal of property and equipment148  29  
Other non-cash items136  162  
Changes in assets and liabilities:
Accounts receivable, net9,055  (2,420) 
Inventories(4,892) (2,041) 
Prepaid expenses and other assets(706) (965) 
Accounts payable3,136  3,439  
Deferred revenue1,965  476  
Other liabilities(2,796) (9,161) 
Net cash used in operating activities(7,085) (25,143) 
Investing activities
Acquisition, net of cash acquired(5,154)   
Purchases of investments  (44,614) 
Proceeds from sale of investments5,011    
Proceeds from maturities of investments29,400    
Purchases of property and equipment(1,671) (685) 
Net cash provided by (used in) investing activities27,586  (45,299) 
Financing activities
Payment of debt issuance cost(375) (15) 
Proceeds from exercise of stock options  1,048  
Proceeds from stock issuance from ESPP645  641  
Payments for taxes related to net share settlement of equity awards and other(262) (487) 
Net cash provided by financing activities8  1,187  
Effect of foreign exchange rate fluctuations on cash and cash equivalents(205) (25) 
Net increase (decrease) in cash, cash equivalents and restricted cash20,304  (69,280) 
Cash, cash equivalents and restricted cash at beginning of period23,736  95,401  
Cash, cash equivalents and restricted cash at end of period$44,040  $26,121  
Supplemental disclosures of cash flow information
Cash paid for interest$1,531  $2,600  
Cash paid for income taxes, net of refunds$194  $139  
Asset retirement obligations$316  $319  

See accompanying notes
5


FLUIDIGM CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2020

1. Description of Business
Fluidigm Corporation (the Company, Fluidigm, we, our or us) creates, manufactures, and markets technologies and tools for life sciences research, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits (IFC), assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We sell our instruments, consumables and services to academic institutions, clinical laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The Company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
2. Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of June 30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.
Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders’ equity, total revenue, total costs and expenses, loss from operations or net loss.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of June 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.
Foreign Currency
Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year.
Revenue Recognition
We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from
6


development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue.
We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.
Product Revenue
We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.
We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.
Service Revenue
We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.
Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally one to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.
Development Revenue
The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement.
We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary.
We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.
Other Revenue
Other revenue consists of license and royalty revenue, and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For
7


contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.
In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.
We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory.
Contract Costs
Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.
Product Warranties
We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.
Significant Judgments
Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.
Accounts Receivable
Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.
Concentrations of Business and Credit Risk
Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.
We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three months ended June 30, 2020. No other customer represented more than 10% of total revenue for three and six months ended June 30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 32% and 30% of total revenue for the three months ended June 30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the six months ended June 30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at June 30, 2020, or December 31, 2019.
8


Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.
Leases
We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country.
Goodwill, Intangible Assets and Other Long-Lived Assets
Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.
Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.
In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.
We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.
Convertible Notes
In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and
9


accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes using valuation techniques that required us to make assumptions related to the implied discount rate. 
In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding.
As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded for as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.
See Note 7 for a detailed discussion of the accounting treatment of the transactions and additional information.
Comprehensive Loss
Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.
The components of accumulated other comprehensive loss, net of tax, for the three and six months ended June 30, 2020 is as follows (in thousands):
Foreign Currency Translation AdjustmentUnrealized Gain (Loss) on InvestmentsAccumulated Other Comprehensive Income (Loss)
Ending balance at December 31, 2019$(618) $36  $(582) 
Other comprehensive income (loss)(303)   (303) 
Ending balance at March 31, 2020(921) 36  (885) 
Other comprehensive income (loss)109  (33) 76  
Ending balance at June 30, 2020$(812) $3  $(809) 
Immaterial amounts of unrealized gains and losses have been reclassified into the condensed consolidated statement of operations for the three and six months ended June 30, 2020 and 2019.
Net Loss per Share
Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.
The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):
 Six Months Ended June 30,
 20202019
Stock options, restricted stock units and performance awards8,237  4,541  
2019 Convertible Notes18,966    
2019 Convertible Notes potential make-whole shares2,412    
2014 Convertible Notes19  916  
Total29,634  5,457  
10


Recent Accounting Changes and Accounting Pronouncements
Adoption of New Accounting Guidance
In August 2018, the U.S.-based Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.
In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.
The FASB issued two ASUs related to financial instruments – credit losses. The ASUs issued were: (1) in June 2016, ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leasing standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders’ equity and decrease current assets by the same amount in our condensed consolidated balance sheet.
Recent Accounting Pronouncements
In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.
3. Business Combination
On January 17, 2020, we completed the acquisition of all of the outstanding shares of InstruNor AS, a privately held Norwegian company (InstruNor).
InstruNor is a provider of the only fully integrated sample preparation system for flow and mass cytometry. The acquisition of InstruNor supports our entry into the sample preparation market for cytometry analysis and expands our capabilities to include fully automated sample preparation for flow and mass cytometry. The value of this technology is reflected in the intangible asset for developed technology. The developed technology was valued using a discounted cash flow model for which the most sensitive assumption was revenue growth rate.
The purchase price of $7.2 million included approximately $5.2 million in cash and 485,451 shares of our common stock valued at the closing price on the effective date of $4.22.
A summary of the net cash flows is summarized below (in thousands):
January 17, 2020
Cash consideration paid to former equity holders$5,165  
Less: cash and cash equivalents acquired(11) 
Acquisition of InstruNor, net of cash acquired$5,154  
11



The acquisition was accounted for in accordance with ASC 805, Business Combinations. The assets acquired and liabilities assumed were recorded at their estimated fair values at the InstruNor acquisition date. Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):
January 17, 2020
Purchase price:
Cash consideration paid on closing to former equity holders$5,165  
Non-cash consideration common shares 2,049  
Total purchase price$7,214  
Assets acquired:
Cash and cash equivalents$11  
Accounts receivable32  
Other receivables13  
Inventories, net153  
Developed technology5,380  
Liabilities assumed:
Accounts payable14  
Other current liabilities15  
Deferred tax liability566  
Fair value of identifiable net assets acquired$4,994  
Goodwill acquired on acquisition$2,220  

12


4. Revenue
Disaggregation of Revenue
The following table presents our revenue for the three and six months ended June 30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Geographic Markets:
Americas$13,940  $11,120  $28,784  $24,091  
EMEA6,557  11,217  14,653  19,373  
Asia-Pacific5,561  5,859  10,238  14,843  
Total revenue$26,058  $28,196  $53,675  $58,307  
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Source:
Instruments$8,577  $12,201  $18,048  $25,041  
Consumables8,828  11,034  18,338  23,021  
Product revenue17,405  23,235  36,386  48,062  
Service revenue5,140  4,961  10,326  10,245  
Development revenue3,000    3,000    
Other revenue
  License and royalty revenue63    3,163    
  Grant revenue450    800    
  Total other revenue513    3,963    
Total revenue$26,058  $28,196  $53,675  $58,307  
Performance Obligations
We reported $20.0 million of deferred revenue in our December 31, 2019 consolidated balance sheet. During the six months ended June 30, 2020, $6.2 million of the opening balance was recognized as revenue and $8.4 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At June 30, 2020, we reported $22.2 million of deferred revenue.
The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at June 30, 2020 (in thousands):
Fiscal Year
Expected Revenue (1)
2020 (remainder of the year)$7,401  
20218,636  
20224,702  
Thereafter3,164  
Total$23,903  
_______
(1) Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.

13


We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.
5. Goodwill and Intangible Assets, net
In connection with our acquisition of DVS Sciences, Inc. in February 2014, we recognized goodwill of $104.1 million and $112.0 million of developed technology. In the first quarter of 2020, we recognized $2.2 million of goodwill from the InstruNor acquisition and $5.4 million of developed technology (see Note 3). We are amortizing InstruNor developed technology over 8.0 years.
Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.
During the first quarter of fiscal 2020, the Company assessed whether the current and potential future impact of the COVID-19 pandemic represented an event which necessitated an impairment review. This assessment included an update of the qualitative and quantitative factors affecting our business. As a result of this assessment, we determined that a triggering event had occurred and a quantitative impairment test was performed. As a result of this quantitative analysis, we determined that the fair values of our goodwill and developed technology intangibles were not less than their carrying values and no impairment was recognized.
Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangible assets, net, were as follows (in thousands):
June 30, 2020
Gross AmountAccumulated AmortizationNetWeighted-Average Amortization Period
Developed technology$117,380  $(71,736) $45,644  9.9 years
Patents and licenses$11,274  $(8,802) $2,472  7.8 years
December 31, 2019
Gross AmountAccumulated AmortizationNetWeighted-Average Amortization Period
Developed technology$112,000  $(65,800) $46,200  10.0 years
Patents and licenses$11,274  $(8,342) $2,932  7.8 years
Total amortization expense for the three months ended June 30, 2020 and 2019 was $3.2 million and $3.1 million, respectively. Amortization of intangibles was $6.4 million and $6.2 million for the six months ended June 30, 2020 and 2019, respectively.

14


Based on the carrying value of intangible assets, net, as of June 30, 2020, the amortization expense is expected to be as follows (in thousands):
Fiscal YearDeveloped Technology Amortization ExpensePatents and Licenses Amortization ExpenseTotal
2020 (remainder of the year)$5,936  $457  $6,393  
202111,873  759  12,632  
202211,873  676  12,549  
202311,873  570  12,443  
20242,073  10  2,083  
Thereafter2,016    2,016  
Total$45,644  $2,472  $48,116  

6. Balance Sheet Details
Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Cash and cash equivalents$42,965  $21,661  
Restricted cash1,075  2,075  
Total cash, cash equivalents and restricted cash$44,040  $23,736  
Short-term restricted cash of approximately $75 thousand is included in prepaid expenses and other current assets and $1.0 million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of June 30, 2020.
Inventories
Inventories consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Raw materials$9,665  $6,133  
Work-in-process1,063  659  
Finished goods8,172  7,092  
Total inventories$18,900  $13,884  
Property and Equipment, net
Property and equipment consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Computer equipment and software$4,376  $3,997  
Laboratory and manufacturing equipment19,652  19,325  
Leasehold improvements7,962  7,788  
Office furniture and fixtures2,076  1,824  
Property and equipment, gross34,066  32,934  
Less accumulated depreciation and amortization(26,309) (24,954) 
Construction-in-progress108  76  
Property and equipment, net$7,865  $8,056  
 
15


Warranties
Activity for our warranty accrual for the six months ended June 30, 2020 and 2019, which are included in other accrued liabilities, is summarized below (in thousands):
Six Months Ended June 30,
20202019
Beginning balance$1,390  $863  
Accrual for current period warranties419  657  
Warranty costs incurred(277) (429) 
Ending balance$1,532  $1,091  

7. Convertible Notes and Credit Facility
2014 Senior Convertible Notes (2014 Notes)
In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2014 Notes. We received $195.2 million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $1.1 million in offering-related expenses. The underwriting discount of $6.0 million and the debt issuance costs of $1.1 million were recorded as offsets to the proceeds. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is 3.0%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. We have retired the majority of the 2014 Notes through the issuance of the 2018 Notes and 2019 Notes, as discussed below. As of June 30, 2020, there is $1.1 million aggregate principal of the 2014 Notes outstanding.
2018 Senior Convertible Notes (2018 Notes)
In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for 2018 Notes, leaving $51.3 million of the aggregate principal amount of 2014 Notes outstanding. As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $145.5 million. The difference between the $150.0 million aggregate principal amount of the 2018 Notes and its fair value was being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023.
The 2018 Notes accrued interest at a rate of 2.75% payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes were set to mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes was 126.9438 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $7.88 per share). The conversion rate was subject to adjustment upon the occurrence of certain specified events. Those certain specified events included holders who converted their 2018 Notes voluntarily prior to our exercise of the issuer’s conversion option described below or in connection with a make-whole fundamental change prior to February 6, 2023, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time prior to the maturity of the 2018 Notes, we could convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equaled or exceeded 110% of the conversion price then in effect for a specified number of days.
Offering-related costs for the 2018 Notes were approximately $2.8 million. Offering-related costs of $2.2 million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and were being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. The effective interest rate on the 2018 Notes was 12.3%. Offering-related costs of $0.6 million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and were not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity.
In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount of the 2018 Notes. In February 2019, we notified the trustee, U.S. Bank National Association, of our intention to exercise our issuer’s conversion option with respect to the remaining approximately $11.9 million in aggregate principal amount of 2018 Notes. In total, $150.0 million of the 2018 Notes were
16


converted into 19.5 million shares of our common stock and the bonds were retired. We recognized a loss of $9.0 million on the retirement of the 2018 Notes, which represented the difference between the fair value of the bonds retired and their carrying costs. The net impact on equity was $133.3 million and represented the fair value of the bonds retired.
2019 Senior Convertible Notes (2019 Notes)
In November 2019, we issued $55.0 million aggregate principal amount of 2019 Notes. Net proceeds of the offering of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs of approximately $2.3 million. $51.8 million of the proceeds of the 2019 Notes were used to retire $50.2 million aggregate principal amount of our 2014 Notes, leaving $1.1 million of aggregate principal value of 2014 Notes outstanding. We accounted for the transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $3.0 million loss in the fourth quarter of 2019. The loss on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2019 Notes) and the net carrying value of the 2014 Notes exchanged.
The 2019 Notes bear interest at 5.25% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company’s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $2.90 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer’s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest.
The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 150% of the Conversion Price then in effect for a specified number of days (Issuer’s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture.
Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The debt issuance costs are being amortized over the expected term of the 2019 Notes using the effective interest method through the maturity date of December 1, 2024. The effective interest rate on the 2019 Notes is 6.2%.
The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands):
June 30, 2020December 31, 2019
   2.75% 2014 Notes due 2034
Principal amount$1,079  $1,079  
Unamortized debt discount(24) (18) 
Unamortized debt issuance cost(4) (4) 
$1,051  $1,057  
    5.25% 2019 Notes due 2024
Principal amount $55,000  $55,000  
Unamortized debt issuance cost(2,038) (2,236) 
$52,962  $52,764  
    Net carrying value of all Notes$54,013  $53,821  
17


2018 Revolving Credit Facility
In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this Borrowing Base, we may make and repay borrowings from time to time until the maturity of the Revolving Credit Facility. The Borrowing Base as of June 30, 2020 under the Revolving Credit Facility was $7.3 million. There were no borrowings outstanding under the Revolving Credit Facility at June 30, 2020.
The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Until an amendment in April 2020, the Revolving Credit Facility was set to mature on August 2, 2020. The interest rate on outstanding loans under the Revolving Credit Facility was the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. In addition, we pay a quarterly unused revolving line facility fee of 0.75% per annum on the average unused facility and an annual commitment fee of $112,500.
Effective April 21, 2020, the Revolving Credit Facility was amended to extend the maturity date to August 2, 2022. In addition, the interest rate on outstanding loans under the Revolving Credit Facility was reduced by 0.25%. The quarterly unused line fee, which was previously based on the Maximum Amount, will now be based on the Borrowing Base. The annual commitment fee of $112,500 is unchanged.
The Revolving Credit Facility contains customary affirmative and negative covenants that, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to 5.0% above the otherwise applicable rate of interest. We were in compliance with all the terms and conditions of the Revolving Credit Facility at June 30, 2020.
8. Leases
We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than one year to ten years. Some leases contain options to extend the lease, usually for up to five years, and termination options.
Supplemental balance sheet information related to leases was as follows as of June 30, 2020 and December 31, 2019 (in thousands, except for discount rate and lease term):
June 30, 2020December 31, 2019
Operating lease right-of-use buildings$40,618  $6,234  
Operating lease right-of-use equipment33  69  
Operating lease right-of-use vehicles452  355  
Total operating lease right-of-use assets, gross41,103  6,658  
Accumulated amortization(2,076) (1,798) 
Total operating lease right-of-use assets, net$39,027  $4,860  
Operating lease liabilities, current$2,170  $1,833  
Operating lease liabilities, non-current39,139  4,323  
Total operating lease liabilities$41,309  $6,156  
Weighted average remaining lease term (in years)9.14.7
Weighted average discount rate per annum11.9 %5.0 %
18


A new operating lease for our corporate headquarters in South San Francisco, California commenced in March 2020. We recorded a ROU asset of $35.7 million at the inception of the lease and an operating lease liability of $35.3 million. The lease term is approximately ten years. Future minimum lease payments over the life of the lease were discounted at a rate of 12.55%, which was our estimated incremental collateralized borrowing rate for the term of the lease at the inception of the lease.
The following table presents the components of lease expense for the three and six months ended June 30, 2020 and 2019, respectively (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Operating lease cost (including variable costs)$2,312  $1,553  $4,511  $3,056  
Variable costs including non-lease component$548  $703  $1,169  $1,303  
Supplemental Cash Flow Information:
Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):
Six Months Ended June 30,
20202019
Operating cash flows from operating leases$1,987  $2,061  
Future minimum lease payments under commenced non-cancelable operating leases, which are as of June 30, 2020 as follows (in thousands):
Fiscal YearMinimum Lease Payments for Operating Leases
2020 (remainder of year)$3,214  
20217,282  
20226,985  
20236,907  
20247,120  
Thereafter39,231  
Total future minimum payments $70,739  
Less: imputed interest(29,430) 
Total$41,309  

19


9. Fair Value of Financial Instruments
The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands):
June 30, 2020
Amortized CostGross Unrealized GainGross Unrealized LossFair ValueCash and Cash EquivalentsShort-Term Marketable SecuritiesCash- Restricted
Assets:
Cash-unrestricted$20,196  $—  $—  $20,196  $20,196  $—  $—  
Cash-restricted1,075  —  —  1,075  —  —  1,075  
  Total cash$21,271  $—  $—  $21,271  $20,196  $—  $1,075  
Available-for-sale:
    Level I:
         Money market funds$22,769  $  $  $22,769  $22,769  $  $  
    US treasury securities2,428  3    2,431    2,431  —  
           Subtotal $25,197  $3  $  $25,200  $22,769  $2,431  $—  
Total$46,468  $3  $  $46,471  $42,965  $2,431  $1,075  
December 31, 2019
Amortized CostGross Unrealized GainGross Unrealized LossFair ValueCash and Cash EquivalentsShort-Term Marketable SecuritiesCash- Restricted
Assets:
Cash-unrestricted$16,614  $—  $—  $16,614  $16,614  $—  $—  
Cash-restricted2,075  —  —  2,075  —  —  2,075  
  Total cash$18,689  $—  $—  $18,689  $16,614  $—  $2,075  
Available-for-sale:
    Level I:
         Money market funds$5,047  $  $  $5,047  $5,047  $  $  
         US treasury securities36,942  36    36,978    36,978  —  
           Subtotal$41,989  $36  $  $42,025  $5,047  $36,978  $—  
Total$60,678  $36  $  $60,714  $21,661  $36,978  $2,075  
There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used, during the six months ended June 30, 2020.
Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the six months ended June 30, 2020 and 2019. None of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired.
Convertible Notes
In 2019, we significantly reduced the amount of our outstanding debt. As a result, these securities are not traded frequently, so it is difficult to estimate a reliable and accurate market price and represent Level III valuations. A fair value for these assets cannot be determined by using readily observable inputs or measures, such as market prices or models. Fair values were estimated using pricing models and risk-adjusted value ranges.
20


The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at June 30, 2020 and December 31, 2019, respectively (in thousands):
June 30, 2020December 31, 2019
Par ValueCarrying ValueFair ValuePar ValueCarrying ValueFair Value
2014 Notes$1,079  $1,051  $1,122  $1,079  $1,057  $1,122  
2019 Notes55,000  52,962  82,369  55,000  52,764  73,975  
Total$56,079  $54,013  $83,491  $56,079  $53,821  $75,097  

10. Shareholders’ Equity
InstruNor Acquisition
In January 2020, we completed the acquisition of all of the outstanding shares of InstruNor (see Note 3). The purchase price was approximately $7.2 million, consisting of $5.2 million in cash and 485,451 shares of our common stock.
Conversion of 2018 Notes
In the first quarter of 2019, we issued 19,460,260 shares of our common stock in connection with the conversion of our 2018 Notes (see Note 7). As a result of this issuance of our common stock, we recorded a total of $133.3 million of equity, which was equivalent to the fair value of the bonds retired.
At June 30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)Securities To Be Issued Upon Exercise Of Options Securities To Be Issued Upon Release Of Restricted Stock and Performance Share UnitsNumber Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan19      
2011 Equity Incentive Plan1,609  6,138  2,823  
DVS Sciences Inc. 2010 Equity Incentive Plan23      
2017 Inducement Award Plan207  241    
2017 Employee Stock Purchase Plan    3,100  
1,858  6,379  5,923  

11. Stock-Based Plans
Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria.
In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of either 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably each quarter over 16 quarters, subject to the employees’ continued employment. In May 2020, we granted 1.8 million retention RSUs that vest over three years, with 50% of the RSUs vesting after one year and 25% of the RSUs vesting each year thereafter.
Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than 10% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than five years from the date of grant and an exercise price of at least 110% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably
21


each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time.
For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.
2011 Equity Incentive Plan
In January 2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately 5.0 million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved an increase in the number of shares reserved for issuance under the 2011 Plan of 1.4 million shares.
2009 Equity Incentive Plan and 2017 Inducement Award Plan
Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan.
In January 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (Inducement Plan) and reserved 2 million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provided for the grant of equity-based awards on terms substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan were only be made to individuals not previously our employees or non-employee members of our board of directors (or following such individual’s bona fide period of non-employment), as an inducement material to the individual’s entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules. In June 2019, concurrently with the increase in shares available for grant under the 2011 Plan, the Inducement Plan was terminated such that no further grants could be made thereunder. Options granted and shares issued under the Inducement Plan that were outstanding when the Inducement Plan was terminated remain outstanding subject to their terms and the terms of the Inducement Plan.
Valuation and Expense Information
We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date.
Activity under the 2011 Plan, the 2009 Plan, and the Inducement Plan was as follows:
Restricted Stock Units:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 20192,551  $7.43  
RSU granted3,642  $3.95  
RSU released(602) $7.72  
RSU forfeited(222) $6.82  
Balance as of June 30, 20205,369  $5.06  
As of June 30, 2020, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $24.8 million. We expect to recognize those costs over a weighted average period of 3.0 years.
22


Stock Options:
 Number of
Options (000s)
Weighted-Average
Exercise Price
per Option
Weighted-
Average Remaining Contractual Life (in Years)
Aggregate
Intrinsic
Value (1) in (000s)
Balance at December 31, 20192,027  $7.78  6.8$81  
Options granted105  $3.74  
Options exercised  $  
Options forfeited(274) $5.71  
Balance as of June 30, 20201,858  $7.86  6.1$163  
Vested at June 30, 20201,372  $8.69  5.4$115  
Awards expected to vest at June 30, 2020474  $5.50  8.1$48  

(1)Aggregate intrinsic value as of June 30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of June 30, 2020, which was $4.01, and the exercise price of the options, multiplied by the number of in-the-money options.
As of June 30, 2020, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $1.4 million. We expect to recognize those costs over a weighted average period of 1.5 years.
Performance-based Awards
Performance Stock Units with Market Conditions
We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable three-year performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted. Under FASB ASC Topic 718, the provisions of the PSU awards related to TSR are considered a market condition, and the effects of that market condition are reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date.
Activity under the TSR-based PSUs is as follows:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2019547  $15.09  
PSU granted509  $4.82  
PSU released  $  
PSU forfeited(94) $14.26  
Balance at June 30, 2020962  $9.74  
As of June 30, 2020, the unrecognized compensation costs related to these awards were $5.7 million. We expect to recognize those costs over a weighted average period of 2.0 years.
23


Performance Stock Units with Performance Conditions
During 2019, we also granted a PSU award under which the number of PSUs that ultimately vest is dependent on achieving certain discrete operational milestones between September 30, 2019 and December 31, 2020. Activity to date under this PSU award is as follows:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 201964  $7.05  
PSU granted  $  
PSU released(4) $7.05  
PSU forfeited(12) $7.05  
Balance at June 30, 202048  $7.05  
2017 Employee Stock Purchase Plan
In August 2017, our stockholders approved our ESPP at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017.
Prior to June 2019, our ESPP program had a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees were eligible to participate through payroll deductions of up to 10% of their compensation. The purchase price at which shares were sold under the ESPP was 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.
Effective in June 2019, our ESPP program was amended to offer a twelve-month offering period with two six-month purchase periods beginning on each of May 31 and November 30. Employees were eligible under the amended program to participate through payroll deductions of up to 15% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year.
Under the updated ESPP program, the purchase price at which shares are sold for the first purchase period is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the first purchase period. For the second purchase period, the purchase price at which shares are sold is 85% of the lower of the fair market value of the common stock on the first day of the offering period and the last day of the offering period. In the event the fair market value of the common stock at the beginning of the second purchase period is less than the fair market value on the beginning of the offering period, the purchase price for the second offering period is reset to 85% of the lower of the fair value of the common stock at the beginning of the second purchase period and the last day of the offering period.
The offering period of June 1, 2019 to May 31, 2020 had two purchase periods, with one period ending November 30, 2019 and the other period ending May 31, 2020. As the fair market value of the common stock at November 30, 2019 was lower than the fair value of the common stock at the beginning of the offering period, the purchase price for the second purchase period was reset based on the lower of the November 30, 2019 price and the May 31, 2020 price. The resetting of the purchase price is considered to be a modification of the original terms of the award. Under ASC 718, the incremental fair value based on the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified was approximately $0.3 million. This amount was amortized over the remaining offering period which ended May 31, 2020.
In April 2020, our board of directors authorized, and in June 2020, our stockholders approved, an amendment and restatement of the ESPP that increased the number of shares reserved for issuance by an additional 3.0 million shares and made various other changes. Effective June 2020, our ESPP program was amended to offer a six-month offering period, with a new offering and purchase period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible under the amended program to participate through payroll deductions of up to 10% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. The purchase price of the shares sold under the ESPP is 85% of the lower of fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.
24


Total stock-based compensation expense recognized was as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Restricted Stock Units, Stock Options and Performance Share Units$3,331  $2,848  $5,443  $4,993  
Employee Stock Purchase Plan303  144  557  270  
Total Share-based Compensation$3,634  $2,992  $6,000  $5,263  

12. Income Taxes
Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.
We recorded a tax benefit of $1.1 million for both the three months ended June 30, 2020 and 2019. We recorded a tax benefit of $1.8 million and $1.1 million for the six months ended June 30, 2020 and 2019, respectively. The benefits for all periods were primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by tax provisions for our foreign operations and state minimum income taxes.
Our tax benefit for income taxes for the periods presented differ from the 21% U.S. Federal statutory rate for the six months ended June 30, 2020 and 2019, respectively, primarily due to maintaining a valuation allowance for most of our deferred tax assets, which primarily consist of net operating loss carryforwards.
Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three and six months ended June 30, 2020, and 2019, respectively, we did not recognize any material interest or penalties related to uncertain tax positions.
Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results. The deferred tax assets have been offset by valuation allowances. In the future we may release valuation allowances and recognize deferred tax assets in certain of our foreign subsidiaries depending on the achievement of future profitability in the relevant jurisdictions. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to monitor the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law. The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax deprecation methods for qualified improvement property. We are currently analyzing the impact of these changes and therefore, an estimate of the impact on income taxes, if any, is not yet available.
13. Information About Geographic Areas
We operate in one reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.
A summary table of our total revenue by geographic areas of our customers and by product and services for the three and six months ended June 30, 2020 and 2019 is included in Note 4 to the condensed consolidated financial statements.
Sales to customers in the United States represented $13.4 million, or 51% of total revenues, and $27.5 million, or 51% of total revenues, for the three and six months ended June 30, 2020, respectively. Sales to customers in the United States
25


represented $9.9 million, or 35% of total revenues, and $22.4 million, or 38% of total revenues, for the three and six months ended June 30, 2019, respectively.
No foreign country or jurisdiction had sales in excess of 10% of total revenues for the three months ended June 30, 2020 and 2019, except for China, which had sales of $3.5 million, or 13% of total revenues, and $4.0 million, or 14% of total revenues, respectively. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the six months ended June 30, 2020 or 2019, except for China, which had sales of $7.5 million, or 13% of total revenues, for the six months ended June 30, 2019.

14. Development Agreement
Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $11.7 million during the development stage. The development stage is expected to last approximately one year from the date of the agreement. We recognized $3.0 million of development revenue from this agreement in the three and six months ended June 30, 2020, along with approximately $1.0 million of deferred revenue.
15. Commitments and Contingencies
Indemnification
From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding.
Contingencies
From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.
16. Subsequent Events
In July 20, 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program aims to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. This project, with a total proposed budget of up to $37.0 million, contemplates expanding production capacity and throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology. The letter contract provides Fluidigm with access to up to $12.2 million of initial funding based on completion and delivery of certain validation milestones prior to execution of a definitive contract.

26


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read together with our condensed consolidated financial statements and the notes to those statements included elsewhere in this Form 10-Q. This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended, or Exchange Act, that are based on our management’s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in the section entitled “Risk Factors” and this Management’s Discussion and Analysis of Financial Condition and Results of Operations. Forward-looking statements include information concerning our possible or assumed future cash flow, revenue, sources of revenue and results of operations, cost of product revenue and product margin, operating and other expenses, unit sales and the selling prices of our products, business strategies, financing plans, expansion of our business, competitive position, industry environment, potential growth opportunities, market growth expectations, and the effects of competition and public health crises (including the COVID-19 pandemic) on our business. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “seeks,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would,” or similar expressions and the negatives of those terms.
Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item 1A, “Risk Factors,” elsewhere in this quarterly report on Form 10-Q, and in our annual report on Form 10-K filed with the Securities and Exchange Commission (SEC). Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Form 10-Q.
Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You should read this Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect.
Fluidigm®, the Fluidigm logo, Access Array™, Advanta™, Biomark™, Bringing new insights to life™, C1™, Callisto™, Cell-ID™, CyTOF®, D3™, Delta Gene™, Direct™, Dynamic Array™, EP1™, EQ™, FC1™, Flex Six™, Helios™, High-Precision 96.96 Genotyping™, HTI™, Hyperion™, IMC™, Imaging Mass Cytometry™, Immune Profiling Assay™, Juno™, Maxpar®, MCD™, MSL®, Nanoflex™, Open App™, Pathsetter™, Polaris™, qdPCR 37K™, Script Builder™, Script Hub™, Singular™, SNP Trace™, and SNP Type™ are trademarks or registered trademarks of Fluidigm Corporation. Other service marks, trademarks and trade names referred to in this quarterly report on Form 10-Q are the property of their respective owners.
___________________________
Unless the context requires otherwise, references in this Form 10-Q to “Fluidigm,” the “Company,” “we,” “us,” and “our” refer to Fluidigm Corporation and its subsidiaries.
Overview
Fluidigm is a global company that improves life through comprehensive health insight. Our innovative technologies and multi-omic tools are used by researchers to reveal meaningful insights into health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. We create, manufacture, and market a range of products and services, including instruments, reagents and software that are used by researchers and clinical labs worldwide.
Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We use proprietary CyTOF® and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies.
We sell our products to leading academic, government, pharmaceutical, biotechnology, clinical, and plant and animal research laboratories worldwide. We distribute our systems through our direct sales force and support organizations located in North America, Europe, and Asia-Pacific, and through distributors or sales agents in several European, Latin American, Middle Eastern, and Asia-Pacific countries.
27


Our manufacturing operations are located in Singapore and Canada. Our facility in Singapore manufactures our genomics instruments, which are assembled by our contract manufacturer located within our Singapore facility. All of our microfluidics IFCs are fabricated at our Singapore facility. Our mass cytometry instruments, assays and reagents are manufactured at our facility in Canada. We also use U.S.-based third-party contract manufacturers for reagent manufacturing.
Our total revenue for the six months ended June 30, 2020 was $53.7 million compared to $58.3 million for the six months ended June 30, 2019. Our total revenue was $117.2 million in 2019 and $113.0 million in 2018. We have incurred significant net losses since our inception in 1999 and, as of June 30, 2020, our accumulated deficit was $652.7 million.
Recent Developments
We have been responding to the COVID-19 pandemic by taking steps to protect our employees, support our customers, and manage our liquidity. As Fluidigm is a designated essential business, our employees have been working from home offices or our laboratories and offices, and in some cases, at customer sites. We have implemented health and safety practices in accordance with evolving government and public health agency guidelines in all of our facilities around the world, including maintaining social distancing and enhanced cleaning protocols, facilities modifications, temperature checks in some locations, and usage of face masks and other personal protective equipment where appropriate. Other operational adjustments made in response to COVID-19 include increased raw material stocking and proactive supplier management.
We have activated our business continuity plans as a result of this pandemic, which include steps taken not only to help keep our workforce healthy and safe, but also to ensure a strong data security and internal control environment. Our controls around financial reporting have been modified slightly as needed to reflect the impact of working remotely. To date we have not needed to take advantage of extended SEC filing deadlines.
While Fluidigm is a designated essential business, widespread global adoption of work-from-home and shelter-in-place orders has resulted in a significant slowdown in customer activities. We estimate that 30-40% of our customers are either closed or working at reduced capacity as of the end of June 2020 because of the COVID-19 pandemic, compared to 60-70% in April 2020. These closures and slowdowns have resulted in lower than expected sales of our instrument systems, IFCs, assays, and reagents. Many of our customers have limited abilities to accept, or prepare facilities to accept, non-critical instrumentation or are limited in their ability continue their lab research activities.
We are seeing and expect to continue to see near-term COVID-19-related priorities temporarily displacing longer term projects and research activities. Fluidigm has been working with a growing body of researchers around the world who are aggressively responding to the pandemic. In June 2020, we filed for emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for our saliva-based Advanta Dx SARS-CoV-2 Assay, which is currently pending FDA revniew. In addition, Fluidigm is actively supporting customers who are developing lab-developed tests and/or have filed for EUA from the FDA, as well as customers who are providing COVID-19 diagnostic tests outside of the U.S. Fluidigm’s mass cytometry technology and workflows are also being used in the U.S. and Europe for multi-site COVID-19 patient immune profiling studies. We believe our microfluidics and mass cytometry capabilities can play a significant role in virus detection as well as in immune profiling of patients and populations. Furthermore, we believe our technologies and solutions will be important to the durable response from government and medical institutions to be prepared for future outbreaks. Despite these opportunities, there is still uncertainty regarding the impact of COVID-19 on the global economy, our customers and our business over the near term.
In this period of uncertainty, we are actively managing our operating expenses and cash flows in response to the evolving market conditions. In addition, we have implemented reductions in our operating expense structure including salary reductions and constrained hiring until our business returns to more normal volumes. We have also taken advantage of various government programs available to us. For example, we have applied for or received wage subsidies in certain countries. In the U.S., the Coronavirus Aid, Relief and Economic Security (CARES) Act includes provisions relating to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, and other tax-related provisions. As a result, we have been preserving cash by deferring payment of U.S. payroll taxes and are currently evaluating the applicability of other provisions in the CARES Act. We have improved the company’s capital structure over the last 18 months by reducing our overall debt levels and extending our remaining debt maturities.
In July 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program aims to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. This project, with a total proposed budget of up to $37.0 million, contemplates expanding production capacity and throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology. The letter contract provides Fluidigm with access to up to $12.2 million of initial funding based on completion and delivery of certain validation milestones prior to execution of a definitive contract.
28


We are continuing to assess the potential impact of the COVID-19 pandemic on our business and operations. For additional information on the various risks posed by the pandemic, refer to Part II, Item 1A. Risk Factors of this Form 10 Q.
Critical Accounting Policies, Significant Judgments and Estimates
Our condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We evaluate our estimates and assumptions on an ongoing basis. To the extent that there are material differences between these estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected.
We have expanded disclosure of our critical accounting policies and estimates in the preparation of our condensed consolidated financial statements during the three and six months ended June 30, 2020 compared to those disclosed in our annual report on Form 10-K for the year ended December 31, 2019, as filed with the SEC on February 27, 2020, to reflect the impact of a new development agreement (see Note 14).
Recent Accounting Changes and Accounting Pronouncements
Adoption of New Accounting Guidance
In August 2018, the FASB issued ASU 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.
In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020, with early adoption permitted, which we did not exercise. The adoption of the new guidance did not have a significant impact on our financial results.
The FASB issued two ASUs related to financial instruments – credit losses. The ASUs issued were: (i) in June 2016, ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and (ii) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leasing standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of $0.1 million to reduce the accumulated deficit component of stockholders’ equity and decrease current assets by the same amount in the condensed consolidated balance sheet.
Recent Accounting Pronouncements
In November 2019, the FASB issued ASU 2019-12 Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The
29


new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.

Results of Operations
The following table presents our historical consolidated statements of operations data for the three and six months ended June 30, 2020 and 2019, and as a percentage of total revenue for the respective periods (in thousands):
 Three Months Ended June 30,Six Months Ended June 30,
 2020201920202019
Revenue:
Total revenue$26,058  100 %$28,196  100 %$53,675  100 %$58,307  100 %
Costs and expenses:
Cost of product revenue9,483  36  11,100  40  19,123  36  22,489  39  
Cost of service revenue1,237   1,733   2,762   3,465   
Research and development8,448  33  7,865  28  17,147  32  16,237  28  
Selling, general and administrative20,616  79  22,134  78  43,311  80  44,958  77  
Total costs and expenses39,784  153  42,832  152  82,343  153  87,149  150  
Loss from operations(13,726) (53) (14,636) (52) (28,668) (53) (28,842) (50) 
Interest expense(897) (3) (491) (1) (1,797) (3) (3,192) (5) 
Loss from extinguishment of debt—  —  —  —  —  —  (9,000) (15) 
Other income (expense), net463   231   (355) (1) 715   
Loss before income taxes(14,160) (54) (14,896) (52) (30,820) (57) (40,319) (69) 
Income tax benefit1,145   1,143   1,825   1,101   
Net loss$(13,015) (50)%$(13,753) (48)%$(28,995) (54)%$(39,218) (67)%
Revenue
We generate revenue primarily from sales of our products and services, and from development agreements, license and royalty agreements, and grants. Our product revenue consists of sales of instruments and consumables. Consumable revenues are largely driven by the size of our installed base of instruments and the annual level of pull-through per instrument. Service revenue is linked to our sales of instruments as our service revenue consists of post-warranty service contracts, preventive maintenance plans, instrument parts, installation and training. We sell our products to leading academic, government, pharmaceutical, biotechnology, clinical, plant and animal research laboratories worldwide.
Excluding the impact of the development revenue recognized during the second quarter, no individual customer represented more than 10% of our total revenue for the three and six months ended June 30, 2020 and 2019, respectively. Including the development revenue, revenues from our five largest customers were 32% and 30% of total revenue for the three months ended June 30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the six months ended June 30, 2020 and 2019, respectively.
30


The following table presents our revenue by source for the three and six months ended June 30, 2020 and 2019, and as a percentage of total revenue for the respective period (in thousands):
Three Months Ended June 30,Year-over-Year ChangeSix Months Ended June 30,Year-over-Year Change
2020201920202019
Revenue:
Instruments$8,577  33 %$12,201  43 %(30)%$18,048  34 %$25,041  43 %(28)%
Consumables8,828  34  11,034  39  (20)%18,338  34  23,021  39  (20)%
Product revenue17,405  67  23,235  82  (25)%36,386  68  48,062  82  (24)%
Service revenue5,140  20  4,961  18  %10,326  19  10,245  18  %
Product and service revenue22,545  87  28,196  100  (20)%46,712  87  58,307  100  (20)%
Development revenue3,000  11  —  —  NA3,000   —  —  NA
Grant revenue450   —  —  NA800   —  —  NA
License revenue63  —  —  —  NA3,163   —  —  NA
Total revenue$26,058  100 %$28,196  100 %(8)%$53,675  100 %$58,307  100 %(8)%
The following table presents our total revenue by geographic area of our customers and as a percentage of total revenue for the three and six months ended June 30, 2020 and 2019 (in thousands):
 Three Months Ended June 30,Year-over-Year ChangeSix Months Ended June 30,Year-over-Year Change
 2020201920202019
Americas$13,940  54 %$11,120  39 %25 %$28,784  54 %$24,091  42 %19 %
EMEA6,557  25  11,217  40  (42)%14,653  27  19,373  33  (24)%
Asia-Pacific5,561  21  5,859  21  (5)%10,238  19  14,843  25  (31)%
Total revenue$26,058  100 %$28,196  100 %(8)%$53,675  100 %$58,307  100 %(8)%
The Americas revenue includes revenue generated in the United States of $13.4 million and $27.5 million for the three and six months ended June 30, 2020, respectively. Sales to customers in the United States represented $9.9 million and $22.4 million for the three and six months ended June 30, 2019, respectively.
No foreign country or jurisdiction had sales in excess of 10% of our total revenues for the three months ended June 30, 2020 and 2019, except for China, which had sales of $3.5 million, or 13%, and $4.0 million, or 14% of total revenues, respectively. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the six months ended June 30, 2020 or 2019, except for China, which had sales of $7.5 million, or 13% of total revenues, for the six months ended June 30, 2019.
Total Revenue
Three Months ended June 30, 2020
Total revenue decreased by $2.1 million or 8%, for the three months ended June 30, 2020 compared to the three months ended June 30, 2019, driven by the COVID-19 pandemic public health crisis and the ensuing shelter-in-place orders that effectively shuttered customer facilities around the world. Lower mass cytometry instruments, mass cytometry consumables and microfluidics consumable revenues were partially offset by higher microfluidics instrument sales, development revenue, grant revenue and license revenue.
Americas revenues increased by $2.8 million, or 25%, driven by higher sales of microfluidics products, development revenue of $3.0 million and grant revenue of $0.5 million, partially offset by lower mass cytometry product revenues for the three months ended June 30, 2020 compared to the three months ended June 30, 2019. EMEA revenues fell $4.7 million or 42%. Lower consumables and mass cytometry instruments sales were partially offset by modest increases in microfluidics instrument revenue and service revenue. Unfavorable foreign exchange rates impacted EMEA revenue by less than 1%. The $0.3 million, or 5%, decrease in Asia-Pacific revenues was broad-based, with declines in both mass cytometry and
31


microfluidics instrument and consumable revenues, partially offset by higher service revenues. On a company-wide basis, weaker foreign exchange rates had a negligible impact on revenues for the three months ended June 30, 2020 compared to the same period in 2019.
Six Months ended June 30, 2020
Total revenue decreased by $4.6 million or 8%, for the six months ended June 30, 2020 compared to the six months ended June 30, 2019, driven by the COVID-19 pandemic public health crisis and the ensuing shelter-in-place orders that effectively shuttered customer facilities around the world. Lower mass cytometry instruments, mass cytometry consumables, and microfluidics consumable revenues were partially offset by higher microfluidics instrument sales, development revenue, license and grant revenue.
Americas revenues increased by $4.7 million, or 19%, driven by license revenue of $3.1 million, development revenue of $3.0 million and grant revenue of $0.8 million for the six months ended June 30, 2020 compared to the six months ended June 30, 2019. These increases were partially offset by lower product revenues. Lower mass cytometry revenues were partially offset by higher microfluidics revenue for the six months ended June 30, 2020 compared to the six months ended June 30, 2019. EMEA revenues fell $4.7 million or 24%, for the same period, driven by lower instrument and consumable revenues. Unfavorable foreign exchange rates negatively impacted EMEA revenues by approximately 1%. The $4.6 million, or 31%, decrease in Asia-Pacific revenues was driven by declines in both mass cytometry and microfluidics instrument and consumable revenues. On a company-wide basis, weaker foreign exchange rates negatively impacted revenues by less than 1% for the six months ended June 30, 2020 compared to the same period in 2019.
Product Revenue
Product revenue decreased by $5.8 million, or 25%, for the three months ended June 30, 2020 compared to the three months ended June 30, 2019 due to lower sales volumes and lower average selling prices of mass cytometry instruments and consumables and lower sales of microfluidics consumables. Partially offsetting these declines were higher microfluidics instrument revenues, largely driven by higher unit sales of Biomark and Juno instruments reflecting the realization of several early-stage COVID-19 related opportunities.
Product revenue decreased by $11.7 million, or 24%, for the six months ended June 30, 2020 compared to the six months ended June 30, 2019 due to lower sales volumes and lower average selling prices of mass cytometry instruments and consumables, and by lower sales of microfluidics consumables. Partially offsetting these declines were higher revenue from Biomark and Juno instruments, noted above, and, to a lesser extent, new products.
We expect the average selling prices of our products to fluctuate over time based on market conditions, product mix, and currency fluctuations.
Service Revenue
Service revenue increased by $0.2 million, or 4%, for the three months ended June 30, 2020 compared to the three months ended June 30, 2019. Service plan revenues, which are recognized over the life of the service agreement and are not activity-dependent, drove the increase in service revenues. The increase in service plan revenues was partially offset by lower revenues from training and product maintenance activities. These revenues declined due primarily to closed customer facilities.
Service revenue increased by $0.1 million, or 1%, for the six months ended June 30, 2020 compared to the six months ended June 30, 2019. Service plan revenues drove the increase, offset by lower revenues from training and product maintenance activities. Training and product revenues declined due primarily to closed customer facilities.
32


Development Revenue
Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $11.7 million during the development stage. The development stage is expected to last approximately one year. We recognized $3.0 million of development revenue from this agreement in the three and six months ended June 30, 2020.
We recognize revenue under the Development Agreement using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward satisfaction of our obligations under the agreement. Costs associated with the Development Agreement are recorded in research and development expense.
Grant Revenue
We receive grants to perform research and development activities over contractually defined periods. Grant revenue in the current quarter is attributable to a grant agreement entered into in the second half of 2019. Costs associated with grant agreements are recorded in research and development expense.
License and Royalty Revenue
In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain of our intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.
Product and Service Cost, Product and Service Gross Profit, and Product and Service Margin
Cost of product revenue includes manufacturing costs incurred in the production process, including component materials, labor and overhead, installation, packaging, and delivery costs. In addition, cost of product revenue includes amortization of developed technology and intangibles, royalty costs for licensed technologies included in our products, warranty, provisions for slow-moving and obsolete inventory, and stock-based compensation expense. Our cost of product revenue and related product margin may fluctuate depending on the capacity utilization of our manufacturing facilities in response to market conditions and the demand for our products.
Cost of service revenue includes direct labor hours, overhead, and instrument parts. Our cost of service revenue and related service margin may fluctuate depending on the variability in material and labor costs of servicing instruments.
The following table presents our product and service cost, product and service gross profit and product and service margin for the three and six months ended June 30, 2020 and 2019 (in thousands):
Three Months Ended June 30,Year-over-Year ChangeSix Months Ended June 30,Year-over-Year Change
2020201920202019
Cost of product revenue$9,483  $11,100  (15)%$19,123  $22,489  (15)%
Cost of service revenue1,237  1,733  (29)%2,762  3,465  (20)%
Cost of product and service revenue$10,720  $12,833  (16)%$21,885  $25,954  (16)%
Product and service gross profit$11,825  $15,363  (23)%$24,827   $32,353  (23)%
Product and service margin52.5 %54.5 %(2.0) ppts53.1 % 55.5 %(2.4) ppts
Product and service margin decreased by 2.0 percentage points for the three months ended June 30, 2020 compared to the three months ended June 30, 2019. Fixed depreciation and amortization costs on a lower revenue base negatively impacted margins by 2.8 percentage points. Lower factory utilization also negatively impacted margins on mass cytometry instruments. This decline was partially offset by lower service costs and improved manufacturing efficiencies across our consumables products.
33


Product and service margin decreased by 2.4 percentage points for the six months ended June 30, 2020 compared to the six months ended June 30, 2019. Fixed depreciation and amortization costs on a lower revenue base negatively impacted margins by 2.6 percentage points. Lower factory utilization also negatively impacted margins on mass cytometry instruments. This decline was partially offset by lower costs for our microfluidics instruments and mass cytometry consumables and lower service costs.
Operating Expenses
The following table presents our operating expenses for the three and six months ended June 30, 2020 and 2019 (in thousands):
Three Months Ended June 30,Year-over-Year ChangeSix Months Ended June 30,Year-over-Year Change
2020201920202019
Research and development$8,448  $7,865  %$17,147  $16,237  %
Selling, general and administrative20,616  22,134  (7)%43,311  44,958  (4)%
     Total$29,064  $29,999  (3)%$60,458  $61,195  (1)%
Research and Development
Research and development expense consists primarily of compensation-related costs, product development and material expenses, and other allocated facilities and information technology expenses. Our research and development efforts have focused primarily on enhancing our technologies and supporting development and commercialization of new and existing products and services. Research and development expense also includes costs incurred in conjunction with research grants and development arrangements. We have made substantial investments in research and development since our inception and expect to continue to do so.
Research and development expense increased by $0.6 million, or 7%, for the three months ended June 30, 2020 compared to the three months ended June 30, 2019. Increases were primarily attributable to outside service costs related to various projects and laboratory supplies costs, partially offset by lower compensation costs. The lower compensation costs reflects temporary salary reductions implemented during the second quarter and reduced recruiting costs.
Research and development expense increased by $0.9 million, or 6%, for the six months ended June 30, 2020 compared to the six months ended June 30, 2019. Increases were primarily attributable to outside service costs related to various projects and higher laboratory supplies costs, partially offset by reduced compensation costs.
We believe that our continued investment in research and development is essential to our long-term competitive position and that these expenses may increase in future periods.
Selling, General and Administrative
Selling, general and administrative expense consists primarily of personnel costs for our sales and marketing, business development, finance, legal, human resources, information technology, and general management, as well as professional services, such as legal and accounting services.
Selling, general and administrative expense decreased by $1.5 million, or 7%, for the three months ended June 30, 2020 compared to the three months ended June 30, 2019. Compensation costs fell by $1.0 million compared to the prior year period. The lower compensation costs includes the impact of temporary salary reductions implemented during the second quarter, partially offset by higher stock-based compensation costs. Lower sales resulted in reduced sales commissions while reduced travel due to the pandemic caused travel expense to decline $1.2 million in the three months ended June 30, 2020 compared to the three months ended June 30, 2019. In addition, we received $0.4 million of wage subsidies from the Singapore government during the second quarter which further reduced operating expenses. These items were partially offset by higher facilities costs. Facilities cost increased approximately $1.1 million for the three months ended June 30, 2020 compared to the three months ended June 30, 2019, reflecting lease costs associated with our new corporate headquarters. Foreign exchange rates had a negligible impact on selling, general and administrative expense.
Selling, general and administrative expense decreased by $1.6 million, or 4%, for the six months ended June 30, 2020 compared to the six months ended June 30, 2019. Decreases in the year-to-date period were largely driven by the same factors as the decreases in the second quarter. Compensation costs fell by $0.7 million compared to the prior year period along with lower commissions due to lower revenues, along with $0.4 million of wage subsidies from the Singapore government. Travel
34


costs fell $1.6 million compared to the prior year period, while costs related to trade shows and other events fell $0.7 million due to the cancellation of these events in light of the COVID-19 pandemic. These items were partially offset by higher facilities costs. Facilities cost increased approximately $2.1 million for six months ended June 30, 2020 compared to the six months ended June 30, 2019, reflecting moving and lease costs associated with our new corporate headquarters. Foreign exchange rates had a negligible impact on selling, general and administrative expense.
Interest Expense, Loss on Extinguishment of Debt and Other Income (Expense), Net
The following table presents these items for the three and six months ended June 30, 2020 and 2019 (in thousands): 

Three Months Ended June 30,Year-over-Year ChangeSix Months Ended June 30,Year-over-Year Change
2020201920202019
Interest expense$(897) $(491) 83 %$(1,797) $(3,192) (44)%
Loss from extinguishment of debt—  —  NA—  (9,000) NA
Other income (expense), net463  231  100 %(355) 715  (150)%
Total$(434) $(260) 67 %$(2,152) $(11,477) (81)%
In November 2019, we issued $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Net proceeds of the 2019 Notes issuance were used primarily to retire $50.2 million aggregate principal amount of our Senior Convertible Notes due 2034 (2014 Notes). The 2019 Notes have an effective interest rate of 6.2% compared to the 2014 Notes, which have an effective interest rate 3.0%. The increase in interest expense for the three months ended June 30, 2020 compared to the prior year period reflects the impact of the higher effective interest rate on the 2019 Notes.
In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2014 Notes. In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Senior Convertible Notes due 2034 (2018 Notes). The 2018 Notes had an effective interest rate of 12.3%. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recognized a loss of $9.0 million on the conversion of 2018 Notes, which was included in loss on extinguishment of debt. This amount represents the difference between the fair value of the bonds converted and the carrying value of the bonds at the time of conversion.
Interest expense of $1.8 million for the six months ended June 30, 2020 consists primarily of interest on $55.0 million of 2019 Notes, while interest expense of $3.2 million for the six months ended June 30, 2019 includes both the interest on $51.3 million of 2014 Notes and a partial quarter of interest expense on $150.0 million of 2018 Notes, which accrued at an effective rate of 12.3%. The higher interest expense for the six months ended June 30, 2019 compared to the current year period reflects the impact of higher debt balances and higher interest rates for the first half of 2019 compared to the first half of 2020.
Other income, net of $0.5 million for the three months ended June 30, 2020 is primarily attributable to $42 thousand of interest income, and $0.4 million of foreign exchange gains. Other income, net of $0.2 million for the three months ended June 30, 2019 includes $0.4 million of interest income, partially offset by $0.1 million of foreign exchange losses. The lower interest income in the current year period is attributable to lower market interest rates. The foreign exchange gains in the second quarter reflects a stronger Canadian dollar in the second quarter, compared to the first quarter of 2020.
Other expense, net of $0.4 million for the six months ended June 30, 2020 is primarily attributable to $0.6 million of foreign exchange losses, reflecting the impact of a stronger U.S. dollar, partially offset by $0.2 million of interest income. Other income, net of $0.7 million for the six months ended June 30, 2019 consists primarily of $0.8 million of interest income, offset by $0.1 million of foreign exchange losses.
Income Tax Benefit
Our tax provision is generally driven by three components: (i) tax provision from our foreign operations, (ii) tax benefits from the amortization of acquisition-related intangible assets, and (iii) discrete items, such as changes in valuation allowances or adjustments upon finalization of tax returns. Depending on the relative value of these components, we can have either a tax benefit or expense for any given period.
We recorded a tax benefit of $1.1 million, for an effective tax rate of 8.1%, for the three months ended June 30, 2020. For the three months ended June 30, 2019, we recorded a tax benefit of $1.1 million for an effective tax rate of 7.7%. For the six months ended June 30, 2020, we recorded an income tax benefit of $1.8 million for an effective rate of 5.9%. For the six
35


months ended June 30, 2019, we recorded a tax benefit of $1.1 million, for an effective tax rate of 2.7%. The benefit for all periods was primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by a provision from our foreign operation and state minimum income taxes.
Liquidity and Capital Resources
Sources of Liquidity
As of June 30, 2020, our principal sources of liquidity consisted of $43.0 million of cash and cash equivalents, and $2.4 million of short-term investments, as well as $1.1 million of restricted cash and $7.3 million of availability under our Revolving Credit Facility.
The following table presents our cash flow summary for the six months ended June 30, 2020 and 2019 (in thousands):
 Six Months Ended June 30,
 20202019
Cash flow summary:
Net cash used in operating activities$(7,085) $(25,143) 
Net cash provided by (used in) investing activities27,586  (45,299) 
Net cash provided by financing activities 1,187  
Effect of foreign exchange rate fluctuations on cash and cash equivalents(205) (25) 
Net increase (decrease) in cash, cash equivalents and restricted cash$20,304  $(69,280) 
Net Cash Used in Operating Activities
We derive cash flows from operations primarily from cash collected from the sale of our products and services, and license agreements and grants. Our cash flows from operating activities are also significantly influenced by our use of cash for operating expenses and working capital to support our business. We have historically experienced negative cash flows from operating activities as we have expanded our business and built our infrastructure domestically and internationally.
Net cash used in operating activities in the six months ended June 30, 2020 was $7.1 million and consisted of net loss of $29.0 million, adjusted for non-cash items of $16.1 million, partially offset by a net decrease in assets and liabilities of $5.8 million. Non-cash items primarily included amortization of developed technology of $5.9 million, stock-based compensation expense of $6.0 million, amortization of debt discounts, premiums and issuance costs of $0.3 million, depreciation and amortization of $2.0 million, and other non-cash items of $0.1 million. The net decrease in assets and liabilities was primarily due to a decrease in accounts receivable of $9.1 million, an increase in accounts payable of $3.1 million, and an increase in deferred revenue of $2.0 million, partially offset by an increase of inventories of $4.9 million, a decrease in other liabilities of $2.8 million and an increase in prepaid expenses and other assets of $0.7 million.
Net cash used in operating activities for the six months ended June 30, 2019 was $25.1 million and consisted of net loss of $39.2 million, adjusted for non-cash items of $24.7 million, and an increase in the assets and liabilities of $10.7 million. Non-cash items primarily included a $9.0 million loss on extinguishment of debt, amortization of developed technology of $5.6 million, stock-based compensation expense of $5.3 million, amortization of debt discounts, premiums, and issuance costs of $2.0 million, depreciation and amortization of $2.4 million, and a provision for excess and obsolete inventory of $0.6 million. The net change in assets and liabilities included a decrease in other liabilities of $9.2 million, an increase in accounts receivable of $2.4 million, an increase in inventories of $2.0 million, and an increase in prepaid and other assets of $1.0 million, partially offset by an increase accounts payable of $3.4 million, and an increase in deferred revenue of $0.5 million.
Net Cash Provided by (Used in) Investing Activities
Our primary investing activities consist of purchases, sales, and maturities of our short-term investments and to a much lesser extent, capital expenditures for manufacturing, laboratory, computer equipment and software to support our infrastructure and work force. We expect to continue to incur costs for capital expenditures to improve manufacturing efficiencies and strengthen information technology and network security, as well as capital expenditures incurred in moving our corporate
36


headquarters in 2020. However, we may choose to decrease or defer certain capital expenditures and development activities, while further optimizing our organization.
Net cash provided by investing activities in the six months ended June 30, 2020 was $27.6 million, which was mainly due to proceeds from maturities of investments of $29.4 million and proceeds from the sale of investments of $5.0 million, partially offset by the acquisition of InstruNor AS, net of cash acquired, of $5.2 million.
Net cash used in investing activities in the six months ended June 30, 2019 was $45.3 million, which consisted of purchases of investments of $44.6 million and capital expenditures of $0.7 million to support our commercial and manufacturing operations.
Net Cash Provided by Financing Activities
We generated cash from financing activities of $8 thousand during the six months ended June 30, 2020, which was primarily due to proceeds from stock issuance from the ESPP of $0.6 million, offset almost entirely by payments of accrued debt issuance costs of $0.4 million from the 2019 Notes offering, and payments for income taxes related to net share settlement of equity awards of $0.3 million.
We generated cash from financing activities of $1.2 million during the six months ended June 30, 2019, which included $1.0 million from exercise of stock options, and $0.6 million of ESPP proceeds, partially offset by $0.5 million for income taxes related to net share settlement of equity awards.
Capital Resources
At June 30, 2020 and December 31, 2019, our working capital, excluding deferred revenues and restricted cash, was $54.3 million and $74.0 million, respectively, including cash and cash equivalents of $43.0 million and $21.7 million, respectively, and short-term investments of $2.4 million and $37.0 million, respectively.
In February 2014, we closed an underwritten public offering of $201.3 million in aggregate principal amount of our 2014 Notes. In March 2018, we entered into privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for $150.0 million in aggregate principal amount of 2018 Notes.
In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert $138.1 million in aggregate principal amount of the 2018 Notes. In February 2019, we notified trustee U.S. Bank National Association of our intention to exercise our issuer’s conversion option with respect to the remaining $11.9 million in aggregate principal amount of 2018 Notes. In total, $150.0 million of the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired.
In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 2019 Notes. Net proceeds of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs. $51.8 million of the proceeds was used to retire $50.2 million aggregate principal amount of our 2014 Notes, leaving $1.1 million of aggregate principal amount of our 2014 Notes outstanding. Pursuant to the Indenture governing the 2014 Notes, holders of the 2014 Notes have the right, subject to certain conditions specified in such indenture, to require the Company to purchase their 2014 Notes beginning in February 2021. The private placement of the 2019 Notes, and concurrent repurchase of a portion of the 2014 Notes, had the effect of refinancing a portion of the Company’s outstanding debt under the 2014 Notes to December 2024.
The 2019 Notes bear interest at 5.25% per annum, payable semiannually on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company’s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of $2.90 per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events but will not be adjusted for any accrued and unpaid interest.
The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 150% of the Conversion Price (as defined in the indenture, currently $2.90, subject to adjustment) for a specified number of days (Issuer’s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after
37


December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture.
The foregoing summaries of the 2014 Notes, the 2018 Notes, the 2019 Notes and the exchange transactions completed in March 2018 and November 2019 are not complete and are qualified in their entirety by the applicable indentures, forms of global notes, and other agreements and documents filed with the SEC.
On August 2, 2018, we entered into a $15.0 million revolving senior credit facility (Revolving Credit Facility) with Silicon Valley Bank (SVB), with a maturity date of August 2, 2020. The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Outstanding loans under the Revolving Credit Facility bear interest, at the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Amounts drawn under the Revolving Credit Facility will be used for working capital and general corporate purposes. As of June 30, 2020, total availability under the Revolving Credit Facility was $7.3 million. We currently have no outstanding debt under the Revolving Credit Facility, and we are in compliance with all the terms and conditions of the loan agreement governing the Revolving Credit Facility. See Note 7 to our consolidated financial statements for more information about the Revolving Credit Facility.
On April 21, 2020, we entered into the Third Amendment to Loan and Security Agreement with SVB (the Amendment), which amends the Loan and Security Agreement dated as of August 2, 2018, between the Company and SVB (as amended by the Default Waiver and First Amendment to Loan and Security Agreement dated September 7, 2018, and the Second Amendment to Loan and Security Agreement dated November 20, 2019, the Revolving Credit Agreement). The Amendment extends the maturity date by two years, to August 2, 2022. We also amended the interest rate to be the greater of (i) prime rate (as customarily defined), plus 0.50%, floating, and (ii) 5.25%. Interest on any outstanding loans continues to be due and payable monthly and the principal balance is due at maturity though loans can be prepaid at any time without penalty. Annual administration fees are unchanged. The Amendment also includes various administrative changes.
In March 2020, we entered into an Open Market Sale Agreement (Sale Agreement) with Jefferies LLC (Jefferies) to sell shares of our common stock having aggregate sales proceeds of up to $50,000,000, from time to time, through an “at the market” equity offering program under which Jefferies will act as sales agent. The Sale Agreement allows us to set the parameters for the sale of shares, including the number of shares to be issued, the time period during which sales are requested to be made, limits on the number of shares that may be sold in any one trading day and a minimum price below which sales may not be made. The compensation to Jefferies for sales of the Company’s common stock will be an amount equal to 3.0% of the gross proceeds of any shares of common stock sold under the Sale Agreement. The Company and Jefferies may each terminate the Sale Agreement upon prior notice. As of the date of this report, there had been no shares of common stock sold under the Sale Agreement.
We believe our existing cash, cash equivalents, and investments will be sufficient to meet our working capital and capital expenditure needs for at least the next 18 months. However, we may experience lower than expected cash generated from operating activities or greater than expected capital expenditures, cost of revenue, or operating expenses, and we may need to raise additional capital to fund our operations, further our research and development activities, or acquire or invest in a business. Our future funding requirements will depend on many factors, including market acceptance of our products, the cost of our research and development activities, the cost of filing and prosecuting patent applications, the cost associated with litigation or disputes relating to intellectual property rights or otherwise, the cost and timing of regulatory clearances or approvals, if any, the cost and timing of establishing additional sales, marketing, and distribution capabilities, the cost and timing of establishing additional technical support capabilities, and the effect of competing technological and market developments. In the future, we may acquire businesses or technologies from third parties, and we may decide to raise additional capital through debt or equity financing to the extent we believe this is necessary to successfully complete these acquisitions.
If we require additional funds in the future, we may not be able to obtain such funds on acceptable terms, or at all, and our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide resulting from the COVID-19 pandemic. If we raise additional funds by issuing equity securities, our stockholders could experience dilution. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt or equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we do not have, or are not able to obtain, sufficient funds, we may have to delay development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products.

38


Off-Balance Sheet Arrangements
Since our inception, we have not had any off-balance sheet arrangements as defined in Item 303(a)(4) of the SEC’s Regulation S-K.

Contractual Obligations and Commitments
Our operating lease obligations relate to leases for our current corporate headquarters and leases for manufacturing and office space for our foreign subsidiaries. Please see Note 8 to our condensed consolidated financial statements for a discussion of our lease obligations.
Other than as disclosed above, there have been no material changes during the six months ended June 30, 2020 to our contractual obligations disclosed in our “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our annual report on Form 10-K for the year ended December 31, 2019.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates. We do not hold or issue financial instruments for trading purposes.
Foreign Currency Exchange Risk
As we expand internationally our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. Our revenue is generally denominated in the local currency of the contracting party. Historically, the majority of our revenue has been denominated in U.S. dollars. Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where our manufacturing facilities are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. For the six months ended June 30, 2020, we had a foreign currency loss of $0.6 million compared to a foreign currency loss of $80 thousand in the prior year for the same period. To date, we have not entered into any foreign currency hedging contracts although we may do so in the future. As our international operations grow, we will continue to reassess our approach to manage our risk relating to fluctuations in currency rates. If foreign currency exchange rates had changed by 10% during the periods presented, it would not have had a material impact on our financial position or results of operations.
Interest Rate Sensitivity
We had cash and cash equivalents of $43.0 million as of June 30, 2020. These amounts were held primarily in cash on deposit with banks and money market funds which are short-term. We also held $2.4 million of investments in treasury securities at June 30, 2020. Cash, cash equivalents and investments are held for working capital purposes. We believe that we do not have any material exposure to changes in the fair value of our money market portfolio as a result of changes in interest rates. Declines in interest rates, however, will reduce future investment income. If overall interest rates had decreased by 10% during the periods presented, our interest income would not have been materially affected.
Fair Value of Financial Instruments
We do not have material exposure to market risk with respect to investments. We do not use derivative financial instruments for speculative or trading purposes. We may adopt specific hedging strategies in the future.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2020. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are
39


designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June 30, 2020, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on the Effectiveness of Controls
Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.

40


PART II. OTHER INFORMATION
Item 1. Legal Proceedings
In the normal course of business, we are from time to time involved in legal proceedings or potential legal proceedings, including matters involving employment, intellectual property, or others. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending matters would not have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.
Item 1A. Risk Factors
We operate in a rapidly changing environment that involves numerous uncertainties and risks. The following risks and uncertainties may have a material and adverse effect on our business, financial condition, or results of operations. You should consider these risks and uncertainties carefully, together with all of the other information included or incorporated by reference in this Form 10-Q. The risks described below are not the only ones we face. Our business is also subject to the risks that affect many other companies, such as employment relations, general economic conditions, global sociopolitical events, and international operations. Further, additional risks not currently known to us or that we currently believe are immaterial may in the future materially and adversely affect our business, operations, liquidity and stock price. If any of these risks occur, our business, results of operations, or financial condition could suffer, the trading price of our securities could decline, and you may lose all or part of your investment.
Risks Related to Fluidigm’s Business and Strategy
The global COVID-19 pandemic has significantly and adversely affected our business operations, financial position, and cash flows, and we expect it will continue to do so.
The pandemic and international public health emergency caused by SARS-CoV-2, the novel strain of coronavirus that causes the disease commonly known as COVID-19, has spread throughout all the countries in which we and our customers, suppliers, and other business partners operate, causing significant disruption and volatility in global financial markets and raising the prospect of an extended global recession. Public health problems resulting from COVID-19 and precautionary measures instituted by governments and businesses to mitigate its spread, including travel restrictions and quarantines, could continue to contribute to a general slowdown in the global economy, cause increasingly adverse impacts on our customers, suppliers, and other business partners, and further disrupt our operations. Changes in our operations as a result of the COVID-19 pandemic have resulted in inefficiencies and delays, including in sales and product development efforts, and additional costs related to business continuity initiatives that cannot be fully mitigated through succession planning, employees working remotely, or teleconferencing technologies.
The COVID-19 pandemic and related governmental reactions have had, and may continue to have, a negative impact on our business, liquidity, results of operations, and stock price due to the occurrence of some or all of the following events or circumstances among others:
reduced demand for our products and services due to the impact of COVID-19 on our customers, particularly in the global academic research community;
diminished business productivity due to inefficiencies in employees working from home or increasing physical distancing and other pandemic response protocols in our production facilities;
increased susceptibility to the risk of information technology security breaches and other disruptions due to increased volumes of remote access to our information systems from our employees working at home;
the negative impact of travel restrictions and social distancing policies on our sales operations, marketing efforts, and customer field support;
impaired ability to hire and effectively train new personnel due to travel restrictions and physical distancing protocols;
increased operating costs if one of our facilities were to experience a COVID-19 outbreak;
disruption of the operations of our contract manufacturers, suppliers, and other business partners; and
41


increased volatility in our stock price due to financial market instability.
The extent to which the COVID-19 pandemic will continue to adversely impact our business and financial results will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the continued spread of the disease, the duration of the public health emergency, and actions taken in the United States and elsewhere to contain the virus and prevent new outbreaks, such as social distancing and quarantines, business closures or business disruptions.
Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain and rapidly changing, we are unable to predict the impact of COVID-19 on our operations, our financial performance, and our ability to successfully execute our business strategies and initiatives. The ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business, and individual actions that have been and continue to be taken in response to the pandemic (including restrictions on travel, transport and workforce pressures); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; and the pace of recovery when the COVID-19 pandemic subsides.
As the COVID-19 crisis continues to adversely affect our operating and financial results, it may also have the effect of heightening many of the other risks described in our other risk factors below. COVID-19 may also affect our operating and financial results in a manner that is not presently known to us or that we currently do not expect to present significant risks to our operations or financial results, particularly if the pandemic and its associated impacts reoccur in the coming months.
Our financial results and revenue growth rates have varied significantly from quarter-to-quarter and year-to-year due to a number of factors, and a significant variance in our operating results or rates of growth, if any, could lead to substantial volatility in our stock price.
Our revenue, results of operations, and revenue growth rates have varied in the past and may continue to vary significantly from quarter-to-quarter or year-to-year. We may experience substantial variability in our product mix from period-to-period as revenue from sales of our instruments relative to sales of our consumables may fluctuate or deviate significantly from expectations. For example, our revenue declined year-over-year in 2017 compared to 2016, but increased year-over-year in 2018 compared to 2017. Our revenue continued to increase year-over-year in 2019 compared to 2018, but we may not be able to achieve similar revenue growth in future periods. We are also increasingly dependent on our mass cytometry business, which is very capital intensive. Variability in our quarterly or annual results of operations, mix of product revenue, including any decline in our mass cytometry revenue, or variability in rates of revenue growth, if any, may lead to volatility in our stock price as research analysts and investors respond to these fluctuations. These fluctuations are due to numerous factors that are difficult to forecast, including: fluctuations in demand for our products; changes in customer budget cycles and capital spending; seasonal variations in customer operations; tendencies among some customers to defer purchase decisions to the end of the quarter; the large unit value of our systems, particularly our proteomics systems; changes in our pricing and sales policies or the pricing and sales policies of our competitors; our ability to design, manufacture, market, sell, and deliver products to our customers in a timely and cost-effective manner; fluctuations or reductions in revenue from sales of legacy instruments that may have contributed significant revenue in prior periods; quality control or yield problems in our manufacturing operations; our ability to timely obtain adequate quantities of the materials or components used in our products, which in certain cases are purchased through sole and single source suppliers; new product introductions and enhancements by us and our competitors; unanticipated increases in costs or expenses; our complex, variable and, at times, lengthy sales cycle; global economic conditions; and fluctuations in foreign currency exchange rates. Additionally, we have certain customers who have historically placed large orders in multiple quarters during a calendar year. A significant reduction in orders from one or more of these customers could adversely affect our revenue and operating results, and if these customers defer or cancel purchases or otherwise alter their purchasing patterns, our financial results and actual results of operations could be significantly impacted. Other unknown or unpredictable factors also could harm our results.
The foregoing factors, as well as other factors, could materially and adversely affect our quarterly and annual results of operations and rates of revenue growth, if any. We have experienced significant revenue growth in the past but we may not achieve similar growth rates in future periods. You should not rely on our operating results for any prior quarterly or annual period as an indication of our future operating performance. If we are unable to achieve adequate revenue growth, our operating results could suffer and our stock price could decline. In addition, a significant amount of our operating expenses are relatively fixed due to our manufacturing, research and development, and sales and general administrative efforts. Any failure to adjust spending quickly enough to compensate for a shortfall relative to our anticipated revenue could magnify the adverse impact of such shortfalls on our results of operations. We expect that our sales will continue to fluctuate on an annual and quarterly basis
42


and that our financial results for some periods may be below those projected by securities analysts, which could significantly decrease the price of our common stock.
We have incurred losses since inception, and we may continue to incur substantial losses for the foreseeable future.
We have incurred significant losses in each fiscal year since our inception, including net losses of $64.8 million, $59.0 million, and $60.5 million during the years 2019, 2018, and 2017, respectively. As of June 30, 2020, we had an accumulated deficit of $652.7 million. These losses have resulted principally from costs incurred in our research and development programs, and from our manufacturing costs and selling, general, and administrative expenses. To date, we have funded our operations primarily through equity offerings, the issuance of debt instruments, and from sales of our products.
Until we are able to generate additional revenue to support our level of operating expenses, we will continue to incur operating and net losses and negative cash flow from operations. We believe that our continued investment in research and development, sales, and marketing is essential to our long-term competitive position and future revenue growth and, as a result, we may incur operating losses for the foreseeable future and may never achieve profitability.
The life science markets are highly competitive and subject to rapid technological change, and we may not be able to successfully compete.
The markets for our products are characterized by rapidly changing technology, evolving industry standards, changes in customer needs, emerging competition, new product introductions, and strong price competition. We compete with both established and development stage life science research companies that design, manufacture, and market instruments and consumables for gene expression analysis, single-cell targeted gene expression and protein expression analysis, SNP genotyping, quantitative polymerase chain reaction (qPCR), digital PCR, flow cytometry, cell imaging, and additional applications using well established laboratory techniques, as well as newer technologies such as bead encoded arrays, microfluidics, next generation DNA sequencing, microdroplets, spatial protein expression, and photolithographic arrays. Most of our current competitors have significantly greater name recognition, greater financial and human resources, broader product lines and product packages, larger sales forces, larger existing installed bases, larger intellectual property portfolios, and greater experience and scale in research and development, manufacturing, and marketing than we do.
We consider Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc. (Thermo), Bio-Rad Laboratories, Inc., NanoString Technologies, Inc. (NanoString), and Agena Bioscience, Inc. to be our principal competitors in the microfluidics space. We believe that Cytek Biosciences, Inc. and Becton, Dickinson and Company are currently our principal competitors for our mass cytometry market share, and that IonPath Inc., Akoya Biosciences, Inc., and NanoString are our principal competitors for our Imaging Mass Cytometry™ market share. While the aforementioned principal competitors are the largest and most prevalent in their representative technology areas, the combined markets in which we compete have an additional 10 to 20 smaller competitors with competing approaches and technologies that we routinely face in selling situations.
Competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards, or customer requirements. In light of these advantages, even if our technology is more effective than the product or service offerings of our competitors, current or potential customers might accept competitive products and services in lieu of purchasing our technology. We anticipate that we will continue to face increased competition in the future as existing companies and competitors develop new or improved products and as new companies enter the market with new technologies. Increased competition is likely to result in pricing pressures, which could reduce our profit margins and increase our sales and marketing expenses. In addition, mergers, consolidations, or other strategic transactions between two or more of our competitors, or between our competitor and one of our key customers, could change the competitive landscape and weaken our competitive position, adversely affecting our business.
Market opportunities may not develop as quickly as we expect, limiting our ability to successfully sell our products, or our product development and strategic plans may change and our entry into certain markets may be delayed, if it occurs at all.
The application of our technologies to high-throughput genomics, single-cell genomics and, particularly, mass cytometry applications are in many cases emerging market opportunities. We believe these opportunities will take several years to develop or mature and we cannot be certain that these market opportunities will develop as we expect. The future growth of our markets and the success of our products depend on many factors beyond our control, including recognition and acceptance by the scientific community, and the growth, prevalence, and costs of competing methods of genetic and protein analysis. Additionally, our success depends on the ability of our sales organization to successfully sell our products into these new markets. If we are not able to successfully market and sell our products, or to achieve the revenue or margins we expect, our
43


operating results may be harmed and we may not recover our product development and marketing expenditures. In addition, our product development and strategic plans may change, which could delay or impede our entry into these markets.
If our products fail to achieve and sustain sufficient market acceptance, our revenue will be adversely affected.
Our success depends on our ability to develop and market products that are recognized and accepted as reliable, enabling and cost-effective. Most of our potential customers already use expensive research systems in their laboratories and may be reluctant to replace those systems. Market acceptance of our systems will depend on many factors, including our ability to convince potential customers that our systems are an attractive alternative to existing technologies. Compared to some competing technologies, our technology is relatively new, and most potential customers have limited knowledge of, or experience with, our products. Prior to adopting our systems, some potential customers may need to devote time and effort to testing and validating our systems. Any failure of our systems to meet these customer benchmarks could result in customers choosing to retain their existing systems or to purchase systems other than ours, and revenue from the sale of legacy instruments that may have contributed significant revenue in prior periods may decrease.
In addition, it is important that our systems be perceived as accurate and reliable by the scientific and medical research community as a whole. Historically, a significant part of our sales and marketing efforts has been directed at convincing industry leaders of the advantages of our systems and encouraging such leaders to publish or present the results of their evaluation of our system. If we are unable to continue to induce leading researchers to use our systems, or if such researchers are unable to achieve and publish or present significant experimental results using our systems, acceptance and adoption of our systems will be slowed and our ability to increase our revenue would be adversely affected.
We may experience development or manufacturing problems or delays that could limit the potential growth of our revenue or increase our losses.
We may encounter unforeseen situations in the manufacturing and assembly of our products that would result in delays or shortfalls in our production. For example, our production processes and assembly methods may have to change to accommodate any significant future expansion of our manufacturing capacity, which may increase our manufacturing costs, delay production of our products, reduce our product margin, and adversely impact our business. Conversely, if demand for our products shifts such that a manufacturing facility is operated below its capacity for an extended period, we may adjust our manufacturing operations to reduce fixed costs, which could lead to uncertainty and delays in manufacturing times and quality during any transition period.
Additionally, all of our integrated fluidic circuits (IFCs) for commercial sale are manufactured at our facility in Singapore. Production of the elastomeric block that is at the core of our IFCs is a complex process requiring advanced clean rooms, sophisticated equipment, and strict adherence to procedures. Any contamination of the clean room, equipment malfunction, or failure to strictly follow procedures can significantly reduce our yield in one or more batches. We have in the past experienced variations in yields due to such factors. A drop in yield can increase our cost to manufacture our IFCs or, in more severe cases, require us to halt the manufacture of our IFCs until the problem is resolved. Identifying and resolving the cause of a drop in yield can require substantial time and resources.
Furthermore, developing an IFC for a new application may require developing a specific production process for that type of IFC. While all of our IFCs are produced using the same basic processes, significant variations may be required to ensure adequate yield of any particular type of IFC. Developing such a process can be very time consuming, and any unexpected difficulty in doing so can delay the introduction of a product.
If our manufacturing activities are adversely impacted, or if we are otherwise unable to keep up with demand for our products by successfully manufacturing, assembling, testing, and shipping our products in a timely manner, our revenue could be impaired, market acceptance for our products could be adversely affected and our customers might instead purchase our competitors’ products.
If our research and product development efforts do not result in commercially viable products within anticipated timelines, if at all, our business and results of operations will be adversely affected.
Our business is dependent on the improvement of our existing products, our development of new products to serve existing markets, and our development of new products to create new markets and applications that were previously not practical with existing systems. We intend to devote significant personnel and financial resources to research and development activities designed to advance the capabilities of our technology. We have developed design rules for the implementation of our technology that are frequently revised to reflect new insights we have gained about the technology. In addition, we have discovered that biological or chemical reactions sometimes behave differently when implemented on our systems rather than in
44


a standard laboratory environment. Furthermore, many such reactions take place within the confines of single cells, which have also demonstrated unexpected behavior when grown and manipulated within microfluidic environments. As a result, research and development efforts may be required to transfer certain reactions and cell handling techniques to our systems. In the past, product development projects have been significantly delayed when we encountered unanticipated difficulties in implementing a process on our systems. We may have similar delays in the future, and we may not obtain any benefits from our research and development activities. Any delay or failure by us to develop and release new products or product enhancements would have a substantial adverse effect on our business and results of operations.
Our products could have defects or errors, which may give rise to claims against us, adversely affect market adoption of our systems, and adversely affect our business, financial condition, and results of operations.
Our systems utilize novel and complex technology and such systems may develop or contain undetected defects or errors. We cannot assure you that material performance problems, defects, or errors will not arise, and as we increase the density and integration of our systems, these risks may increase. We generally provide warranties that our systems will meet performance expectations and will be free from defects. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins. For example, we have experienced a performance issue with respect to certain IFCs used in our C1 systems due to the presence of more than one cell in an IFC chamber. Although we have redesigned such C1 IFCs, we may experience additional unexpected product defects or errors that could affect our ability to adequately address these performance issues.
In manufacturing our products, including our systems, IFCs, and assays, we depend upon third parties for the supply of various components, many of which require a significant degree of technical expertise to produce. In addition, we purchase certain products from third-party suppliers for resale. If our suppliers fail to produce components to specification or provide defective products to us for resale and our quality control tests and procedures fail to detect such errors or defects, or if we or our suppliers use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised.
If our products contain defects, we may experience:
a failure to achieve market acceptance or expansion of our product sales;
loss of customer orders and delay in order fulfillment;
damage to our brand reputation;
increased cost of our warranty program due to product repair or replacement;
product recalls or replacements;
inability to attract new customers;
diversion of resources from our manufacturing and research and development departments into our service department; and
legal claims against us, including product liability claims, which could be costly and time consuming to defend and result in substantial damages.
In addition, certain of our products are marketed for use with products sold by third parties. For example, certain of our systems are marketed as compatible with major next-generation DNA sequencing instruments. If such third-party products are not produced to specification, are produced in accordance with modified specifications, or are defective, they may not be compatible with our products. In such case, the reliability and performance of our products may be compromised.
The occurrence of any one or more of the foregoing could negatively affect our business, financial condition, and results of operations.
Our business depends on research and development spending levels of our customers, a reduction in which could limit our ability to sell our products and adversely affect our business.
We expect that our revenue in the foreseeable future will continue to be derived primarily from sales of our systems, IFCs, assays, and reagents to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories biopharmaceutical, biotechnology, and plant and animal research companies, and contract research organizations worldwide. Our success will depend upon their demand for and use of our products. Accordingly, the spending
45


policies and practices of these customers—which may additionally be impacted by factors such as the COVID-19 pandemic—could have a significant effect on the demand for our technology. These policies may be based on a wide variety of factors, including concerns regarding any future federal government budget sequestrations, the availability of resources to make purchases, the spending priorities among various types of equipment, policies regarding spending during recessionary periods, and changes in the political climate. In addition, academic, governmental, and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations, or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results may fluctuate substantially due to reductions and delays in research and development expenditures by our customers. For example, reductions in operating expenditures by global academic research facilities, approximately 30% to 40% of which are either closed or working at reduced capacity as of the end of June 2020 because of the COVID-19 pandemic, have resulted in lower than expected sales of our systems, IFCs, assays, and reagents. Similar reductions and delays in customer spending may result from other factors that are not within our control, such as:
changes in economic conditions;
natural disasters or public health crises;
changes in government programs that provide funding to research institutions and companies;
changes in the regulatory environment affecting life science and plant and animal research companies engaged in research and commercial activities;
differences in budget cycles across various geographies and industries;
market-driven pressures on companies to consolidate operations and reduce costs;
mergers and acquisitions in the life science and plant and animal research industries; and
other factors affecting research and development spending.
Any decrease in our customers’ budgets or expenditures, or in the size, scope, or frequency of capital or operating expenditures, could materially and adversely affect our operations or financial condition.
If one or more of our manufacturing facilities become unavailable or inoperable, we will be unable to continue manufacturing our instruments, IFCs, assays and/or reagents and, as a result, our business will be harmed until we are able to secure a new facility.
We manufacture our genomics analytical and preparatory instruments and IFCs for commercial sale at our facility in Singapore and our mass cytometry instruments, assays, and reagents for commercial sale at our facility in Canada. No other manufacturing facilities are currently available to us, particularly facilities of the size and scope of our Singapore and Canada operations. Our facilities and the equipment we use to manufacture our instruments, IFCs, assays, and reagents would be costly to replace and could require substantial lead times to repair or replace. Our facilities may be harmed or rendered inoperable by natural or man-made disasters, which may render it difficult or impossible for us to manufacture our products for some period of time. If any of our facilities become unavailable to us, we cannot provide assurances that we will be able to secure a new manufacturing facility on acceptable terms, if at all. The inability to manufacture our products, combined with our limited inventory of manufactured supplies, may result in the loss of customers or harm our reputation, and we may be unable to reestablish relationships with those customers in the future. Although we possess insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all. If our manufacturing capabilities are impaired, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business.
Disruption of our manufacturing facilities or other operations, or in the operations of our customers or business partners, due to earthquake, flood, other natural catastrophic events, public health crises, or terrorism could result in cancellation of orders, delays in deliveries or other business activities, or loss of customers and could seriously harm our business.
We have significant manufacturing operations in Singapore and Canada and operations in the United States. In addition, our business is international in nature, with our sales, service and administrative personnel and our customers located in numerous countries throughout the world. Operations at our manufacturing facilities and our subcontractors, as well as our other operations and those of our customers, are subject to disruption for a variety of reasons, including work stoppages, acts of war, terrorism, public health crises (including the ongoing COVID-19 pandemic), fire, earthquake, volcanic eruptions, energy
46


shortages, flooding, or other natural disasters. Such disruption could cause delays in, among other things, shipments of products to our customers, our ability to perform services requested by our customers, or the installation of our products at customer sites.
We cannot provide any assurance that alternate means of conducting our operations (whether through alternate production capacity or service providers or otherwise) would be available if a major disruption were to occur or that, if such alternate means were available, they could be obtained on favorable terms.
We generate a substantial portion of our revenue internationally and our international business exposes us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside of the United States.
During the years 2019, 2018, and 2017, approximately 63%, 57%, and 55%, respectively, of our product and service revenue was generated from sales to customers located outside of the United States. We believe that a significant percentage of our future revenue will continue to come from international sources as we expand our international operations and develop opportunities in other countries. Engaging in international business inherently involves a number of difficulties and risks, including:
required compliance with existing and changing foreign regulatory requirements and laws that are or may be applicable to our business in the future, such as the European Union’s General Data Protection Regulation and other data privacy requirements, labor and employment regulations, anticompetition regulations, the U.K. Bribery Act of 2010 and other anticorruption laws, and the RoHS and WEEE directives, which regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture;
required compliance with U.S. laws such as the Foreign Corrupt Practices Act, and other U.S. federal laws and regulations established by the office of Foreign Asset Control;
export requirements and import or trade restrictions;
laws and business practices favoring local companies;
longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;
changes in social, economic, and political conditions or in laws, regulations and policies governing foreign trade, manufacturing, development, and investment both domestically as well as in the other countries and jurisdictions in which we operate and into which we sell our products, including as a result of the separation of the United Kingdom from the European Union (Brexit);
business interruptions resulting from global sociopolitical events, including war and terrorism, public health crises such as the COVID-19 pandemic, and natural disasters including earthquakes, typhoons, floods and fires;
potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements, and other trade barriers;
difficulties and costs of staffing and managing foreign operations; and
difficulties protecting or procuring intellectual property rights.
If one or more of these risks occurs, it could require us to dedicate significant resources to remedy, and if we are unsuccessful in finding a solution, our financial results will suffer.
We are subject to fluctuations in the exchange rate of the U.S. Dollar and foreign currencies.
A majority of our product sales are currently denominated in U.S. dollars and fluctuations in the value of the U.S. dollar relative to foreign currencies could decrease demand for our products and adversely impact our financial performance. For example, if the value of the U.S. dollar increases relative to foreign currencies, our products could become more costly to the international consumer and therefore less competitive in international markets, or if the value of the U.S. dollar decreases relative to the Singapore dollar or the Canadian dollar, it would become more costly in U.S. dollars for us to manufacture our products in Singapore and/or in Canada. Additionally, our expenses are generally denominated in the currencies of the countries in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where a significant portion of our manufacturing operations are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates
47


depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. Fluctuations in currency exchange rates could have an adverse impact on our financial results in the future.
Any disruption or delay in the shipping or off-loading of our products, whether domestically or internationally, may have an adverse effect on our financial condition and results of operations.
We rely on shipping providers to deliver products to our customers globally. Labor, tariff, or World Trade Organization-related disputes, piracy, physical damage to shipping facilities or equipment caused by severe weather or terrorist incidents, congestion at shipping facilities, complications related to public health crises, inadequate equipment to load, dock, and offload our products, energy-related tie-ups, or other factors could disrupt or delay shipping or off-loading of our products domestically and internationally. Such disruptions or delays may have an adverse effect on our financial condition and results of operations.
We are dependent on single and sole source suppliers for some of the components and materials used in our products, and the loss of any of these suppliers could harm our business.
We rely on single and sole source suppliers for certain components and materials used in our products. Additionally, several of our instruments are assembled at the facilities of contract manufacturers in Singapore. We do not have long term contracts with our suppliers of these components and materials or our assembly service providers. The loss of a single or sole source supplier of any of the following components and/or materials would require significant time and effort to locate and qualify an alternative source of supply, if at all:
The IFCs used in our microfluidic systems are fabricated using a specialized polymer, and other specialized materials, that are available from a limited number of sources. In the past, we have encountered quality issues that have reduced our manufacturing yield or required the use of additional manufacturing processes.
The electron multiplier detector included in the Hyperion/Helios systems and certain metal isotopes used with the Hyperion/Helios systems are purchased from sole source suppliers.
The raw materials for our Delta Gene and SNP Type assays and Access Array target-specific primers are available from a limited number of sources.
Our reliance on single and sole source suppliers and assembly service providers also subjects us to other risks that could harm our business, including the following:
we may be subject to increased component or assembly costs and
we may not be able to obtain adequate supply or services in a timely manner or on commercially reasonable terms.
We have in the past experienced quality control and supply problems with some of our suppliers, such as manufacturing errors, and may again experience problems in the future. We may not be able to quickly establish additional or replacement suppliers, particularly for our single source components, or assembly service providers. Any interruption or delay in the supply of components or materials or assembly of our instruments, or our inability to obtain components, materials, or assembly services from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products.
Our future success is dependent upon our ability to expand our customer base and introduce new applications.
Our customer base is primarily composed of academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, biopharmaceutical, biotechnology, and plant and animal research companies, and contract research organizations that perform analyses for research and commercial purposes. Our success will depend, in part, upon our ability to increase our market share among these customers, attract additional customers outside of these markets, and market new applications to existing and new customers as we develop such applications. Attracting new customers and introducing new applications require substantial time and expense. For example, it may be difficult to identify, engage, and market to customers who are unfamiliar with the current applications of our systems. Any failure to expand our existing customer base or launch new applications would adversely affect our ability to increase our revenue.
48


We may not be able to develop new products or enhance the capabilities of our existing systems to keep pace with rapidly changing technology and customer requirements, which could have a material adverse effect on our business, revenue, financial condition, and operating results.
Our success depends on our ability to develop new products and applications for our technology in existing and new markets, while improving the performance and cost-effectiveness of our systems. New technologies, techniques, or products could emerge that might offer better combinations of price and performance than our current or future product lines and systems. Existing markets for our products, including high-throughput genomics, single-cell genomics and mass cytometry, as well as potential markets for our products such as high-throughput DNA sequencing and molecular applications, are characterized by rapid technological change and innovation. It is critical to our success for us to anticipate changes in technology and customer requirements and to successfully introduce new, enhanced, and competitive technology to meet our customers’ and prospective customers’ needs on a timely and cost-effective basis. Developing and implementing new technologies will require us to incur substantial development costs and we may not have adequate resources available to be able to successfully introduce new applications of, or enhancements to, our systems. We cannot guarantee that we will be able to maintain technological advantages over emerging technologies in the future. While we typically plan improvements to our systems, we may not be able to successfully implement these improvements. If we fail to keep pace with emerging technologies, demand for our systems will not grow and may decline, and our business, revenue, financial condition, and operating results could suffer materially. In addition, if we introduce enhanced systems but fail to manage product transitions effectively, customers may delay or forgo purchases of our systems and our operating results may be adversely affected by product obsolescence and excess inventory. Even if we successfully implement some or all of these planned improvements, we cannot guarantee that our current and potential customers will find our enhanced systems to be an attractive alternative to existing technologies, including our current products.
Our business operations depend upon the continuing efforts of our management team and other skilled and experienced personnel, and if we are unable to retain them or to recruit and train new key executives, scientists, and technical support personnel, we may be unable to achieve our goals.
Our success depends largely on the skills, experience, and performance of our management team and scientific and technical support personnel. The loss of the services of any key member of our management team or our scientific or technical support staff might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management’s attention to transition matters and identification of suitable replacements, if any, and could have a material adverse effect on our business. Our research and product development efforts could also be delayed or curtailed if we are unable to attract, train, and retain highly skilled employees, particularly, senior scientists and engineers. In April 2020, we implemented a temporary, enterprise-wide reduction in salaries as part of our efforts to reduce our operating expenses in response to the COVID-19 pandemic. As of the date of this filing, all salaries have been restored to prior levels but 2020 merit-based salary increases are on hold pending a clearer view of our projected revenue for 2020. We cannot predict our employees’ willingness to remain with us if raises are delayed indefinitely or if further salary reductions become necessary. We do not maintain fixed term employment contracts or significant key person life insurance with any of our employees.
Additionally, to expand our research and product development efforts, we need to retain and recruit scientists skilled in areas such as molecular and cellular biology, assay development, and manufacturing. We also need highly trained technical support personnel with the necessary scientific background and ability to understand our systems at a technical level to effectively support potential new customers and the expanding needs of current customers. Competition for these people is intense and we may face challenges in retaining and recruiting such individuals if, for example, our stock price declines, reducing the retention value of equity awards, or our business or technology is no longer perceived as leading in our field. Because of the complex and technical nature of our systems and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our technology.
Our business growth strategy involves the potential for significant acquisitions, and our operating results and prospects could be harmed if we are unable to integrate future acquisitions successfully.
We may acquire other businesses to improve our product offerings or expand into new markets. Our future acquisition strategy will depend on our ability to identify, negotiate, complete, and integrate acquisitions and, if necessary, to obtain satisfactory debt or equity financing to fund those acquisitions. Mergers and acquisitions are inherently risky, and any transaction we complete may not be successful. Any merger or acquisition we may pursue would involve numerous risks, including but not limited to the following:
difficulties in integrating and managing the operations, technologies, and products of the companies we acquire;
49


diversion of our management’s attention from normal daily operation of our business;
our inability to maintain the key business relationships and the reputations of the businesses we acquire;
our inability to retain key personnel of the acquired company;
uncertainty of entry into markets in which we have limited or no prior experience and in which competitors have stronger market positions;
our dependence on unfamiliar affiliates and customers of the companies we acquire;
insufficient revenue to offset our increased expenses associated with acquisitions;
our responsibility for the liabilities of the businesses we acquire, including those which we may not anticipate; and
our inability to maintain internal standards, controls, procedures, and policies.
We may be unable to secure the equity or debt funding necessary to finance future acquisitions on terms that are acceptable to us. If we finance acquisitions by issuing equity or convertible debt securities, our existing stockholders will likely experience dilution, and if we finance future acquisitions with debt funding, we will incur interest expense and may have to comply with financial covenants and secure that debt obligation with our assets.
Security breaches, loss of data, cyberattacks, and other information technology failures could disrupt our operations, damage our reputation, and adversely affect our business, operations, and financial results.
We are dependent upon our data and information technology systems for the effective operation of our business and for the secure maintenance and storage of confidential data relating to our business and third-party businesses. Our information technology systems may be damaged, disrupted or shut down due to attacks by experienced programmers or hackers who may be able to penetrate our security controls and deploy computer viruses, cyberattacks, phishing schemes, or other malicious software programs, or due to employee error or malfeasance, power outages, hardware failures, telecommunication or utility failures, catastrophes or other unforeseen events, and our system redundancy and other disaster recovery planning may be ineffective or inadequate in preventing or responding to any of these circumstances. Any such compromise of our information technology systems could result in the unauthorized publication of our confidential business or proprietary information and unauthorized release of customer, supplier or employee data, any of which could expose us to a risk of legal claims or proceedings, liability under privacy or other laws, disruption of our operations and damage to our reputation, which could divert our management’s attention from the operation of our business and materially and adversely affect our business, revenues and competitive position. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyberattacks and other related breaches. The cost and operational consequences of implementing further data protection measures, either as a response to specific breaches or as a result of evolving risks, could be significant. In addition, our inability to use or access our information systems at critical points in time could adversely affect the timely and efficient operation of our business. Any delayed sales, significant costs or lost customers resulting from these technology failures could adversely affect our business, operations, and financial results.
We have implemented security controls to protect our information technology infrastructure but, despite our efforts, we are not fully insulated from technology disruptions that could adversely impact us. For example, in March 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we believe we were able to restore their operation without significant loss of business data. Based on the nature of the attack and its impact on our systems, we do not believe confidential data was lost or disclosed. If, however, confidential data is later determined to have been released in the course of this or any future event, it is possible that we could be the subject of actions by governmental authorities or claims from persons alleging they suffered damages from such a release. Although we believe we have contained the disruption from the March 2019 attack, we anticipate additional work and expense in the future as we continue to enhance our security processes and initiatives in response to ever-evolving information security threats.
In addition to risks affecting our own systems, we could also be negatively impacted by a data breach or cyber incident happening to a third party’s network and affecting us. Third parties with which we conduct business have access to certain portions of our sensitive data, including information pertaining to our customers and employees. In the event that these third parties do not adequately safeguard our data, security breaches could result and negatively impact our business, operations, and financial results.
Due to the COVID-19 pandemic, we have an increased number of employees working remotely. As a result, we may have increased cyber security and data security risks, due to increased use of home wi-fi networks and virtual private networks,
50


as well as increased disbursement of physical machines. While we implement security controls to reduce the risk of cyberattacks and security breaches, there is no guarantee that these measures will be adequate to safeguard all systems with the increased number of employees working remotely.
Our efficiency and cost-savings initiatives could be disruptive to our operations and adversely affect our results of operations and financial condition, and we may not realize some or all of the anticipated benefits of these initiatives in the time frame anticipated or at all.
Since 2017, we have implemented efficiency and cost-savings initiatives intended to stabilize our business operations and return to growth. These efficiency initiatives have included targeted workforce reductions, optimizing our facilities, and reducing excess space. In response to the COVID-19 pandemic, we initiated a range of additional actions aimed at temporarily reducing our operating expenses and preserving liquidity. These actions included implementing temporary enterprise-wide salary reductions of 20% for employees at or above the ‘director’ level and 10% for all others, temporarily reducing our board members’ cash retainers by 20%, and constraining hiring. As of the date of this filing, we have restored all salaries and board member retainers to prior levels, but 2020 merit-based salary increases have been delayed pending a clearer view of our projected revenue for 2020. Further actions such as these may be required on an ongoing basis to preserve liquidity and optimize our organization. For example, we may need to decrease or defer capital expenditures and development activities or implement further operating expense reduction measures. The implementation of these further efficiency and cost-savings initiatives could impair our ability to invest in developing, marketing and selling new and existing products, be disruptive to our operations, make it difficult to attract or retain employees, result in higher than anticipated charges, divert the attention of management, result in a loss of accumulated knowledge, impact our customer and supplier relationships, and otherwise adversely affect our results of operations and financial condition. In addition, our ability to complete our efficiency and cost-savings initiatives and achieve the anticipated benefits within the expected time frame is subject to estimates and assumptions and may vary materially from our expectations, including as a result of factors that are beyond our control. Furthermore, our efforts to grow our business and become profitable may not be successful.
To use our products, our Biomark, EP1, Helios/CyTOF 2, and Hyperion systems in particular, customers typically need to purchase specialized reagents. Any interruption in the availability of these reagents for use in our products could limit our ability to market our products.
Our products, our Biomark, EP1, Helios, and Hyperion systems in particular, must be used in conjunction with one or more reagents designed to produce or facilitate the particular biological or chemical reaction desired by the user. Many of these reagents are highly specialized and available to the user only from a single supplier or a limited number of suppliers. Although we sell reagents for use with certain of our products, our customers may purchase these reagents directly from third-party suppliers, and we have no control over the supply of those materials. In addition, our products are designed to work with these reagents as they are currently formulated. We have no control over the formulation of reagents sold by third-party suppliers, and the performance of our products might be adversely affected if the formulation of these reagents is changed. If one or more of these reagents were to become unavailable or were reformulated, our ability to market and sell our products could be materially and adversely affected.
In addition, the use of a reagent for a particular process may be covered by one or more patents relating to the reagent itself, the use of the reagent for the particular process, the performance of that process, or the equipment required to perform the process. Typically, reagent suppliers, who are either the patent holders or their authorized licensees, sell the reagents along with a license or covenant not to sue with respect to such patents. The license accompanying the sale of a reagent often purports to restrict the purposes for which the reagent may be used. If a patent holder or authorized licensee were to assert against us or our customers that the license or covenant relating to a reagent precluded its use with our systems, our ability to sell and market our products could be materially and adversely affected. For example, our Biomark system involves real-time quantitative polymerase chain reaction (qPCR) technology. Leading suppliers of reagents for real-time qPCR reactions include Life Technologies Corporation (now part of Thermo) and Roche Diagnostics Corporation, who are our direct competitors, and their licensees. These real-time qPCR reagents are typically sold pursuant to limited licenses or covenants not to sue with respect to patents held by these companies. We do not have any contractual supply agreements for these real-time qPCR reagents, and we cannot assure you that these reagents will continue to be available to our customers for use with our systems, or that these patent holders will not seek to enforce their patents against us, our customers, or suppliers.
51


There can be no assurance that the test we have developed to detect the SARS-CoV-2 virus will be granted Emergency Use Authorization (EUA) by the FDA. If the FDA does not grant the EUA for our test or if the FDA revokes or terminates the EUA after issuance, such as when the federally -declared public health emergency ends, we will be required to stop commercial distribution of our test immediately unless we can obtain FDA clearance for our test under a traditional regulatory pathway for in vitro diagnostics, which is lengthy and expensive.
Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA has authority to allow certain unapproved medical products or unapproved uses of approved medical products to be used during a public health emergency. In issuing an EUA, the FDA will consider the totality of scientific evidence available to the FDA regarding safety, efficacy and known and potential risks of such products and availability of alternatives to the emergency use products, among others. EUAs issued by the FDA will specify the scope of authorization and conditions of authorization, including limitations on distribution and conditions related to product advertising and promotion. Once granted, an EUA is effective until the declaration that circumstances exist justifying the authorization of the emergency use is terminated under Section 564(b)(2) of the Act or the EUA is revoked under Section 564(g) of the Act, after which the product must be approved by the FDA under a traditional pathway in order to remain on the market or to continue commercialization of the product.
On June 12, 2020, we announced our submission of an application for an EUA from the FDA for our Advanta™ Dx SARS-CoV-2 RT-PCR assay, an extraction-free saliva-based test to detect the SARS-CoV-2 virus. We have not yet received an EUA. The FDA may require additional data, including additional validation data and clinical performance data, and may not ultimately issue an authorization. Changes in FDA policies, guidance, and requirements for EUA submission may delay FDA authorization of our product. Further, given the high volume of EUA requests received by the FDA and other factors due to the COVID-19 pandemic, including any disruptions in the FDA’s normal operations, FDA review of our EUA application may be delayed. We can make no assurance that the FDA will grant an EUA for our product on a timely basis or at all.
If an EUA is granted for our Advanta™ Dx SARS-CoV-2 RT-PCR assay, the distribution and advertising conditions set forth in the EUA may limit our market opportunities or restrict how we can commercialize our product. If the FDA’s policies and guidance change unexpectedly and/or materially or if we misinterpret them, potential sales of Advanta™ Dx could be adversely impacted. In addition, the FDA will revoke an EUA where it is determined that the underlying public health emergency no longer exists or warrants such authorization, or if new evidence becomes available that indicates the test is not as safe, effective, or reliable as the data provided in the EUA application. If granted, we cannot predict how long an EUA f will remain effective. The termination or revocation of an EUA for our product, if granted, and changing policies and regulatory requirements could adversely impact our business, financial condition and results of operations.
Our letter contract with the National Institutes of Health (NIH) could expose us to unique risks and costs as an entity contracting with the federal government.
The NIH launched the Rapid Acceleration of Diagnostics (RADx) program to expedite development, commercialization, and implementation of technologies for COVID-19 testing to help increase testing in the United States. In July 2020, we entered into a letter contract with the NIH for a project under the RADx program. The letter contract provides access to up to $12.2 million of the total proposed funding for the project prior to execution of a further definitive contract for the project. Release of the up to $12.2 million of initial funding under the letter contract will be based on the achievement of milestones, including an initial validation assessment followed by deliverables related to the development of our microfluidics technology and expansion of our manufacturing capacity.
There is significant competition among RADx projects, which are evaluated by experts on a rolling basis. Projects with the most potential for success are advanced to the next stage. There is no assurance that we can meet all the milestones in our letter contract with NIH on a timely basis, if at all. If we do not meet all the milestones, we will not be able access all $12 million in funding under the letter contract, and may not be able to execute a further definitive contract. We must prioritize among many different opportunities, and we may expend our limited resources on programs that do not yield a successful or profitable product candidate and may forego other more profitable opportunities. Further, the Bayh-Dole Act applies to all NIH research and development funding granted to for-profit organizations, which requires the government to be provided a nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the United States any subject invention throughout the world. We cannot guarantee that we will be able to access all the available funding under the letter contract in a timely manner, or at all, or execute a further definitive contract with NIH.
Factors that could materially adversely affect our revenue stemming from this letter contract and, if awarded, the further definitive contract include:
budgetary constraints affecting U.S. government spending generally, or NIH in particular;
52


changes in U.S. government or NIH fiscal policies or available funding, including due to Congressional appropriations;
changes in U.S. government or NIH programs, requirements or priorities;
adoption of new laws or regulations;
technological developments;
U.S. government shutdowns, threatened shutdowns or budget delays;
competition and consolidation in our industry; and
general economic conditions.
These or other factors could cause NIH to reduce its funding or future activities under this letter contract and, if awarded, the further definitive contract, or to exercise its right to terminate either contract for convenience, either of which could have a material adverse effect on the revenue generated by this contract.
During the contract definitization process, the government may include certain provisions from the Federal Acquisition Regulations (FAR), some of which are customary or legally required, that give the U.S. government substantial rights and remedies, many of which are not typically found in commercial contracts. For example, the contracts with NIH will contain provisions permitting unilateral termination or modification, in whole or in part, at the U.S. government’s convenience. Under general principles of government contracting law, if the U.S. government terminates a contract for convenience, the government contractor may recover only its incurred or committed costs, settlement expenses and profit on work completed prior to the termination. If the U.S. government terminates a contract for default, the government contractor is entitled to recover costs incurred and associated profits on accepted items only and may be liable for excess costs incurred by the government in procuring undelivered items from another source. In addition, government contracts normally contain additional requirements that may increase our costs of doing business, reduce our profits, and expose us to liability for failure to comply with these terms and conditions. These requirements include, for example, mandatory internal control systems and policies, mandatory socioeconomic compliance requirements, including labor standards, non-discrimination and affirmative action programs and environmental compliance requirements and public disclosures of certain contract information, which may enable competitors to gain insights into our research program. If we fail to maintain compliance with these requirements, we may be subject to potential contract or False Claims Act liability and to termination of our contracts:
Other examples of rights and remedies likely to be provided to the government under this contract include provisions that allow NIH to:
terminate the contract, in whole or in part, for any reason or no reason;
unilaterally reduce or modify the government’s obligations under the contract, without the Company’s consent, including by imposing price adjustments;
claim rights, including intellectual property rights, in products and data developed under contract;
under certain circumstances involving public health and safety, license inventions made under such agreements to third parties;
suspend the contractor from receiving new contracts pending resolution of alleged violations of procurement laws or regulations;
impose U.S. manufacturing requirements for products that embody inventions conceived or first reduced to practice under such contracts;
suspend or debar the contractor from doing future business with the government;
claim rights to facilities or to products, including intellectual property, developed under the contract;
change the course of a development program in a manner that differs from the contract’s original terms or from our desired development plan, including decisions regarding our partners in the program;
pursue civil or criminal remedies under the False Claims Act and False Statements Act; and
control or prohibit the export of products.
53


Furthermore, we may be required to enter into agreements and subcontracts with third parties, including suppliers, consultants and other third-party contractors in order to satisfy our contractual obligations pursuant to our agreements with the United States government. Negotiating and entering into such arrangements can be time-consuming and we may not be able to reach agreement with such third parties. Any such agreement must also be compliant with the terms of our government contract. Any delay or inability to enter into such arrangements or entering into such arrangements in a manner that is non-compliant with the terms of our contract, may result in violations of our contract.
U.S. government agencies routinely audit and investigate government contractors and recipients of federal grants and contracts. These agencies review a contractor’s performance under its contracts, cost structure and compliance with applicable laws, regulations and standards. The audit may also include review of the adequacy of, and a contractor’s compliance with, its internal control systems and policies, including the contractor’s accounting, purchasing, property, estimating, compensation and management information systems. If an audit uncovers improper or illegal activities, we may be subject to civil and criminal penalties and administrative sanctions. In addition, we could suffer serious reputational harm if allegations of impropriety were made against us, which could cause our stock price to decrease.
If we elect to label and promote any of our products as medical devices, we would be required to obtain prior approval or clearance by the FDA, which would take significant time and expense and could fail to result in FDA clearance or approval for the intended uses we believe are commercially attractive.
Our products are currently labeled, promoted and sold to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, contract research organizations, and biopharmaceutical, biotechnology, and plant and animal research companies as “research use only” (RUO), and are not designed, or intended to be used, for clinical diagnostic tests or as medical devices as currently marketed. If we elect to label and market our products for use as, or in the performance of, clinical diagnostics in the United States, thereby subjecting them to FDA regulation as medical devices, we would be required to obtain premarket 510(k) clearance or premarket approval from the FDA, unless an exception applies.
We may in the future register with the FDA as a medical device manufacturer and list some of our products with the FDA pursuant to an FDA Class I listing for general purpose laboratory equipment. While this regulatory classification is exempt from certain FDA requirements, such as the need to submit a premarket notification commonly known as a 510(k), and some of the requirements of the FDA’s Quality System Regulations (QSRs), we would be subject to ongoing FDA “general controls,” which include compliance with FDA regulations for labeling, inspections by the FDA, complaint evaluation, corrections and removals reporting, promotional restrictions, reporting adverse events or malfunctions for our products, and general prohibitions against misbranding and adulteration.
In addition, we may in the future submit 510(k) premarket notifications to the FDA to obtain FDA clearance of certain of our products on a selected basis. It is possible, in the event we elect to submit 510(k) applications for certain of our products, that the FDA would take the position that a more burdensome premarket application, such as a premarket approval application or a de novo application is required for some of our products. If such applications were required, greater time and investment would be required to obtain FDA approval. Even if the FDA agreed that a 510(k) was appropriate, FDA clearance can be expensive and time consuming. It generally takes a significant amount of time to prepare a 510(k), including conducting appropriate testing on our products, and several months to years for the FDA to review a submission. Notwithstanding the effort and expense, FDA clearance or approval could be denied for some or all of our products. Even if we were to seek and obtain regulatory approval or clearance, it may not be for the intended uses we believe are important or commercially attractive.
If we sought and received regulatory clearance or approval for certain of our products, we would be subject to ongoing FDA obligations and continued regulatory oversight and review, including the general controls listed above and the FDA’s QSRs for our development and manufacturing operations. In addition, we would be required to obtain a new 510(k) clearance before we could introduce subsequent modifications or improvements to such products. We could also be subject to additional FDA post-marketing obligations for such products, any or all of which would increase our costs and divert resources away from other projects. If we sought and received regulatory clearance or approval and are not able to maintain regulatory compliance with applicable laws, we could be prohibited from marketing our products for use as, or in the performance of, clinical diagnostics and/or could be subject to enforcement actions, including warning letters and adverse publicity, fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions; and criminal prosecution.
In addition, we could decide to seek regulatory clearance or approval for certain of our products in countries outside of the United States. Sales of such products outside the United States will likely be subject to foreign regulatory requirements, which can vary greatly from country to country. As a result, the time required to obtain clearances or approvals outside the United States may differ from that required to obtain FDA clearance or approval and we may not be able to obtain foreign
54


regulatory approvals on a timely basis or at all. In Europe, we would need to comply with the new Medical Device Regulation 2017/745 and In Vitro Diagnostic Regulation 2017/746, which became effective May 26, 2017, with application dates of May 26, 2021 (postponed from 2020) and May 26, 2022 respectively. This will increase the difficulty of regulatory approvals in Europe in the future. In addition, the FDA regulates exports of medical devices. Failure to comply with these regulatory requirements or obtain and maintain required approvals, clearances and certifications could impair our ability to commercialize our products for diagnostic use outside of the United States.
Our products could become subject to regulation as medical devices by the FDA or other regulatory agencies even if we do not elect to seek regulatory clearance or approval to market our products for diagnostic purposes, which would adversely impact our ability to market and sell our products and harm our business.
As products that are currently labeled, promoted and intended as RUO, our products are not currently subject to regulation as medical devices by the FDA or comparable agencies of other countries. However, the FDA or comparable agencies of other countries could disagree with our conclusion that our products are currently intended for research use only or deem our current sales, marketing and promotional efforts as being inconsistent with research use only products. For example, our customers may independently elect to use our research use only labeled products in their own laboratory developed tests (LDTs) for clinical diagnostic use. The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against laboratories offering LDTs. However, on October 3, 2014, the FDA issued two draft guidance documents that set forth the FDA’s proposed risk-based framework for regulating LDTs, which are designed, manufactured, and used within a single laboratory. The draft guidance documents provide the anticipated details through which the FDA would propose to establish an LDT oversight framework, including premarket review for higher-risk LDTs, such as those that have the same intended use as FDA-approved or cleared companion diagnostic tests currently on the market. In January 2017, the FDA announced that it would not issue final guidance on the oversight of LDTs and manufacturers of products used for LDTs, but would seek further public discussion on an appropriate oversight approach, and give Congress an opportunity to develop a legislative solution. More recently, the FDA has issued warning letters to certain genomics labs for illegally marketing genetic tests that claim to predict patients’ responses to specific medications, noting that the FDA has not created a legal “carve-out” for LDTs and retains discretion to take action when appropriate, such as when certain genomic tests raise significant public health concerns. As manufacturers develop more complex genetic tests and diagnostic software, the FDA may increase its regulation of LDTs. Any future legislative or administrative rule making or oversight of LDTs, if and when finalized, may impact the sales of our products and how customers use our products, and may require us to change our business model in order to maintain compliance with these laws. We cannot predict how these various efforts will be resolved, how Congress or the FDA will regulate LDTs in the future, or how that regulatory system will impact our business.
Additionally, on November 25, 2013, the FDA issued Final Guidance “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only.” The guidance emphasizes that the FDA will review the totality of the circumstances when it comes to evaluating whether equipment and testing components are properly labeled as RUO. The final guidance states that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA’s clearance, approval, and other regulatory requirements if the circumstances surrounding the distribution, marketing and promotional practices indicate that the manufacturer knows its products are, or intends for its products to be, used for clinical diagnostic purposes. These circumstances may include written or verbal sales and marketing claims or links to articles regarding a product’s performance in clinical applications and a manufacturer’s provision of technical support for clinical applications.
If the FDA determines our products or related applications should be subject to additional regulation as in vitro diagnostic devices based upon customers’ use of our products for clinical diagnostic or therapeutic purposes, our ability to market and sell our products could be impeded and our business, prospects, results of operations and financial condition may be adversely affected. In addition, the FDA could consider our products to be misbranded or adulterated under the Federal Food, Drug, and Cosmetic Act and subject to recall and/or other enforcement action.
Compliance or the failure to comply with current and future regulations affecting our products and business operations worldwide, such as environmental regulations enacted in the European Union, could cause us significant expense and adversely impact our business.
We are subject to many federal, state, local, and foreign regulations relating to various aspects of our business operations. Governmental entities at all levels are continuously enacting new regulations, and it is difficult to identify all applicable regulations and anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with applicable regulations. To comply with applicable regulations, we have and will continue to incur significant expense and allocate valuable internal resources to manage compliance-related issues. In addition, such regulations could restrict our ability to expand or equip our facilities, or could require us to acquire costly equipment or to incur
55


other significant expenses to comply with the regulations. For example, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive (RoHS) and the Waste Electrical and Electronic Equipment Directive (WEEE), both enacted in the European Union, regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture. Certain of our products sold in these countries are subject to WEEE and RoHS. These and similar regulations that have been or are in the process of being enacted in other countries may require us to redesign our products, use different types of materials in certain components, or source alternative components to ensure compliance with applicable standards, and may reduce the availability of parts and components used in our products by negatively impacting our suppliers’ ability to source parts and components in a timely and cost-effective manner.
The Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation (EC) No. 1907/206 is the European Union’s regulation on chemicals and their safe use. The list of chemicals has been updated and some of the updates affect chemicals used in our products. We will request a research exception, but if not granted, we will need to reduce the concentration of some of the chemicals in our products, which will require significant research and development and operations efforts.
Any such redesigns, required use of alternative materials, or limited availability of parts and components used in our products may detrimentally impact the performance of our products, add greater testing lead times for product introductions, reduce our product margins, or limit the markets for our products, and if we fail to comply with any present and future regulations, we could be subject to future fines, penalties, and restrictions, such as the suspension of manufacturing of our products or a prohibition on the sale of products we manufacture. Any of the foregoing could adversely affect our business, financial condition, or results of operations.
If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of our financial reporting may be impaired, which could adversely affect our business and our stock price.
The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. Our testing may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses.
Our compliance with Section 404 requires that we incur substantial accounting expense and expend significant management time on compliance-related issues. We currently do not have an internal audit group, and we continue to evaluate our need for additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. Moreover, if we do not comply with the requirements of Section 404, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline and we could be subject to sanctions or investigations by The Nasdaq Stock Market LLC, the SEC, or other regulatory authorities, which would require additional financial and management resources.
Impairment of our goodwill or other intangible assets could materially and adversely affect our business, operating results, and financial condition.
As of June 30, 2020, we had approximately $154.4 million of goodwill and net intangible assets, including approximately $106.3 million of goodwill and $48.1 million of net intangible assets. These assets represent a significant portion of the assets recorded on our consolidated balance sheet and relate primarily to our acquisition of DVS Sciences, Inc. (DVS) in February 2014. In addition, if in the future we acquire additional businesses, technologies, or other intangible assets, a substantial portion of the value of such assets may be recorded as goodwill or intangible assets. In the fourth quarter of 2019, we concluded that certain of our patents and licenses were impaired and reduced the applicable carrying value to zero, recognizing a charge of $0.4 million, which is reflected in accumulated amortization.
The carrying amounts of goodwill and intangible assets are affected whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We review goodwill and indefinite lived intangible assets for impairment at least annually and more frequently under certain circumstances. Other intangible assets that are deemed to have finite useful lives will continue to be amortized over their useful lives but must be reviewed for impairment when events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include declines in our stock price or market capitalization, declines in our market share or revenues, an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. In particular, these or other adverse events or changes in circumstances may affect the estimated
56


undiscounted future operating cash flows expected to be derived from our goodwill and intangible assets. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge. We cannot provide assurances that we will not in the future be required to recognize impairment charges.
Our future capital needs are uncertain and we may need to raise additional funds in the future, which may cause dilution to stockholders or may be upon terms that are not favorable to us.
We have continued to experience losses and, if that trend continues, we may need to seek additional sources of financing. In addition, we may need to raise substantial additional capital for various purposes, including:
expanding the commercialization of our products;
funding our operations;
furthering our research and development; and
acquiring other businesses or assets and licensing technologies.
Our future funding requirements will depend on many factors, including:
market acceptance of our products;
the cost of our research and development activities;
the cost of filing and prosecuting patent applications;
the cost of defending any litigation including intellectual property, employment, contractual or other litigation;
the cost and timing of regulatory clearances or approvals, if any;
the cost and timing of establishing additional sales, marketing, and distribution capabilities;
the cost and timing of establishing additional technical support capabilities;
fluctuations in cash demands (e.g., due to interest or principal payments or payouts under existing cash compensation plans);
variability in sales and timing of related cash collections;
the effectiveness of our efficiency and cost-savings initiatives;
the impact of any natural disasters or public health crises, such as the COVID-19 pandemic;
the effect of competing technological and market developments; and
the extent to which we acquire or invest in businesses, products, and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.
To the extent we draw on our Revolving Credit Facility or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we cannot assure you that we will be able to obtain additional funds on acceptable terms, or at all. The ongoing COVID-19 pandemic has led to significant disruption and volatility in the global capital markets, increasing the cost of—and adversely impacting access to—capital. We have an Open Market Sale Agreement (Sale Agreement) with Jefferies LLC (Jefferies) to sell shares of our common stock having aggregate sales proceeds of up to $50,000,000, from time to time, through an “at the market” (ATM) equity offering program under which Jefferies will act as sales agent. As of the date of this report, there had been no shares of common stock sold under the Sale Agreement. If we raise additional funds by issuing equity securities, either under the ATM program or otherwise, our stockholders may experience dilution. Debt financing in addition to the Revolving Credit Facility, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt or equity financing that we raise may contain terms that are not favorable to us or our stockholders, and our ability to raise additional capital may be adversely impacted by the impact of the COVID-19 pandemic on the economy.
If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. If we do not
57


have or are unable to raise adequate funds, we may have to liquidate some or all of our assets, delay development or commercialization of our products, or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products, or cease operations. Any of these factors could harm our operating results.
If we fail to comply with the covenants and other obligations under our Revolving Credit Facility, the lenders may be able to accelerate amounts owed under the facilities and may foreclose upon the assets securing our obligations.
In April 2020, we amended our Revolving Credit Facility, which provides for secured revolving loans in an aggregate amount of up to $15.0 million, to extend the maturity date to August 2, 2022. The Revolving Credit Facility is secured by substantially all of our assets, other than intellectual property. The Revolving Credit Facility contains customary affirmative and negative covenants which, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. If we fail to comply with the covenants and our other obligations under the Revolving Credit Facility, the lenders would be able to accelerate the required repayment of amounts due under the Revolving Credit Agreement and, if they are not repaid, could foreclose upon the assets securing our obligations under the Revolving Credit Facility.
We are subject to risks related to taxation in multiple jurisdictions and if taxing authorities disagree with our interpretations of existing tax laws or regulations, our effective income tax rate could be adversely affected and we could have additional tax liability.
We are subject to income taxes in both the United States and certain foreign jurisdictions. Significant judgments based on interpretations of existing tax laws or regulations are required in determining the provision for income taxes. For example, we have made certain interpretations of existing tax laws or regulations based upon the operations of our business internationally and we have implemented intercompany agreements based upon these interpretations and related transfer pricing analyses. If the U.S. Internal Revenue Service or other taxing authorities disagree with the positions, our effective income tax rate could be adversely affected and we could have additional tax liability, including interest and penalties. From time to time, we may review our corporate structure and tax positions in the various international jurisdictions in which we operate and such review may result in changes to how we structure our international business operations, which may adversely impact our effective income tax rate. Our effective income tax rate could also be adversely affected by changes in the mix of earnings in tax jurisdictions with different statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in existing tax laws or tax rates, changes in the level of non-deductible expenses (including share-based compensation), changes in our future levels of research and development spending, mergers and acquisitions, or the result of examinations by various tax authorities. Payment of additional amounts as a result of changes in applicable tax law or upon final adjudication of any disputes could have a material impact on our results of operations and financial position.
Our ability to use net operating loss carryforwards to offset future taxable income for U.S. federal income tax purposes and other tax benefits may be limited.
Section 382 of the Internal Revenue Code of 1986, as amended (the Code), imposes an annual limitation on the amount of taxable income that may be offset by net operating loss carryforwards (NOLs) if a corporation experiences an “ownership change.” As provided in Section 382 of the Code, an “ownership change” occurs when a company’s “five-percent shareholders” collectively increase their ownership in the company by more than 50 percentage points (by value) over a rolling three-year period. Various states also have limitations on the use of state NOLs following an ownership change.
Future changes in our stock ownership, some of which are outside our control, could result in an ownership change under Section 382 of the Code. If we experience an ownership change, our ability to use our NOLs or other tax benefits could be substantially limited, which could significantly impair their value.  There is no assurance that we will be able to fully utilize our NOLs or other tax benefits, which could adversely impact our results of operations.
We believe that these tax benefits are a valuable asset for us and we monitor our stock ownership to determine whether our NOLs are at material risk of limitation based on an ownership change pursuant to Section 382. If our board of directors determines a potential risk exists that our NOLs could be limited, it could elect to adopt a tax benefit preservation plan in an effort to protect our tax benefits. Adoption of a tax benefit preservation plan could make it more difficult for a third party to acquire, or could discourage a third party from acquiring, us or a large block of our common stock.
58


Adverse conditions in the global economy and disruption of financial markets may significantly harm our revenue, profitability, and results of operations.
Adverse economic conditions in the U.S. and international markets, including the worldwide economic disruption related to the COVID-19 pandemic, have negatively affected our revenues and operating results and may continue to do so. Even before the current public health crisis took hold, the global credit and financial markets had been experiencing volatility and disruptions, including diminished liquidity and credit availability, increased concerns about inflation and deflation, and the downgrade of U.S. debt and exposure risks on other sovereign debts, decreased consumer confidence, lower economic growth, volatile energy costs, increased unemployment rates, and uncertainty about economic stability. Geopolitical events including the COVID-19 pandemic, the United States government’s adoption and expansion of trade restrictions, and the United Kingdom’s withdrawal from the European Union have caused significant economic, market, political and regulatory uncertainty in some of our markets. Volatility and disruption of financial markets could limit our customers’ ability to obtain adequate financing or credit to purchase and pay for our products in a timely manner or to maintain operations, which could result in a decrease in sales volume that could harm our results of operations. General concerns about the fundamental soundness of domestic and international economies may also cause our customers to reduce their purchases. Changes in governmental banking, monetary, and fiscal policies to address liquidity and increase credit availability may not be effective. Significant government investment and allocation of resources to assist the economic recovery of sectors that do not include our customers may reduce the resources available for government grants and related funding for life science, plant and animal research, and clinical research and development. Continuation or further deterioration of these financial and macroeconomic conditions could significantly harm our sales, profitability, and results of operations.
If we are unable to expand our direct sales and marketing force or distribution capabilities to adequately address our customers’ needs, our business may be adversely affected.
We may not be able to market, sell, and, distribute our products effectively enough to support our planned growth. We sell our products primarily through our own sales force and through distributors in certain territories. Our future sales will depend in large part on our ability to continue to develop and substantially expand our direct sales force and to increase the scope of our marketing efforts. Our products are technically complex and used for highly specialized applications. As a result, we believe it is necessary to continue to develop a direct sales force that includes people with specific scientific backgrounds and expertise, and a marketing group with technical sophistication. We have experienced significant changes in our sales organization in the past year due to reorganizations and changes in leadership. In addition, as part of our cost reduction program to manage the impact of the COVID-19 pandemic, we implemented temporary enterprise-wide salary reductions, including with respect to our sales and marketing employees. Although all salaries have been restored to prior levels as of the date of this filing, 2020 merit-based salary increases have been delayed pending a clearer view of our projected revenue for 2020. Any reinstatement of salary reductions or failure to implement salary increases may negatively impact our ability to maintain the skilled sales and marketing force necessary to support our business activities. As a result, our future success will depend largely on our ability to retain and motivate such personnel. Because competition for such employees is intense, we can provide no assurance that we will be able to retain them on favorable or commercially reasonable terms, if at all. Failure to attract and retain our current personnel or to build an efficient and effective sales and marketing force would negatively impact sales of our products and reduce our revenue and profitability.
In addition, we may continue to enlist one or more sales representatives and distributors to assist with sales, distribution, and customer support globally or in certain regions of the world. If we do seek to enter into such arrangements, we may not be successful in attracting desirable sales representatives and distributors, or we may not be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales representatives and distributors, are not successful, our technologies and products may not gain market acceptance, which would materially and adversely impact our business operations.
If we seek to implement a company-wide enterprise resource planning (ERP) system, such implementation could adversely affect our business and results of operations or the effectiveness of internal control over financial reporting.
We have considered implementing a company-wide ERP system to handle the business and financial processes within our operations and corporate functions. ERP implementations are complex and time-consuming projects that involve substantial expenditures on system software and implementation activities that can continue for several years. ERP implementations also require transformation of business and financial processes in order to reap the benefits of the ERP system. If we decide to implement a company-wide ERP system, our business and results of operations could be adversely affected if we experience operating problems and/or cost overruns during the ERP implementation process, or if the ERP system and the associated process changes do not give rise to the benefits that we expect. If we do not effectively implement the ERP system as planned
59


or if the system does not operate as intended, our business, results of operations, and internal controls over financial reporting could be adversely affected.
Changes in accounting principles, or interpretations thereof, could have a significant impact on our financial position and results of operations.
We prepare our consolidated financial statements in accordance with U.S. GAAP. These principles are subject to interpretation by the SEC and various bodies formed to interpret and create appropriate accounting principles. A change in these principles can have a significant effect on our reported results and may even retroactively affect previously reported transactions. Additionally, the adoption of new or revised accounting principles may require that we make significant changes to our systems, processes and controls.
For example, the U.S.-based Financial Accounting Standards Board (FASB) is currently working together with the International Accounting Standards Board (IASB), on several projects to further align accounting principles and facilitate more comparable financial reporting between companies who are required to follow U.S. GAAP under SEC regulations and those who are required to follow International Financial Reporting Standards outside of the United States. These efforts by the FASB and IASB may result in different accounting principles under U.S. GAAP that may result in materially different financial results for us in areas including, but not limited to, principles for recognizing revenue and lease accounting. Additionally, significant changes to U.S. GAAP resulting from the FASB’s and IASB’s efforts may require that we change how we process, analyze and report financial information and that we change financial reporting controls. Additionally, the FASB issued new guidance (ASU 2014-09) Revenue from Contracts with Customers (Topic 606) which supersedes nearly all existing U.S. GAAP revenue recognition guidance. The new guidance was effective for our fiscal year 2018. We adopted ASU 2014-09 in the first quarter of 2018 using the modified retrospective method. Under the modified retrospective method, periods prior to the adoption of ASU 2014-09 are not restated and the cumulative effect of initially applying the new standard is reflected in the opening balance of accumulated deficit as of January 1, 2018. To date, the adoption has not had a material impact on our consolidated financial statements. Additional disclosures are required for significant differences between the reported results under the new standard and those that would have been reported under the legacy standard, which required us to make certain changes to our business processes and controls to support revenue recognition and disclosure under the new standard.
The FASB also issued Accounting Standards Update (ASU) 2016-02, Leases (Topic 842) (ASU 2016-02). The core principle is that lessees should recognize the assets and liabilities arising from leases on the balance sheet. Under the new standard, lessees will be required to recognize lease assets and liabilities for all leases, with certain exceptions, on their balance sheets. We adopted ASU 2016-02 as of January 1, 2019. The adoption of this standard had a material impact on our consolidated financial statements. We continue to identify the appropriate changes to our business processes, systems, and controls to support the new lease standard and the required disclosures under the new standard.
It is not clear if or when potential changes in accounting principles may become effective, whether we have the proper systems and controls in place to accommodate such changes and the impact that any such changes may have on our financial position and results of operations.
We have a significant amount of outstanding indebtedness, and our financial condition and results of operations could be adversely affected if we do not efficiently manage our liabilities.
We have significant outstanding convertible debt. As of June 30, 2020, we had outstanding $1.1 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes) and $55.0 million aggregate principal amount of our 5.25% convertible senior notes due 2024 (2019 Notes). The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. Holders of the 2014 Notes may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2021, February 6, 2024, and February 6, 2029 at a repurchase price in cash equal to 100% of the principal amount of the Notes plus accrued and unpaid interest. The 2019 Notes will mature on December 1, 2024, unless earlier converted, or repurchased in accordance with the terms of the 2019 Notes. If we undergo a fundamental change (as defined in the terms of the indenture governing either the 2014 Notes or the 2019 Notes (collectively, the Convertible Notes)), holders of the applicable series of Convertible Notes may require us to repurchase such Convertible Notes in whole or in part for cash at a repurchase price equal to 100% of the principal amount of the applicable series of Convertible Notes plus accrued and unpaid interest. If we refinance the debt owed under the 2014 Notes or 2019 Notes, we may issue additional convertible notes or other debt, which could include additional company obligations and represent more dilution to existing stockholders and noteholders.
This significant amount of debt has important risks to us and our investors, including:
requiring a portion of our cash flow from operations to make interest payments on this debt;
60


increasing our vulnerability to general adverse economic and industry conditions;
reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business;
limiting our flexibility in planning for, or reacting to, changes in our business and the industry; and
limiting our ability to borrow additional funds as needed or take advantage of business opportunities as they arise.
In addition, to the extent we draw on our Revolving Credit Facility or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to refinance our debt.
Risks Related to Intellectual Property
Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain.
Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of copyright, trade secret, and trademark laws, and nondisclosure, confidentiality, and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, we may fail to apply for patents on important products and technologies in a timely fashion or at all. Our pending U.S. and foreign patent applications may not issue as patents or may not issue in a form that will be sufficient to protect our proprietary technology and gain or keep our competitive advantage. Any patents we have obtained or do obtain may be subject to re-examination, reissue, opposition, or other administrative proceeding, or may be challenged in litigation, and such challenges could result in a determination that the patent is invalid or unenforceable. In addition, competitors may be able to design alternative methods or devices that avoid infringement of our patents. Both the patent application process and the process of managing patent disputes can be time consuming and expensive.
Furthermore, the laws of some foreign countries may not protect our intellectual property rights to the same extent as do the laws of the United States, and many companies have encountered significant problems in protecting and defending such rights in foreign jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. For example:
we might not have been the first to make the inventions covered by each of our pending patent applications;
we might not have been the first to file patent applications for these inventions;
the patents of others may have an adverse effect on our business; and
others may independently develop similar or alternative products and technologies or duplicate any of our products and technologies.
To the extent our intellectual property, including licensed intellectual property, offers inadequate protection, or is found to be invalid or unenforceable, our competitive position and our business could be adversely affected.
We may be involved in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage and validity of others’ proprietary rights, or to defend against third-party claims of intellectual property infringement, any of which could be time-intensive and costly and may adversely impact our business or stock price.
Litigation may be necessary for us to enforce our patent and proprietary rights, determine the scope, coverage, and validity of others’ proprietary rights, and/or defend against third-party claims of intellectual property infringement against us as well as against our suppliers, distributors, customers, and other entities with whom we do business. Litigation could result in substantial legal fees and could adversely affect the scope of our patent protection. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us, and we might not be able to obtain licenses to technology that we require. Even if such licenses are obtainable, they may not be available at a reasonable cost. We could therefore incur
61


substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our product margins or financial position. Further, we could encounter delays in product introductions, or interruptions in product sales, as we develop alternative methods or products.
As we move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of impeding our entry into such markets or as a means to extract substantial license and royalty payments from us. Our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties. Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in our existing and targeted markets. For example, some of our products provide for the testing and analysis of genetic material, and patent rights relating to genetic materials remain a developing area of patent law. A recent U.S. Supreme Court decision held, among other things, that claims to isolated genomic DNA occurring in nature are not patent eligible, while claims relating to synthetic DNA may be patent eligible. We expect the ruling will result in additional litigation in our industry. In addition, third parties may assert that we are employing their proprietary technology without authorization, and if they are successful in making such claims, we may be forced to enter into license agreements, pay additional royalties or license fees, or enter into settlements that include monetary obligations or restrictions on our business.
Our customers have been sued for various claims of intellectual property infringement in the past, and we expect that our customers will be involved in additional litigation in the future. In particular, our customers may become subject to lawsuits claiming that their use of our products infringes third-party patent rights, and we could become subject to claims that we contributed to or induced our customer’s infringement. In addition, our agreements with some of our suppliers, distributors, customers, and other entities with whom we do business may require us to defend or indemnify these parties to the extent they become involved in infringement claims against us, including the claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify any of these third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, operating results, or financial condition.
We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees’ former employers or other institutions or third parties with whom such employees may have been previously affiliated.
Many of our employees were previously employed at universities or other life science or plant and animal research companies, including our competitors or potential competitors. In the future, we may become subject to claims that our employees, or we, have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers or other third parties or institutions with whom our employees may have been previously affiliated. Litigation may be necessary to defend against these claims. For example, we were a defendant in litigation brought against us and one of our non-executive employees by Thermo alleging, among other claims, misappropriation of proprietary information and breach of contractual and fiduciary obligations. While we resolved our dispute with Thermo in July 2017, if we fail in defending against similar claims brought in the future, we could be subject to injunctive relief against us. A loss of key research personnel work product could hamper or prevent our ability to commercialize certain potential products or a loss of or inability to hire key marketing, sales or research and development personnel could adversely affect our future product development, sales and revenues, any of which could severely harm our business. Even if we are successful in defending against any similar claims brought in the future, litigation could result in substantial costs and be a distraction to management.
We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from selling our products, which would have an adverse effect on our business.
We rely on licenses in order to be able to use various proprietary technologies that are material to our business, including our core IFC, multi-layer soft lithography, and mass cytometry technologies. In some cases, we do not control the prosecution, maintenance, or filing of the patents to which we hold licenses, or the enforcement of these patents against third parties. Additionally, our business and product development plans anticipate and may substantially depend on future in-license agreements with additional third parties, some of which are currently in the early discussion phase. For example, Fluidigm Canada Inc., or Fluidigm Canada, an Ontario corporation and wholly owned subsidiary of Fluidigm Sciences, was party to an interim license agreement, now expired, with Nodality, Inc., or Nodality, under which Nodality granted Fluidigm Canada a worldwide, non-exclusive, research use only, royalty bearing license to certain cytometric reagents, instruments, and other products. While we were able to secure a license under a new license agreement with Nodality, we cannot provide assurances that we will always be able to obtain suitable license rights to technologies or intellectual property of other third parties on acceptable terms, if at all.
62


In-licensed intellectual property rights that are fundamental to our business being operated present numerous risks and limitations. For example, all or a portion of the license rights granted may be limited for research use only, and in the event we attempt to expand into diagnostic applications, we would be required to negotiate additional rights, which may not be available to us on commercially reasonable terms, if at all.
Our rights to use the technology we license are also subject to the negotiation and continuation of those licenses. Certain of our licenses contain provisions that allow the licensor to terminate the license upon specific conditions. Our rights under the licenses are subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Because of the complexity of our products and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a dispute could lead to an increase in the royalties payable pursuant to the license. If a licensor believed we were not paying the royalties due under the license or were otherwise not in compliance with the terms of the license, the licensor might attempt to revoke the license. If such an attempt were successful and the license is terminated, we might be barred from marketing, producing, and selling some or all of our products, which would have an adverse effect on our business. Potential disputes between us and one of our existing licensors concerning the terms or conditions of the applicable license agreement could result, among other risks, in substantial management distraction; increased expenses associated with litigation or efforts to resolve disputes; substantial customer uncertainty concerning the direction of our product lines; potential infringement claims against us and/or our customers, which could include efforts by a licensor to enjoin sales of our products; customer requests for indemnification by us; and, in the event of an adverse determination, our inability to operate our business as currently operated. Termination of material license agreements could prevent us from manufacturing and selling our products unless we can negotiate new license terms or develop or acquire alternative intellectual property rights that cover or enable similar functionality. Any of these factors would be expected to have a material adverse effect on our business, operating results, and financial condition and could result in a substantial decline in our stock price.
We are subject to certain manufacturing restrictions related to licensed technologies that were developed with the financial assistance of U.S. governmental grants.
We are subject to certain U.S. government regulations because we have licensed technologies that were developed with U.S. government grants. In accordance with these regulations, these licenses provide that products embodying the technologies are subject to domestic manufacturing requirements. If this domestic manufacturing requirement is not met, the government agency that funded the relevant grant is entitled to exercise specified rights, referred to as “march-in rights,” which if exercised would allow the government agency to require the licensors or us to grant a non-exclusive, partially exclusive, or exclusive license in any field of use to a third party designated by such agency. All of our microfluidic systems revenue is dependent upon the availability of our IFCs, which incorporate technology developed with U.S. government grants. Our genomics instruments, including microfluidic systems, and IFCs are manufactured at our facility in Singapore. The federal regulations allow the funding government agency to grant, at the request of the licensors of such technology, a waiver of the domestic manufacturing requirement. Waivers may be requested prior to any government notification. We have assisted the licensors of these technologies with the analysis of the domestic manufacturing requirement, and, in December 2008, the sole licensor subject to the requirement applied for a waiver of the domestic manufacturing requirement with respect to the relevant patents licensed to us by this licensor. In July 2009, the funding government agency granted the requested waiver of the domestic manufacturing requirement for a three-year period commencing in July 2009. In June 2012, the licensor requested a continued waiver of the domestic manufacturing requirement with respect to the relevant patents, but the government agency has not yet taken any action in response to this request. If the government agency does not grant the requested waiver or the government fails to grant additional waivers of such requirement that may be sought in the future, then the U.S. government could exercise its march-in rights with respect to the relevant patents licensed to us. In addition, the license agreement under which the relevant patents are licensed to us contains provisions that obligate us to comply with this domestic manufacturing requirement. We are not currently manufacturing instruments and IFCs in the United States that incorporate the relevant licensed technology. If our lack of compliance with this provision constituted a material breach of the license agreement, the license of the relevant patents could be terminated or we could be compelled to relocate our manufacturing of microfluidic systems and IFCs to the United States to avoid or cure a material breach of the license agreement. Any of the exercise of march-in rights, the termination of our license of the relevant patents or the relocation of our manufacturing of microfluidic systems and IFCs to the United States could materially adversely affect our business, operations and financial condition.
We are subject to certain obligations and restrictions relating to technologies developed in cooperation with Canadian government agencies.
Some of our Canadian research and development is funded in part through government grants and by government agencies. The intellectual property developed through these projects is subject to rights and restrictions in favor of government agencies and Canadians generally. In most cases the government agency retains the right to use intellectual property developed
63


through the project for non-commercial purposes and to publish the results of research conducted in connection with the project. This may increase the risk of public disclosure of information relating to our intellectual property, including confidential information, and may reduce its competitive advantage in commercializing intellectual property developed through these projects. In certain projects, we have also agreed to use commercially reasonable efforts to commercialize intellectual property in Canada, or more specifically in the province of Ontario, for the economic benefit of Canada and the province of Ontario. These restrictions will limit our choice of business and manufacturing locations, business partners and corporate structure and may, in certain circumstances, restrict our ability to achieve maximum profitability and cost efficiency from the intellectual property generated by these projects. In one instance, a dispute with the applicable government funded entity may require mediation, which could lead to unanticipated delays in our commercialization efforts to that project. One of our Canadian government funded projects is also subject to certain limited “march-in” rights in favor of the government of the Province of Ontario, under which we may be required to grant a license to our intellectual property, including background intellectual property developed outside the scope of the project, to a responsible applicant on reasonable terms in circumstances where the government determines that such a license is necessary in order to alleviate emergency or extraordinary health or safety needs or for public use. In addition, we must provide reasonable assistance to the government in obtaining similar licenses from third parties required in connection with the use of its intellectual property. Instances in which the government of the Province of Ontario has exercised similar “march-in” rights are rare; however, the exercise of such rights could materially adversely affect our business, operations and financial condition.
Risks Related to Our Common Stock
Our stock price may fluctuate significantly, particularly if holders of substantial amounts of our stock attempt to sell, and holders may have difficulty selling their shares based on current trading volumes of our stock. In addition, numerous other factors could result in substantial volatility in the trading price of our stock.
Our stock is currently traded on the Nasdaq Global Select Market (Nasdaq), but we can provide no assurance that we will be able to maintain an active trading market on Nasdaq or any other exchange in the future. The trading volume of our stock tends to be low relative to our total outstanding shares, and we have several stockholders who hold substantial blocks of our stock. As of December 31, 2019, we had 69,956.397 shares of common stock outstanding, and stockholders holding at least 5% of our stock, individually or with affiliated persons or entities, collectively beneficially owned or controlled approximately 46.3% of such shares and one stockholder beneficially owned approximately 9.8% of our outstanding common stock. Sales of large numbers of shares by any of our large stockholders could adversely affect our trading price, particularly given our relatively small historic trading volumes. If stockholders holding shares of our common stock sell, indicate an intention to sell, or if it is perceived that they will sell, substantial amounts of their common stock in the public market, the trading price of our common stock could decline. Moreover, if there is no active trading market or if the volume of trading is limited, holders of our common stock may have difficulty selling their shares. In addition, the concentration of ownership of our outstanding common stock (approximately 46.3% held by our top six stockholders) means that a relatively small number of stockholders have significant control over the outcomes of stockholder voting.
In addition, the trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include:
the impact of public health crises, including the COVID-19 pandemic, on global financial markets;
actual or anticipated quarterly variation in our results of operations or the results of our competitors;
announcements or communications by us or our competitors relating to, among other things, new commercial products, technological advances, significant contracts, commercial relationships, capital commitments, acquisitions or sales of businesses, and/or misperceptions in or speculation by the market regarding such announcements or communications;
issuance of new or changed securities analysts’ reports or recommendations for our stock;
developments or disputes concerning our intellectual property or other proprietary rights;
commencement of, or our involvement in, litigation;
market conditions in the life science, plant and animal research, and contract research organization sectors;
failure to complete significant sales;
manufacturing disruptions that could occur if we are unable to successfully expand our production in our current or an alternative facility;
64


any future sales of our common stock or other securities in connection with raising additional capital or otherwise;
any major change to the composition of our board of directors or management; and
general economic conditions and slow or negative growth of our markets.
The stock market in general, and market prices for the securities of technology-based companies like ours in particular, have from time to time experienced volatility that often has been unrelated to the operating performance of the underlying companies. These broad market and industry fluctuations may adversely affect the market price of our common stock regardless of our operating performance. In several recent situations where the market price of a stock has been volatile, holders of that stock have instituted securities class action litigation against the company that issued the stock. If any of our stockholders were to bring a lawsuit against us, the defense and disposition of the lawsuit could be costly and divert the time and attention of our management and harm our operating results.
Future sales of our common stock in the public market could cause our stock price to fall.
Our stock price could decline as a result of sales of a large number of shares of our common stock or the perception that these sales could occur. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.
In addition, in the future, we may issue additional shares of common stock or other equity or debt securities convertible into common stock in connection with a financing, acquisition, litigation settlement, employee arrangements or otherwise. Any such future issuance, including any issuances pursuant to our ATM equity offering program under our Sale Agreement with Jefferies, could result in substantial dilution to our existing stockholders and could cause our stock price to decline.
We will have broad discretion over the use of the proceeds to us from our ATM equity offering program and may apply the proceeds to uses that do not improve our operating results or the value of your securities.
We will have broad discretion to use the net proceeds to us from our ATM equity offering program, and investors will be relying solely on the judgment of our board of directors and management regarding the application of these proceeds. Although we expect to use the net proceeds from our ATM equity offering program for general corporate purposes, we have not allocated these net proceeds for specific purposes. Investors will not have the opportunity, as part of their investment decision, to assess whether the proceeds are being used appropriately. Our use of the proceeds may not improve our operating results or increase the value of the securities offered pursuant to the ATM equity offering program.
If securities or industry analysts publish unfavorable research about our business or cease to cover our business, our stock price and/or trading volume could decline.
The trading market for our common stock may rely, in part, on the research and reports that equity research analysts publish about us and our business. We do not have any control of the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline.
Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.
Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management, including provisions that:
authorize our board of directors to issue, without further action by the stockholders, up to 10,000,000 shares of undesignated preferred stock;
require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;
specify that special meetings of our stockholders can be called only by our board of directors, the chairman of the board, the chief executive officer or the president;
65


establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;
establish that our board of directors is divided into three classes, Class I, Class II, and Class III, with each class serving staggered three-year terms;
provide that our directors may be removed only for cause;
provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;
specify that no stockholder is permitted to cumulate votes at any election of directors; and
require a super-majority of votes to amend certain of the above-mentioned provisions.
These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us.
We have never paid cash dividends on our capital stock, and we do not anticipate paying any cash dividends in the foreseeable future.
We have paid no cash dividends on any of our classes of capital stock to date and currently intend to retain our future earnings to fund the development and growth of our business. In addition, we cannot pay any cash dividends on any of our classes of common stock without approval from the lender under our Revolving Credit Facility, and may become subject to covenants under future debt arrangements that place restrictions on our ability to pay dividends. As a result, capital appreciation, if any, of our common stock will be stockholders’ sole source of gain for the foreseeable future.
Any conversions of the 2014 Notes or 2019 Notes will dilute the ownership interest of our existing stockholders and may otherwise depress the price of our common stock.
Any conversion of some or all of the 2014 Notes or 2019 Notes will dilute the ownership interests of our existing stockholders. Any sales in the public market of our common stock issuable upon such conversion could also adversely affect prevailing market prices of our common stock. In addition, holders of the 2014 Notes or 2019 Notes may hedge their position in such Convertible Notes by entering into short positions with respect to the underlying common stock. As a result, any anticipated conversion of the 2014 Notes or 2019 Notes could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 5. Other Information
The information set forth below below and in Exhibit 10.5 of this quarterly report on Form 10-Q is provided in accordance with and in satisfaction of the requirement of Item 5.02 “Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers” of Form 8-K.
On August 4, 2020, the compensation committee of our board of directors approved the Fluidigm Corporation 2020 Change of Control and Severance Plan (the Severance Plan), under which our executive officers are eligible to receive severance benefits. The Severance Plan replaces the Company’s existing Change of Control and Severance Plan, which expires according to its terms on August 21, 2020 (the Prior Plan).
Under the Severance Plan, if any executive officer’s employment is terminated outside of the period beginning three months before a Change of Control (as defined in the Severance Plan) or the signing of a definitive agreement for a Change of Control and ending 12 months after a Change of Control (the Change of Control Period) for a reason other than Cause or the executive officer’s death or Disability (as such terms are defined in the Severance Plan) (an Involuntary Termination), then the executive officer will be entitled to receive the following:
66


75% of the executive officer’s annual base salary in effect as of the date of termination, paid in equal installments (less applicable withholding) over nine months (or, in the case of Stephen Christopher Linthwaite, our President and CEO, 200% of his annual base salary paid over a period of 24 months) following termination,
payment of continued health coverage for the executive officer, his or her spouse and/or dependents, if applicable (such coverage, COBRA Coverage), for a period of up to nine months (or, in Mr. Linthwaite’s case, 12 months) following termination, and
reasonable outplacement services in accordance with the Severance Plan.
Under the Severance Plan, if any executive officer’s employment is terminated within the Change of Control Period either (i) by us in an Involuntary Termination or (ii) by the executive officer for Good Reason (as defined in the executive officer’s participation agreement under the Severance Plan), then the executive officer will be entitled to receive the following:
a lump-sum payment (less applicable withholding) totaling 150% (or, in Mr. Linthwaite’s case, 250%) of the sum of (x) his or her annual base salary (as in effect immediately before termination or immediately before the Change of Control, whichever is higher) plus (y) the greater of (A) his or her annual target bonus (as in effect immediately before termination or immediately before the Change of Control, whichever is higher) or (B) the average of the annual bonuses actually paid to him or her for the three fiscal years preceding the year in which the termination occurs,
a lump-sum amount (less applicable withholding) totaling his or her annual target bonus (as in effect immediately before termination or immediately before the Change of Control, whichever is higher) prorated to reflect the number of days worked during the year in which the termination occurs,
payment of costs of COBRA Coverage, for a period of up to 18 months (or, in Mr. Linthwaite’s case, 30 months) following termination,
100% vesting acceleration of his or her then-outstanding and unvested equity awards, with any equity awards subject to outstanding performance-based vesting criteria vesting as to 100% of the baseline number of shares (or 100% at target achievement), and
reasonable outplacement services in accordance with the Severance Plan.
Upon any termination of Mr. Linthwaite’s employment for a reason other than Cause or death or Disability, the Company will assign to Mr. Linthwaite the life insurance policy insuring his life and reimburse him for payment of premiums on such policy for up to 30 months following his termination of employment.
Upon execution of participation agreements, the Severance Plan will supersede the severance benefits provided to the executive officers under the Prior Plan. To receive Severance Plan benefits, an executive officer would also be required sign and not revoke a separation and release of claims agreement in a form reasonably satisfactory to us within the period specified in the Severance Plan, and comply with any confidentiality, proprietary information and inventions assignment agreement and any other appropriate agreement with us.
If any of the severance and other benefits provided for in the Severance Plan or otherwise payable to an executive officer constitute “parachute payments” within the meaning of Section 280G of the Internal Revenue Code (the Code) and could be subject to excise tax under Section 4999 of the Code, then the benefits will be delivered in full or delivered as to such lesser extent that would result in no portion of such benefits being subject to excise tax, whichever results in the greater amount of after-tax benefits to such executive officer. The Severance Plan does not require us to provide any tax gross-up payment to any executive officer participating in the Severance Plan.
The Severance Plan will have a term of three years commencing on August 4, 2021 and expiring on the third anniversary of that date, and will thereafter automatically renew for successive one-year periods unless the Company notifies participants of the Severance Plan’s nonrenewal at least 12 months prior to the commencement of such Renewal Term. If a Change of Control occurs, the term of the Severance Plan will extend automatically through the date that is 12 months following the effective date of the Change of Control, subject to continuation with respect to benefits to which a participant is entitled. The Severance Plan allows our management team to designate employees for participation who are not executive officers.
The above description of the Severance Plan is not complete and is qualified in its entirety by reference to the full text of the Severance Plan, which is attached hereto as Exhibit 10.5 and incorporated herein by reference.
67


Item 6. Exhibits
The documents listed in the Exhibit List, which follows below, are incorporated by reference or are filed with this quarterly report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

EXHIBIT LIST
Exhibit
Number
DescriptionIncorporated
by Reference
From Form
Incorporated
by Reference
From Exhibit
Number
Date Filed
10.18-K1.13/5/2020
10.28-K10.16/24/2020
10.38-K10.26/24/2020
10.48-K10.14/22/2020
10.5*Filed herewith
31.1Filed herewith
31.2Filed herewith
32.1(1)
Filed herewith
32.2(1)
Filed herewith
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.Filed herewith
101.SCHXBRL Taxonomy Extension Schema DocumentFiled herewith
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentFiled herewith
101.DEFXBRL Taxonomy Extension Definition Linkbase DocumentFiled herewith
101.LABXBRL Taxonomy Extension Label DocumentFiled herewith
101.PREXBRL Taxonomy Extension Presentation DocumentFiled herewith
(1) In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.
* Indicates a management contract or compensatory plan.
68


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
FLUIDIGM CORPORATION
Dated: August 7, 2020By:/s/ Stephen Christopher Linthwaite
Stephen Christopher Linthwaite
President and Chief Executive Officer
Dated: August 7, 2020By:/s/ Vikram Jog
Vikram Jog
Chief Financial Officer


69
EX-10.5 2 exhibit10510q2q2020.htm EX-10.5 Document

Exhibit 10.5
FLUIDIGM CORPORATION
2020 CHANGE OF CONTROL AND SEVERANCE PLAN
AND SUMMARY PLAN DESCRIPTION

Adopted as of August 4, 2020

1.Introduction. The purpose of this Fluidigm Corporation 2020 Change of Control and Severance Plan, or Plan (as defined in Section 2 below), is to provide assurances of specified benefits to certain employees of the Company whose employment is subject to being involuntarily terminated other than for death, Disability, or Cause or voluntarily terminated for Good Reason under the circumstances described herein. This Plan is an “employee welfare benefit plan,” as defined in Section 3(1) of the U.S. Employee Retirement Income Security Act of 1974, as amended (“ERISA”). This document constitutes both the written instrument under which the Plan is maintained and the required summary plan description for the Plan. This Plan is a replacement for that certain Fluidigm Corporation Change of Control and Severance Plan and Summary Plan Description adopted by the Compensation Committee of Fluidigm Corporation on August 21, 2017 (the “Prior Plan”). The Prior Plan expires according to its terms and will not be renewed. By becoming a Participant under this Plan (and immediately upon execution of the Participation Agreement), the Participant expressly acknowledges that Participant will cease being a participant under or entitled to any benefits under the Prior Plan.
2.Important Terms. The following words and phrases, when the initial letter of the term is capitalized, will have the meanings set forth in this Section 2, unless a different meaning is plainly required by the context:
2.1 “Administrator” means the Company, acting through the Compensation Committee or another duly constituted committee of members of the Board, or any person to whom the Administrator has delegated any authority or responsibility with respect to the Plan pursuant to Section 12, but only to the extent of such delegation.
2.2 “Board” means the Board of Directors of the Company.
2.3. “Cause” exists upon (i) a Participant’s conviction of, or plea of guilty or nolo contendere to, any crime involving dishonesty or moral turpitude or any felony; or (ii) a Participant’s (a) engagement in material dishonesty, willful misconduct, or gross negligence—in each case in connection with the Participant’s position at the Company; (b) breach of any confidentiality, invention assignment, non-disclosure, or non-solicitation agreement entered into between the Company and the Participant; (c) material violation of a written Company policy or procedure that has been provided to the Participant, which violation causes substantial injury to the Company; or (d) willful refusal to perform the Participant’s assigned duties to the Company, following written notice of such refusal by the Company and a period of fifteen (15) days to cure the same and the Participant’s failure to cure during such time period. No act or omission shall be considered “willful” if such act or omission was done, or not done, in the reasonable, good-faith belief that such act or omission was in the best interests of the Company or upon the advice of counsel to the Company.
1 of 13


2.4. Change of Control” means the occurrence of any of the following events:
2.4.1 Change in Ownership of the Company. A change in the ownership of the Company that occurs on the date that any one person, or more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company; provided, however, that for purposes of this subsection, the acquisition of additional stock by any one Person considered to own more than fifty percent (50%) of the total voting power of the stock of the Company will not be considered a Change in Control. Further, if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership direct or indirect beneficial ownership of fifty percent (50%) or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company in substantially the same proportions as their ownership of the Company’s voting stock immediately prior to the change in ownership, such event shall not be considered a Change in Control under this subsection. For this purpose, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities that own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities.
2.4.2.  Change in Effective Control of the Company. A change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twenty-four (24) month period with individuals whose appointment or election to the Board is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this subsection (b), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or
2.4.3 Change in Ownership of a Substantial Portion of the Company’s Assets. A change in the ownership of a substantial portion of the Company’s assets that occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such Person) assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection 2.4.3, the following will not constitute a change in the ownership of a substantial portion of the Company’s assets: (a) a transfer to an entity that is controlled by the Company’s stockholders immediately after the transfer; or (b) a transfer of assets by the Company to (i) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company’s stock; (ii) an entity as to which fifty percent (50%) or more of the total value or voting power is owned, directly or indirectly, by the Company; (iii) a Person that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding stock of the Company; or (iv) an entity as to which at least fifty percent (50%) of the total value or voting power is owned, directly or indirectly, by a Person described in 2.4.3(b)(iii). For purposes of this subsection 2.4.3, “gross fair market value” means the value of the assets of the Company, or
2 of 13


the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.
For purposes of this Section 2.4, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.
Notwithstanding any of the foregoing, however, in any circumstance or transaction in which compensation or benefits paid under this Plan would result in imposition of an additional tax under Section 409A of the Code (as defined below) if the foregoing definition of “Change of Control” were to apply, but would not result in the imposition of any additional tax if the term “Change of Control” were defined herein to mean a “change in control event” within the meaning of Treasury Regulation Section 1.409A-3(i)(5), then “Change of Control” shall mean a “change in control event” within the meaning of Treasury Regulation Section 1.409A-3(i)(5), but only to the extent necessary to prevent such compensation from becoming subject to an additional tax under Section 409A.
Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (i) its primary purpose is to change the jurisdiction of the Company’s incorporation, or (ii) its primary purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.
2.5. “Change of Control Period” means the time period beginning three (3) months prior to a Change of Control (or three months prior to signing of a definitive agreement to consummate a Change of Control if the Company enters into such an agreement) and ending on the date that is twelve (12) months following the Change of Control.
2.6. “Code” means the Internal Revenue Code of 1986, as amended. Reference to a specific section of the Code or regulation thereunder shall include such section or regulation, any valid regulation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.
2.7. “Company” means Fluidigm Corporation and any successor that assumes the obligations of the Company under the Plan by way of merger, acquisition, consolidation or other transaction.
2.8. “Disability” means that Participant has been unable to perform his or her Company duties as the result of Participant’s incapacity due to physical or mental illness, and such inability, at least twenty-six (26) weeks after its commencement, is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to Participant or Participant’s legal representative (such agreement as to acceptability not to be unreasonably withheld). Termination resulting from Disability may only be effected after at least 30 days’ written notice by the Company of its intention to terminate Participant’s employment. In the event that Participant resumes the performance of substantially all of his or her duties hereunder before the termination of employment becomes effective, the notice of intent to terminate will automatically be deemed to have been revoked.
3 of 13


2.9. “Effective Date” means August 4, 2020, which is the date the Plan was adopted by the Compensation Committee of the Board.
2.10. “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended.
2.11. “Equity Awards” means a Participant’s outstanding stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance stock units, and any other Company equity compensation awards.
2.12. “Good Reason” has the meaning set forth in the Participant’s Participation Agreement.
2.13. “Involuntary Termination” means a Non-COC Involuntary Termination or a COC Involuntary Termination, in each case, under the circumstances described in Section 4 or Section 5, as applicable.
2.14. “Participant” means an employee of the Company or of any parent or subsidiary of the Company who (a) has been designated by the Administrator to participate in the Plan and (b) has timely and properly executed and delivered a Participation Agreement to the Company.
2.15. “Participation Agreement” means the individual agreement (as will be provided in separate cover as Appendix A) provided by the Administrator to a Participant under the Plan, which has been signed and accepted by the Participant.
2.16. “Plan” means the Fluidigm Corporation 2020 Change of Control and Severance Plan as set forth in this document and as hereafter amended from time to time.
2.17. “Section 409A” means Section 409A of the Code and the final regulations and any guidance promulgated thereunder.
2.18. “Section 409A Limit” means two (2) times the lesser of: (i) the Participant’s annualized compensation based upon the annual rate of pay paid to the Participant during the taxable year preceding the taxable year of the Participant’s termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which the Participant’s employment is terminated.
2.19. “Severance Benefits” means the compensation and other benefits that the Participant will be provided in the circumstances described in Section 4 or Section 5 of the Plan, as applicable.
3.Eligibility for Severance Benefits. An individual is eligible for Severance Benefits under the Plan, as described in Section 4 or Section 5, as applicable, only if he or she experiences an Involuntary Termination.
4.Involuntary Termination Outside the Change of Control Period. If, outside of the Change of Control Period, the Company (or any parent or subsidiary of the Company) terminates the Participant’s employment for a reason other than for Cause, the Participant’s
4 of 13


death or Disability (a “Non-COC Involuntary Termination”), subject to the Participant’s compliance with Section 7, the Participant will receive the following Severance Benefits:
4.1. Cash Severance Benefits. Continued payments of cash severance for the period set forth in the Participant’s Participation Agreement;
4.2. Continued Medical Benefits. If the Participant and any spouse and/or other dependents of the Participant (“Family Members”) have coverage on the date of the Participant’s Involuntary Termination under a group health plan sponsored by the Company, the Company will pay on behalf of Participant the total applicable premium cost for continued group health plan coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) during the period of time following the Participant’s employment termination, as set forth in the Participant’s Participation Agreement, provided that the Participant validly elects and is eligible to continue coverage under COBRA for the Participant and any such Family Members; and
4.3. Outplacement Services. Reasonable outplacement services in accordance with any applicable Company policy in effect as of the Participant’s Non-COC Involuntary Termination (or if no such policy is in effect, as determined by the Company, in its sole discretion).
5.Involuntary Termination During the Change of Control Period. If, during the Change of Control Period, (i) a Participant terminates his or her employment with the Company (or any parent or subsidiary of the Company) for Good Reason, or (ii) the Company (or any parent or subsidiary of the Company) terminates the Participant’s employment for a reason other than Cause or the Participant’s death or Disability (a “COC Involuntary Termination”), then, in each case, subject to the Participant’s compliance with Section 7, the Participant will receive the following Severance Benefits:
5.1. Cash Severance Benefits. A lump-sum payment of cash severance and/or bonus equal to the amount set forth in the Participant’s Participation Agreement;
5.2. Equity Award Vesting Acceleration Benefit. The Participant’s Equity Awards will accelerate and vest to the amount set forth in the Participant’s Participation Agreement, as applicable;
5.3. Continued Medical Benefits. If the Participant, and any Family Member(s) has/have coverage on the date of the Participant’s Involuntary Termination under a group health plan sponsored by the Company, the Company will pay on behalf of Participant the total applicable premium cost for continued group health plan coverage under the COBRA during the period of time following the Participant’s employment termination, as set forth in the Participant’s Participation Agreement, provided that the Participant validly elects and is eligible to continue coverage under COBRA for the Participant and his or her Family Members; and
5.4. Outplacement Services. Reasonable outplacement services in accordance with any applicable Company policy in effect as of the Participant’s COC Involuntary Termination (or if no such policy is in effect, as determined by the Company, in its sole discretion); provided, however, that such outplacement services shall be in no case less than
5 of 13


the outplacement services provided under any applicable Company policy in effect immediately prior to the applicable Change of Control.
6.Limitation on Payments. In the event that the severance and other benefits provided for in this Plan or otherwise (“280G Payments”) payable to a Participant (i) constitute “parachute payments” within the meaning of Section 280G of the Code, and (ii) but for this Section 6, would be subject to the excise tax imposed by Section 4999 of the Code, then the 280G Payments will be either:
6.1. delivered in full, or
6.2. delivered as to such lesser extent as would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by the Participant on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999. If a reduction in severance and other benefits constituting “parachute payments” is necessary so that benefits are delivered to a lesser extent, reduction will occur in the following order: (a) cancellation of awards granted “contingent on a change in ownership or control” (within the meaning of Code Section 280G); (b) a pro rata reduction of (i) cash payments that are subject to Section 409A as deferred compensation and (ii) cash payments not subject to Section 409A; (c) a pro rata reduction of (i) employee benefits that are subject to Section 409A as deferred compensation and (ii) employee benefits not subject to Section 409A; and (d) a pro rata cancellation of (i) accelerated vesting equity awards that are subject to Section 409A as deferred compensation and (ii) equity awards not subject to Section 409A. In the event that acceleration of vesting of equity awards is to be cancelled, such acceleration of vesting will be cancelled in the reverse order of the date of grant of the Participant’s equity awards. Notwithstanding the foregoing, to the extent the Company submits any payment or benefit payable to the Participant under this Plan or otherwise to the Company’s stockholders for approval in accordance with Treasury Regulation Section 1.280G-1 Q&A 7, the foregoing provisions shall not apply following such submission and such payments and benefits will be treated in accordance with the results of such vote, except that any reduction in, or waiver of, such payments or benefits required by such vote will be applied without any application of discretion by the Participant and in the order prescribed by this Section 6.
Unless the Participant and the Company otherwise agree in writing, any determination required under this Section 6 will be made in writing by the Company’s independent public accountants immediately prior to the Change of Control or such other person or entity to which the parties mutually agree (the “Firm”), whose determination will be conclusive and binding upon the Participant and the Company. For purposes of making the calculations required by this Section 6 the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Participant and the Company will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section 6. The Company will bear all costs the Firm may incur in connection with any calculations contemplated by this Section 6.
6 of 13


7.Conditions to Receipt of Severance.
7.1. Release Agreement. As a condition to receiving the Severance Benefits under this Plan, each Participant will be required to sign and not revoke a separation and release of claims agreement in substantially the form attached this Plan as Appendix B (the “Release”). In all cases, the Release must become effective and irrevocable no later than the 60th day following the Participant’s Involuntary Termination (the “Release Deadline Date”). If the Release does not become effective and irrevocable by the Release Deadline Date, the Participant will forfeit any right to the Severance Benefits. In no event will the Severance Benefits be paid or provided until the Release becomes effective and irrevocable.
7.2. Other Requirements. A Participant’s receipt of Severance Benefits will be subject to the Participant continuing to comply with the provisions of this Section 7 and the terms of any confidentiality, proprietary information and inventions agreement and such other appropriate agreement between the Participant and the Company. Severance Benefits under this Plan will terminate immediately for a Participant if the Participant, at any time, violates any such agreement and/or the provisions of this Section 7.
8.Timing of Severance Benefits. Provided that the Release becomes effective and irrevocable by the Release Deadline Date and subject to Section 10, the Severance Benefits will be paid (or in the case of Severance Benefits scheduled to be paid installments, will commence) on the first Company payroll date following the Release Deadline Date (such payment date, the “Severance Start Date”), and any severance payments or benefits otherwise payable to the Participant during the period immediately following the Participant’s termination of employment with the Company through the Severance Start Date will be paid in a lump sum to the Participant on the Severance Start Date, with any remaining payments to be made as provided in this Plan.
9.Exclusive Benefit. The benefits provided under this Plan shall be the exclusive benefit for a Participant related to termination of employment and/or change in control and shall supersede and replace any severance and/or change in control benefits set forth in any offer letter, employment agreement and/or severance agreement, including without limitation the Prior Plan. For the avoidance of doubt, if a Participant was otherwise eligible to participate in any other Company severance plan (whether or not subject to ERISA), then participation in this Plan will supersede and replace eligibility in such other plan.
10.Section 409A.
10.1. Notwithstanding anything to the contrary in this Plan, no severance payments or benefits to be paid or provided to a Participant, if any, under this Plan that, when considered together with any other severance payments or separation benefits, are considered deferred compensation under Section 409A (together, the “Deferred Payments”) will be paid or provided until the Participant has a “separation from service” within the meaning of Section 409A. Similarly, no severance payable to a Participant, if any, under this Plan that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A 1(b)(9) will be payable until the Participant has a “separation from service” within the meaning of Section 409A.
7 of 13


10.2. It is intended that none of the severance payments or benefits under this Plan will constitute Deferred Payments but rather will be exempt from Section 409A as a payment that would fall within the “short-term deferral period” as described in Section 10.3 below or resulting from an involuntary separation from service as described in Section 10.4 below. In no event will a Participant have discretion to determine the taxable year of payment of any Deferred Payment.
10.3. Notwithstanding anything to the contrary in this Plan or in any Participation Agreement, if a Participant is a “specified employee” within the meaning of Section 409A at the time of the Participant’s separation from service (other than due to death), then the Deferred Payments, if any, that are payable within the first six (6) months following the Participant’s separation from service, will become payable on the date six (6) months and one (1) day following the date of the Participant’s separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, in the event of the Participant’s death following the Participant’s separation from service, but before the six-month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of the Participant’s death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Plan is intended to constitute a separate payment under Section 1.409A-2(b)(2) of the Treasury Regulations.
10.4. Any amount paid under this Plan that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Payments for purposes of Section 10 above.
10.5. Any amount paid under this Plan that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit will not constitute Deferred Payments for purposes of Section 10 above.
10.6. The foregoing provisions are intended to comply with or be exempt from the requirements of Section 409A so that none of the payments and benefits to be provided under the Plan will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply or be exempt. Notwithstanding anything to the contrary in the Plan, including but not limited to Sections 12 and 15, the Company reserves the right to amend the Plan as it deems necessary or advisable, in its sole discretion and without the consent of the Participants, to comply with Section 409A or to avoid income recognition under Section 409A prior to the actual payment of benefits under the Plan or imposition of any additional tax. In no event will the Company reimburse a Participant for any taxes that may be imposed on the Participant as result of Section 409A.
11.Withholdings. The Company will withhold from any payments or benefits under the Plan all applicable U.S. federal, state, local and non-U.S. taxes required to be withheld and any other required payroll deductions.
8 of 13


12.Administration. The Company is the administrator of the Plan (within the meaning of section 3(16)(A) of ERISA). The Plan will be administered and interpreted by the Administrator (in its sole discretion). The Administrator is the “named fiduciary” of the Plan for purposes of ERISA and will be subject to the fiduciary standards of ERISA when acting in such capacity. Any decision made or other action taken by the Administrator with respect to the Plan, and any interpretation by the Administrator of any term or condition of the Plan, or any related document, will be conclusive and binding on all persons and be given the maximum possible deference allowed by law. In accordance with Section 2.1, the Administrator (a) may, in its sole discretion and on such terms and conditions as it may provide, delegate in writing to one or more officers of the Company all or any portion of its authority or responsibility with respect to the Plan, and (b) has the authority to act for the Company (in a non-fiduciary capacity) as to any matter pertaining to the Plan; provided, however, that any Plan amendment or termination or any other action that reasonably could be expected to increase materially the cost of the Plan must be approved by the Board.
13.Eligibility to Participate. To the extent that the Administrator has delegated administrative authority or responsibility to one or more officers of the Company in accordance with Sections 2.1 and 12, each such officer will not be excluded from participating in the Plan if otherwise eligible, but he or she is not entitled to act upon or make determinations regarding any matters pertaining specifically to his or her own benefit or eligibility under the Plan. The Administrator will act upon and make determinations regarding any matters pertaining specifically to the benefit or eligibility of each such officer under the Plan.
14.Term. This Plan will have a term of three years commencing on the Effective Date and expiring on the third anniversary of the Effective Date (the “Initial Term”) and shall, thereafter, automatically renew for successive one-year periods (each a “Renewal Term” and, collectively with the Initial Term, the “Term”) unless, upon the decision of the Administrator, the Company notifies the Participants who remain eligible for benefits under this Plan of the Plan’s nonrenewal at least twelve (12) months prior to the commencement of such Renewal Term, in which case such Renewal Term will be canceled and the Plan will expire on the anniversary of Initial Term or the relevant Renewal Term, as applicable. If a Change of Control occurs, the Term will extend automatically through the date that is twelve (12) months following the effective date of the Change of Control. If a Participant becomes entitled to benefits during the Term, the Plan will not terminate with respect to such Participant until all of the obligations of the Company and such Participant with respect to this Plan have been satisfied.
15.Amendment or Termination. The Company, by action of the Administrator, reserves the right to amend or terminate the Plan at any time, without advance notice to any Participant and without regard to the effect of the amendment or termination on any Participant or on any other individual. Any amendment or termination of the Plan will be in writing. In addition, notwithstanding the preceding, during the Term, the Company may not, without a Participant’s written consent, amend or terminate the Plan in any way, nor take any other action, that (i) prevents that Participant from becoming eligible for the Severance Benefits under the Plan, or (ii) reduces or alters to the detriment of the Participant the Severance Benefits payable, or potentially payable, to a Participant under the Plan (including,
9 of 13


without limitation, imposing additional conditions). Any action of the Company in amending or terminating the Plan will be taken in a non-fiduciary capacity.
16.Claims and Appeals.
16.1. Claims Procedure. Any employee or other person who believes he or she is entitled to any payment under the Plan may submit a claim in writing to the Administrator within 90 days of the earlier of (i) the date the claimant learned the amount of his or her benefits under the Plan or (ii) the date the claimant learned that he or she will not be entitled to any benefits under the Plan. If the claim is denied (in full or in part), the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Plan on which the denial is based. The notice also will describe any additional information needed to support the claim and the Plan’s procedures for appealing the denial. The denial notice will be provided within 90 days after the claim is received. If special circumstances require an extension of time (up to 90 days), written notice of the extension will be given within the initial 90-day period. This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the Administrator expects to render its decision on the claim.
16.2. Appeal Procedure. If the claimant’s claim is denied, the claimant (or his or her authorized representative) may apply in writing to the Administrator for a review of the decision denying the claim. Review must be requested within 60 days following the date the claimant received the written notice of their claim denial or else the claimant loses the right to review. The claimant (or representative) then has the right to review and obtain copies of all documents and other information relevant to the claim, upon request and at no charge, and to submit issues and comments in writing. The Administrator will provide written notice of its decision on review within 60 days after it receives a review request. If additional time (up to 60 days) is needed to review the request, the claimant (or representative) will be given written notice of the reason for the delay. This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the Administrator expects to render its decision. If the claim is denied (in full or in part), the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Plan on which the denial is based. The notice also will include a statement that the claimant will be provided, upon request and free of charge, reasonable access to, and copies of, all documents and other information relevant to the claim and a statement regarding the claimant’s right to bring an action under Section 502(a) of ERISA.
17.Attorneys’ Fees. The parties shall each bear their own expenses, legal fees and other fees incurred in connection with this Plan.
18.Source of Payments. All payments under the Plan will be paid from the general funds of the Company; no separate fund will be established under the Plan, and the Plan will have no assets. No right of any person to receive any payment under the Plan will be any greater than the right of any other general unsecured creditor of the Company.
19.Inalienability. In no event may any current or former employee of the Company or any of its subsidiaries or affiliates sell, transfer, anticipate, assign or otherwise dispose of any
10 of 13


right or interest under the Plan. At no time will any such right or interest be subject to the claims of creditors nor liable to attachment, execution or other legal process.
20.No Enlargement of Employment Rights. Neither the establishment or maintenance or amendment of the Plan, nor the making of any benefit payment hereunder, will be construed to confer upon any individual any right to continue to be an employee of the Company. The Company expressly reserves the right to discharge any of its employees at any time, with or without cause. However, as described in the Plan, a Participant may be entitled to benefits under the Plan depending upon the circumstances of his or her termination of employment.
21.Successors. Any successor to the Company of all or substantially all of the Company’s business and/or assets (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or other transaction) will assume the obligations under the Plan and agree expressly to perform the obligations under the Plan in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under the Plan, the term “Company” will include any successor to the Company’s business and/or assets which become bound by the terms of the Plan by operation of law, or otherwise.
22.Applicable Law. The provisions of the Plan will be construed, administered and enforced in accordance with ERISA and, to the extent applicable, the internal substantive laws of the state of California (but not its conflict of laws provisions).
23.Severability. If any provision of the Plan is held invalid or unenforceable, its invalidity or unenforceability will not affect any other provision of the Plan, and the Plan will be construed and enforced as if such provision had not been included.
24.Headings. Headings in this Plan document are for purposes of reference only and will not limit or otherwise affect the meaning hereof.
25.Indemnification. The Company hereby agrees to indemnify and hold harmless the officers and employees of the Company, and the members of its Board, from all losses, claims, costs or other liabilities arising from their acts or omissions in connection with the administration, amendment or termination of the Plan, to the maximum extent permitted by applicable law. This indemnity will cover all such liabilities, including judgments, settlements and costs of defense. The Company will provide this indemnity from its own funds to the extent that insurance does not cover such liabilities. This indemnity is in addition to and not in lieu of any other indemnity provided to such person by the Company.
26.Additional Information.
Plan Name:   Fluidigm Corporation 2020 Change of Control and  Severance Plan
Plan Sponsor:   Fluidigm Corporation
c/o General Counsel
2 Tower Place, Suite 2000
South San Francisco, CA 94080
11 of 13


Identification NumbersEIN: 77-0513190
PLAN: 502
Plan Year:   Company’s fiscal year
Plan Administrator:  Fluidigm Corporation
Attention: Administrator of the Fluidigm Corporation 2020 Change of Control and Severance Plan
2 Tower Place, Suite 2000
South San Francisco, CA 94080
650-266-6000
Agent for Service of
Legal Process:   Fluidigm Corporation
           Attention: General Counsel
2020 Change of Control and Severance Plan
2 Tower Place, Suite 2000
South San Francisco, CA 94080
650-266-6000
           Service of process also may be made upon the Administrator.
Type of Plan:   Severance Plan/Employee Welfare Benefit Plan
Plan Costs:   The cost of the Plan is paid by the Employer.
27.Statement of ERISA Rights.
As a Participant under the Plan, you have certain rights and protections under ERISA:
You may examine (without charge) all Plan documents, including any amendments and copies of all documents filed with the U.S. Department of Labor. These documents are available for your review in the Company’s Human Resources Department.

You may obtain copies of all Plan documents and other Plan information upon written request to the Administrator. A reasonable charge may be made for such copies.
In addition to creating rights for Participants, ERISA imposes duties upon the people who are responsible for the operation of the Plan. The people who operate the Plan (called “fiduciaries”) have a duty to do so prudently and in the interests of you and the other Participants. No one, including the Company or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a benefit under the Plan or exercising your rights under ERISA. If your claim for payments or benefits under the Plan is denied, in whole or in part, you must receive a written explanation of the reason for the denial. You have the right to have the denial of your claim reviewed. (The claim review procedure is explained in Section 16 above.)
Under ERISA, there are steps you can take to enforce the above rights. For example, if you request materials and do not receive them within 30 days, you may file suit in a federal court. In such a case, the court may require the Administrator to provide the materials and to pay you up
12 of 13


to $110 a day until you receive the materials, unless the materials were not sent due to reasons beyond the control of the Administrator. If you have a claim which is denied or ignored, in whole or in part, you may file suit in a federal court. If it should happen that you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a federal court.
In any case, the court will decide who will pay court costs and legal fees. If you are successful, the court may order the person you have sued to pay these costs and fees. If you lose, the court may order you to pay these costs and fees, for example, if it finds that your claim is frivolous.
If you have any questions regarding the Plan, please contact the Administrator. If you have any questions about this statement or about your rights under ERISA, you may contact the nearest area office of the Employee Benefits Security Administration (formerly the Pension and Welfare Benefits Administration), U.S. Department of Labor, listed in your telephone directory, or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, N.W. Washington, D.C. 20210. You also may obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration.

13 of 13


CEO
Appendix A
Fluidigm Corporation 2020 Change of Control and Severance Plan
Participation Agreement

Fluidigm Corporation (the “Company”) is pleased to inform you, S. Christopher Linthwaite, that you have been selected to participate in the Company’s 2020 Change of Control and Severance Plan (the “Plan”) as a Participant.
A copy of the Plan was delivered to you with this Participation Agreement. Your participation in the Plan is subject to all of the terms and conditions of the Plan. The capitalized terms used but not defined herein will have the meanings ascribed to them in the Plan.
In order to actually become a participant in the Plan, you must complete and sign this Participation Agreement.
Definition of “Good Reason”
Good Reason” means the occurrence of one or more of the following events effected without your prior consent, provided you terminate your employment with the Company within one (1) year following the initial existence of the “Good Reason” condition (discussed below): (i) the assignment to you of any duties or the reduction of your then-current duties, either of which results in a material diminution in your then-current position or responsibilities with the Company, including a requirement that you are required to report to a corporate officer or employee instead of reporting directly to the board of directors of the Company or, if the Company becomes a subsidiary of another corporation, the board of directors of the Company’s parent company; (ii) a material reduction by the Company in your then-current base salary; (iii) a material change in the geographic location at which you must perform services (for purposes of this Participation Agreement, your relocation to a facility or a location less than 25 miles from your then-present location shall not be considered a material change in geographic location); or (iv) any material breach by the Company of any material provision of this Participation Agreement. You will not resign for Good Reason without first providing the Company with written notice of the acts or omissions constituting the grounds for “Good Reason” within 90 days of the initial existence of the grounds for “Good Reason” and a reasonable cure period of not less than 30 days following the date of such notice.
Non-COC Involuntary Termination
If, outside of the Change of Control Period, you incur a Non-COC Involuntary Termination, then subject to the terms and conditions of the Plan, you will receive:
1.Cash Severance Benefits. An aggregate amount equal to 200% of your annual base salary in effect as of the date of your Non-COC Involuntary Termination paid in equal installments over a period of 24 months following your termination date.
2.Continued Medical Benefits. Payment by the Company of continued health coverage under COBRA for a period of 12 months following your termination of employment.
3.Outplacement Services. Outplacement services as described in Section 4.3 of the Plan.
A-1


COC Involuntary Termination
If, during the Change of Control Period, you incur a COC Involuntary Termination, then subject to the terms and conditions of the Plan, you will receive:
1.Cash Severance Benefits.
a.A lump-sum payment equal to 250% of the sum of (x) your annual base salary (as in effect immediately prior to the Change of Control or your COC Involuntary Termination, whichever is greater), plus (y) the greater of (A) your annual target bonus (as in effect immediately prior to the Change of Control or your COC Involuntary Termination, whichever is greater) or (B) the average of the annual bonuses actually paid to you for the three (3) fiscal years preceding the year in which your COC Involuntary Termination occurs. For the avoidance of doubt, if you incurred a termination prior to a Change of Control that qualifies as a COC Involuntary Termination, then you will be entitled to a lump-sum payment of the amount calculated under the preceding sentence, less amounts already paid as cash Severance Benefits for a Non-COC Involuntary Termination.
b.A lump sum amount equal to (i) your annual target bonus (as in effect immediately prior to the Change of Control or your COC Involuntary Termination, whichever is greater), multiplied by (ii) a fraction, the numerator of which is the number of days worked by you during the year in which the COC Involuntary Termination occurs and the denominator of which is 365.
2.Continued Medical Benefits. Payment by the Company of continued health coverage under COBRA (or, for any period after expiration of COBRA eligibility, reimbursement of health insurance monthly costs up the amount of the COBRA premium that would be payable if COBRA were available at such time) for a period of 30 months following your termination of employment.
3.Equity Award Vesting Acceleration. 100% of your then-outstanding and unvested Equity Awards will become vested in full. If, however, an outstanding Equity Award is to vest and/or the amount of the award to vest is to be determined based on the achievement of performance criteria, then, unless expressly otherwise provided in the applicable Equity Award agreement, the Equity Award will vest as to 100% of the “Baseline Number of Restricted Stock Units” or “Baseline Number of Performance Units” (as defined in the Company’s grant agreements) or the equivalent measure of the number of units or shares that vest at 100% of target levels of achievement under the relevant Equity Award. Except otherwise provided in the applicable Equity Award agreement, shares owed upon such vesting (and exercise if applicable) of Equity Awards will issued to you as promptly as practicable and no more than 30 days after they become issuable (whether through the vesting acceleration alone or upon an exercise of options following such vesting acceleration). Notwithstanding the foregoing, to the extent that the payment or settlement of an Equity Award is subject to Section 409A, the Equity Award will be paid or settled in a manner that will meet the requirements of Section 409A such that the payment or settlement will not be subject to the additional tax or interest applicable under Section 409A.
4.Outplacement Services. Outplacement services as described in Section 5.4 of the Plan.
A-2


Additional Benefits
In addition to the foregoing benefits, in addition to the Plan benefits described above, if, during the Change of Control Period, you incur a COC Involuntary Termination, then subject to the terms and conditions of the Plan, the Company will reimburse your reasonable attorneys’ fees incurred in connection with the review of the Release and any related separation agreements and documents, up to $8,000.
Furthermore, if you incur a Non-COC Involuntary Termination or a COC Involuntary Termination, the Company will assign to you and reimburse you for payment of premiums paid by you to maintain the life insurance policy insuring your life (as referenced in your Endorsement Split-Dollar Life Insurance Agreement, dated as of September 9, 2017, with the Company) for up to 30 months following your termination of employment.
General Provisions
For clarity, any severance payments provided for herein that are based on annual base salary (and any reduction to base salary constituting “Good Reason”) shall be calculated without giving effect to any temporary reduction in base salary imposed by the Company or agreed to by you in connection with any global pandemic or comparable global or U.S. emergency that threatens the Company’s economic position.
In order to receive any Severance Benefits for which you otherwise become eligible under the Plan, you must sign and deliver to the Company the Release, which must have become effective and irrevocable within the requisite period set forth in the Plan.
[Remainder of This Page Intentionally Left Blank]

A-3


By your signature below, you and the Company agree that your participation in the Plan is governed by this Participation Agreement and the provisions of the Plan. Your signature below confirms that: (1) you have received a copy of the 2020 Change of Control and Severance Plan and Summary Plan Description; (2) you have carefully read this Participation Agreement and the 2020 Change of Control and Severance Plan and Summary Plan Description; (3) decisions and determinations by the Administrator under the Plan will be final and binding on you and your successors; and (4) participation in the Plan and this Participation Agreement replaces in its entirety any severance and/or change of control provisions set forth in any offer letter, employment agreement and/or Equity Award agreement, including, but not limited to, the Prior Plan and your Employment and Severance Agreement with the Company dated August 1, 2016.
FLUIDIGM CORPORATION

________________________________
Signature

_________________________________
Name

_________________________________
Title
PARTICIPANT

________________________________
Signature

_________________________________
Name

_________________________________
Date
Attachment: Fluidigm Corporation 2020 Change of Control and Severance Plan and Summary Plan Description
[Signature Page to the Participation Agreement]
A-4


Executive Leadership Team Members
Appendix A
Fluidigm Corporation 2020 Change of Control and Severance Plan
Participation Agreement

Fluidigm Corporation (the “Company”) is pleased to inform you that you have been selected to participate in the Company’s 2020 Change of Control and Severance Plan (the “Plan”) as a Participant.
A copy of the Plan was delivered to you with this Participation Agreement. Your participation in the Plan is subject to all of the terms and conditions of the Plan. The capitalized terms used but not defined herein will have the meanings ascribed to them in the Plan.
In order to actually become a participant in the Plan, you must complete and sign this Participation Agreement.
Definition of “Good Reason”
Good Reason” means the occurrence of one or more of the following events effected without your prior consent, provided you terminate your employment with the Company within one (1) year following the initial existence of the “Good Reason” condition (discussed below): (i) the assignment to you of any duties or the reduction of your then-current duties, either of which results in a material diminution in your then-current position or responsibilities with the Company including, without limitation, any negative change in reporting hierarchy involving you or the person to whom you directly report; (ii) a material reduction by the Company in your then-current base salary; (iii) a material change in the geographic location at which you must perform services (for purposes of this Participation Agreement, your relocation to a facility or a location less than 25 miles from your then-present location shall not be considered a material change in geographic location); or (iv) any material breach by the Company of any material provision of this Participation Agreement. You will not resign for Good Reason without first providing the Company with written notice of the acts or omissions constituting the grounds for “Good Reason” within 90 days of the initial existence of the grounds for “Good Reason” and a reasonable cure period of not less than 30 days following the date of such notice.
Non-COC Involuntary Termination
If, outside of the Change of Control Period, you incur a Non-COC Involuntary Termination, then subject to the terms and conditions of the Plan, you will receive:
1.Cash Severance Benefits. An aggregate amount equal to 75% of your annual base salary in effect as of the date of your Non-COC Involuntary Termination paid in equal installments over a period of nine (9) months following your termination date.
2.Continued Medical Benefits. Payment by the Company of continued health coverage under COBRA for a period of nine (9) months following your termination of employment. Notwithstanding the foregoing, if you are not employed in the United States, the benefit under this paragraph will be a regional equivalent to COBRA determined by the Administrator in its sole discretion.



3.Outplacement Services. Outplacement services as described in Section 4.3 of the Plan.
COC Involuntary Termination
If, during the Change of Control Period, you incur a COC Involuntary Termination, then subject to the terms and conditions of the Plan, you will receive:
1.Cash Severance Benefits.
a.A lump-sum payment equal to 150% of the sum of (x) your annual base salary (as in effect immediately prior to the Change of Control or your COC Involuntary Termination, whichever is greater), plus (y) the greater of (A) your annual target bonus (as in effect immediately prior to the Change of Control or your COC Involuntary Termination, whichever is greater) or (B) the average of the annual bonuses actually paid to you for the three (3) fiscal years preceding the year in which your COC Involuntary Termination occurs. For the avoidance of doubt, if you incurred a termination prior to a Change of Control that qualifies as a COC Involuntary Termination, then you will be entitled to a lump-sum payment of the amount calculated under the preceding sentence, less amounts already paid as cash Severance Benefits for a Non-COC Involuntary Termination.
b.A lump sum amount equal to (i) your annual target bonus (as in effect immediately prior to the Change of Control or your COC Involuntary Termination, whichever is greater), multiplied by (ii) a fraction, the numerator of which is the number of days worked by you during the year in which the COC Involuntary Termination occurs and the denominator of which is 365.
2.Continued Medical Benefits. Payment by the Company of continued health coverage under COBRA for a period of 18 months following your termination of employment. Notwithstanding the foregoing, if you are not employed in the United States, the benefit under this paragraph will be a regional equivalent to COBRA determined by the Administrator in its sole discretion.
3.Equity Award Vesting Acceleration. 100% of your then-outstanding and unvested Equity Awards will become vested in full. If, however, an outstanding Equity Award is to vest and/or the amount of the award to vest is to be determined based on the achievement of performance criteria, then, unless expressly otherwise provided in the applicable Equity Award agreement, the Equity Award will vest as to 100% of the “Baseline Number of Restricted Stock Units” or “Baseline Number of Performance Units” (as defined in the Company’s grant agreements) or the equivalent measure of the number of units or shares that vest at 100% of target levels of achievement under the relevant Equity Award. Except otherwise provided in the applicable Equity Award agreement, shares owed upon such vesting (and exercise if applicable) of Equity Awards will issued to you as promptly as practicable and no more than 30 days after they become issuable (whether through the vesting acceleration alone or upon an exercise of options following such vesting acceleration). Notwithstanding the foregoing, to the extent that the payment or settlement of an Equity Award is subject to Section 409A, the Equity Award will be paid or settled in a manner that will meet the requirements of Section 409A such that the payment or settlement will not be subject to the additional tax or interest applicable under Section 409A.
A-2


4.Outplacement Services. Outplacement services as described in Section 5.4 of the Plan.
Additional Benefits
In addition to the foregoing benefits, in addition to the Plan benefits described above, if, during the Change of Control Period, you incur a COC Involuntary Termination, then subject to the terms and conditions of the Plan, the Company will reimburse your reasonable attorneys’ fees incurred in connection with the review of the Release and any related separation agreements and documents, up to $5,000.
General Provisions
For clarity, any severance payments provided for herein that are based on annual base salary (and any reduction to base salary constituting “Good Reason”) shall be calculated without giving effect to any temporary reduction in base salary imposed by the Company or agreed to by you in connection with any global pandemic or comparable global or U.S. emergency that threatens the Company’s economic position.
In order to receive any Severance Benefits for which you otherwise become eligible under the Plan, you must sign and deliver to the Company the Release, which must have become effective and irrevocable within the requisite period set forth in the Plan.
[Remainder of This Page Intentionally Left Blank]
A-3



By your signature below, you and the Company agree that your participation in the Plan is governed by this Participation Agreement and the provisions of the Plan. Your signature below confirms that: (1) you have received a copy of the 2020 Change of Control and Severance Plan and Summary Plan Description; (2) you have carefully read this Participation Agreement and the 2020 Change of Control and Severance Plan and Summary Plan Description; (3) decisions and determinations by the Administrator under the Plan will be final and binding on you and your successors; and (4) participation in the Plan and this Participation Agreement replaces in its entirety any severance and/or change of control provisions set forth in any offer letter, employment agreement and/or Equity Award agreement, including, but not limited to, the Prior Plan.
FLUIDIGM CORPORATION

________________________________
Signature

_________________________________
Name

_________________________________
Title
PARTICIPANT

________________________________
Signature

_________________________________
Name

_________________________________
Date
Attachment: Fluidigm Corporation 2020 Change of Control and Severance Plan and Summary Plan Description
[Signature Page to the Participation Agreement]
A-4


Appendix B
Fluidigm Corporation 2020 Change of Control and Severance Plan
Form of Release


B-1
EX-31.1 3 exhibit31110q2q2020ng.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER
PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Stephen Christopher Linthwaite, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Fluidigm Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 7, 2020 By:/s/ Stephen Christopher Linthwaite
 Stephen Christopher Linthwaite
 President and Chief Executive Officer

EX-31.2 4 exhibit31210q2q2020ng.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Vikram Jog, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Fluidigm Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 7, 2020  By:/s/ Vikram Jog
 Vikram Jog
 Chief Financial Officer

EX-32.1 5 exhibit32110q2q2020ng.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Stephen Christopher Linthwaite, the chief executive officer of Fluidigm Corporation (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,
1.the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 7, 2020By:/s/ Stephen Christopher Linthwaite
 Stephen Christopher Linthwaite
 President and Chief Executive Officer
 



EX-32.2 6 exhibit32210q2q2020ng.htm EX-32.2 Document

Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Vikram Jog, the chief financial officer of Fluidigm Corporation (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,
1.the Company’s Quarterly Report on Form 10-Q for the quarter year ended June 30, 2020 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 7, 2020By:/s/ Vikram Jog
 Vikram Jog
 Chief Financial Officer
 

EX-101.SCH 7 fldm-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 2102102 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2108103 - Disclosure - Business Combination link:presentationLink link:calculationLink link:definitionLink 2309302 - Disclosure - Business Combination (Tables) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Business Combination - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Business Combination - Net Cash Flows (Details) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2113104 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 2314303 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2415407 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2416408 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - Revenue - Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - Revenue - Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2118105 - Disclosure - Goodwill and Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 2319304 - Disclosure - Goodwill and Intangible Assets, net (Tables) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2421411 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2422412 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2123106 - Disclosure - Balance Sheet Details link:presentationLink link:calculationLink link:definitionLink 2324305 - Disclosure - Balance Sheet Details (Tables) link:presentationLink link:calculationLink link:definitionLink 2425413 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 2426414 - Disclosure - Balance Sheet Details - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2427415 - Disclosure - Balance Sheet Details - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2428416 - Disclosure - Balance Sheet Details - Warranty Accrual (Details) link:presentationLink link:calculationLink link:definitionLink 2129107 - Disclosure - Convertible Notes and Credit Facility link:presentationLink link:calculationLink link:definitionLink 2330306 - Disclosure - Convertible Notes and Credit Facility (Tables) link:presentationLink link:calculationLink link:definitionLink 2431417 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2432418 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2133108 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2334307 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2435419 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2436420 - Disclosure - Leases - Supplemental Balance sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2437421 - Disclosure - Leases - Schedule of Operating Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 2438422 - Disclosure - Leases - Operating Lease Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 2438422 - Disclosure - Leases - Operating Lease Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 2139109 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2340308 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2441423 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 2442424 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2143110 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2344309 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2445425 - Disclosure - Shareholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2446426 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 2147111 - Disclosure - Stock-Based Plans link:presentationLink link:calculationLink link:definitionLink 2348310 - Disclosure - Stock-Based Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2449427 - Disclosure - Stock-Based Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2450428 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2451429 - Disclosure - Stock-Based Plans - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2452430 - Disclosure - Stock-Based Plans - Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2153112 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2454431 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2155113 - Disclosure - Information About Geographic Areas link:presentationLink link:calculationLink link:definitionLink 2456432 - Disclosure - Information About Geographic Areas (Details) link:presentationLink link:calculationLink link:definitionLink 2157114 - Disclosure - Development Agreement link:presentationLink link:calculationLink link:definitionLink 2458433 - Disclosure - Development Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 2159115 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2160116 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2461434 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 fldm-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 fldm-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 fldm-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Certain Employee Certain Employee [Member] Certain Employee [Member] Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Other income (expense), net Other Nonoperating Income (Expense) Activity of warranty accrual Schedule of Product Warranty Liability [Table Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Product Information [Line Items] Product Information [Line Items] Proceeds from legal settlements Proceeds from Legal Settlements Deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Service revenue Service revenue Service [Member] Released (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Components of accumulated other comprehensive loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] China CHINA Stock option grants exercise price minimum percentage on fair market value Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value Additional awards authorized for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Consumables Consumables [Member] Consumables [Member] Leases Lessee, Leases [Policy Text Block] Offering related costs Debt Issuance Costs, Gross InstruNor AS InstruNor AS [Member] InstruNor AS [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Product warranty term Product Warranty Term Product Warranty Term Deferred tax liability Deferred Income Tax Liabilities, Net Proceeds from debt issuance Proceeds from Issuance of Debt Current Fiscal Year End Date Current Fiscal Year End Date Developed technology, net Intangible Assets, Net (Excluding Goodwill) Proceeds from convertible debt issuance Proceeds from Convertible Debt Loss from operations Operating Income (Loss) Instruments Instruments [Member] Instruments [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Total current liabilities Liabilities, Current Performance Shares Performance Shares [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Beginning Balance (usd per share) Ending Balance (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Variable Rate [Domain] Variable Rate [Domain] Variable Rate [Axis] Variable Rate [Axis] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and contingencies Commitments and Contingencies Issuance of restricted stock, net of shares withheld for taxes, and other Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Tranche Two Share-based Payment Arrangement, Tranche Two [Member] ASSETS Assets [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Less: cash and cash equivalents acquired Cash Acquired from Acquisition Accounting Policies [Abstract] Accounting Policies [Abstract] Convertible notes, net Convertible Notes Payable, Noncurrent Entity Shell Company Entity Shell Company Released (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Cover [Abstract] Cover [Abstract] Operating cash flows from operating leases Operating Lease, Payments Accounts payable Accounts Payable, Current Document Type Document Type 2019 Convertible Notes potential make-whole shares Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member] Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member] ESPP, offering period Employee Stock Purchase Plan, Offering Period Employee Stock Purchase Plan, Offering Period Accumulated deficit Retained Earnings (Accumulated Deficit) Operating lease right-of-use asset, net Right-of-use asset Total operating lease right-of-use assets, net Operating Lease, Right-of-Use Asset Unamortized debt discount Debt Instrument, Unamortized Discount Loss from extinguishment of debt Loss on extinguishment of debt Gain (loss) on extinguishment of debt Gain (Loss) on Extinguishment of Debt Acquired finite-lived intangible assets, useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 2014 Convertible Notes Two Thousand And Fourteen Convertible Notes [Member] Two Thousand And Fourteen Convertible Notes [Member] 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price Beginning Balance (shares) Ending Balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Total unrecognized compensation cost related to stock-based compensation arrangements Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Customer [Axis] Customer [Axis] Remaining lease term Lessee, Operating Lease, Remaining Term Of Contract Lessee, Operating Lease, Remaining Term Of Contract Collaboration agreement, deferred revenue Collaborative Arrangement, Revenue Deferred Collaborative Arrangement, Revenue Deferred Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either June 30, 2020 or December 31, 2019 Preferred Stock, Value, Issued Total costs and expenses Operating Expenses Operating lease right-of-use buildings Building [Member] Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Document Annual Report Document Quarterly Report Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Other non-current liabilities Other Liabilities, Noncurrent Work-in-process Inventory, Work in Process, Net of Reserves Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Effect of foreign exchange rate fluctuations on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Construction-in-progress Construction in Progress, Gross Inventories Total inventories Inventory, Net Total revenue Sales to customers Revenue from Contract with Customer, Excluding Assessed Tax Lender Name [Axis] Lender Name [Axis] Share price (usd per share) Share Price Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Schedule of balance sheet information Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Concentration risk, percentage Concentration Risk, Percentage Entity File Number Entity File Number Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Initial conversion rate of notes Debt Instrument, Convertible, Conversion Ratio Percentage of performance period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest Statement [Line Items] Statement [Line Items] Acquisition of InstruNor AS (shares) Stock Issued During Period, Shares, Acquisitions Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Statement [Table] Statement [Table] Senior Convertible Notes due 2034 Senior Convertible Notes due 2034 [Member] Senior Convertible Notes due 2034 [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Convertible Notes Convertible Debt Securities [Member] Legal fees Legal Fees Credit Facility [Axis] Credit Facility [Axis] Lease amortization Operating Lease, Right-of-Use Asset, Amortization Expense Debt Debt Instrument, Fair Value Disclosure Liabilities assumed: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] Preferred stock, shares issued (shares) Preferred Stock, Shares Issued Performance obligation period Revenue From Contract With Customer, Performance Obligation Period Revenue From Contract With Customer, Performance Obligation Period Business Combinations [Abstract] Business Combinations [Abstract] Net loss per share, basic and diluted (usd per share) Earnings Per Share, Basic and Diluted DVS Sciences, Inc. DVS Sciences, Inc. [Member] DVS Sciences, Inc. [Member] Collaboration agreement, up-front and periodic milestone payments, up to Up-Front And Milestone Payments, Maximum Up-Front And Milestone Payments, Maximum Minimum Lease Payments for Operating Leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Equity Incentive Plan Equity Incentive Plan [Member] Equity Incentive Plan [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Redemption, Period One Debt Instrument, Redemption, Period One [Member] Schedule Of Significant Accounting Policies [Table] Schedule Of Significant Accounting Policies [Table] Schedule Of Significant Accounting Policies [Table] Schedule of common stock reserved for future issuance Schedule of stock-based compensation expense Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Securities To Be Issued (in shares) Awards authorized for issuance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Schedule of consideration transferred and assets acquired and liabilities assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Amendment Flag Amendment Flag Line of credit outstanding Long-term Line of Credit 2017 Inducement Award Plan 2017 Inducement Award Plan [Member] 2017 Inducement Award Plan [Member] Inventories, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Balance Sheet Details Supplemental Balance Sheet Disclosures [Text Block] Maximum employee purchase amount Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Additional advance payments received Contract With Customer, Liability, Increase From Cash Receipts Contract With Customer, Liability, Increase From Cash Receipts Financial Instruments [Domain] Financial Instruments [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Schedule of finite-lived intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Geographical [Axis] Geographical [Axis] Subsequent Events Subsequent Events [Text Block] Local Phone Number Local Phone Number Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Renewal term Lessee, Operating Lease, Renewal Term Gross Unrealized Gain Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Weighted-Average Grant Date Fair Value per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Employee Stock Employee Stock Purchase Plan Employee Stock [Member] 2009 Equity Incentive Plan Two Thousand And Nine Equity Incentive Plan [Member] Two Thousand And Nine Equity Incentive Plan [Member] Accounts receivable, allowances Accounts Receivable, Allowance for Credit Loss, Current Acquisition of InstruNor AS Stock Issued During Period, Value, Acquisitions Total cash Cash [Member] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Accounts Receivable Receivable [Policy Text Block] Selling, general and administrative Selling, General and Administrative Expense Accumulated amortization Operating Lease, Right-Of-Use Asset, Accumulated Amortization Operating Lease, Right-Of-Use Asset, Accumulated Amortization Amortization of developed technology Amortization of intangibles Amortization of Intangible Assets Schedule of lease expense Lease, Cost [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Capitalized Contract Cost [Domain] Capitalized Contract Cost [Domain] Other non-current assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Information About Geographic Areas Segment Reporting Disclosure [Text Block] Issuance of restricted stock, net of shares withheld for taxes, and other (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Unvested awards (shares) Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number Total assets Assets Revenue from Contract with Customer Revenue from Contract with Customer Benchmark [Member] Beginning Balance (shares) Ending Balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Developed technology Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Net Finite-Lived Intangible Assets, Net Subsequent Event Type [Axis] Subsequent Event Type [Axis] Net change in unrealized gain (loss) on investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Antidilutive Securities [Axis] Antidilutive Securities [Axis] Description of Business Business Description and Basis of Presentation [Text Block] Entity Small Business Entity Small Business Concentrations of Business and Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Vesting [Domain] Vesting [Domain] Interest expense Interest Expense Entity Filer Category Entity Filer Category Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Underwriting discount Underwriting Discount Underwriting Discount Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Entity Address, City or Town Entity Address, City or Town Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Commission Costs Commission Costs [Member] Commission Costs [Member] Contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Revenue recognized Contract with Customer, Liability, Revenue Recognized Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Vested Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One Proceeds from stock issuance from ESPP Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised Level I Fair Value, Inputs, Level 1 [Member] Inventories Increase (Decrease) in Inventories Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Document Fiscal Year Focus Document Fiscal Year Focus Shareholders' Equity [Line Items] Shareholders' Equity [Line Items] [Line Items] for Shareholders' Equity [Table] Accounts payable Increase (Decrease) in Accounts Payable Number of Nonvested and Outstanding Units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Raw materials Inventory, Raw Materials, Net of Reserves Shareholders' Equity [Table] Shareholders' Equity [Table] Shareholders' Equity [Table] Debt Instrument [Axis] Debt Instrument [Axis] Additional Paid-in Capital Additional Paid-in Capital [Member] Schedule of consideration transferred Schedule of Business Acquisitions, by Acquisition [Table Text Block] Unvested awards Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Other non-cash items Other Operating Activities, Cash Flow Statement Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Capitalized Contract Cost [Axis] Capitalized Contract Cost [Axis] Class of Stock [Line Items] Class of Stock [Line Items] Unvested awards Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1 COVID-19 project, budget COVID-19 Project, Budget COVID-19 Project, Budget Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Litigation Case [Axis] Litigation Case [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Common stock, shares outstanding (shares) Beginning Balance (shares) Ending Balance (shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Variable costs including non-lease component Variable Lease, Cost Revolving Credit Facility Revolving Credit Facility [Member] Research and development Research and Development Expense Subsequent event Subsequent Event [Member] Beginning Balance (usd per share) Ending Balance (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Acquisition, net of cash acquired Acquisition of InstruNor, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Common stock, shares authorized (shares) Common Stock, Shares Authorized Concentration Risk Type [Axis] Concentration Risk Type [Axis] Property and equipment, gross Property, Plant and Equipment, Gross Proceeds from exercise of stock options Proceeds from Stock Options Exercised Document Period End Date Document Period End Date Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Entity Registrant Name Entity Registrant Name Fair Value Estimate of Fair Value Measurement [Member] Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Operating lease liabilities, non-current Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Four Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Proceeds from maturities of investments Proceeds from Maturities, Prepayments and Calls of Other Investments Unvested awards (usd per share) Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price Use of Estimates Use of Estimates, Policy [Policy Text Block] Current assets: Assets, Current [Abstract] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Prepayment fee, percentage Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity Preferred stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Other revenue License and royalty revenue License [Member] Patents and licenses Patents and License Agreements [Member] Patents and License Agreements [Member] Schedule of nonvested performance-based units activity Schedule of Nonvested Performance-based Units Activity [Table Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Asia-Pacific Asia Pacific [Member] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment 5 Largest Customers Five Largest Customers [Member] Five Largest Customers [Member] Entity Tax Identification Number Entity Tax Identification Number Convertible Notes and Credit Facility Long-term Debt [Text Block] Number Of Remaining Securities Available For Future Issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Amortized Cost Cash, Cash Equivalents, And Short Term Investments, Amortized Cost Cash, Cash Equivalents, And Short Term Investments, Amortized Cost Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands): Cash Paid For Operating Lease Liabilities [Abstract] Cash Paid For Operating Lease Liabilities [Abstract] Computer equipment and software Computer Equipment And Software [Member] Computer Equipment And Software [Member] Summary of disaggregation of revenue Disaggregation of Revenue [Table Text Block] Loss before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Trading Symbol Trading Symbol Lease term Lessee, Operating Lease, Term of Contract Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Inventories Schedule of Inventory, Current [Table Text Block] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense 2017 Employee Stock Purchase Plan 2017 Employee Stock Purchase Plan Two Thousand Seventeen Employee Stock Purchase Plan [Member] Two Thousand Seventeen Employee Stock Purchase Plan [Member] Payments for taxes related to net share settlement of equity awards and other Payment, Tax Withholding, Share-based Payment Arrangement Schedule of cash and available-for-sale securities Debt Securities, Available-for-sale [Table Text Block] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable 2017 Inducement Award Plan Two Thousand And Seventeen Inducement Award Plan [Member] Two Thousand And Seventeen Inducement Award Plan [Member] Goodwill and Intangible Assets, net Intangible Assets Disclosure [Text Block] Vested (usd per share) Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price Cash-restricted Restricted Cash And Cash Equivalents [Domain] Restricted Cash And Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Long-term Debt, Total Long-term Debt Deferred revenue Increase (Decrease) in Contract with Customer, Liability Leases Lessee, Operating Leases [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Cash-restricted Restricted Cash and Cash Equivalents City Area Code City Area Code Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Cost of revenue Cost of Goods and Services Sold Fair Value Debt Securities, Available-for-sale CALIFORNIA CALIFORNIA Equity Components [Axis] Equity Components [Axis] Title of 12(b) Security Title of 12(b) Security Warranty costs incurred Standard and Extended Product Warranty Accrual, Decrease for Payments Finished goods Inventory, Finished Goods, Net of Reserves Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Minimum Minimum [Member] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Operating lease liabilities, current Operating lease liabilities, current Operating Lease, Liability, Current Beginning balance Ending balance Standard and Extended Product Warranty Accrual Percentage of eligible inventory Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory Forfeited (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value United States UNITED STATES Options exercised (usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Schedule of restricted cash Restrictions on Cash and Cash Equivalents [Table Text Block] Revenue: Revenues [Abstract] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Activity under stock options Share-based Payment Arrangement, Option, Activity [Table Text Block] Weighted-Average Amortization Period Finite-Lived Intangible Assets, Remaining Amortization Period 2020 (remainder of the year) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Customer [Domain] Customer [Domain] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Depreciation and amortization Depreciation, Amortization and Accretion, Net Subsequent Event Type [Domain] Subsequent Event Type [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Weighted average discount rate per annum Operating Lease, Weighted Average Discount Rate, Percent Other liabilities Increase (Decrease) in Other Operating Liabilities Terms of payment period Revenue From Contract With Customer, Terms Of Payment Period Revenue From Contract With Customer, Terms Of Payment Period Grant revenue Grant [Member] COVID-19 project, initial funding COVID-19 Project, Initial Funding COVID-19 Project, Initial Funding Debt issuance costs Unamortized debt issuance cost Debt Issuance Costs, Net Weighted-Average Exercise Price per Option Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Number of reporting segment Number of Reportable Segments Accrual for current period warranties Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Operating lease right-of-use vehicles Vehicles [Member] Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Issuance of common stock on bond conversion Stock Issued During Period, Value, Conversion of Convertible Securities Impairment of goodwill Goodwill, Impairment Loss Accounts receivable (net of allowances of $101 and $6, at June 30, 2020 and December 31, 2019, respectively) Accounts Receivable, after Allowance for Credit Loss, Current Total future minimum payments Lessee, Operating Lease, Liability, to be Paid Summary of cash and cash equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Non-current restricted cash Restricted Cash, Noncurrent Gross Unrealized Loss Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] 2019 Convertible Notes Two Thousand And Nineteen Convertible Notes [Member] Two Thousand And Nineteen Convertible Notes [Member] Shares used in computing net loss per share, basic and diluted (shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Purchase price of common stock, percent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Goodwill Goodwill Other comprehensive income (loss), net of tax Other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Title of Individual [Axis] Title of Individual [Axis] Development revenue Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Restricted cash Restricted Cash and Cash Equivalents, Current Par Value Principal amount Debt Instrument, Face Amount Vesting [Axis] Vesting [Axis] Options forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Equity [Abstract] Equity [Abstract] Stock issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs EMEA EMEA [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Entity Central Index Key Entity Central Index Key Deferred revenue, current Contract with Customer, Liability, Current Entity Emerging Growth Company Entity Emerging Growth Company Subsequent Event [Line Items] Subsequent Event [Line Items] Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible List] Options granted (usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Customer Concentration Risk Customer Concentration Risk [Member] Credit Facility [Domain] Credit Facility [Domain] Estimated future intangible asset amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Litigation Case [Domain] Litigation Case [Domain] Stock options held by owners of more than 10% of common stock Awards Held By Owners Of More Than 10% Of Common Stock [Member] Awards Held By Owners Of More Than 10% Of Common Stock 2011 Equity Incentive Plan Equity Incentive Plan Twenty Eleven [Member] Equity Incentive Plan Twenty Eleven [Member] Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Finite-lived intangible assets acquired Finite-lived Intangible Assets Acquired Amortization of debt discounts, premiums and issuance costs Amortization of Debt Issuance Costs and Discounts Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Total Share-based Compensation Share-based Payment Arrangement, Expense Unrealized Gain (Loss) on Investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Issuance of common stock under ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Counterparty Name [Axis] Counterparty Name [Axis] Long-term Investments Long-term Investments Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2020 and December 31, 2019; 71,283 and 69,956 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Two ESPP, number of six-month offering periods Employee Stock Purchase Plan, Number Of Six Month Offering Periods Employee Stock Purchase Plan, Number Of Six Month Offering Periods Vested Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value Short-term restricted cash Restricted Cash, Current Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Subsequent Event [Table] Subsequent Event [Table] Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Fair value of identifiable net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Granted (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Award vesting percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Development Agreement Collaborative Arrangement Disclosure [Text Block] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Common stock, shares issued (shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and cash equivalents Cash-unrestricted Cash and Cash Equivalents, at Carrying Value Number of months over which options vest ratably Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement Schedule of Product Information [Table] Schedule of Product Information [Table] Convertible Notes Debt, Policy [Policy Text Block] Proceeds from sale of investments Proceeds from Sale of Other Investments Other receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables Reorganized lease liabilities Total operating lease liabilities Total Operating Lease, Liability Debt extinguished Extinguishment of Debt, Amount Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts receivable, net Increase (Decrease) in Accounts Receivable Debt Instrument [Line Items] Debt Instrument [Line Items] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Total stockholders’ equity Beginning Balance Ending Balance Cumulative-effect of new accounting standard for Topic 326 Credit Losses Stockholders' Equity Attributable to Parent Total purchase price Total purchase price Business Combination, Consideration Transferred Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total liabilities and stockholders’ equity Liabilities and Equity Purchase price in shares (shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Commitment fee amount Line of Credit Facility, Commitment Fee Amount Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Incremental compensation cost Share-based Payment Arrangement, Plan Modification, Incremental Cost Accrued compensation and related benefits Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Operating lease cost (including variable costs) Operating Lease, Cost Maximum employee subscription rate Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate Financial Instrument [Axis] Financial Instrument [Axis] Anti-dilutive securities excluded from computations of net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Product revenue Product revenue Product [Member] Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Equity Component [Domain] Equity Component [Domain] Fair Value Cash, Cash Equivalents, and Short-term Investments Entity Address, Address Line One Entity Address, Address Line One Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Three Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Restricted Stock And Performance Share Units Restricted Stock And Performance Share Units [Member] Restricted Stock And Performance Share Units [Member] Stock-Based Plans Share-based Payment Arrangement [Text Block] Net loss Net loss Net Income (Loss) Attributable to Parent Entity Address, State or Province Entity Address, State or Province Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] 2020 (remainder of year) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Leases [Abstract] Leases [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Asset retirement obligations Asset Retirement Obligations Incurred But Not Yet Paid Asset Retirement Obligations Incurred But Not Yet Paid Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Developed technology Developed Technology Rights [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Entity Interactive Data Current Entity Interactive Data Current Number of Options (000s) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Entity Common Stock, Shares Outstanding (shares) Entity Common Stock, Shares Outstanding Deferred revenue, non-current Contract with Customer, Liability, Noncurrent Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Options granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Initial conversion price of stock (usd per share) Initial Conversion Price Of Stock Initial Conversion Price Of Stock Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Issuance of common stock under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Common Stock Common Stock [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Discount rate Lessee, Operating Lease, Discount Rate Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Convertible Debt Convertible Debt [Member] Geographic Concentration Risk Geographic Concentration Risk [Member] Property and equipment Property, Plant and Equipment [Table Text Block] Laboratory and manufacturing equipment Laboratory And Manufacturing Equipment [Member] Laboratory And Manufacturing Equipment [Member] US treasury securities US Treasury Securities [Member] Shares sold (shares) Stock Issued During Period, Shares, New Issues Percentage of eligible receivables Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Senior Convertible Notes Due 2024 Senior Convertible Notes Due 2024 [Member] Senior Convertible Notes Due 2024 [Member] Leasehold improvements Leasehold Improvements [Member] Gross Amount Finite-Lived Intangible Assets, Gross Collaboration agreement, term Collaborative Arrangement, Term Collaborative Arrangement, Term Interest rate on notes Debt Instrument, Interest Rate, Stated Percentage Issuance of common stock on bond conversion (in shares) Conversion of debt into common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Money market funds Money Market Funds [Member] Remaining performance obligation, expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Stock options Share-based Payment Arrangement [Member] Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule Of Significant Accounting Policies [Line Items] Schedule Of Significant Accounting Policies [Line Items] Schedule Of Significant Accounting Policies [Line Items] Other revenue Product and Service, Other [Member] Issuance of common stock from option exercises (in shares) Option exercised (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Business Combination Business Combination Disclosure [Text Block] Schedule of future minimum lease payments Lessee, Operating Lease, Liability, Maturity [Table Text Block] Stock options, restricted stock units and performance awards Stock Option Share-based Payment Arrangement, Option [Member] Basis of Presentation and Consolidation Basis of Accounting, Policy [Policy Text Block] Percentage of voting power which impacts the term of equity incentive plan Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock Additional interest rate Debt Instrument, Basis Spread on Variable Rate Costs and expenses: Costs and Expenses [Abstract] Subsequent Events [Abstract] Subsequent Events [Abstract] Options forfeited (usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of investment in unrealized loss positions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Cash-unrestricted Cash and Cash Equivalents [Member] Debt and equity offering costs Debt And Equity Offering Costs Debt And Equity Offering Costs Rate at which outstanding options vest on the first anniversary of the option grant date Portion Of Stock Options Vest On First Anniversary Portion Of Stock Options Vest On First Anniversary Carrying Value Reported Value Measurement [Member] Plan Name [Domain] Plan Name [Domain] Revenue Revenue from Contract with Customer [Text Block] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Percentage of interest on obligation upon default Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default Additional paid-in capital Additional Paid in Capital Estimated fair value of debt Long-term Debt, Fair Value 2021 Finite-Lived Intangible Asset, Expected Amortization, Year One Income tax benefit Income tax (benefit) expense Income Tax Expense (Benefit) Cash paid for income taxes, net of refunds Income Taxes Paid, Net Activity under restricted stock units Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Title of Individual [Domain] Title of Individual [Domain] Other accrued liabilities Accrued Liabilities, Current Restricted Stock Units, Stock Options and Performance Share Units Options, Performance Share Units And Restricted Stock Units [Member] Options, Performance Share Units And Restricted Stock Units [Member] Exchange Convertible Senior Notes due 2034 Exchange Convertible Senior Notes Due 2034 [Member] Exchange Convertible Senior Notes Due 2034 [Member] Purchase price in cash Cash consideration paid on closing to former equity holders Payments to Acquire Businesses, Gross Americas Americas [Member] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Tranche One Share-based Payment Arrangement, Tranche One [Member] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Non-cash consideration common shares Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Schedule of debt Schedule of Debt [Table Text Block] Goodwill, Intangible Assets and Other Long-Lived Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Principal amount Long-term Debt, Gross Prime Rate Prime Rate [Member] Deferred revenue Contract with Customer, Liability Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Issuance of common stock from option exercises Stock Issued During Period, Value, Stock Options Exercised Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Intellectual Property Infringement Claims Intellectual Property Infringement Claims [Member] Intellectual Property Infringement Claims [Member] Maximum ability to borrow under line of credit Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Gross Amount Operating Lease, Right-Of-Use Asset, Gross Operating Lease, Right-Of-Use Asset, Gross Maximum Maximum [Member] Security Exchange Name Security Exchange Name Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Accumulated Deficit Retained Earnings [Member] Preferred stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Measurement Basis [Axis] Measurement Basis [Axis] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Purchases of investments Payments to Acquire Investments Weighted- Average Remaining Contractual Life Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Domain] Award Type [Domain] Document Transition Report Document Transition Report DVS Sciences Inc. 2010 Equity Incentive Plan Two Thousand And Ten Equity Incentive Plan [Member] Two Thousand And Ten Equity Incentive Plan [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Trustee Trustee [Member] Trustee [Member] Development revenue Collaboration Revenue [Member] Collaboration Revenue Weighted average remaining contractual terms Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Unused revolving line of credit Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Summary of expected timing of revenue recognition Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Payment of debt issuance cost Payment of Financing and Stock Issuance Costs Office furniture and fixtures Office Equipment [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Operating lease right-of-use equipment Equipment [Member] Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables Current liabilities: Liabilities, Current [Abstract] Provision for excess and obsolete inventory Inventory, LIFO Reserve, Period Charge Recent Accounting Changes and Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] 2011 Equity Incentive Plan Two Thousand And Eleven Equity Incentive Plan [Member] Two Thousand And Eleven Equity Incentive Plan [Member] Short-term investments Short-Term Marketable Securities Short-term Investments EX-101.PRE 11 fldm-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 fldm-20200630_g1.jpg GRAPHIC begin 644 fldm-20200630_g1.jpg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end XML 13 fldm-20200630_htm.xml IDEA: XBRL DOCUMENT 0001162194 2020-01-01 2020-06-30 0001162194 2020-07-31 0001162194 2020-06-30 0001162194 2019-12-31 0001162194 us-gaap:ProductMember 2020-04-01 2020-06-30 0001162194 us-gaap:ProductMember 2019-04-01 2019-06-30 0001162194 us-gaap:ProductMember 2020-01-01 2020-06-30 0001162194 us-gaap:ProductMember 2019-01-01 2019-06-30 0001162194 us-gaap:ServiceMember 2020-04-01 2020-06-30 0001162194 us-gaap:ServiceMember 2019-04-01 2019-06-30 0001162194 us-gaap:ServiceMember 2020-01-01 2020-06-30 0001162194 us-gaap:ServiceMember 2019-01-01 2019-06-30 0001162194 fldm:CollaborationRevenueMember 2020-04-01 2020-06-30 0001162194 fldm:CollaborationRevenueMember 2019-04-01 2019-06-30 0001162194 fldm:CollaborationRevenueMember 2020-01-01 2020-06-30 0001162194 fldm:CollaborationRevenueMember 2019-01-01 2019-06-30 0001162194 us-gaap:ProductAndServiceOtherMember 2020-04-01 2020-06-30 0001162194 us-gaap:ProductAndServiceOtherMember 2019-04-01 2019-06-30 0001162194 us-gaap:ProductAndServiceOtherMember 2020-01-01 2020-06-30 0001162194 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-06-30 0001162194 2020-04-01 2020-06-30 0001162194 2019-04-01 2019-06-30 0001162194 2019-01-01 2019-06-30 0001162194 us-gaap:CommonStockMember 2019-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001162194 us-gaap:RetainedEarningsMember 2019-12-31 0001162194 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001162194 2020-01-01 2020-03-31 0001162194 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001162194 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001162194 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001162194 us-gaap:CommonStockMember 2020-03-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001162194 us-gaap:RetainedEarningsMember 2020-03-31 0001162194 2020-03-31 0001162194 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001162194 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001162194 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001162194 us-gaap:CommonStockMember 2020-06-30 0001162194 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001162194 us-gaap:RetainedEarningsMember 2020-06-30 0001162194 us-gaap:CommonStockMember 2018-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001162194 us-gaap:RetainedEarningsMember 2018-12-31 0001162194 2018-12-31 0001162194 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001162194 2019-01-01 2019-03-31 0001162194 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001162194 us-gaap:CommonStockMember 2019-03-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001162194 us-gaap:RetainedEarningsMember 2019-03-31 0001162194 2019-03-31 0001162194 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001162194 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001162194 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001162194 us-gaap:CommonStockMember 2019-06-30 0001162194 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001162194 us-gaap:RetainedEarningsMember 2019-06-30 0001162194 2019-06-30 0001162194 us-gaap:ProductMember srt:MinimumMember 2020-01-01 2020-06-30 0001162194 us-gaap:ProductMember srt:MaximumMember 2020-01-01 2020-06-30 0001162194 us-gaap:ServiceMember srt:MinimumMember 2020-01-01 2020-06-30 0001162194 us-gaap:ServiceMember srt:MaximumMember 2020-01-01 2020-06-30 0001162194 fldm:IntellectualPropertyInfringementClaimsMember 2020-03-01 2020-03-31 0001162194 us-gaap:LicenseMember 2020-03-01 2020-03-31 0001162194 2020-03-01 2020-03-31 0001162194 srt:MinimumMember fldm:CommissionCostsMember 2020-01-01 2020-06-30 0001162194 srt:MaximumMember fldm:CommissionCostsMember 2020-01-01 2020-06-30 0001162194 fldm:FiveLargestCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2020-06-30 0001162194 fldm:FiveLargestCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001162194 fldm:FiveLargestCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001162194 fldm:FiveLargestCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-28 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2018-03-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2019-01-01 2019-03-31 0001162194 fldm:SeniorConvertibleNotesDue2024Member us-gaap:ConvertibleDebtMember 2019-11-30 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2019-11-01 2019-11-30 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2019-11-30 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-04-01 2020-06-30 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0001162194 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001162194 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndNineteenConvertibleNotesMember 2020-01-01 2020-06-30 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndNineteenConvertibleNotesMember 2019-01-01 2019-06-30 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember 2020-01-01 2020-06-30 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember 2019-01-01 2019-06-30 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2020-01-01 2020-06-30 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2019-01-01 2019-06-30 0001162194 fldm:InstruNorASMember 2020-01-17 2020-01-17 0001162194 2020-01-17 0001162194 fldm:InstruNorASMember 2020-01-17 0001162194 srt:AmericasMember 2020-04-01 2020-06-30 0001162194 srt:AmericasMember 2019-04-01 2019-06-30 0001162194 srt:AmericasMember 2020-01-01 2020-06-30 0001162194 srt:AmericasMember 2019-01-01 2019-06-30 0001162194 us-gaap:EMEAMember 2020-04-01 2020-06-30 0001162194 us-gaap:EMEAMember 2019-04-01 2019-06-30 0001162194 us-gaap:EMEAMember 2020-01-01 2020-06-30 0001162194 us-gaap:EMEAMember 2019-01-01 2019-06-30 0001162194 srt:AsiaPacificMember 2020-04-01 2020-06-30 0001162194 srt:AsiaPacificMember 2019-04-01 2019-06-30 0001162194 srt:AsiaPacificMember 2020-01-01 2020-06-30 0001162194 srt:AsiaPacificMember 2019-01-01 2019-06-30 0001162194 fldm:InstrumentsMember 2020-04-01 2020-06-30 0001162194 fldm:InstrumentsMember 2019-04-01 2019-06-30 0001162194 fldm:InstrumentsMember 2020-01-01 2020-06-30 0001162194 fldm:InstrumentsMember 2019-01-01 2019-06-30 0001162194 fldm:ConsumablesMember 2020-04-01 2020-06-30 0001162194 fldm:ConsumablesMember 2019-04-01 2019-06-30 0001162194 fldm:ConsumablesMember 2020-01-01 2020-06-30 0001162194 fldm:ConsumablesMember 2019-01-01 2019-06-30 0001162194 us-gaap:LicenseMember 2020-04-01 2020-06-30 0001162194 us-gaap:LicenseMember 2019-04-01 2019-06-30 0001162194 us-gaap:LicenseMember 2020-01-01 2020-06-30 0001162194 us-gaap:LicenseMember 2019-01-01 2019-06-30 0001162194 us-gaap:GrantMember 2020-04-01 2020-06-30 0001162194 us-gaap:GrantMember 2019-04-01 2019-06-30 0001162194 us-gaap:GrantMember 2020-01-01 2020-06-30 0001162194 us-gaap:GrantMember 2019-01-01 2019-06-30 0001162194 2020-07-01 2020-06-30 0001162194 2021-01-01 2020-06-30 0001162194 2022-01-01 2020-06-30 0001162194 2023-01-01 2020-06-30 0001162194 fldm:DVSSciencesInc.Member 2014-02-28 0001162194 fldm:DVSSciencesInc.Member us-gaap:DevelopedTechnologyRightsMember 2014-02-01 2014-02-28 0001162194 fldm:InstruNorASMember 2020-03-31 0001162194 fldm:InstruNorASMember us-gaap:DevelopedTechnologyRightsMember 2020-01-01 2020-03-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2020-06-30 0001162194 us-gaap:DevelopedTechnologyRightsMember 2020-01-01 2020-06-30 0001162194 fldm:PatentsandLicenseAgreementsMember 2020-06-30 0001162194 fldm:PatentsandLicenseAgreementsMember 2020-01-01 2020-06-30 0001162194 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2019-01-01 2019-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2019-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2019-01-01 2019-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2020-04-01 2020-06-30 0001162194 us-gaap:DevelopedTechnologyRightsMember 2019-04-01 2019-06-30 0001162194 us-gaap:DevelopedTechnologyRightsMember 2019-01-01 2019-06-30 0001162194 fldm:ComputerEquipmentAndSoftwareMember 2020-06-30 0001162194 fldm:ComputerEquipmentAndSoftwareMember 2019-12-31 0001162194 fldm:LaboratoryAndManufacturingEquipmentMember 2020-06-30 0001162194 fldm:LaboratoryAndManufacturingEquipmentMember 2019-12-31 0001162194 us-gaap:LeaseholdImprovementsMember 2020-06-30 0001162194 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001162194 us-gaap:OfficeEquipmentMember 2020-06-30 0001162194 us-gaap:OfficeEquipmentMember 2019-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-01 2014-02-28 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2018-03-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2018-03-12 0001162194 2018-03-01 2018-03-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2018-03-01 2018-03-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member fldm:TrusteeMember us-gaap:ConvertibleDebtMember 2019-03-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member fldm:TrusteeMember us-gaap:ConvertibleDebtMember 2019-02-28 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2019-02-28 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember 2019-02-01 2019-02-28 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member fldm:TrusteeMember us-gaap:ConvertibleDebtMember 2019-02-01 2019-02-28 0001162194 us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001162194 fldm:SeniorConvertibleNotesDue2024Member us-gaap:ConvertibleDebtMember 2019-11-01 2019-11-30 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2019-10-01 2019-12-31 0001162194 2019-11-01 2019-11-30 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2019-11-30 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2019-11-01 2019-11-30 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:ConvertibleDebtMember 2019-11-01 2019-11-30 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 fldm:SeniorConvertibleNotesDue2024Member us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 fldm:SeniorConvertibleNotesDue2024Member us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-08-31 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-08-01 2018-08-31 0001162194 us-gaap:RevolvingCreditFacilityMember 2020-06-30 0001162194 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2018-08-01 2018-08-31 0001162194 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2018-08-01 2018-08-31 0001162194 2018-08-01 2018-08-31 0001162194 2020-04-21 2020-04-21 0001162194 us-gaap:RevolvingCreditFacilityMember 2020-01-01 2020-06-30 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2019-11-01 2019-11-30 0001162194 srt:MinimumMember 2020-01-01 2020-06-30 0001162194 srt:MaximumMember 2020-01-01 2020-06-30 0001162194 us-gaap:BuildingMember 2020-06-30 0001162194 us-gaap:BuildingMember 2019-12-31 0001162194 us-gaap:EquipmentMember 2020-06-30 0001162194 us-gaap:EquipmentMember 2019-12-31 0001162194 us-gaap:VehiclesMember 2020-06-30 0001162194 us-gaap:VehiclesMember 2019-12-31 0001162194 stpr:CA 2020-03-31 0001162194 us-gaap:CashAndCashEquivalentsMember 2020-06-30 0001162194 fldm:RestrictedCashAndCashEquivalentsDomain 2020-06-30 0001162194 us-gaap:CashMember 2020-06-30 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2020-06-30 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2020-06-30 0001162194 us-gaap:FairValueInputsLevel1Member 2020-06-30 0001162194 us-gaap:CashAndCashEquivalentsMember 2019-12-31 0001162194 fldm:RestrictedCashAndCashEquivalentsDomain 2019-12-31 0001162194 us-gaap:CashMember 2019-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2019-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2019-12-31 0001162194 us-gaap:FairValueInputsLevel1Member 2019-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 fldm:SeniorConvertibleNotesDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 fldm:SeniorConvertibleNotesDue2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 fldm:SeniorConvertibleNotesDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2020-06-30 0001162194 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2019-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndNineEquityIncentivePlanMember 2020-06-30 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndNineEquityIncentivePlanMember 2020-06-30 0001162194 fldm:TwoThousandAndNineEquityIncentivePlanMember 2020-06-30 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndElevenEquityIncentivePlanMember 2020-06-30 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndElevenEquityIncentivePlanMember 2020-06-30 0001162194 fldm:TwoThousandAndElevenEquityIncentivePlanMember 2020-06-30 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndTenEquityIncentivePlanMember 2020-06-30 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndTenEquityIncentivePlanMember 2020-06-30 0001162194 fldm:TwoThousandAndTenEquityIncentivePlanMember 2020-06-30 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2020-06-30 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2020-06-30 0001162194 fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2020-06-30 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2020-06-30 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2020-06-30 0001162194 fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2020-06-30 0001162194 us-gaap:EmployeeStockOptionMember 2020-06-30 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember 2020-06-30 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2020-05-31 0001162194 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-06-30 0001162194 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-05-01 2020-05-31 0001162194 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-01-01 2020-06-30 0001162194 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-05-01 2020-05-31 0001162194 us-gaap:StockCompensationPlanMember 2020-01-01 2020-06-30 0001162194 fldm:AwardsHeldByOwnersOfMoreThan10OfCommonStockMember 2020-01-01 2020-06-30 0001162194 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-06-30 0001162194 fldm:EquityIncentivePlanTwentyElevenMember 2019-06-30 0001162194 fldm:EquityIncentivePlanTwentyElevenMember 2020-06-30 0001162194 fldm:A2017InducementAwardPlanMember 2017-01-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2020-06-30 0001162194 2019-01-01 2019-12-31 0001162194 fldm:EquityIncentivePlanMember 2020-06-30 0001162194 fldm:EquityIncentivePlanMember 2020-01-01 2020-06-30 0001162194 us-gaap:PerformanceSharesMember 2020-01-01 2020-06-30 0001162194 srt:MinimumMember us-gaap:PerformanceSharesMember 2020-01-01 2020-06-30 0001162194 srt:MaximumMember us-gaap:PerformanceSharesMember 2020-01-01 2020-06-30 0001162194 us-gaap:PerformanceSharesMember 2019-12-31 0001162194 us-gaap:PerformanceSharesMember 2020-06-30 0001162194 fldm:CertainEmployeeMember us-gaap:PerformanceSharesMember 2019-12-31 0001162194 fldm:CertainEmployeeMember us-gaap:PerformanceSharesMember 2020-01-01 2020-06-30 0001162194 fldm:CertainEmployeeMember us-gaap:PerformanceSharesMember 2020-06-30 0001162194 2019-05-31 2019-05-31 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2019-05-31 0001162194 2019-06-01 2019-06-01 0001162194 2020-05-31 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2019-06-01 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2019-06-01 2019-06-01 0001162194 fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2020-01-01 2020-06-30 0001162194 fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2020-06-01 2020-06-30 0001162194 2020-06-01 2020-06-01 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2020-06-30 0001162194 fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember 2020-04-01 2020-06-30 0001162194 fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember 2019-04-01 2019-06-30 0001162194 fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember 2020-01-01 2020-06-30 0001162194 fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember 2019-01-01 2019-06-30 0001162194 us-gaap:EmployeeStockMember 2020-04-01 2020-06-30 0001162194 us-gaap:EmployeeStockMember 2019-04-01 2019-06-30 0001162194 us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001162194 us-gaap:EmployeeStockMember 2019-01-01 2019-06-30 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2020-04-01 2020-06-30 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-06-30 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-04-01 2019-06-30 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-06-30 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2020-04-01 2020-06-30 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-04-01 2019-06-30 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-06-30 0001162194 us-gaap:SubsequentEventMember 2020-07-31 shares iso4217:USD iso4217:USD shares pure utr:Rate fldm:investment fldm:numberOfOfferingPeriods fldm:segment false 2020 Q2 0001162194 --12-31 us-gaap:AccountingStandardsUpdate201613Member P1Y P1Y us-gaap:AccountingStandardsUpdate201613Member P6M P1Y P1Y 0.1269438 0.3448276 10-Q true 2020-06-30 false 001-34180 FLUIDIGM CORP DE 77-0513190 2 Tower Place, Ste 2000 South San Francisco, CA 94080 650 266-6000 Common Stock, $0.001 par value per share FLDM NASDAQ Yes Yes Large Accelerated Filer false false false 71316370 42965000 21661000 2431000 36978000 101000 6000 9983000 18981000 18900000 13884000 4171000 4592000 78450000 96096000 7865000 8056000 39027000 4860000 5034000 5492000 45644000 46200000 106328000 104108000 282348000 264812000 9384000 6510000 6757000 5160000 2170000 1833000 5758000 7515000 14279000 11803000 38348000 32821000 54013000 53821000 9655000 11494000 39139000 4323000 7936000 8168000 538000 573000 149629000 111200000 0.001 0.001 10000000 10000000 0 0 0 0 0 0 0.001 0.001 200000000 200000000 71283000 71283000 69956000 69956000 71000 70000 786193000 777765000 -809000 -582000 -652736000 -623641000 132719000 153612000 282348000 264812000 17405000 23235000 36386000 48062000 5140000 4961000 10326000 10245000 3000000 0 3000000 0 513000 0 3963000 0 26058000 28196000 53675000 58307000 9483000 11100000 19123000 22489000 1237000 1733000 2762000 3465000 8448000 7865000 17147000 16237000 20616000 22134000 43311000 44958000 39784000 42832000 82343000 87149000 -13726000 -14636000 -28668000 -28842000 897000 491000 1797000 3192000 0 0 0 -9000000 463000 231000 -355000 715000 -14160000 -14896000 -30820000 -40319000 -1145000 -1143000 -1825000 -1101000 -13015000 -13753000 -28995000 -39218000 -0.18 -0.20 -0.41 -0.61 70916000 69158000 70691000 63923000 -13015000 -13753000 -28995000 -39218000 109000 -9000 -194000 -1000 -33000 63000 -33000 65000 76000 54000 -227000 64000 -12939000 -13699000 -29222000 -39154000 69956000 70000 777765000 -582000 -623641000 153612000 255000 -146000 -146000 -100000 -100000 2364000 2364000 485000 1000 2048000 2049000 -15980000 -15980000 -303000 -303000 70696000 71000 782031000 -885000 -639721000 141496000 286000 -116000 -116000 301000 645000 645000 3633000 3633000 -13015000 -13015000 76000 76000 71283000 71000 786193000 -809000 -652736000 132719000 49338000 49000 631605000 -687000 -558851000 72116000 19460000 19000 133279000 133298000 140000 1000 -177000 -176000 53000 255000 255000 2207000 2207000 -25465000 -25465000 10000 10000 68991000 69000 767169000 -677000 -584316000 182245000 183000 -325000 -325000 130000 793000 793000 96000 641000 641000 2985000 2985000 -13753000 -13753000 54000 54000 69400000 69000 771263000 -623000 -598069000 172640000 -28995000 -39218000 2016000 2351000 6000000 5263000 5936000 5600000 275000 2037000 1331000 -250000 0 -9000000 306000 555000 -148000 -29000 136000 162000 -9055000 2420000 4892000 2041000 706000 965000 3136000 3439000 1965000 476000 -2796000 -9161000 -7085000 -25143000 5154000 0 0 44614000 5011000 0 29400000 0 1671000 685000 27586000 -45299000 375000 15000 0 1048000 645000 641000 262000 487000 8000 1187000 -205000 -25000 20304000 -69280000 23736000 95401000 44040000 26121000 1531000 2600000 194000 139000 316000 319000 Description of BusinessFluidigm Corporation (the Company, Fluidigm, we, our or us) creates, manufactures, and markets technologies and tools for life sciences research, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits (IFC), assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We sell our instruments, consumables and services to academic institutions, clinical laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The Company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California. Summary of Significant Accounting Policies<div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Basis of Presentation and Consolidation</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of June 30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders’ equity, total revenue, total costs and expenses, loss from operations or net loss.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of June 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Foreign Currency</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year. </span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Product Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Service Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZhN2I3NmUyZTZiYTQyMjFiNDM3NTIzNGE4ZThlYjkxL3NlYzo2YTdiNzZlMmU2YmE0MjIxYjQzNzUyMzRhOGU4ZWI5MV80MC9mcmFnOjhmN2U4NmUxZDlmOTQ4OTRhMjI4OGNkMDQyMjUyMDlhL3RleHRyZWdpb246OGY3ZTg2ZTFkOWY5NDg5NGEyMjg4Y2QwNDIyNTIwOWFfNTYyMA_dcdf51db-9f3e-4be4-a95e-eeb988eb1e8d">one</span> to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Development Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other revenue consists of license and royalty revenue, and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory. </span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Contract Costs</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZhN2I3NmUyZTZiYTQyMjFiNDM3NTIzNGE4ZThlYjkxL3NlYzo2YTdiNzZlMmU2YmE0MjIxYjQzNzUyMzRhOGU4ZWI5MV80MC9mcmFnOjhmN2U4NmUxZDlmOTQ4OTRhMjI4OGNkMDQyMjUyMDlhL3RleHRyZWdpb246OGY3ZTg2ZTFkOWY5NDg5NGEyMjg4Y2QwNDIyNTIwOWFfMjE5OTAyMzI3NzI3Mw_47fe3048-acd6-4cbf-87df-8516c9ced606">one</span> to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Product Warranties</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Significant Judgments</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Concentrations of Business and Credit Risk</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three months ended June 30, 2020. No other customer represented more than 10% of total revenue for three and six months ended June 30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 32% and 30% of total revenue for the three months ended June 30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the six months ended June 30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at June 30, 2020, or December 31, 2019.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country. </span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Convertible Notes</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes using valuation techniques that required us to make assumptions related to the implied discount rate. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded for as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Note 7 for a detailed discussion of the accounting treatment of the transactions and additional information.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Comprehensive Loss </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of accumulated other comprehensive loss, net of tax, for the three and six months ended June 30, 2020 is as follows (in thousands): </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:57.649%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.723%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(618)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(582)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(303)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(303)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(921)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(885)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">109 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(812)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(809)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:27pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Immaterial amounts of unrealized gains and losses have been reclassified into the condensed consolidated statement of operations for the three and six months ended June 30, 2020 and 2019.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Loss per Share </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.099%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,237 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,541 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,412 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">916 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,634 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,457 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Adoption of New Accounting Guidance </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the U.S.-based Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FASB issued two ASUs related to financial instruments – credit losses. The ASUs issued were: (1) in June 2016, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZhN2I3NmUyZTZiYTQyMjFiNDM3NTIzNGE4ZThlYjkxL3NlYzo2YTdiNzZlMmU2YmE0MjIxYjQzNzUyMzRhOGU4ZWI5MV80MC9mcmFnOjhmN2U4NmUxZDlmOTQ4OTRhMjI4OGNkMDQyMjUyMDlhL3RleHRyZWdpb246OGY3ZTg2ZTFkOWY5NDg5NGEyMjg4Y2QwNDIyNTIwOWFfMjE5OTAyMzI5MDcyNA_82ea5c68-4c4d-46bb-8d93-d2901fa393d1">ASU 2016-13, Financial Instruments-Credit Losses (Topic 326)</span>: Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leasing standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders’ equity and decrease current assets by the same amount in our condensed consolidated balance sheet.</span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div> The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of June 30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders’ equity, total revenue, total costs and expenses, loss from operations or net loss. <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of June 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.</span></div> Foreign CurrencyAssets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year. <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Revenue Recognition</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Product Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Service Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZhN2I3NmUyZTZiYTQyMjFiNDM3NTIzNGE4ZThlYjkxL3NlYzo2YTdiNzZlMmU2YmE0MjIxYjQzNzUyMzRhOGU4ZWI5MV80MC9mcmFnOjhmN2U4NmUxZDlmOTQ4OTRhMjI4OGNkMDQyMjUyMDlhL3RleHRyZWdpb246OGY3ZTg2ZTFkOWY5NDg5NGEyMjg4Y2QwNDIyNTIwOWFfNTYyMA_dcdf51db-9f3e-4be4-a95e-eeb988eb1e8d">one</span> to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Development Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other revenue consists of license and royalty revenue, and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory. </span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Contract Costs</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZhN2I3NmUyZTZiYTQyMjFiNDM3NTIzNGE4ZThlYjkxL3NlYzo2YTdiNzZlMmU2YmE0MjIxYjQzNzUyMzRhOGU4ZWI5MV80MC9mcmFnOjhmN2U4NmUxZDlmOTQ4OTRhMjI4OGNkMDQyMjUyMDlhL3RleHRyZWdpb246OGY3ZTg2ZTFkOWY5NDg5NGEyMjg4Y2QwNDIyNTIwOWFfMjE5OTAyMzI3NzI3Mw_47fe3048-acd6-4cbf-87df-8516c9ced606">one</span> to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Product Warranties</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Significant Judgments</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.</span></div> P30D P60D P3Y 3500000 3100000 400000 P3Y P1Y <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.</span></div> <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Concentrations of Business and Credit Risk</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three months ended June 30, 2020. No other customer represented more than 10% of total revenue for three and six months ended June 30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 32% and 30% of total revenue for the three months ended June 30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the six months ended June 30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at June 30, 2020, or December 31, 2019.</span></div>Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components. 0.32 0.30 0.23 0.20 <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></div>We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country. <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.</span></div> 0 0 0 0 <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Convertible Notes</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes using valuation techniques that required us to make assumptions related to the implied discount rate. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded for as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.</span></div> 201300000 0.0275 150000000.0 0.0275 19500000 -9000000.0 55000000.0 0.0525 50200000 1100000 <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Comprehensive Loss </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div> <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of accumulated other comprehensive loss, net of tax, for the three and six months ended June 30, 2020 is as follows (in thousands): </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:57.649%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.723%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(618)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(582)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(303)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(303)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(921)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(885)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">109 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(812)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(809)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> -618000 36000 -582000 -303000 0 -303000 -921000 36000 -885000 109000 -33000 76000 -812000 3000 -809000 <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Net Loss per Share </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.</span></div> <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.099%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,237 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,541 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,966 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,412 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">916 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,634 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,457 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 8237000 4541000 18966000 0 2412000 0 19000 916000 29634000 5457000 <div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Adoption of New Accounting Guidance </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the U.S.-based Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The FASB issued two ASUs related to financial instruments – credit losses. The ASUs issued were: (1) in June 2016, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjZhN2I3NmUyZTZiYTQyMjFiNDM3NTIzNGE4ZThlYjkxL3NlYzo2YTdiNzZlMmU2YmE0MjIxYjQzNzUyMzRhOGU4ZWI5MV80MC9mcmFnOjhmN2U4NmUxZDlmOTQ4OTRhMjI4OGNkMDQyMjUyMDlhL3RleHRyZWdpb246OGY3ZTg2ZTFkOWY5NDg5NGEyMjg4Y2QwNDIyNTIwOWFfMjE5OTAyMzI5MDcyNA_82ea5c68-4c4d-46bb-8d93-d2901fa393d1">ASU 2016-13, Financial Instruments-Credit Losses (Topic 326)</span>: Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leasing standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders’ equity and decrease current assets by the same amount in our condensed consolidated balance sheet.</span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.</span></div> -100000 Business Combination<div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 17, 2020, we completed the acquisition of all of the outstanding shares of InstruNor AS, a privately held Norwegian company (InstruNor). </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">InstruNor is a provider of the only fully integrated sample preparation system for flow and mass cytometry. The acquisition of InstruNor supports our entry into the sample preparation market for cytometry analysis and expands our capabilities to include fully automated sample preparation for flow and mass cytometry. The value of this technology is reflected in the intangible asset for developed technology. The developed technology was valued using a discounted cash flow model for which the most sensitive assumption was revenue growth rate.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The purchase price of $7.2 million included approximately $5.2 million in cash and 485,451 shares of our common stock valued at the closing price on the effective date of $4.22. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of the net cash flows is summarized below (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:84.237%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.739%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 17, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash consideration paid to former equity holders</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,165 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: cash and cash equivalents acquired</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition of InstruNor, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,154 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The acquisition was accounted for in accordance with ASC 805, Business Combinations. The assets acquired and liabilities assumed were recorded at their estimated fair values at the InstruNor acquisition date. Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):</span></div><div style="text-align:center;margin-top:14pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:84.237%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.739%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 17, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase price:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash consideration paid on closing to former equity holders</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,165 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash consideration common shares </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,049 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,214 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other receivables</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,380 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">566 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,994 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill acquired on acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,220 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr></table></div> 7200000 5200000 485451 4.22 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary of the net cash flows is summarized below (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:84.237%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.739%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 17, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash consideration paid to former equity holders</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,165 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: cash and cash equivalents acquired</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition of InstruNor, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,154 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 5165000 11000 5154000 Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:84.237%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.824%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.739%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 17, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchase price:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash consideration paid on closing to former equity holders</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,165 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-cash consideration common shares </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,049 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,214 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets acquired:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other receivables</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,380 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">566 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of identifiable net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,994 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill acquired on acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,220 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr></table> 2200000 5165000 2049000 7214000 11000 32000 13000 153000 5380000 14000 15000 566000 4994000 2220000 Revenue<div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Disaggregation of Revenue</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents our revenue for the three and six months ended June 30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:49.023%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.702%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Americas</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,940 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,120 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,784 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EMEA</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,557 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,217 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,653 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,373 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,561 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,859 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,238 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,843 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,058 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,675 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58,307 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:49.023%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.702%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Source:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instruments</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,577 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,201 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,048 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,041 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumables</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,828 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,034 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,338 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,021 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,405 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,235 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,386 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48,062 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,961 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,326 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,245 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Development revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  License and royalty revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,163 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Grant revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">800 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total other revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">513 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,963 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,058 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,675 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58,307 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Performance Obligations</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We reported $20.0 million of deferred revenue in our December 31, 2019 consolidated balance sheet. During the six months ended June 30, 2020, $6.2 million of the opening balance was recognized as revenue and $8.4 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At June 30, 2020, we reported $22.2 million of deferred revenue.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at June 30, 2020 (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:81.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.798%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.265%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Year</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Expected Revenue </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020 (remainder of the year)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,401 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,636 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,702 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,164 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,903 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">_______</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (1) </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div>We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less. <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents our revenue for the three and six months ended June 30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:49.023%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.702%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Americas</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,940 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,120 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,784 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EMEA</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,557 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,217 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,653 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,373 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,561 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,859 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,238 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,843 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,058 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,675 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58,307 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:49.023%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.702%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Source:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instruments</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,577 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,201 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,048 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,041 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumables</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,828 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,034 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,338 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,021 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,405 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,235 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,386 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48,062 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,140 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,961 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,326 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,245 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Development revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  License and royalty revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,163 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Grant revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">800 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total other revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">513 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,963 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,058 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,675 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58,307 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 13940000 11120000 28784000 24091000 6557000 11217000 14653000 19373000 5561000 5859000 10238000 14843000 26058000 28196000 53675000 58307000 8577000 12201000 18048000 25041000 8828000 11034000 18338000 23021000 17405000 23235000 36386000 48062000 5140000 4961000 10326000 10245000 3000000 0 3000000 0 63000 0 3163000 0 450000 0 800000 0 513000 0 3963000 0 26058000 28196000 53675000 58307000 20000000.0 6200000 8400000 22200000 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at June 30, 2020 (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:81.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.798%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.265%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Year</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Expected Revenue </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020 (remainder of the year)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,401 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,636 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,702 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,164 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,903 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">_______</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (1) </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div> 7401000 8636000 4702000 3164000 23903000 Goodwill and Intangible Assets, net<div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with our acquisition of DVS Sciences, Inc. in February 2014, we recognized goodwill of $104.1 million and $112.0 million of developed technology. In the first quarter of 2020, we recognized $2.2 million of goodwill from the InstruNor acquisition and $5.4 million of developed technology (see Note 3). We are amortizing InstruNor developed technology over 8.0 years. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the first quarter of fiscal 2020, the Company assessed whether the current and potential future impact of the COVID-19 pandemic represented an event which necessitated an impairment review. This assessment included an update of the qualitative and quantitative factors affecting our business. As a result of this assessment, we determined that a triggering event had occurred and a quantitative impairment test was performed. As a result of this quantitative analysis, we determined that the fair values of our goodwill and developed technology intangibles were not less than their carrying values and no impairment was recognized.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangible assets, net, were as follows (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:44.120%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="24" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117,380 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(71,736)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,644 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.9 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and licenses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,274 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,802)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,472 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8 years</span></td></tr></table></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:44.120%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(65,800)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,200 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.0 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and licenses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,274 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,342)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,932 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8 years</span></td></tr></table></div><div style="text-indent:27pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total amortization expense for the three months ended June 30, 2020 and 2019 was $3.2 million and $3.1 million, respectively. Amortization of intangibles was $6.4 million and $6.2 million for the six months ended June 30, 2020 and 2019, respectively. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on the carrying value of intangible assets, net, as of June 30, 2020, the amortization expense is expected to be as follows (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:57.882%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.971%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed Technology Amortization Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020 (remainder of the year)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,936 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">457 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,393 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">759 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,632 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">676 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,549 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,443 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,073 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,083 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,016 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,016 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,644 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,472 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48,116 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 104100000 112000000.0 2200000 5400000 P8Y Intangible assets, net, were as follows (in thousands): <div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:44.120%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="24" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117,380 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(71,736)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,644 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.9 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and licenses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,274 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,802)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,472 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8 years</span></td></tr></table></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:44.120%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(65,800)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,200 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.0 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and licenses</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,274 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,342)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,932 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8 years</span></td></tr></table></div> 117380000 71736000 45644000 P9Y10M24D 11274000 8802000 2472000 P7Y9M18D 112000000 65800000 46200000 P10Y 11274000 8342000 2932000 P7Y9M18D 3200000 3100000 6400000 6200000 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on the carrying value of intangible assets, net, as of June 30, 2020, the amortization expense is expected to be as follows (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:57.882%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.971%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.741%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Year</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Developed Technology Amortization Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020 (remainder of the year)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,936 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">457 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,393 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">759 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,632 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">676 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,549 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,873 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">570 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,443 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,073 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,083 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,016 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,016 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:middle;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,644 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,472 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48,116 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:middle;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 5936000 457000 6393000 11873000 759000 12632000 11873000 676000 12549000 11873000 570000 12443000 2073000 10000 2083000 2016000 0 2016000 45644000 2472000 48116000 Balance Sheet Details<div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash, Cash Equivalents and Restricted Cash </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash, cash equivalents and restricted cash consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):</span></div><div style="text-align:center;margin-top:15pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,965 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,661 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,040 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,736 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:27pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Short-term restricted cash of approximately $75 thousand is included in prepaid expenses and other current assets and $1.0 million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of June 30, 2020. </span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Inventories</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,665 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,133 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,063 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">659 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,172 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,092 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,900 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,884 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Property and Equipment, net </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,376 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,997 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,652 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,325 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,788 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,076 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,824 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,066 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,934 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(26,309)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24,954)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,865 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,056 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Warranties</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity for our warranty accrual for the six months ended June 30, 2020 and 2019, which are included in other accrued liabilities, is summarized below (in thousands): </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,390 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">863 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrual for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">419 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">657 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(277)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(429)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,532 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash, cash equivalents and restricted cash consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):</span></div><div style="text-align:center;margin-top:15pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,965 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,661 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,040 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,736 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash, cash equivalents and restricted cash consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):</span></div><div style="text-align:center;margin-top:15pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,965 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,661 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,040 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,736 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 42965000 21661000 1075000 2075000 44040000 23736000 75000 1000000.0 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,665 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,133 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,063 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">659 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,172 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,092 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,900 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,884 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 9665000 6133000 1063000 659000 8172000 7092000 18900000 13884000 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,376 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,997 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,652 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,325 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,788 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,076 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,824 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,066 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,934 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(26,309)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24,954)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,865 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,056 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 4376000 3997000 19652000 19325000 7962000 7788000 2076000 1824000 34066000 32934000 26309000 24954000 108000 76000 7865000 8056000 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity for our warranty accrual for the six months ended June 30, 2020 and 2019, which are included in other accrued liabilities, is summarized below (in thousands): </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,390 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">863 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrual for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">419 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">657 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(277)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(429)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,532 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,091 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 1390000 863000 419000 657000 277000 429000 1532000 1091000 Convertible Notes and Credit Facility<div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">2014 Senior Convertible Notes (2014 Notes)</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2014 Notes. We received $195.2 million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $1.1 million in offering-related expenses. The underwriting discount of $6.0 million and the debt issuance costs of $1.1 million were recorded as offsets to the proceeds. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is 3.0%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. We have retired the majority of the 2014 Notes through the issuance of the 2018 Notes and 2019 Notes, as discussed below. As of June 30, 2020, there is $1.1 million aggregate principal of the 2014 Notes outstanding. </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">2018 Senior Convertible Notes (2018 Notes)</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for 2018 Notes, leaving $51.3 million of the aggregate principal amount of 2014 Notes outstanding. As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $145.5 million. The difference between the $150.0 million aggregate principal amount of the 2018 Notes and its fair value was being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2018 Notes accrued interest at a rate of 2.75% payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes were set to mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes was 126.9438 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $7.88 per share). The conversion rate was subject to adjustment upon the occurrence of certain specified events. Those certain specified events included holders who converted their 2018 Notes voluntarily prior to our exercise of the issuer’s conversion option described below or in connection with a make-whole fundamental change prior to February 6, 2023, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time prior to the maturity of the 2018 Notes, we could convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equaled or exceeded 110% of the conversion price then in effect for a specified number of days. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Offering-related costs for the 2018 Notes were approximately $2.8 million. Offering-related costs of $2.2 million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and were being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. The effective interest rate on the 2018 Notes was 12.3%. Offering-related costs of $0.6 million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and were not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount of the 2018 Notes. In February 2019, we notified the trustee, U.S. Bank National Association, of our intention to exercise our issuer’s conversion option with respect to the remaining approximately $11.9 million in aggregate principal amount of 2018 Notes. In total, $150.0 million of the 2018 Notes were </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">converted into 19.5 million shares of our common stock and the bonds were retired. We recognized a loss of $9.0 million on the retirement of the 2018 Notes, which represented the difference between the fair value of the bonds retired and their carrying costs. The net impact on equity was $133.3 million and represented the fair value of the bonds retired.</span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">2019 Senior Convertible Notes (2019 Notes)</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, we issued $55.0 million aggregate principal amount of 2019 Notes. Net proceeds of the offering of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs of approximately $2.3 million. $51.8 million of the proceeds of the 2019 Notes were used to retire $50.2 million aggregate principal amount of our 2014 Notes, leaving $1.1 million of aggregate principal value of 2014 Notes outstanding. We accounted for the transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $3.0 million loss in the fourth quarter of 2019. The loss on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2019 Notes) and the net carrying value of the 2014 Notes exchanged. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2019 Notes bear interest at 5.25% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company’s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $2.90 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer’s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 150% of the Conversion Price then in effect for a specified number of days (Issuer’s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The debt issuance costs are being amortized over the expected term of the 2019 Notes using the effective interest method through the maturity date of December 1, 2024. The effective interest rate on the 2019 Notes is 6.2%.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">   2.75% 2014 Notes due 2034 </span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,051 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,057 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">    5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Principal amount </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,038)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,236)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,764 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54,013 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,821 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">2018 Revolving Credit Facility </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this Borrowing Base, we may make and repay borrowings from time to time until the maturity of the Revolving Credit Facility. The Borrowing Base as of June 30, 2020 under the Revolving Credit Facility was $7.3 million. There were no borrowings outstanding under the Revolving Credit Facility at June 30, 2020.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Until an amendment in April 2020, the Revolving Credit Facility was set to mature on August 2, 2020. The interest rate on outstanding loans under the Revolving Credit Facility was the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. In addition, we pay a quarterly unused revolving line facility fee of 0.75% per annum on the average unused facility and an annual commitment fee of $112,500.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Effective April 21, 2020, the Revolving Credit Facility was amended to extend the maturity date to August 2, 2022. In addition, the interest rate on outstanding loans under the Revolving Credit Facility was reduced by 0.25%. The quarterly unused line fee, which was previously based on the Maximum Amount, will now be based on the Borrowing Base. The annual commitment fee of $112,500 is unchanged.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Revolving Credit Facility contains customary affirmative and negative covenants that, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to 5.0% above the otherwise applicable rate of interest. We were in compliance with all the terms and conditions of the Revolving Credit Facility at June 30, 2020.</span></div> 201300000 195200000 1100000 6000000.0 1100000 0.030 1100000 150000000.0 51300000 145500000 150000000.0 0.0275 0.01269438 0.001 7.88 1.10 2800000 2200000 0.123 600000 138100000 11900000 150000000.0 19500000 -9000000.0 133300000 55000000.0 52700000 2300000 51800000 50200000 1100000 -3000000.0 0.0525 3.448276 2.90 1.50 1.30 0.062 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands): </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.429%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.073%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.511%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.076%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">   2.75% 2014 Notes due 2034 </span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,051 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,057 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">    5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Principal amount </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,038)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,236)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,764 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54,013 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,821 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at June 30, 2020 and December 31, 2019, respectively (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:43.467%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.187%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.780%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Par Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Par Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2014 Notes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,051 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,122 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,057 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,122 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019 Notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82,369 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,764 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73,975 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54,013 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83,491 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,821 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75,097 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 0.0275 1079000 1079000 24000 18000 4000 4000 1051000 1057000 0.0525 55000000 55000000 2038000 2236000 52962000 52764000 54013000 53821000 15000000.0 0.85 0.50 7300000 0 0.0050 0.0550 0.0075 112500 0.0025 112500 0.050 Leases<div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than one year to ten years. Some leases contain options to extend the lease, usually for up to five years, and termination options.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Supplemental balance sheet information related to leases was as follows as of June 30, 2020 and December 31, 2019 (in thousands, except for discount rate and lease term):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.298%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.623%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use buildings</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,618 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,234 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use equipment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use vehicles</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">452 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">355 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,103 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,658 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,076)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,798)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,860 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,170 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,833 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,139 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,323 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,309 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,156 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average discount rate per annum</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A new operating lease for our corporate headquarters in South San Francisco, California commenced in March 2020. We recorded a ROU asset of $35.7 million at the inception of the lease and an operating lease liability of $35.3 million. The lease term is approximately ten years. Future minimum lease payments over the life of the lease were discounted at a rate of 12.55%, which was our estimated incremental collateralized borrowing rate for the term of the lease at the inception of the lease. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the components of lease expense for the three and six months ended June 30, 2020 and 2019, respectively (in thousands):</span></div><div style="text-align:center;margin-top:15pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.146%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.702%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease cost (including variable costs)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,312 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,553 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,511 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,056 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Variable costs including non-lease component</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">548 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">703 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,169 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,303 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="27" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,987 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,061 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:27pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Future minimum lease payments under commenced non-cancelable operating leases, which are as of June 30, 2020 as follows (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:84.842%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.428%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Year</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Minimum Lease Payments for Operating Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020 (remainder of year)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,214 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,282 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,985 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,907 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,120 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,231 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total future minimum payments </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70,739 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29,430)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,309 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr></table></div> P1Y P10Y P5Y <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Supplemental balance sheet information related to leases was as follows as of June 30, 2020 and December 31, 2019 (in thousands, except for discount rate and lease term):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:67.298%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.623%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use buildings</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,618 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,234 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use equipment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use vehicles</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">452 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">355 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,103 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,658 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,076)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,798)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,860 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,170 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,833 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,139 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,323 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,309 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,156 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average discount rate per annum</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div> 40618000 6234000 33000 69000 452000 355000 41103000 6658000 2076000 1798000 39027000 4860000 2170000 1833000 39139000 4323000 41309000 6156000 P9Y1M6D P4Y8M12D 0.119 0.050 35700000 35300000 P10Y 0.1255 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the components of lease expense for the three and six months ended June 30, 2020 and 2019, respectively (in thousands):</span></div><div style="text-align:center;margin-top:15pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.146%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.702%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease cost (including variable costs)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,312 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,553 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,511 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,056 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Variable costs including non-lease component</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">548 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">703 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,169 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,303 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="27" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:0.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,987 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,061 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 2312000 1553000 4511000 3056000 548000 703000 1169000 1303000 1987000 2061000 <div style="text-indent:27pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Future minimum lease payments under commenced non-cancelable operating leases, which are as of June 30, 2020 as follows (in thousands): </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:84.842%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.428%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Year</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Minimum Lease Payments for Operating Leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020 (remainder of year)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,214 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,282 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,985 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,907 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,120 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,231 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total future minimum payments </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70,739 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29,430)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,309 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr></table></div> 3214000 7282000 6985000 6907000 7120000 39231000 70739000 29430000 41309000 Fair Value of Financial Instruments<div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:31.918%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.918%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.040%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.356%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.210%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.928%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="39" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-Term Marketable Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash- Restricted</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-unrestricted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-restricted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,271 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,271 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    Level I:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">         Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    US treasury securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,428 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">           Subtotal </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,197 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,200 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,468 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,965 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="39" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-Term Marketable Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash- Restricted</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-unrestricted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-restricted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,689 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,689 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    Level I:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">         Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">         US treasury securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,942 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">           Subtotal</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,989 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,025 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,678 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,661 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:27pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used, during the six months ended June 30, 2020.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the six months ended June 30, 2020 and 2019. None of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired. </span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Convertible Notes</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2019, we significantly reduced the amount of our outstanding debt. As a result, these securities are not traded frequently, so it is difficult to estimate a reliable and accurate market price and represent Level III valuations. A fair value for these assets cannot be determined by using readily observable inputs or measures, such as market prices or models. Fair values were estimated using pricing models and risk-adjusted value ranges. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at June 30, 2020 and December 31, 2019, respectively (in thousands):</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:43.467%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.187%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.780%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Par Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Par Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2014 Notes</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,051 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,122 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,057 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,122 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019 Notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82,369 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52,764 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73,975 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54,013 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83,491 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56,079 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,821 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75,097 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:31.918%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.918%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.040%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.356%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.210%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.928%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="39" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-Term Marketable Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash- Restricted</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-unrestricted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-restricted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,271 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,271 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,196 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    Level I:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">         Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    US treasury securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,428 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">           Subtotal </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,197 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,200 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,769 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,468 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46,471 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,965 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,431 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="39" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortized Cost</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Unrealized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-Term Marketable Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash- Restricted</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-unrestricted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash-restricted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,689 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,689 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,614 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">    Level I:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">         Money market funds</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">         US treasury securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,942 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">           Subtotal</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41,989 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,025 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,047 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,678 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,714 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,661 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,978 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 20196000 20196000 20196000 1075000 1075000 1075000 21271000 21271000 20196000 1075000 22769000 0 0 22769000 22769000 0 0 2428000 3000 0 2431000 0 2431000 25197000 3000 0 25200000 22769000 2431000 46468000 3000 0 46471000 42965000 2431000 1075000 16614000 16614000 16614000 2075000 2075000 2075000 18689000 18689000 16614000 2075000 5047000 0 0 5047000 5047000 0 0 36942000 36000 0 36978000 0 36978000 41989000 36000 0 42025000 5047000 36978000 60678000 36000 0 60714000 21661000 36978000 2075000 0 1079000 1051000 1122000 1079000 1057000 1122000 55000000 52962000 82369000 55000000 52764000 73975000 56079000 54013000 83491000 56079000 53821000 75097000 Shareholders’ Equity<div style="text-indent:13.5pt;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">InstruNor Acquisition</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2020, we completed the acquisition of all of the outstanding shares of InstruNor (see Note 3). The purchase price was approximately $7.2 million, consisting of $5.2 million in cash and 485,451 shares of our common stock.</span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Conversion of 2018 Notes</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of 2019, we issued 19,460,260 shares of our common stock in connection with the conversion of our 2018 Notes (see Note 7). As a result of this issuance of our common stock, we recorded a total of $133.3 million of equity, which was equivalent to the fair value of the bonds retired.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At June 30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:57.649%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.723%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in 000's)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2009 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,609 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,138 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,823 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,100 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,858 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,379 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,923 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 7200000 5200000 485451 19460260 133300000 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At June 30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:57.649%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.723%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in 000's)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2009 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,609 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,138 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,823 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,100 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,858 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,379 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,923 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="padding-left:22.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total stock-based compensation expense recognized was as follows (in thousands): </span></div><div style="text-align:center;margin-top:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"><tr><td style="width:1.0pt;"/><td style="width:257.50pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units, Stock Options and Performance Share Units</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,331 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,848 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,443 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,993 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">144 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">557 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Share-based Compensation</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,634 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,992 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,263 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 19000 0 0 1609000 6138000 2823000 23000 0 0 207000 241000 0 0 0 3100000 1858000 6379000 5923000 Stock-Based Plans<div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of either 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably each quarter over 16 quarters, subject to the employees’ continued employment. In May 2020, we granted 1.8 million retention RSUs that vest over three years, with 50% of the RSUs vesting after one year and 25% of the RSUs vesting each year thereafter. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than 10% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than five years from the date of grant and an exercise price of at least 110% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2011 Equity Incentive Plan</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately 5.0 million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved an increase in the number of shares reserved for issuance under the 2011 Plan of 1.4 million shares. </span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2009 Equity Incentive Plan and 2017 Inducement Award Plan </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (Inducement Plan) and reserved 2 million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provided for the grant of equity-based awards on terms substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan were only be made to individuals not previously our employees or non-employee members of our board of directors (or following such individual’s bona fide period of non-employment), as an inducement material to the individual’s entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules. In June 2019, concurrently with the increase in shares available for grant under the 2011 Plan, the Inducement Plan was terminated such that no further grants could be made thereunder. Options granted and shares issued under the Inducement Plan that were outstanding when the Inducement Plan was terminated remain outstanding subject to their terms and the terms of the Inducement Plan.</span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Valuation and Expense Information</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity under the 2011 Plan, the 2009 Plan, and the Inducement Plan was as follows:</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock Units</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">:</span></div><div style="margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,551 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.43 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,642 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.95 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RSU released</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(602)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.72 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(222)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,369 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.06 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:27pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $24.8 million. We expect to recognize those costs over a weighted average period of 3.0 years.</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">: </span></div><div style="margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.596%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.596%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.725%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of <br/>Options (000s)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Aggregate</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Intrinsic </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"> in (000s)</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,027 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.78 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.74 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(274)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.71 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,858 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.86 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">163 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,372 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.69 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Awards expected to vest at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">474 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.50 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.1</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(1)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt;">Aggregate intrinsic value as of June 30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of June 30, 2020, which was $4.01, and the exercise price of the options, multiplied by the number of in-the-money options. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $1.4 million. We expect to recognize those costs over a weighted average period of 1.5 years. </span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Performance-based Awards</span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Performance Stock Units with Market Conditions</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable three-year performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted. Under FASB ASC Topic 718, the provisions of the PSU awards related to TSR are considered a market condition, and the effects of that market condition are reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity under the TSR-based PSUs is as follows: </span></div><div style="text-align:center;margin-top:9pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">547 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.09 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">509 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU released</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(94)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.74 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:24.75pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the unrecognized compensation costs related to these awards were $5.7 million. We expect to recognize those costs over a weighted average period of 2.0 years.</span></div><div style="text-indent:13.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Performance Stock Units with Performance Conditions</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During 2019, we also granted a PSU award under which the number of PSUs that ultimately vest is dependent on achieving certain discrete operational milestones between September 30, 2019 and December 31, 2020. Activity to date under this PSU award is as follows:</span></div><div style="text-align:center;margin-top:11pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU released</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">2017 Employee Stock Purchase Plan</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2017, our stockholders approved our ESPP at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to June 2019, our ESPP program had a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees were eligible to participate through payroll deductions of up to 10% of their compensation. The purchase price at which shares were sold under the ESPP was 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Effective in June 2019, our ESPP program was amended to offer a twelve-month offering period with two six-month purchase periods beginning on each of May 31 and November 30. Employees were eligible under the amended program to participate through payroll deductions of up to 15% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Under the updated ESPP program, the purchase price at which shares are sold for the first purchase period is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the first purchase period. For the second purchase period, the purchase price at which shares are sold is 85% of the lower of the fair market value of the common stock on the first day of the offering period and the last day of the offering period. In the event the fair market value of the common stock at the beginning of the second purchase period is less than the fair market value on the beginning of the offering period, the purchase price for the second offering period is reset to 85% of the lower of the fair value of the common stock at the beginning of the second purchase period and the last day of the offering period.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The offering period of June 1, 2019 to May 31, 2020 had two purchase periods, with one period ending November 30, 2019 and the other period ending May 31, 2020. As the fair market value of the common stock at November 30, 2019 was lower than the fair value of the common stock at the beginning of the offering period, the purchase price for the second purchase period was reset based on the lower of the November 30, 2019 price and the May 31, 2020 price. The resetting of the purchase price is considered to be a modification of the original terms of the award. Under ASC 718, the incremental fair value based on the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified was approximately $0.3 million. This amount was amortized over the remaining offering period which ended May 31, 2020. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, our board of directors authorized, and in June 2020, our stockholders approved, an amendment and restatement of the ESPP that increased the number of shares reserved for issuance by an additional 3.0 million shares and made various other changes. Effective June 2020, our ESPP program was amended to offer a six-month offering period, with a new offering and purchase period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible under the amended program to participate through payroll deductions of up to 10% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. The purchase price of the shares sold under the ESPP is 85% of the lower of fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.</span></div><div style="padding-left:22.5pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Total stock-based compensation expense recognized was as follows (in thousands): </span></div><div style="text-align:center;margin-top:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt;"><tr><td style="width:1.0pt;"/><td style="width:257.50pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.75pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:1.00pt;"/><td style="width:1.0pt;"/><td style="width:1.0pt;"/><td style="width:58.00pt;"/><td style="width:1.0pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Stock Units, Stock Options and Performance Share Units</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,331 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,848 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,443 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,993 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">144 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">557 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Share-based Compensation</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,634 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,992 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,000 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,263 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> P4Y 0.25 1800000 P3Y 0.50 P1Y 0.25 P10Y 1 0.10 P5Y 1.10 0.25 P36M P48M 5000000.0 1400000 2000000 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity under the 2011 Plan, the 2009 Plan, and the Inducement Plan was as follows:</span></div><div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock Units</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">:</span></div><div style="margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,551 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.43 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,642 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.95 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RSU released</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(602)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.72 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(222)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,369 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.06 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 2551000 7.43 3642000 3.95 602000 7.72 222000 6.82 5369000 5.06 24800000 P3Y <div style="text-indent:13.5pt;margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">: </span></div><div style="margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.444%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.596%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.596%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.725%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of <br/>Options (000s)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Aggregate</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Intrinsic </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"> in (000s)</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,027 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.78 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.74 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(274)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.71 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance as of June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,858 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.86 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">163 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested at June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,372 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.69 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Awards expected to vest at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">474 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.50 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.1</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div>(1)Aggregate intrinsic value as of June 30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of June 30, 2020, which was $4.01, and the exercise price of the options, multiplied by the number of in-the-money options. 2027000 7.78 P6Y9M18D 81000 105000 3.74 0 0 274000 5.71 1858000 7.86 P6Y1M6D 163000 1372000 8.69 P5Y4M24D 115000 474000 5.50 P8Y1M6D 48000 4.01 1400000 P1Y6M P3Y 0 2 <div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Activity under the TSR-based PSUs is as follows: </span></div><div style="text-align:center;margin-top:9pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">547 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.09 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">509 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU released</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(94)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.26 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">962 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.74 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div>Activity to date under this PSU award is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of Units (in 000s)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU released</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table> 547000 15.09 509000 4.82 0 0 94000 14.26 962000 9.74 5700000 P2Y 64000 7.05 0 0 4000 7.05 12000 7.05 48000 7.05 P6M 0.10 0.85 P12M 2 0.15 25000 0.85 0.85 0.85 2 300000 3000000.0 P6M 0.10 25000 0.85 3331000 2848000 5443000 4993000 303000 144000 557000 270000 3634000 2992000 6000000 5263000 Income Taxes<div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recorded a tax benefit of $1.1 million for both the three months ended June 30, 2020 and 2019. We recorded a tax benefit of $1.8 million and $1.1 million for the six months ended June 30, 2020 and 2019, respectively. The benefits for all periods were primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by tax provisions for our foreign operations and state minimum income taxes. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our tax benefit for income taxes for the periods presented differ from the 21% U.S. Federal statutory rate for the six months ended June 30, 2020 and 2019, respectively, primarily due to maintaining a valuation allowance for most of our deferred tax assets, which primarily consist of net operating loss carryforwards. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three and six months ended June 30, 2020, and 2019, respectively, we did not recognize any material interest or penalties related to uncertain tax positions.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results. The deferred tax assets have been offset by valuation allowances. In the future we may release valuation allowances and recognize deferred tax assets in certain of our foreign subsidiaries depending on the achievement of future profitability in the relevant jurisdictions. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to monitor the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law. The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax deprecation methods for qualified improvement property. We are currently analyzing the impact of these changes and therefore, an estimate of the impact on income taxes, if any, is not yet available.</span></div> -1100000 -1100000 -1800000 -1100000 Information About Geographic Areas<div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We operate in one reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A summary table of our total revenue by geographic areas of our customers and by product and services for the three and six months ended June 30, 2020 and 2019 is included in Note 4 to the condensed consolidated financial statements. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales to customers in the United States represented $13.4 million, or 51% of total revenues, and $27.5 million, or 51% of total revenues, for the three and six months ended June 30, 2020, respectively. Sales to customers in the United States </span></div><div style="margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">represented $9.9 million, or 35% of total revenues, and $22.4 million, or 38% of total revenues, for the three and six months ended June 30, 2019, respectively. </span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">No foreign country or jurisdiction had sales in excess of 10% of total revenues for the three months ended June 30, 2020 and 2019, except for China, which had sales of $3.5 million, or 13% of total revenues, and $4.0 million, or 14% of total revenues, respectively. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the six months ended June 30, 2020 or 2019, except for China, which had sales of $7.5 million, or 13% of total revenues, for the six months ended June 30, 2019.</span></div> 1 13400000 0.51 27500000 0.51 9900000 0.35 22400000 0.38 3500000 0.13 4000000.0 0.14 7500000 0.13 Development Agreement Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $11.7 million during the development stage. The development stage is expected to last approximately one year from the date of the agreement. We recognized $3.0 million of development revenue from this agreement in the three and six months ended June 30, 2020, along with approximately $1.0 million of deferred revenue. 11700000 P1Y 3000000.0 1000000.0 Commitments and Contingencies<div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Indemnification</span></div><div style="text-indent:27pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. </span></div><div style="margin-top:15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Contingencies</span></div>From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates. Subsequent EventsIn July 20, 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program aims to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. This project, with a total proposed budget of up to $37.0 million, contemplates expanding production capacity and throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology. The letter contract provides Fluidigm with access to up to $12.2 million of initial funding based on completion and delivery of certain validation milestones prior to execution of a definitive contract. 37000000.0 12200000 XML 14 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover - shares
6 Months Ended
Jun. 30, 2020
Jul. 31, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Annual Report true  
Document Period End Date Jun. 30, 2020  
Document Transition Report false  
Entity File Number 001-34180  
Entity Registrant Name FLUIDIGM CORP  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q2  
Entity Central Index Key 0001162194  
Current Fiscal Year End Date --12-31  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0513190  
Entity Address, Address Line One 2 Tower Place, Ste 2000  
Entity Address, City or Town South San Francisco,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94080  
City Area Code 650  
Local Phone Number 266-6000  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol FLDM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (shares)   71,316,370

XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 42,965 $ 21,661
Short-term investments 2,431 36,978
Accounts receivable (net of allowances of $101 and $6, at June 30, 2020 and December 31, 2019, respectively) 9,983 18,981
Inventories 18,900 13,884
Prepaid expenses and other current assets 4,171 4,592
Total current assets 78,450 96,096
Property and equipment, net 7,865 8,056
Operating lease right-of-use asset, net 39,027 4,860
Other non-current assets 5,034 5,492
Developed technology, net 45,644 46,200
Goodwill 106,328 104,108
Total assets 282,348 264,812
Current liabilities:    
Accounts payable 9,384 6,510
Accrued compensation and related benefits 6,757 5,160
Operating lease liabilities, current 2,170 1,833
Other accrued liabilities 5,758 7,515
Deferred revenue, current 14,279 11,803
Total current liabilities 38,348 32,821
Convertible notes, net 54,013 53,821
Deferred tax liability 9,655 11,494
Operating lease liabilities, non-current 39,139 4,323
Deferred revenue, non-current 7,936 8,168
Other non-current liabilities 538 573
Total liabilities 149,629 111,200
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either June 30, 2020 or December 31, 2019 0 0
Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2020 and December 31, 2019; 71,283 and 69,956 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 71 70
Additional paid-in capital 786,193 777,765
Accumulated other comprehensive loss (809) (582)
Accumulated deficit (652,736) (623,641)
Total stockholders’ equity 132,719 153,612
Total liabilities and stockholders’ equity $ 282,348 $ 264,812
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 101 $ 6
Preferred stock, par value (usd per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (shares) 10,000,000 10,000,000
Preferred stock, shares issued (shares) 0 0
Preferred stock, shares outstanding (shares) 0 0
Common stock, par value (usd per share) $ 0.001 $ 0.001
Common stock, shares authorized (shares) 200,000,000 200,000,000
Common stock, shares issued (shares) 71,283,000 69,956,000
Common stock, shares outstanding (shares) 71,283,000 69,956,000
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenue:        
Total revenue $ 26,058 $ 28,196 $ 53,675 $ 58,307
Costs and expenses:        
Research and development 8,448 7,865 17,147 16,237
Selling, general and administrative 20,616 22,134 43,311 44,958
Total costs and expenses 39,784 42,832 82,343 87,149
Loss from operations (13,726) (14,636) (28,668) (28,842)
Interest expense (897) (491) (1,797) (3,192)
Loss from extinguishment of debt 0 0 0 (9,000)
Other income (expense), net 463 231 (355) 715
Loss before income taxes (14,160) (14,896) (30,820) (40,319)
Income tax benefit 1,145 1,143 1,825 1,101
Net loss $ (13,015) $ (13,753) $ (28,995) $ (39,218)
Net loss per share, basic and diluted (usd per share) $ (0.18) $ (0.20) $ (0.41) $ (0.61)
Shares used in computing net loss per share, basic and diluted (shares) 70,916 69,158 70,691 63,923
Product revenue        
Revenue:        
Total revenue $ 17,405 $ 23,235 $ 36,386 $ 48,062
Costs and expenses:        
Cost of revenue 9,483 11,100 19,123 22,489
Service revenue        
Revenue:        
Total revenue 5,140 4,961 10,326 10,245
Costs and expenses:        
Cost of revenue 1,237 1,733 2,762 3,465
Development revenue        
Revenue:        
Total revenue 3,000 0 3,000 0
Other revenue        
Revenue:        
Total revenue $ 513 $ 0 $ 3,963 $ 0
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Statement of Comprehensive Income [Abstract]        
Net loss $ (13,015) $ (13,753) $ (28,995) $ (39,218)
Other comprehensive income (loss), net of tax        
Foreign currency translation adjustment 109 (9) (194) (1)
Net change in unrealized gain (loss) on investments (33) 63 (33) 65
Other comprehensive income (loss), net of tax 76 54 (227) 64
Comprehensive loss $ (12,939) $ (13,699) $ (29,222) $ (39,154)
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance (shares) at Dec. 31, 2018     49,338,000        
Beginning Balance at Dec. 31, 2018 $ 72,116   $ 49 $ 631,605 $ (687) $ (558,851)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock on bond conversion (in shares)     19,460,000        
Issuance of common stock on bond conversion 133,298   $ 19 133,279      
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)     140,000        
Issuance of restricted stock, net of shares withheld for taxes, and other (176)   $ 1 (177)      
Issuance of common stock from option exercises (in shares)     53,000        
Issuance of common stock from option exercises 255     255      
Stock-based compensation expense 2,207     2,207      
Net loss (25,465)         (25,465)  
Other comprehensive income (loss) 10       10    
Ending Balance (shares) at Mar. 31, 2019     68,991,000        
Ending Balance at Mar. 31, 2019 182,245   $ 69 767,169 (677) (584,316)  
Beginning Balance (shares) at Dec. 31, 2018     49,338,000        
Beginning Balance at Dec. 31, 2018 72,116   $ 49 631,605 (687) (558,851)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (39,218)            
Other comprehensive income (loss) 64            
Ending Balance (shares) at Jun. 30, 2019     69,400,000        
Ending Balance at Jun. 30, 2019 172,640   $ 69 771,263 (623) (598,069)  
Beginning Balance (shares) at Mar. 31, 2019     68,991,000        
Beginning Balance at Mar. 31, 2019 182,245   $ 69 767,169 (677) (584,316)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)     183,000        
Issuance of restricted stock, net of shares withheld for taxes, and other (325)     (325)      
Issuance of common stock from option exercises (in shares)     130,000        
Issuance of common stock from option exercises 793     793      
Issuance of common stock under ESPP (in shares)     96,000        
Issuance of common stock under ESPP 641     641      
Stock-based compensation expense 2,985     2,985      
Net loss (13,753)         (13,753)  
Other comprehensive income (loss) 54       54    
Ending Balance (shares) at Jun. 30, 2019     69,400,000        
Ending Balance at Jun. 30, 2019 $ 172,640   $ 69 771,263 (623) (598,069)  
Beginning Balance (shares) at Dec. 31, 2019 69,956,000   69,956,000        
Beginning Balance at Dec. 31, 2019 $ 153,612 $ (100) $ 70 777,765 (582) (623,641) $ (100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)     255,000        
Issuance of restricted stock, net of shares withheld for taxes, and other (146)     (146)      
Stock-based compensation expense 2,364     2,364      
Acquisition of InstruNor AS (shares)     485,000        
Acquisition of InstruNor AS 2,049   $ 1 2,048      
Net loss (15,980)         (15,980)  
Other comprehensive income (loss) (303)       (303)    
Ending Balance (shares) at Mar. 31, 2020     70,696,000        
Ending Balance at Mar. 31, 2020 $ 141,496   $ 71 782,031 (885) (639,721)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member            
Beginning Balance (shares) at Dec. 31, 2019 69,956,000   69,956,000        
Beginning Balance at Dec. 31, 2019 $ 153,612 $ (100) $ 70 777,765 (582) (623,641) $ (100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from option exercises (in shares) 0            
Net loss $ (28,995)            
Other comprehensive income (loss) $ (227)            
Ending Balance (shares) at Jun. 30, 2020 71,283,000   71,283,000        
Ending Balance at Jun. 30, 2020 $ 132,719   $ 71 786,193 (809) (652,736)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member            
Beginning Balance (shares) at Mar. 31, 2020     70,696,000        
Beginning Balance at Mar. 31, 2020 $ 141,496   $ 71 782,031 (885) (639,721)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)     286,000        
Issuance of restricted stock, net of shares withheld for taxes, and other (116)     (116)      
Issuance of common stock under ESPP (in shares)     301,000        
Issuance of common stock under ESPP 645     645      
Stock-based compensation expense 3,633     3,633      
Net loss (13,015)         (13,015)  
Other comprehensive income (loss) $ 76       76    
Ending Balance (shares) at Jun. 30, 2020 71,283,000   71,283,000        
Ending Balance at Jun. 30, 2020 $ 132,719   $ 71 $ 786,193 $ (809) $ (652,736)  
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating activities    
Net loss $ (28,995) $ (39,218)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,016 2,351
Stock-based compensation expense 6,000 5,263
Amortization of developed technology 5,936 5,600
Amortization of debt discounts, premiums and issuance costs 275 2,037
Lease amortization 1,331 (250)
Loss on extinguishment of debt 0 9,000
Provision for excess and obsolete inventory 306 555
Loss on disposal of property and equipment 148 29
Other non-cash items 136 162
Changes in assets and liabilities:    
Accounts receivable, net 9,055 (2,420)
Inventories (4,892) (2,041)
Prepaid expenses and other assets (706) (965)
Accounts payable 3,136 3,439
Deferred revenue 1,965 476
Other liabilities (2,796) (9,161)
Net cash used in operating activities (7,085) (25,143)
Investing activities    
Acquisition, net of cash acquired (5,154) 0
Purchases of investments 0 (44,614)
Proceeds from sale of investments 5,011 0
Proceeds from maturities of investments 29,400 0
Purchases of property and equipment (1,671) (685)
Net cash provided by (used in) investing activities 27,586 (45,299)
Financing activities    
Payment of debt issuance cost (375) (15)
Proceeds from exercise of stock options 0 1,048
Proceeds from stock issuance from ESPP 645 641
Payments for taxes related to net share settlement of equity awards and other (262) (487)
Net cash provided by financing activities 8 1,187
Effect of foreign exchange rate fluctuations on cash and cash equivalents (205) (25)
Net increase (decrease) in cash, cash equivalents and restricted cash 20,304 (69,280)
Cash, cash equivalents and restricted cash at beginning of period 23,736 95,401
Cash, cash equivalents and restricted cash at end of period 44,040 26,121
Supplemental disclosures of cash flow information    
Cash paid for interest 1,531 2,600
Cash paid for income taxes, net of refunds 194 139
Asset retirement obligations $ 316 $ 319
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Description of Business
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business Description of BusinessFluidigm Corporation (the Company, Fluidigm, we, our or us) creates, manufactures, and markets technologies and tools for life sciences research, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits (IFC), assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including infectious disease, cancer, immunology and immunotherapy. We sell our instruments, consumables and services to academic institutions, clinical laboratories, and contract research organizations, as well as biopharmaceutical, biotechnology, and agricultural biotechnology companies. The Company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of June 30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.
Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders’ equity, total revenue, total costs and expenses, loss from operations or net loss.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of June 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.
Foreign Currency
Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year.
Revenue Recognition
We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from
development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue.
We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.
Product Revenue
We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.
We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.
Service Revenue
We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.
Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally one to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.
Development Revenue
The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement.
We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary.
We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.
Other Revenue
Other revenue consists of license and royalty revenue, and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For
contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.
In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.
We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory.
Contract Costs
Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.
Product Warranties
We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.
Significant Judgments
Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.
Accounts Receivable
Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.
Concentrations of Business and Credit Risk
Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.
We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three months ended June 30, 2020. No other customer represented more than 10% of total revenue for three and six months ended June 30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 32% and 30% of total revenue for the three months ended June 30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the six months ended June 30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at June 30, 2020, or December 31, 2019.
Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.
Leases
We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country.
Goodwill, Intangible Assets and Other Long-Lived Assets
Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.
Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.
In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.
We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.
Convertible Notes
In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and
accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes using valuation techniques that required us to make assumptions related to the implied discount rate. 
In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding.
As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded for as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.
See Note 7 for a detailed discussion of the accounting treatment of the transactions and additional information.
Comprehensive Loss
Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.
The components of accumulated other comprehensive loss, net of tax, for the three and six months ended June 30, 2020 is as follows (in thousands):
Foreign Currency Translation AdjustmentUnrealized Gain (Loss) on InvestmentsAccumulated Other Comprehensive Income (Loss)
Ending balance at December 31, 2019$(618) $36  $(582) 
Other comprehensive income (loss)(303) —  (303) 
Ending balance at March 31, 2020(921) 36  (885) 
Other comprehensive income (loss)109  (33) 76  
Ending balance at June 30, 2020$(812) $ $(809) 
Immaterial amounts of unrealized gains and losses have been reclassified into the condensed consolidated statement of operations for the three and six months ended June 30, 2020 and 2019.
Net Loss per Share
Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.
The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):
 Six Months Ended June 30,
 20202019
Stock options, restricted stock units and performance awards8,237  4,541  
2019 Convertible Notes18,966  —  
2019 Convertible Notes potential make-whole shares2,412  —  
2014 Convertible Notes19  916  
Total29,634  5,457  
Recent Accounting Changes and Accounting Pronouncements
Adoption of New Accounting Guidance
In August 2018, the U.S.-based Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.
In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.
The FASB issued two ASUs related to financial instruments – credit losses. The ASUs issued were: (1) in June 2016, ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leasing standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders’ equity and decrease current assets by the same amount in our condensed consolidated balance sheet.
Recent Accounting Pronouncements
In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Business Combination Business Combination
On January 17, 2020, we completed the acquisition of all of the outstanding shares of InstruNor AS, a privately held Norwegian company (InstruNor).
InstruNor is a provider of the only fully integrated sample preparation system for flow and mass cytometry. The acquisition of InstruNor supports our entry into the sample preparation market for cytometry analysis and expands our capabilities to include fully automated sample preparation for flow and mass cytometry. The value of this technology is reflected in the intangible asset for developed technology. The developed technology was valued using a discounted cash flow model for which the most sensitive assumption was revenue growth rate.
The purchase price of $7.2 million included approximately $5.2 million in cash and 485,451 shares of our common stock valued at the closing price on the effective date of $4.22.
A summary of the net cash flows is summarized below (in thousands):
January 17, 2020
Cash consideration paid to former equity holders$5,165  
Less: cash and cash equivalents acquired(11) 
Acquisition of InstruNor, net of cash acquired$5,154  
The acquisition was accounted for in accordance with ASC 805, Business Combinations. The assets acquired and liabilities assumed were recorded at their estimated fair values at the InstruNor acquisition date. Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):
January 17, 2020
Purchase price:
Cash consideration paid on closing to former equity holders$5,165  
Non-cash consideration common shares 2,049  
Total purchase price$7,214  
Assets acquired:
Cash and cash equivalents$11  
Accounts receivable32  
Other receivables13  
Inventories, net153  
Developed technology5,380  
Liabilities assumed:
Accounts payable14  
Other current liabilities15  
Deferred tax liability566  
Fair value of identifiable net assets acquired$4,994  
Goodwill acquired on acquisition$2,220  
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue
6 Months Ended
Jun. 30, 2020
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregation of Revenue
The following table presents our revenue for the three and six months ended June 30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Geographic Markets:
Americas$13,940  $11,120  $28,784  $24,091  
EMEA6,557  11,217  14,653  19,373  
Asia-Pacific5,561  5,859  10,238  14,843  
Total revenue$26,058  $28,196  $53,675  $58,307  
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Source:
Instruments$8,577  $12,201  $18,048  $25,041  
Consumables8,828  11,034  18,338  23,021  
Product revenue17,405  23,235  36,386  48,062  
Service revenue5,140  4,961  10,326  10,245  
Development revenue3,000  —  3,000  —  
Other revenue
  License and royalty revenue63  —  3,163  —  
  Grant revenue450  —  800  —  
  Total other revenue513  —  3,963  —  
Total revenue$26,058  $28,196  $53,675  $58,307  
Performance Obligations
We reported $20.0 million of deferred revenue in our December 31, 2019 consolidated balance sheet. During the six months ended June 30, 2020, $6.2 million of the opening balance was recognized as revenue and $8.4 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At June 30, 2020, we reported $22.2 million of deferred revenue.
The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at June 30, 2020 (in thousands):
Fiscal Year
Expected Revenue (1)
2020 (remainder of the year)$7,401  
20218,636  
20224,702  
Thereafter3,164  
Total$23,903  
_______
(1) Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.
We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets, net
6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, net Goodwill and Intangible Assets, net
In connection with our acquisition of DVS Sciences, Inc. in February 2014, we recognized goodwill of $104.1 million and $112.0 million of developed technology. In the first quarter of 2020, we recognized $2.2 million of goodwill from the InstruNor acquisition and $5.4 million of developed technology (see Note 3). We are amortizing InstruNor developed technology over 8.0 years.
Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.
During the first quarter of fiscal 2020, the Company assessed whether the current and potential future impact of the COVID-19 pandemic represented an event which necessitated an impairment review. This assessment included an update of the qualitative and quantitative factors affecting our business. As a result of this assessment, we determined that a triggering event had occurred and a quantitative impairment test was performed. As a result of this quantitative analysis, we determined that the fair values of our goodwill and developed technology intangibles were not less than their carrying values and no impairment was recognized.
Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangible assets, net, were as follows (in thousands):
June 30, 2020
Gross AmountAccumulated AmortizationNetWeighted-Average Amortization Period
Developed technology$117,380  $(71,736) $45,644  9.9 years
Patents and licenses$11,274  $(8,802) $2,472  7.8 years
December 31, 2019
Gross AmountAccumulated AmortizationNetWeighted-Average Amortization Period
Developed technology$112,000  $(65,800) $46,200  10.0 years
Patents and licenses$11,274  $(8,342) $2,932  7.8 years
Total amortization expense for the three months ended June 30, 2020 and 2019 was $3.2 million and $3.1 million, respectively. Amortization of intangibles was $6.4 million and $6.2 million for the six months ended June 30, 2020 and 2019, respectively.
Based on the carrying value of intangible assets, net, as of June 30, 2020, the amortization expense is expected to be as follows (in thousands):
Fiscal YearDeveloped Technology Amortization ExpensePatents and Licenses Amortization ExpenseTotal
2020 (remainder of the year)$5,936  $457  $6,393  
202111,873  759  12,632  
202211,873  676  12,549  
202311,873  570  12,443  
20242,073  10  2,083  
Thereafter2,016  —  2,016  
Total$45,644  $2,472  $48,116  
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Balance Sheet Details
6 Months Ended
Jun. 30, 2020
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Details Balance Sheet Details
Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Cash and cash equivalents$42,965  $21,661  
Restricted cash1,075  2,075  
Total cash, cash equivalents and restricted cash$44,040  $23,736  
Short-term restricted cash of approximately $75 thousand is included in prepaid expenses and other current assets and $1.0 million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of June 30, 2020.
Inventories
Inventories consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Raw materials$9,665  $6,133  
Work-in-process1,063  659  
Finished goods8,172  7,092  
Total inventories$18,900  $13,884  
Property and Equipment, net
Property and equipment consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Computer equipment and software$4,376  $3,997  
Laboratory and manufacturing equipment19,652  19,325  
Leasehold improvements7,962  7,788  
Office furniture and fixtures2,076  1,824  
Property and equipment, gross34,066  32,934  
Less accumulated depreciation and amortization(26,309) (24,954) 
Construction-in-progress108  76  
Property and equipment, net$7,865  $8,056  
 
Warranties
Activity for our warranty accrual for the six months ended June 30, 2020 and 2019, which are included in other accrued liabilities, is summarized below (in thousands):
Six Months Ended June 30,
20202019
Beginning balance$1,390  $863  
Accrual for current period warranties419  657  
Warranty costs incurred(277) (429) 
Ending balance$1,532  $1,091  
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes and Credit Facility
6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Convertible Notes and Credit Facility Convertible Notes and Credit Facility
2014 Senior Convertible Notes (2014 Notes)
In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2014 Notes. We received $195.2 million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $1.1 million in offering-related expenses. The underwriting discount of $6.0 million and the debt issuance costs of $1.1 million were recorded as offsets to the proceeds. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is 3.0%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. We have retired the majority of the 2014 Notes through the issuance of the 2018 Notes and 2019 Notes, as discussed below. As of June 30, 2020, there is $1.1 million aggregate principal of the 2014 Notes outstanding.
2018 Senior Convertible Notes (2018 Notes)
In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for 2018 Notes, leaving $51.3 million of the aggregate principal amount of 2014 Notes outstanding. As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $145.5 million. The difference between the $150.0 million aggregate principal amount of the 2018 Notes and its fair value was being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023.
The 2018 Notes accrued interest at a rate of 2.75% payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes were set to mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes was 126.9438 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $7.88 per share). The conversion rate was subject to adjustment upon the occurrence of certain specified events. Those certain specified events included holders who converted their 2018 Notes voluntarily prior to our exercise of the issuer’s conversion option described below or in connection with a make-whole fundamental change prior to February 6, 2023, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time prior to the maturity of the 2018 Notes, we could convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equaled or exceeded 110% of the conversion price then in effect for a specified number of days.
Offering-related costs for the 2018 Notes were approximately $2.8 million. Offering-related costs of $2.2 million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and were being amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. The effective interest rate on the 2018 Notes was 12.3%. Offering-related costs of $0.6 million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and were not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity.
In the first quarter of 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount of the 2018 Notes. In February 2019, we notified the trustee, U.S. Bank National Association, of our intention to exercise our issuer’s conversion option with respect to the remaining approximately $11.9 million in aggregate principal amount of 2018 Notes. In total, $150.0 million of the 2018 Notes were
converted into 19.5 million shares of our common stock and the bonds were retired. We recognized a loss of $9.0 million on the retirement of the 2018 Notes, which represented the difference between the fair value of the bonds retired and their carrying costs. The net impact on equity was $133.3 million and represented the fair value of the bonds retired.
2019 Senior Convertible Notes (2019 Notes)
In November 2019, we issued $55.0 million aggregate principal amount of 2019 Notes. Net proceeds of the offering of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs of approximately $2.3 million. $51.8 million of the proceeds of the 2019 Notes were used to retire $50.2 million aggregate principal amount of our 2014 Notes, leaving $1.1 million of aggregate principal value of 2014 Notes outstanding. We accounted for the transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $3.0 million loss in the fourth quarter of 2019. The loss on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2019 Notes) and the net carrying value of the 2014 Notes exchanged.
The 2019 Notes bear interest at 5.25% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2020. The Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the Notes is 344.8276 shares of the Company’s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $2.90 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer’s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest.
The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 150% of the Conversion Price then in effect for a specified number of days (Issuer’s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company’s common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture.
Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The debt issuance costs are being amortized over the expected term of the 2019 Notes using the effective interest method through the maturity date of December 1, 2024. The effective interest rate on the 2019 Notes is 6.2%.
The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands):
June 30, 2020December 31, 2019
   2.75% 2014 Notes due 2034
Principal amount$1,079  $1,079  
Unamortized debt discount(24) (18) 
Unamortized debt issuance cost(4) (4) 
$1,051  $1,057  
    5.25% 2019 Notes due 2024
Principal amount $55,000  $55,000  
Unamortized debt issuance cost(2,038) (2,236) 
$52,962  $52,764  
    Net carrying value of all Notes$54,013  $53,821  
2018 Revolving Credit Facility
In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this Borrowing Base, we may make and repay borrowings from time to time until the maturity of the Revolving Credit Facility. The Borrowing Base as of June 30, 2020 under the Revolving Credit Facility was $7.3 million. There were no borrowings outstanding under the Revolving Credit Facility at June 30, 2020.
The Revolving Credit Facility is collateralized by substantially all our property, other than intellectual property. Until an amendment in April 2020, the Revolving Credit Facility was set to mature on August 2, 2020. The interest rate on outstanding loans under the Revolving Credit Facility was the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. In addition, we pay a quarterly unused revolving line facility fee of 0.75% per annum on the average unused facility and an annual commitment fee of $112,500.
Effective April 21, 2020, the Revolving Credit Facility was amended to extend the maturity date to August 2, 2022. In addition, the interest rate on outstanding loans under the Revolving Credit Facility was reduced by 0.25%. The quarterly unused line fee, which was previously based on the Maximum Amount, will now be based on the Borrowing Base. The annual commitment fee of $112,500 is unchanged.
The Revolving Credit Facility contains customary affirmative and negative covenants that, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to 5.0% above the otherwise applicable rate of interest. We were in compliance with all the terms and conditions of the Revolving Credit Facility at June 30, 2020.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Leases
6 Months Ended
Jun. 30, 2020
Leases [Abstract]  
Leases Leases
We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than one year to ten years. Some leases contain options to extend the lease, usually for up to five years, and termination options.
Supplemental balance sheet information related to leases was as follows as of June 30, 2020 and December 31, 2019 (in thousands, except for discount rate and lease term):
June 30, 2020December 31, 2019
Operating lease right-of-use buildings$40,618  $6,234  
Operating lease right-of-use equipment33  69  
Operating lease right-of-use vehicles452  355  
Total operating lease right-of-use assets, gross41,103  6,658  
Accumulated amortization(2,076) (1,798) 
Total operating lease right-of-use assets, net$39,027  $4,860  
Operating lease liabilities, current$2,170  $1,833  
Operating lease liabilities, non-current39,139  4,323  
Total operating lease liabilities$41,309  $6,156  
Weighted average remaining lease term (in years)9.14.7
Weighted average discount rate per annum11.9 %5.0 %
A new operating lease for our corporate headquarters in South San Francisco, California commenced in March 2020. We recorded a ROU asset of $35.7 million at the inception of the lease and an operating lease liability of $35.3 million. The lease term is approximately ten years. Future minimum lease payments over the life of the lease were discounted at a rate of 12.55%, which was our estimated incremental collateralized borrowing rate for the term of the lease at the inception of the lease.
The following table presents the components of lease expense for the three and six months ended June 30, 2020 and 2019, respectively (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Operating lease cost (including variable costs)$2,312  $1,553  $4,511  $3,056  
Variable costs including non-lease component$548  $703  $1,169  $1,303  
Supplemental Cash Flow Information:
Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):
Six Months Ended June 30,
20202019
Operating cash flows from operating leases$1,987  $2,061  
Future minimum lease payments under commenced non-cancelable operating leases, which are as of June 30, 2020 as follows (in thousands):
Fiscal YearMinimum Lease Payments for Operating Leases
2020 (remainder of year)$3,214  
20217,282  
20226,985  
20236,907  
20247,120  
Thereafter39,231  
Total future minimum payments $70,739  
Less: imputed interest(29,430) 
Total$41,309  
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands):
June 30, 2020
Amortized CostGross Unrealized GainGross Unrealized LossFair ValueCash and Cash EquivalentsShort-Term Marketable SecuritiesCash- Restricted
Assets:
Cash-unrestricted$20,196  $—  $—  $20,196  $20,196  $—  $—  
Cash-restricted1,075  —  —  1,075  —  —  1,075  
  Total cash$21,271  $—  $—  $21,271  $20,196  $—  $1,075  
Available-for-sale:
    Level I:
         Money market funds$22,769  $—  $—  $22,769  $22,769  $—  $—  
    US treasury securities2,428   —  2,431  —  2,431  —  
           Subtotal $25,197  $ $—  $25,200  $22,769  $2,431  $—  
Total$46,468  $ $—  $46,471  $42,965  $2,431  $1,075  
December 31, 2019
Amortized CostGross Unrealized GainGross Unrealized LossFair ValueCash and Cash EquivalentsShort-Term Marketable SecuritiesCash- Restricted
Assets:
Cash-unrestricted$16,614  $—  $—  $16,614  $16,614  $—  $—  
Cash-restricted2,075  —  —  2,075  —  —  2,075  
  Total cash$18,689  $—  $—  $18,689  $16,614  $—  $2,075  
Available-for-sale:
    Level I:
         Money market funds$5,047  $—  $—  $5,047  $5,047  $—  $—  
         US treasury securities36,942  36  —  36,978  —  36,978  —  
           Subtotal$41,989  $36  $—  $42,025  $5,047  $36,978  $—  
Total$60,678  $36  $—  $60,714  $21,661  $36,978  $2,075  
There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used, during the six months ended June 30, 2020.
Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the six months ended June 30, 2020 and 2019. None of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired.
Convertible Notes
In 2019, we significantly reduced the amount of our outstanding debt. As a result, these securities are not traded frequently, so it is difficult to estimate a reliable and accurate market price and represent Level III valuations. A fair value for these assets cannot be determined by using readily observable inputs or measures, such as market prices or models. Fair values were estimated using pricing models and risk-adjusted value ranges.
The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at June 30, 2020 and December 31, 2019, respectively (in thousands):
June 30, 2020December 31, 2019
Par ValueCarrying ValueFair ValuePar ValueCarrying ValueFair Value
2014 Notes$1,079  $1,051  $1,122  $1,079  $1,057  $1,122  
2019 Notes55,000  52,962  82,369  55,000  52,764  73,975  
Total$56,079  $54,013  $83,491  $56,079  $53,821  $75,097  
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
InstruNor Acquisition
In January 2020, we completed the acquisition of all of the outstanding shares of InstruNor (see Note 3). The purchase price was approximately $7.2 million, consisting of $5.2 million in cash and 485,451 shares of our common stock.
Conversion of 2018 Notes
In the first quarter of 2019, we issued 19,460,260 shares of our common stock in connection with the conversion of our 2018 Notes (see Note 7). As a result of this issuance of our common stock, we recorded a total of $133.3 million of equity, which was equivalent to the fair value of the bonds retired.
At June 30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)Securities To Be Issued Upon Exercise Of Options Securities To Be Issued Upon Release Of Restricted Stock and Performance Share UnitsNumber Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan19  —  —  
2011 Equity Incentive Plan1,609  6,138  2,823  
DVS Sciences Inc. 2010 Equity Incentive Plan23  —  —  
2017 Inducement Award Plan207  241  —  
2017 Employee Stock Purchase Plan—  —  3,100  
1,858  6,379  5,923  
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Plans
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Plans Stock-Based Plans
Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria.
In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of either 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably each quarter over 16 quarters, subject to the employees’ continued employment. In May 2020, we granted 1.8 million retention RSUs that vest over three years, with 50% of the RSUs vesting after one year and 25% of the RSUs vesting each year thereafter.
Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than 10% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than five years from the date of grant and an exercise price of at least 110% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably
each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time.
For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.
2011 Equity Incentive Plan
In January 2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately 5.0 million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved an increase in the number of shares reserved for issuance under the 2011 Plan of 1.4 million shares.
2009 Equity Incentive Plan and 2017 Inducement Award Plan
Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan.
In January 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (Inducement Plan) and reserved 2 million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provided for the grant of equity-based awards on terms substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan were only be made to individuals not previously our employees or non-employee members of our board of directors (or following such individual’s bona fide period of non-employment), as an inducement material to the individual’s entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules. In June 2019, concurrently with the increase in shares available for grant under the 2011 Plan, the Inducement Plan was terminated such that no further grants could be made thereunder. Options granted and shares issued under the Inducement Plan that were outstanding when the Inducement Plan was terminated remain outstanding subject to their terms and the terms of the Inducement Plan.
Valuation and Expense Information
We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date.
Activity under the 2011 Plan, the 2009 Plan, and the Inducement Plan was as follows:
Restricted Stock Units:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 20192,551  $7.43  
RSU granted3,642  $3.95  
RSU released(602) $7.72  
RSU forfeited(222) $6.82  
Balance as of June 30, 20205,369  $5.06  
As of June 30, 2020, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $24.8 million. We expect to recognize those costs over a weighted average period of 3.0 years.
Stock Options:
 Number of
Options (000s)
Weighted-Average
Exercise Price
per Option
Weighted-
Average Remaining Contractual Life (in Years)
Aggregate
Intrinsic
Value (1) in (000s)
Balance at December 31, 20192,027  $7.78  6.8$81  
Options granted105  $3.74  
Options exercised—  $—  
Options forfeited(274) $5.71  
Balance as of June 30, 20201,858  $7.86  6.1$163  
Vested at June 30, 20201,372  $8.69  5.4$115  
Awards expected to vest at June 30, 2020474  $5.50  8.1$48  

(1)Aggregate intrinsic value as of June 30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of June 30, 2020, which was $4.01, and the exercise price of the options, multiplied by the number of in-the-money options.
As of June 30, 2020, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $1.4 million. We expect to recognize those costs over a weighted average period of 1.5 years.
Performance-based Awards
Performance Stock Units with Market Conditions
We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable three-year performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted. Under FASB ASC Topic 718, the provisions of the PSU awards related to TSR are considered a market condition, and the effects of that market condition are reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date.
Activity under the TSR-based PSUs is as follows:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2019547  $15.09  
PSU granted509  $4.82  
PSU released—  $—  
PSU forfeited(94) $14.26  
Balance at June 30, 2020962  $9.74  
As of June 30, 2020, the unrecognized compensation costs related to these awards were $5.7 million. We expect to recognize those costs over a weighted average period of 2.0 years.
Performance Stock Units with Performance Conditions
During 2019, we also granted a PSU award under which the number of PSUs that ultimately vest is dependent on achieving certain discrete operational milestones between September 30, 2019 and December 31, 2020. Activity to date under this PSU award is as follows:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 201964  $7.05  
PSU granted—  $—  
PSU released(4) $7.05  
PSU forfeited(12) $7.05  
Balance at June 30, 202048  $7.05  
2017 Employee Stock Purchase Plan
In August 2017, our stockholders approved our ESPP at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017.
Prior to June 2019, our ESPP program had a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees were eligible to participate through payroll deductions of up to 10% of their compensation. The purchase price at which shares were sold under the ESPP was 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.
Effective in June 2019, our ESPP program was amended to offer a twelve-month offering period with two six-month purchase periods beginning on each of May 31 and November 30. Employees were eligible under the amended program to participate through payroll deductions of up to 15% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year.
Under the updated ESPP program, the purchase price at which shares are sold for the first purchase period is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the first purchase period. For the second purchase period, the purchase price at which shares are sold is 85% of the lower of the fair market value of the common stock on the first day of the offering period and the last day of the offering period. In the event the fair market value of the common stock at the beginning of the second purchase period is less than the fair market value on the beginning of the offering period, the purchase price for the second offering period is reset to 85% of the lower of the fair value of the common stock at the beginning of the second purchase period and the last day of the offering period.
The offering period of June 1, 2019 to May 31, 2020 had two purchase periods, with one period ending November 30, 2019 and the other period ending May 31, 2020. As the fair market value of the common stock at November 30, 2019 was lower than the fair value of the common stock at the beginning of the offering period, the purchase price for the second purchase period was reset based on the lower of the November 30, 2019 price and the May 31, 2020 price. The resetting of the purchase price is considered to be a modification of the original terms of the award. Under ASC 718, the incremental fair value based on the difference between the fair value of the modified award and the fair value of the original award immediately before it was modified was approximately $0.3 million. This amount was amortized over the remaining offering period which ended May 31, 2020.
In April 2020, our board of directors authorized, and in June 2020, our stockholders approved, an amendment and restatement of the ESPP that increased the number of shares reserved for issuance by an additional 3.0 million shares and made various other changes. Effective June 2020, our ESPP program was amended to offer a six-month offering period, with a new offering and purchase period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible under the amended program to participate through payroll deductions of up to 10% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. The purchase price of the shares sold under the ESPP is 85% of the lower of fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period.
Total stock-based compensation expense recognized was as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Restricted Stock Units, Stock Options and Performance Share Units$3,331  $2,848  $5,443  $4,993  
Employee Stock Purchase Plan303  144  557  270  
Total Share-based Compensation$3,634  $2,992  $6,000  $5,263  
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes
6 Months Ended
Jun. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.
We recorded a tax benefit of $1.1 million for both the three months ended June 30, 2020 and 2019. We recorded a tax benefit of $1.8 million and $1.1 million for the six months ended June 30, 2020 and 2019, respectively. The benefits for all periods were primarily attributable to the tax benefit from the amortization of our acquisition-related deferred tax liabilities partially offset by tax provisions for our foreign operations and state minimum income taxes.
Our tax benefit for income taxes for the periods presented differ from the 21% U.S. Federal statutory rate for the six months ended June 30, 2020 and 2019, respectively, primarily due to maintaining a valuation allowance for most of our deferred tax assets, which primarily consist of net operating loss carryforwards.
Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three and six months ended June 30, 2020, and 2019, respectively, we did not recognize any material interest or penalties related to uncertain tax positions.
Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results. The deferred tax assets have been offset by valuation allowances. In the future we may release valuation allowances and recognize deferred tax assets in certain of our foreign subsidiaries depending on the achievement of future profitability in the relevant jurisdictions. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to monitor the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act was signed into law. The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax deprecation methods for qualified improvement property. We are currently analyzing the impact of these changes and therefore, an estimate of the impact on income taxes, if any, is not yet available.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Information About Geographic Areas
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Information About Geographic Areas Information About Geographic Areas
We operate in one reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.
A summary table of our total revenue by geographic areas of our customers and by product and services for the three and six months ended June 30, 2020 and 2019 is included in Note 4 to the condensed consolidated financial statements.
Sales to customers in the United States represented $13.4 million, or 51% of total revenues, and $27.5 million, or 51% of total revenues, for the three and six months ended June 30, 2020, respectively. Sales to customers in the United States
represented $9.9 million, or 35% of total revenues, and $22.4 million, or 38% of total revenues, for the three and six months ended June 30, 2019, respectively.
No foreign country or jurisdiction had sales in excess of 10% of total revenues for the three months ended June 30, 2020 and 2019, except for China, which had sales of $3.5 million, or 13% of total revenues, and $4.0 million, or 14% of total revenues, respectively. There was no foreign country or jurisdiction with sales in excess of 10% of our total revenues for the six months ended June 30, 2020 or 2019, except for China, which had sales of $7.5 million, or 13% of total revenues, for the six months ended June 30, 2019.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Development Agreement
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Development Agreement Development Agreement Effective March 31, 2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, Fluidigm will develop products based on our microfluidics technology. The Development Agreement provides up-front and periodic milestone payments of up to $11.7 million during the development stage. The development stage is expected to last approximately one year from the date of the agreement. We recognized $3.0 million of development revenue from this agreement in the three and six months ended June 30, 2020, along with approximately $1.0 million of deferred revenue.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Indemnification
From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding.
Contingencies
From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
6 Months Ended
Jun. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events Subsequent EventsIn July 20, 2020, we entered into a letter contract with the National Institutes of Health (NIH) for a project under the NIH Rapid Acceleration of Diagnostics (RADx) program. The RADx program aims to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of COVID-19 tests. This project, with a total proposed budget of up to $37.0 million, contemplates expanding production capacity and throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology. The letter contract provides Fluidigm with access to up to $12.2 million of initial funding based on completion and delivery of certain validation milestones prior to execution of a definitive contract.
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of June 30, 2020, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.
Reclassifications Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders’ equity, total revenue, total costs and expenses, loss from operations or net loss.
Use of Estimates
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of June 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.
Foreign Currency Foreign CurrencyAssets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year.
Revenue Recognition
Revenue Recognition
We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. We also generate revenue from
development agreements, license and royalty agreements and grants. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities. Research and development cost includes costs associated with development and grant revenue.
We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.
Product Revenue
We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.
We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.
Service Revenue
We recognize revenue from repairs, maintenance, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.
Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally one to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our condensed consolidated balance sheet as deferred revenue.
Development Revenue
The Company has entered and may continue to enter into development agreements with third parties that provide for up-front and periodic milestone payments. Our development agreements may include more than one performance obligation. At the inception of the contract, we assess whether each obligation represents a separate performance obligation or whether such obligations should be combined as a single performance obligation. The transaction price for each development agreement is determined based on the amount of consideration we expect to be entitled to for satisfying all performance obligations within the agreement.
We assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. In arrangements where we satisfy performance obligation(s) over time, we recognize development revenue typically using an input method based on our costs incurred relative to the total expected cost which determines the extent of our progress toward completion. As part of the accounting for these arrangements, we must develop estimates and assumptions that require judgment to determine the transaction price and progress towards completion. We review our estimate of the transaction price and progress toward completion based on the best information available to recognize the cumulative progress toward completion as of the end of each reporting period, and make revisions to such estimates as necessary.
We may also generate revenue from development or collaboration agreements that do not include upfront or milestone-based payments and generally recognize revenue on these types of agreements based on the timing of development activities.
Other Revenue
Other revenue consists of license and royalty revenue, and grant revenue. We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. For
contracts that include sales-based royalties, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied.
In March 2020, we entered into an agreement to settle intellectual property infringement claims, in which we received a $3.5 million payment in exchange for a perpetual license under certain Fluidigm intellectual property. The settlement is considered a multiple-element arrangement with each element accounted for individually. Accordingly, $3.1 million of the proceeds was recognized as license revenue and $0.4 million was offset against legal costs.
We receive grants from various entities to perform research and development activities over contractually defined periods. Revenue is generally recognized provided that the conditions under which the grants were provided have been met and any remaining performance obligations are perfunctory.
Contract Costs
Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred. To date, capitalized contract costs have been immaterial.
Product Warranties
We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the condensed consolidated statements of operations.
Significant Judgments
Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements, determining the transaction price and progress towards completion on development arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.
Accounts Receivable
Accounts Receivable
Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.
Concentrations of Business and Credit Risk
Concentrations of Business and Credit Risk
Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.
We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three months ended June 30, 2020. No other customer represented more than 10% of total revenue for three and six months ended June 30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 32% and 30% of total revenue for the three months ended June 30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the six months ended June 30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at June 30, 2020, or December 31, 2019.
Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.
Leases
Leases
We determine if an arrangement is a lease, or contains a lease, at inception. Operating leases are included in operating lease right-of-use (ROU) assets and current and non-current operating lease liabilities in our condensed consolidated balance sheets. ROU assets represent our right-to-use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. Significant judgment is required in determining the incremental collateralized borrowing rate. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
We elected the short-term lease recognition exemption for all leases that qualify. For those leases that qualify, we will not recognize ROU assets or lease liabilities for leases with an initial lease term of one year or less. We also elected not to separate lease and nonlease components for our building leases. The nonlease components are generally variable in nature and are expected to represent most of our variable lease costs. Variable costs are expensed as incurred. We have taken a portfolio approach for our vehicle leases by country.
Goodwill, Intangible Assets and Other Long-Lived Assets
Goodwill, Intangible Assets and Other Long-Lived Assets
Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.
Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include, but are not limited to, declines in our stock price or market capitalization, economic downturns and other macroeconomic events, including the current COVID-19 pandemic, declines in our market share or revenues, and an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge.
In evaluating our goodwill and intangible assets with indefinite lives for indications of impairment, we first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then an impairment loss equal to the difference would be recorded to goodwill. We did not recognize any impairment of goodwill for any of the periods presented herein.
We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of intangibles for any of the periods presented herein.
Convertible Notes
Convertible Notes
In February 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). As the 2018 Notes were convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and
accounted for in equity. In the first quarter of 2019, the 2018 Notes were converted into 19.5 million shares of our common stock and the 2018 Notes were retired. We recorded a loss of $9.0 million on the retirement of the 2018 Notes. We determined the fair value of the 2018 Notes using valuation techniques that required us to make assumptions related to the implied discount rate. 
In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 5.25% Senior Convertible Notes due 2024 (2019 Notes). Most of the issuance proceeds were used to retire approximately $50.2 million of aggregate principal amount of our 2014 Notes, leaving approximately $1.1 million of aggregate principal amount of our 2014 Notes outstanding.
As the 2019 Notes do not provide for a cash conversion feature, the 2019 Notes are recorded for as debt in their entirety in accordance with ASC 470. For the 2014, 2018 and 2019 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.
Comprehensive Loss
Comprehensive Loss
Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.
Net Loss per Share
Net Loss per Share
Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units, performance share units, and stock options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.
Recent Accounting Changes and Accounting Pronouncements
Recent Accounting Changes and Accounting Pronouncements
Adoption of New Accounting Guidance
In August 2018, the U.S.-based Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-15-Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. The adoption of the new guidance did not have a significant impact on our financial results.
In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU is effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020. The adoption of the new guidance did not have a significant impact on our financial results.
The FASB issued two ASUs related to financial instruments – credit losses. The ASUs issued were: (1) in June 2016, ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and (2) in November 2018, ASU 2018-19-Codification Improvements to Topic 326, Financial Instruments-Credit Losses. ASU 2016-13 is intended to improve financial reporting by requiring more timely recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leasing standard. These ASUs are effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted. The modified retrospective method is required upon adoption. The adoption of the new guidance resulted in an adjustment of approximately $0.1 million to reduce the accumulated deficit component of stockholders’ equity and decrease current assets by the same amount in our condensed consolidated balance sheet.
Recent Accounting Pronouncements
In November 2019, the FASB issued ASU 2019-12-Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The amendments in this update improve consistent application of and simplify U.S. GAAP for Topic 740 by clarifying and amending existing guidance for, among other items, intra-period allocation, reporting tax law changes and losses in interim periods, state and local taxes not fully based on income and recognition of deferred tax liability related to certain transactions. There is also new guidance related to consolidated group reporting and tax impacts resulting from business combinations. The new guidance is effective for fiscal years beginning after December 15, 2020. We are currently evaluating the impact of adoption on our condensed consolidated financial statements.
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Components of accumulated other comprehensive loss
The components of accumulated other comprehensive loss, net of tax, for the three and six months ended June 30, 2020 is as follows (in thousands):
Foreign Currency Translation AdjustmentUnrealized Gain (Loss) on InvestmentsAccumulated Other Comprehensive Income (Loss)
Ending balance at December 31, 2019$(618) $36  $(582) 
Other comprehensive income (loss)(303) —  (303) 
Ending balance at March 31, 2020(921) 36  (885) 
Other comprehensive income (loss)109  (33) 76  
Ending balance at June 30, 2020$(812) $ $(809) 
Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders
The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):
 Six Months Ended June 30,
 20202019
Stock options, restricted stock units and performance awards8,237  4,541  
2019 Convertible Notes18,966  —  
2019 Convertible Notes potential make-whole shares2,412  —  
2014 Convertible Notes19  916  
Total29,634  5,457  
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination (Tables)
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Schedule of consideration transferred
A summary of the net cash flows is summarized below (in thousands):
January 17, 2020
Cash consideration paid to former equity holders$5,165  
Less: cash and cash equivalents acquired(11) 
Acquisition of InstruNor, net of cash acquired$5,154  
Schedule of consideration transferred and assets acquired and liabilities assumed Goodwill of $2.2 million was calculated as the purchase price less the fair value of the net assets acquired as follows (in thousands):
January 17, 2020
Purchase price:
Cash consideration paid on closing to former equity holders$5,165  
Non-cash consideration common shares 2,049  
Total purchase price$7,214  
Assets acquired:
Cash and cash equivalents$11  
Accounts receivable32  
Other receivables13  
Inventories, net153  
Developed technology5,380  
Liabilities assumed:
Accounts payable14  
Other current liabilities15  
Deferred tax liability566  
Fair value of identifiable net assets acquired$4,994  
Goodwill acquired on acquisition$2,220  
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue (Tables)
6 Months Ended
Jun. 30, 2020
Revenue from Contract with Customer [Abstract]  
Summary of disaggregation of revenue
The following table presents our revenue for the three and six months ended June 30, 2020 and 2019, respectively, based on geographic area and by source (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Geographic Markets:
Americas$13,940  $11,120  $28,784  $24,091  
EMEA6,557  11,217  14,653  19,373  
Asia-Pacific5,561  5,859  10,238  14,843  
Total revenue$26,058  $28,196  $53,675  $58,307  
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Source:
Instruments$8,577  $12,201  $18,048  $25,041  
Consumables8,828  11,034  18,338  23,021  
Product revenue17,405  23,235  36,386  48,062  
Service revenue5,140  4,961  10,326  10,245  
Development revenue3,000  —  3,000  —  
Other revenue
  License and royalty revenue63  —  3,163  —  
  Grant revenue450  —  800  —  
  Total other revenue513  —  3,963  —  
Total revenue$26,058  $28,196  $53,675  $58,307  
Summary of expected timing of revenue recognition
The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at June 30, 2020 (in thousands):
Fiscal Year
Expected Revenue (1)
2020 (remainder of the year)$7,401  
20218,636  
20224,702  
Thereafter3,164  
Total$23,903  
_______
(1) Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets, net (Tables)
6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of finite-lived intangible assets Intangible assets, net, were as follows (in thousands):
June 30, 2020
Gross AmountAccumulated AmortizationNetWeighted-Average Amortization Period
Developed technology$117,380  $(71,736) $45,644  9.9 years
Patents and licenses$11,274  $(8,802) $2,472  7.8 years
December 31, 2019
Gross AmountAccumulated AmortizationNetWeighted-Average Amortization Period
Developed technology$112,000  $(65,800) $46,200  10.0 years
Patents and licenses$11,274  $(8,342) $2,932  7.8 years
Estimated future intangible asset amortization expense
Based on the carrying value of intangible assets, net, as of June 30, 2020, the amortization expense is expected to be as follows (in thousands):
Fiscal YearDeveloped Technology Amortization ExpensePatents and Licenses Amortization ExpenseTotal
2020 (remainder of the year)$5,936  $457  $6,393  
202111,873  759  12,632  
202211,873  676  12,549  
202311,873  570  12,443  
20242,073  10  2,083  
Thereafter2,016  —  2,016  
Total$45,644  $2,472  $48,116  
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Balance Sheet Details (Tables)
6 Months Ended
Jun. 30, 2020
Balance Sheet Related Disclosures [Abstract]  
Summary of cash and cash equivalents
Cash, cash equivalents and restricted cash consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Cash and cash equivalents$42,965  $21,661  
Restricted cash1,075  2,075  
Total cash, cash equivalents and restricted cash$44,040  $23,736  
Schedule of restricted cash
Cash, cash equivalents and restricted cash consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Cash and cash equivalents$42,965  $21,661  
Restricted cash1,075  2,075  
Total cash, cash equivalents and restricted cash$44,040  $23,736  
Inventories
Inventories consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Raw materials$9,665  $6,133  
Work-in-process1,063  659  
Finished goods8,172  7,092  
Total inventories$18,900  $13,884  
Property and equipment
Property and equipment consisted of the following as of June 30, 2020 and December 31, 2019 (in thousands):
June 30, 2020December 31, 2019
Computer equipment and software$4,376  $3,997  
Laboratory and manufacturing equipment19,652  19,325  
Leasehold improvements7,962  7,788  
Office furniture and fixtures2,076  1,824  
Property and equipment, gross34,066  32,934  
Less accumulated depreciation and amortization(26,309) (24,954) 
Construction-in-progress108  76  
Property and equipment, net$7,865  $8,056  
Activity of warranty accrual
Activity for our warranty accrual for the six months ended June 30, 2020 and 2019, which are included in other accrued liabilities, is summarized below (in thousands):
Six Months Ended June 30,
20202019
Beginning balance$1,390  $863  
Accrual for current period warranties419  657  
Warranty costs incurred(277) (429) 
Ending balance$1,532  $1,091  
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes and Credit Facility (Tables)
6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Schedule of debt
The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands):
June 30, 2020December 31, 2019
   2.75% 2014 Notes due 2034
Principal amount$1,079  $1,079  
Unamortized debt discount(24) (18) 
Unamortized debt issuance cost(4) (4) 
$1,051  $1,057  
    5.25% 2019 Notes due 2024
Principal amount $55,000  $55,000  
Unamortized debt issuance cost(2,038) (2,236) 
$52,962  $52,764  
    Net carrying value of all Notes$54,013  $53,821  
The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at June 30, 2020 and December 31, 2019, respectively (in thousands):
June 30, 2020December 31, 2019
Par ValueCarrying ValueFair ValuePar ValueCarrying ValueFair Value
2014 Notes$1,079  $1,051  $1,122  $1,079  $1,057  $1,122  
2019 Notes55,000  52,962  82,369  55,000  52,764  73,975  
Total$56,079  $54,013  $83,491  $56,079  $53,821  $75,097  
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Leases (Tables)
6 Months Ended
Jun. 30, 2020
Leases [Abstract]  
Schedule of balance sheet information
Supplemental balance sheet information related to leases was as follows as of June 30, 2020 and December 31, 2019 (in thousands, except for discount rate and lease term):
June 30, 2020December 31, 2019
Operating lease right-of-use buildings$40,618  $6,234  
Operating lease right-of-use equipment33  69  
Operating lease right-of-use vehicles452  355  
Total operating lease right-of-use assets, gross41,103  6,658  
Accumulated amortization(2,076) (1,798) 
Total operating lease right-of-use assets, net$39,027  $4,860  
Operating lease liabilities, current$2,170  $1,833  
Operating lease liabilities, non-current39,139  4,323  
Total operating lease liabilities$41,309  $6,156  
Weighted average remaining lease term (in years)9.14.7
Weighted average discount rate per annum11.9 %5.0 %
Schedule of lease expense
The following table presents the components of lease expense for the three and six months ended June 30, 2020 and 2019, respectively (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Operating lease cost (including variable costs)$2,312  $1,553  $4,511  $3,056  
Variable costs including non-lease component$548  $703  $1,169  $1,303  
Supplemental Cash Flow Information:
Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):
Six Months Ended June 30,
20202019
Operating cash flows from operating leases$1,987  $2,061  
Schedule of future minimum lease payments
Future minimum lease payments under commenced non-cancelable operating leases, which are as of June 30, 2020 as follows (in thousands):
Fiscal YearMinimum Lease Payments for Operating Leases
2020 (remainder of year)$3,214  
20217,282  
20226,985  
20236,907  
20247,120  
Thereafter39,231  
Total future minimum payments $70,739  
Less: imputed interest(29,430) 
Total$41,309  
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of cash and available-for-sale securities
The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands):
June 30, 2020
Amortized CostGross Unrealized GainGross Unrealized LossFair ValueCash and Cash EquivalentsShort-Term Marketable SecuritiesCash- Restricted
Assets:
Cash-unrestricted$20,196  $—  $—  $20,196  $20,196  $—  $—  
Cash-restricted1,075  —  —  1,075  —  —  1,075  
  Total cash$21,271  $—  $—  $21,271  $20,196  $—  $1,075  
Available-for-sale:
    Level I:
         Money market funds$22,769  $—  $—  $22,769  $22,769  $—  $—  
    US treasury securities2,428   —  2,431  —  2,431  —  
           Subtotal $25,197  $ $—  $25,200  $22,769  $2,431  $—  
Total$46,468  $ $—  $46,471  $42,965  $2,431  $1,075  
December 31, 2019
Amortized CostGross Unrealized GainGross Unrealized LossFair ValueCash and Cash EquivalentsShort-Term Marketable SecuritiesCash- Restricted
Assets:
Cash-unrestricted$16,614  $—  $—  $16,614  $16,614  $—  $—  
Cash-restricted2,075  —  —  2,075  —  —  2,075  
  Total cash$18,689  $—  $—  $18,689  $16,614  $—  $2,075  
Available-for-sale:
    Level I:
         Money market funds$5,047  $—  $—  $5,047  $5,047  $—  $—  
         US treasury securities36,942  36  —  36,978  —  36,978  —  
           Subtotal$41,989  $36  $—  $42,025  $5,047  $36,978  $—  
Total$60,678  $36  $—  $60,714  $21,661  $36,978  $2,075  
Schedule of debt
The carrying values of the components of the 2014 Notes and the 2019 Notes are as follows (in thousands):
June 30, 2020December 31, 2019
   2.75% 2014 Notes due 2034
Principal amount$1,079  $1,079  
Unamortized debt discount(24) (18) 
Unamortized debt issuance cost(4) (4) 
$1,051  $1,057  
    5.25% 2019 Notes due 2024
Principal amount $55,000  $55,000  
Unamortized debt issuance cost(2,038) (2,236) 
$52,962  $52,764  
    Net carrying value of all Notes$54,013  $53,821  
The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2019 Notes at June 30, 2020 and December 31, 2019, respectively (in thousands):
June 30, 2020December 31, 2019
Par ValueCarrying ValueFair ValuePar ValueCarrying ValueFair Value
2014 Notes$1,079  $1,051  $1,122  $1,079  $1,057  $1,122  
2019 Notes55,000  52,962  82,369  55,000  52,764  73,975  
Total$56,079  $54,013  $83,491  $56,079  $53,821  $75,097  
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of common stock reserved for future issuance
At June 30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)Securities To Be Issued Upon Exercise Of Options Securities To Be Issued Upon Release Of Restricted Stock and Performance Share UnitsNumber Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan19  —  —  
2011 Equity Incentive Plan1,609  6,138  2,823  
DVS Sciences Inc. 2010 Equity Incentive Plan23  —  —  
2017 Inducement Award Plan207  241  —  
2017 Employee Stock Purchase Plan—  —  3,100  
1,858  6,379  5,923  
Total stock-based compensation expense recognized was as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Restricted Stock Units, Stock Options and Performance Share Units$3,331  $2,848  $5,443  $4,993  
Employee Stock Purchase Plan303  144  557  270  
Total Share-based Compensation$3,634  $2,992  $6,000  $5,263  
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Plans (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Activity under restricted stock units
Activity under the 2011 Plan, the 2009 Plan, and the Inducement Plan was as follows:
Restricted Stock Units:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 20192,551  $7.43  
RSU granted3,642  $3.95  
RSU released(602) $7.72  
RSU forfeited(222) $6.82  
Balance as of June 30, 20205,369  $5.06  
Activity under stock options
Stock Options:
 Number of
Options (000s)
Weighted-Average
Exercise Price
per Option
Weighted-
Average Remaining Contractual Life (in Years)
Aggregate
Intrinsic
Value (1) in (000s)
Balance at December 31, 20192,027  $7.78  6.8$81  
Options granted105  $3.74  
Options exercised—  $—  
Options forfeited(274) $5.71  
Balance as of June 30, 20201,858  $7.86  6.1$163  
Vested at June 30, 20201,372  $8.69  5.4$115  
Awards expected to vest at June 30, 2020474  $5.50  8.1$48  
(1)Aggregate intrinsic value as of June 30, 2020 was calculated as the difference between the closing price per share of our common stock on the last trading day of June 30, 2020, which was $4.01, and the exercise price of the options, multiplied by the number of in-the-money options.
Schedule of nonvested performance-based units activity
Activity under the TSR-based PSUs is as follows:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2019547  $15.09  
PSU granted509  $4.82  
PSU released—  $—  
PSU forfeited(94) $14.26  
Balance at June 30, 2020962  $9.74  
Activity to date under this PSU award is as follows:
Number of Units (in 000s)Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 201964  $7.05  
PSU granted—  $—  
PSU released(4) $7.05  
PSU forfeited(12) $7.05  
Balance at June 30, 202048  $7.05  
Schedule of stock-based compensation expense
At June 30, 2020, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)Securities To Be Issued Upon Exercise Of Options Securities To Be Issued Upon Release Of Restricted Stock and Performance Share UnitsNumber Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan19  —  —  
2011 Equity Incentive Plan1,609  6,138  2,823  
DVS Sciences Inc. 2010 Equity Incentive Plan23  —  —  
2017 Inducement Award Plan207  241  —  
2017 Employee Stock Purchase Plan—  —  3,100  
1,858  6,379  5,923  
Total stock-based compensation expense recognized was as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2020201920202019
Restricted Stock Units, Stock Options and Performance Share Units$3,331  $2,848  $5,443  $4,993  
Employee Stock Purchase Plan303  144  557  270  
Total Share-based Compensation$3,634  $2,992  $6,000  $5,263  
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
shares in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2020
Nov. 30, 2019
Feb. 28, 2019
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2018
Mar. 31, 2018
Feb. 28, 2014
Schedule Of Significant Accounting Policies [Line Items]                          
Total revenue       $ 26,058,000     $ 28,196,000   $ 53,675,000 $ 58,307,000      
Legal fees $ 400,000                        
Product warranty term                 1 year        
Impairment of goodwill       0     0   $ 0 0      
Loss on extinguishment of debt       0     0   $ 0 9,000,000      
Accounting Standards Update [Extensible List]         us-gaap:AccountingStandardsUpdate201613Member       us-gaap:AccountingStandardsUpdate201613Member        
Cumulative-effect of new accounting standard for Topic 326 Credit Losses 141,496,000     $ 132,719,000 $ 141,496,000 $ 153,612,000 $ 172,640,000 $ 182,245,000 $ 132,719,000 $ 172,640,000 $ 72,116,000    
5 Largest Customers | Revenue from Contract with Customer | Customer Concentration Risk                          
Schedule Of Significant Accounting Policies [Line Items]                          
Concentration risk, percentage       32.00%     30.00%   23.00% 20.00%      
Cumulative Effect, Period of Adoption, Adjustment                          
Schedule Of Significant Accounting Policies [Line Items]                          
Cumulative-effect of new accounting standard for Topic 326 Credit Losses           (100,000)              
Commission Costs | Minimum                          
Schedule Of Significant Accounting Policies [Line Items]                          
Performance obligation period                 1 year        
Commission Costs | Maximum                          
Schedule Of Significant Accounting Policies [Line Items]                          
Performance obligation period                 3 years        
Convertible Debt                          
Schedule Of Significant Accounting Policies [Line Items]                          
Par Value       $ 56,079,000   56,079,000     $ 56,079,000        
Senior Convertible Notes due 2034 | Convertible Debt                          
Schedule Of Significant Accounting Policies [Line Items]                          
Par Value       1,079,000   1,079,000     1,079,000       $ 201,300,000
Interest rate on notes                       2.75% 2.75%
Debt extinguished   $ 50,200,000                      
Principal amount   1,100,000   1,079,000   1,079,000     1,079,000     $ 51,300,000  
Exchange Convertible Senior Notes due 2034 | Convertible Debt                          
Schedule Of Significant Accounting Policies [Line Items]                          
Par Value                       $ 150,000,000.0  
Interest rate on notes                       2.75%  
Loss on extinguishment of debt           3,000,000.0   $ 9,000,000.0          
Principal amount                       $ 150,000,000.0  
Senior Convertible Notes Due 2024 | Convertible Debt                          
Schedule Of Significant Accounting Policies [Line Items]                          
Par Value   $ 55,000,000.0   55,000,000   55,000,000     55,000,000        
Interest rate on notes   5.25%                      
Debt extinguished   $ 51,800,000                      
Principal amount       55,000,000   55,000,000     55,000,000        
Product revenue                          
Schedule Of Significant Accounting Policies [Line Items]                          
Total revenue       17,405,000     $ 23,235,000   $ 36,386,000 $ 48,062,000      
Product revenue | Minimum                          
Schedule Of Significant Accounting Policies [Line Items]                          
Terms of payment period                 30 days        
Product revenue | Maximum                          
Schedule Of Significant Accounting Policies [Line Items]                          
Terms of payment period                 60 days        
Service revenue                          
Schedule Of Significant Accounting Policies [Line Items]                          
Total revenue       5,140,000     4,961,000   $ 10,326,000 10,245,000      
Service revenue | Minimum                          
Schedule Of Significant Accounting Policies [Line Items]                          
Performance obligation period                 1 year        
Service revenue | Maximum                          
Schedule Of Significant Accounting Policies [Line Items]                          
Performance obligation period                 3 years        
Other revenue                          
Schedule Of Significant Accounting Policies [Line Items]                          
Total revenue 3,100,000     63,000     0   $ 3,163,000 0      
Common Stock                          
Schedule Of Significant Accounting Policies [Line Items]                          
Conversion of debt into common stock (in shares)               19,460          
Cumulative-effect of new accounting standard for Topic 326 Credit Losses 71,000     71,000 71,000 70,000 69,000 $ 69,000 71,000 69,000 49,000    
Common Stock | Senior Convertible Notes due 2034 | Convertible Debt                          
Schedule Of Significant Accounting Policies [Line Items]                          
Conversion of debt into common stock (in shares)               19,500          
Common Stock | Exchange Convertible Senior Notes due 2034 | Convertible Debt                          
Schedule Of Significant Accounting Policies [Line Items]                          
Conversion of debt into common stock (in shares)     19,500                    
Accumulated Deficit                          
Schedule Of Significant Accounting Policies [Line Items]                          
Cumulative-effect of new accounting standard for Topic 326 Credit Losses (639,721,000)     $ (652,736,000) $ (639,721,000) (623,641,000) $ (598,069,000) $ (584,316,000) $ (652,736,000) $ (598,069,000) $ (558,851,000)    
Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment                          
Schedule Of Significant Accounting Policies [Line Items]                          
Cumulative-effect of new accounting standard for Topic 326 Credit Losses           $ (100,000)              
Intellectual Property Infringement Claims                          
Schedule Of Significant Accounting Policies [Line Items]                          
Proceeds from legal settlements $ 3,500,000                        
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning Balance $ 141,496 $ 153,612 $ 182,245 $ 72,116 $ 153,612 $ 72,116
Other comprehensive income (loss) 76 (303) 54 10 (227) 64
Ending Balance 132,719 141,496 172,640 182,245 132,719 172,640
Foreign Currency Translation Adjustment            
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning Balance (921) (618)     (618)  
Other comprehensive income (loss) 109 (303)        
Ending Balance (812) (921)     (812)  
Unrealized Gain (Loss) on Investments            
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning Balance 36 36     36  
Other comprehensive income (loss) (33) 0        
Ending Balance 3 36     3  
Accumulated Other Comprehensive Income (Loss)            
AOCI Attributable to Parent, Net of Tax [Roll Forward]            
Beginning Balance (885) (582) (677) (687) (582) (687)
Other comprehensive income (loss) 76 (303) 54 10    
Ending Balance $ (809) $ (885) $ (623) $ (677) $ (809) $ (623)
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) - shares
shares in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from computations of net loss per share (in shares) 29,634 5,457
Stock options, restricted stock units and performance awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from computations of net loss per share (in shares) 8,237 4,541
2019 Convertible Notes | Convertible Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from computations of net loss per share (in shares) 18,966 0
2019 Convertible Notes potential make-whole shares | Convertible Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from computations of net loss per share (in shares) 2,412 0
2014 Convertible Notes | Convertible Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from computations of net loss per share (in shares) 19 916
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
Jan. 17, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]        
Share price (usd per share) $ 4.22 $ 4.01    
Goodwill   $ 106,328   $ 104,108
InstruNor AS        
Business Acquisition [Line Items]        
Total purchase price $ 7,214      
Purchase price in cash $ 5,165      
Purchase price in shares (shares) 485,451      
Goodwill $ 2,220   $ 2,200  
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination - Net Cash Flows (Details) - USD ($)
$ in Thousands
6 Months Ended
Jan. 17, 2020
Jun. 30, 2020
Jun. 30, 2019
Business Acquisition [Line Items]      
Acquisition of InstruNor, net of cash acquired   $ 5,154 $ 0
InstruNor AS      
Business Acquisition [Line Items]      
Purchase price in cash $ 5,165    
Less: cash and cash equivalents acquired (11)    
Acquisition of InstruNor, net of cash acquired $ 5,154    
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 17, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Liabilities assumed:        
Goodwill   $ 106,328   $ 104,108
InstruNor AS        
Business Acquisition [Line Items]        
Cash consideration paid on closing to former equity holders $ 5,165      
Non-cash consideration common shares 2,049      
Total purchase price 7,214      
Assets acquired:        
Cash and cash equivalents 11      
Accounts receivable 32      
Other receivables 13      
Inventories, net 153      
Developed technology 5,380      
Liabilities assumed:        
Accounts payable 14      
Other current liabilities 15      
Deferred tax liability 566      
Fair value of identifiable net assets acquired 4,994      
Goodwill $ 2,220   $ 2,200  
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Disaggregation of Revenue [Line Items]          
Total revenue   $ 26,058 $ 28,196 $ 53,675 $ 58,307
Instruments          
Disaggregation of Revenue [Line Items]          
Total revenue   8,577 12,201 18,048 25,041
Consumables          
Disaggregation of Revenue [Line Items]          
Total revenue   8,828 11,034 18,338 23,021
Product revenue          
Disaggregation of Revenue [Line Items]          
Total revenue   17,405 23,235 36,386 48,062
Service revenue          
Disaggregation of Revenue [Line Items]          
Total revenue   5,140 4,961 10,326 10,245
Development revenue          
Disaggregation of Revenue [Line Items]          
Total revenue   3,000 0 3,000 0
License and royalty revenue          
Disaggregation of Revenue [Line Items]          
Total revenue $ 3,100 63 0 3,163 0
Grant revenue          
Disaggregation of Revenue [Line Items]          
Total revenue   450 0 800 0
Other revenue          
Disaggregation of Revenue [Line Items]          
Total revenue   513 0 3,963 0
Americas          
Disaggregation of Revenue [Line Items]          
Total revenue   13,940 11,120 28,784 24,091
EMEA          
Disaggregation of Revenue [Line Items]          
Total revenue   6,557 11,217 14,653 19,373
Asia-Pacific          
Disaggregation of Revenue [Line Items]          
Total revenue   $ 5,561 $ 5,859 $ 10,238 $ 14,843
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Narrative (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Deferred revenue $ 22.2 $ 20.0
Revenue recognized (6.2)  
Additional advance payments received $ 8.4  
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Performance Obligations (Details)
$ in Thousands
Jun. 30, 2020
USD ($)
Revenue from External Customer [Line Items]  
Remaining performance obligation $ 23,903
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-07-01  
Revenue from External Customer [Line Items]  
Remaining performance obligation $ 7,401
Remaining performance obligation, expected timing of satisfaction 6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01  
Revenue from External Customer [Line Items]  
Remaining performance obligation $ 8,636
Remaining performance obligation, expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01  
Revenue from External Customer [Line Items]  
Remaining performance obligation $ 4,702
Remaining performance obligation, expected timing of satisfaction 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01  
Revenue from External Customer [Line Items]  
Remaining performance obligation $ 3,164
Remaining performance obligation, expected timing of satisfaction
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets, net - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2014
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Jan. 17, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]                
Goodwill   $ 106,328     $ 106,328     $ 104,108
Amortization of intangibles         5,936 $ 5,600    
DVS Sciences, Inc.                
Finite-Lived Intangible Assets [Line Items]                
Goodwill $ 104,100              
InstruNor AS                
Finite-Lived Intangible Assets [Line Items]                
Goodwill     $ 2,200       $ 2,220  
Developed technology                
Finite-Lived Intangible Assets [Line Items]                
Amortization of intangibles   $ 3,200   $ 3,100 $ 6,400 $ 6,200    
Developed technology | DVS Sciences, Inc.                
Finite-Lived Intangible Assets [Line Items]                
Finite-lived intangible assets acquired $ 112,000              
Developed technology | InstruNor AS                
Finite-Lived Intangible Assets [Line Items]                
Finite-lived intangible assets acquired     $ 5,400          
Acquired finite-lived intangible assets, useful life     8 years          
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]    
Net $ 48,116  
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 117,380 $ 112,000
Accumulated Amortization (71,736) (65,800)
Net $ 45,644 $ 46,200
Weighted-Average Amortization Period 9 years 10 months 24 days 10 years
Patents and licenses    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount $ 11,274 $ 11,274
Accumulated Amortization (8,802) (8,342)
Net $ 2,472 $ 2,932
Weighted-Average Amortization Period 7 years 9 months 18 days 7 years 9 months 18 days
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets, net - Future Amortization Expense (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]    
2020 (remainder of the year) $ 6,393  
2021 12,632  
2022 12,549  
2023 12,443  
2024 2,083  
Thereafter 2,016  
Net 48,116  
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
2020 (remainder of the year) 5,936  
2021 11,873  
2022 11,873  
2023 11,873  
2024 2,073  
Thereafter 2,016  
Net 45,644 $ 46,200
Patents and licenses    
Finite-Lived Intangible Assets [Line Items]    
2020 (remainder of the year) 457  
2021 759  
2022 676  
2023 570  
2024 10  
Thereafter 0  
Net $ 2,472 $ 2,932
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]        
Cash and cash equivalents $ 42,965 $ 21,661    
Restricted cash 1,075 2,075    
Total cash, cash equivalents and restricted cash 44,040 $ 23,736 $ 26,121 $ 95,401
Short-term restricted cash 75      
Non-current restricted cash $ 1,000      
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Balance Sheet Details - Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Balance Sheet Related Disclosures [Abstract]    
Raw materials $ 9,665 $ 6,133
Work-in-process 1,063 659
Finished goods 8,172 7,092
Total inventories $ 18,900 $ 13,884
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Balance Sheet Details - Property and Equipment (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 34,066 $ 32,934
Less accumulated depreciation and amortization (26,309) (24,954)
Construction-in-progress 108 76
Property and equipment, net 7,865 8,056
Computer equipment and software    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 4,376 3,997
Laboratory and manufacturing equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 19,652 19,325
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 7,962 7,788
Office furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 2,076 $ 1,824
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Balance Sheet Details - Warranty Accrual (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Movement in Standard Product Warranty Accrual [Roll Forward]    
Beginning balance $ 1,390 $ 863
Accrual for current period warranties 419 657
Warranty costs incurred (277) (429)
Ending balance $ 1,532 $ 1,091
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes and Credit Facility - Narrative (Details)
$ / shares in Units, shares in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 21, 2020
USD ($)
Nov. 30, 2019
USD ($)
$ / shares
Rate
Feb. 28, 2019
USD ($)
shares
Aug. 31, 2018
USD ($)
Mar. 31, 2018
USD ($)
$ / shares
Rate
Feb. 28, 2014
USD ($)
Jun. 30, 2020
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
$ / shares
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
shares
Jun. 30, 2020
USD ($)
$ / shares
Jun. 30, 2019
USD ($)
Mar. 12, 2018
USD ($)
Debt Instrument [Line Items]                          
Initial conversion rate of notes | Rate   344.8276%     1.26944%                
Common stock, par value (usd per share) | $ / shares             $ 0.001 $ 0.001     $ 0.001    
Gain (loss) on extinguishment of debt             $ 0   $ 0   $ 0 $ (9,000,000)  
Prepayment fee, percentage 0.25%                        
Commitment fee amount $ 112,500     $ 112,500                  
Convertible Debt                          
Debt Instrument [Line Items]                          
Principal amount             56,079,000 $ 56,079,000     56,079,000    
Convertible Debt | Senior Convertible Notes due 2034                          
Debt Instrument [Line Items]                          
Principal amount           $ 201,300,000 1,079,000 1,079,000     1,079,000    
Proceeds from convertible debt issuance           195,200,000              
Debt issuance costs           1,100,000 4,000 4,000     4,000    
Underwriting discount           $ 6,000,000.0              
Effective interest rate           3.00%              
Principal amount   $ 1,100,000     $ 51,300,000   1,079,000 1,079,000     1,079,000    
Interest rate on notes         2.75% 2.75%              
Proceeds from debt issuance   52,700,000                      
Debt extinguished   $ 50,200,000                      
Convertible Debt | Exchange Convertible Senior Notes due 2034                          
Debt Instrument [Line Items]                          
Principal amount         $ 150,000,000.0                
Effective interest rate         12.30%                
Principal amount         $ 150,000,000.0                
Estimated fair value of debt                         $ 145,500,000
Interest rate on notes         2.75%                
Initial conversion rate of notes   0.3448276     0.1269438                
Common stock, par value (usd per share) | $ / shares         $ 0.001                
Initial conversion price of stock (usd per share) | $ / shares   $ 2.90     $ 7.88                
Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price         110.00%                
Debt and equity offering costs         $ 2,800,000                
Offering related costs         2,200,000                
Stock issuance costs         $ 600,000                
Maximum ability to borrow under line of credit     $ 150,000,000.0                    
Gain (loss) on extinguishment of debt               (3,000,000.0)   $ (9,000,000.0)      
Convertible Debt | Senior Convertible Notes Due 2024                          
Debt Instrument [Line Items]                          
Principal amount   $ 55,000,000.0         55,000,000 55,000,000     55,000,000    
Debt issuance costs             2,038,000 2,236,000     2,038,000    
Effective interest rate   6.20%                      
Principal amount             55,000,000 $ 55,000,000     55,000,000    
Interest rate on notes   5.25%                      
Offering related costs   $ 2,300,000                      
Debt extinguished   $ 51,800,000                      
Redemption, Period One | Convertible Debt | Exchange Convertible Senior Notes due 2034                          
Debt Instrument [Line Items]                          
Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price   150.00%                      
Redemption, Period Two | Convertible Debt | Exchange Convertible Senior Notes due 2034                          
Debt Instrument [Line Items]                          
Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price   130.00%                      
Revolving Credit Facility                          
Debt Instrument [Line Items]                          
Principal amount             7,300,000       7,300,000    
Maximum ability to borrow under line of credit       $ 15,000,000.0                  
Percentage of eligible receivables       85.00%                  
Percentage of eligible inventory       50.00%                  
Line of credit outstanding             $ 0       $ 0    
Unused revolving line of credit       0.75%                  
Percentage of interest on obligation upon default                     5.00%    
Revolving Credit Facility | Minimum | Prime Rate                          
Debt Instrument [Line Items]                          
Additional interest rate       0.50%                  
Revolving Credit Facility | Maximum | Prime Rate                          
Debt Instrument [Line Items]                          
Additional interest rate       5.50%                  
Common Stock                          
Debt Instrument [Line Items]                          
Conversion of debt into common stock (in shares) | shares                   19,460      
Common Stock | Convertible Debt                          
Debt Instrument [Line Items]                          
Proceeds from issuance of common stock                   $ 133,300,000      
Common Stock | Convertible Debt | Senior Convertible Notes due 2034                          
Debt Instrument [Line Items]                          
Conversion of debt into common stock (in shares) | shares                   19,500      
Common Stock | Convertible Debt | Exchange Convertible Senior Notes due 2034                          
Debt Instrument [Line Items]                          
Conversion of debt into common stock (in shares) | shares     19,500                    
Trustee | Convertible Debt | Exchange Convertible Senior Notes due 2034                          
Debt Instrument [Line Items]                          
Maximum ability to borrow under line of credit     $ 11,900,000             $ 138,100,000      
Gain (loss) on extinguishment of debt     $ (9,000,000.0)                    
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Notes and Credit Facility - Schedule of Debt (Details) - Convertible Debt - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Nov. 30, 2019
Mar. 31, 2018
Feb. 28, 2014
Debt Instrument [Line Items]          
Long-term Debt, Total $ 54,013 $ 53,821      
Senior Convertible Notes due 2034          
Debt Instrument [Line Items]          
Interest rate on notes       2.75% 2.75%
Principal amount 1,079 1,079 $ 1,100 $ 51,300  
Unamortized debt discount (24) (18)      
Unamortized debt issuance cost (4) (4)     $ (1,100)
Long-term Debt, Total 1,051 1,057      
Senior Convertible Notes Due 2024          
Debt Instrument [Line Items]          
Interest rate on notes     5.25%    
Principal amount 55,000 55,000      
Unamortized debt issuance cost (2,038) (2,236)      
Long-term Debt, Total $ 52,962 $ 52,764      
Exchange Convertible Senior Notes due 2034          
Debt Instrument [Line Items]          
Interest rate on notes       2.75%  
Principal amount       $ 150,000  
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Leases - Narrative (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Operating Leased Assets [Line Items]      
Renewal term 5 years    
Right-of-use asset $ 39,027   $ 4,860
Reorganized lease liabilities $ 41,309   $ 6,156
Minimum      
Operating Leased Assets [Line Items]      
Remaining lease term 1 year    
Maximum      
Operating Leased Assets [Line Items]      
Remaining lease term 10 years    
CALIFORNIA      
Operating Leased Assets [Line Items]      
Right-of-use asset   $ 35,700  
Reorganized lease liabilities   $ 35,300  
Lease term   10 years  
Discount rate   12.55%  
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Leases - Supplemental Balance sheet (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Operating Leased Assets [Line Items]    
Gross Amount $ 41,103 $ 6,658
Accumulated amortization (2,076) (1,798)
Total operating lease right-of-use assets, net 39,027 4,860
Operating lease liabilities, current 2,170 1,833
Operating lease liabilities, non-current 39,139 4,323
Total operating lease liabilities $ 41,309 $ 6,156
Weighted average remaining lease term (in years) 9 years 1 month 6 days 4 years 8 months 12 days
Weighted average discount rate per annum 11.90% 5.00%
Operating lease right-of-use buildings    
Operating Leased Assets [Line Items]    
Gross Amount $ 40,618 $ 6,234
Operating lease right-of-use equipment    
Operating Leased Assets [Line Items]    
Gross Amount 33 69
Operating lease right-of-use vehicles    
Operating Leased Assets [Line Items]    
Gross Amount $ 452 $ 355
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Leases - Schedule of Operating Lease Cost (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Leases [Abstract]        
Operating lease cost (including variable costs) $ 2,312 $ 1,553 $ 4,511 $ 3,056
Variable costs including non-lease component $ 548 $ 703 1,169 1,303
Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):        
Operating cash flows from operating leases     $ 1,987 $ 2,061
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Leases - Operating Lease Maturity (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Minimum Lease Payments for Operating Leases    
2020 (remainder of year) $ 3,214  
2021 7,282  
2022 6,985  
2023 6,907  
2024 7,120  
Thereafter 39,231  
Total future minimum payments 70,739  
Less: imputed interest (29,430)  
Total $ 41,309 $ 6,156
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)
$ in Thousands
Jun. 30, 2020
USD ($)
investment
Dec. 31, 2019
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Fair Value Disclosures [Abstract]        
Number of investment in unrealized loss positions | investment 0      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Cash-unrestricted $ 42,965 $ 21,661    
Cash-restricted 1,075 2,075    
Total cash, cash equivalents and restricted cash 44,040 23,736 $ 26,121 $ 95,401
Amortized Cost 46,468 60,678    
Gross Unrealized Gain 3 36    
Gross Unrealized Loss 0 0    
Fair Value 46,471 60,714    
Short-Term Marketable Securities 2,431 36,978    
Level I        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Cash-unrestricted 22,769 5,047    
Amortized Cost 25,197 41,989    
Gross Unrealized Gain 3 36    
Gross Unrealized Loss 0 0    
Fair Value 25,200 42,025    
Short-Term Marketable Securities 2,431 36,978    
Money market funds | Level I        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Cash-unrestricted 22,769 5,047    
Amortized Cost 22,769 5,047    
Gross Unrealized Gain 0 0    
Gross Unrealized Loss 0 0    
Fair Value 22,769 5,047    
Short-Term Marketable Securities 0 0    
Long-term Investments 0 0    
US treasury securities | Level I        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Cash-unrestricted 0 0    
Amortized Cost 2,428 36,942    
Gross Unrealized Gain 3 36    
Gross Unrealized Loss 0 0    
Fair Value 2,431 36,978    
Short-Term Marketable Securities 2,431 36,978    
Total cash        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Cash-unrestricted 20,196 16,614    
Cash-restricted 1,075 2,075    
Total cash, cash equivalents and restricted cash 21,271 18,689    
Cash-unrestricted        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Cash-unrestricted 20,196 16,614    
Cash-restricted        
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Cash-restricted $ 1,075 $ 2,075    
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value of Financial Instruments - Schedule of Debt (Details) - Convertible Debt - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Nov. 30, 2019
Feb. 28, 2014
Debt Instrument [Line Items]        
Par Value $ 56,079,000 $ 56,079,000    
Carrying Value        
Debt Instrument [Line Items]        
Debt 54,013,000 53,821,000    
Fair Value        
Debt Instrument [Line Items]        
Debt 83,491,000 75,097,000    
Senior Convertible Notes due 2034        
Debt Instrument [Line Items]        
Par Value 1,079,000 1,079,000   $ 201,300,000
Senior Convertible Notes due 2034 | Carrying Value        
Debt Instrument [Line Items]        
Debt 1,051,000 1,057,000    
Senior Convertible Notes due 2034 | Fair Value        
Debt Instrument [Line Items]        
Debt 1,122,000 1,122,000    
Senior Convertible Notes Due 2024        
Debt Instrument [Line Items]        
Par Value 55,000,000 55,000,000 $ 55,000,000.0  
Senior Convertible Notes Due 2024 | Carrying Value        
Debt Instrument [Line Items]        
Debt   52,764,000    
Senior Convertible Notes Due 2024 | Fair Value        
Debt Instrument [Line Items]        
Debt $ 82,369,000 $ 73,975,000    
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Jan. 17, 2020
Mar. 31, 2019
Convertible Debt | Common Stock    
Shareholders' Equity [Line Items]    
Shares sold (shares)   19,460,260
Proceeds from issuance of common stock   $ 133,300
InstruNor AS    
Shareholders' Equity [Line Items]    
Total purchase price $ 7,214  
Purchase price in cash $ 5,165  
Purchase price in shares (shares) 485,451  
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity - Schedule of Stock Options (Details)
shares in Thousands
Jun. 30, 2020
shares
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 5,923
2009 Equity Incentive Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 0
2011 Equity Incentive Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 2,823
DVS Sciences Inc. 2010 Equity Incentive Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 0
2017 Inducement Award Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 0
2017 Employee Stock Purchase Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 3,100
Stock Option  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 1,858
Stock Option | 2009 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 19
Stock Option | 2011 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 1,609
Stock Option | DVS Sciences Inc. 2010 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 23
Stock Option | 2017 Inducement Award Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 207
Stock Option | 2017 Employee Stock Purchase Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 0
Restricted Stock And Performance Share Units  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 6,379
Restricted Stock And Performance Share Units | 2009 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 0
Restricted Stock And Performance Share Units | 2011 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 6,138
Restricted Stock And Performance Share Units | DVS Sciences Inc. 2010 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 0
Restricted Stock And Performance Share Units | 2017 Inducement Award Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 241
Restricted Stock And Performance Share Units | 2017 Employee Stock Purchase Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 0
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Plans - Narrative (Details)
1 Months Ended 6 Months Ended
Jun. 01, 2020
Jun. 01, 2019
USD ($)
May 31, 2019
Jun. 30, 2020
USD ($)
shares
May 31, 2020
numberOfOfferingPeriods
shares
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2019
shares
Jan. 31, 2017
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of voting power which impacts the term of equity incentive plan       10.00%   10.00%    
ESPP, offering period 6 months 12 months 6 months          
Purchase price of common stock, percent 85.00%   85.00%          
ESPP, number of six-month offering periods | numberOfOfferingPeriods         2      
Tranche One                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period           3 years    
Award vesting percentage         50.00%      
Number of months over which options vest ratably           36 months    
Tranche Two                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period           1 year    
Award vesting percentage         25.00%      
Number of months over which options vest ratably           48 months    
Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period           4 years    
Rate at which outstanding options vest on the first anniversary of the option grant date           25.00%    
Awards authorized for issuance (shares) | shares         1,800,000      
Total unrecognized compensation cost related to stock-based compensation arrangements       $ 24,800,000   $ 24,800,000    
Weighted average remaining contractual terms           3 years    
Restricted Stock Units (RSUs) | Tranche One                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Rate at which outstanding options vest on the first anniversary of the option grant date           25.00%    
Performance Shares                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period           3 years    
Total unrecognized compensation cost related to stock-based compensation arrangements       $ 5,700,000   $ 5,700,000    
Weighted average remaining contractual terms           2 years    
Performance Shares | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of performance period           200.00%    
Performance Shares | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of performance period           0.00%    
Stock options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Expiration period           10 years    
Stock option grants exercise price minimum percentage on fair market value           100.00%    
Stock options held by owners of more than 10% of common stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Expiration period           5 years    
Stock option grants exercise price minimum percentage on fair market value           110.00%    
2011 Equity Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards authorized for issuance (shares) | shares       1,400,000   1,400,000 5,000,000.0  
2017 Inducement Award Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards authorized for issuance (shares) | shares               2,000,000
Equity Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total unrecognized compensation cost related to stock-based compensation arrangements       $ 1,400,000   $ 1,400,000    
Weighted average remaining contractual terms           1 year 6 months    
2017 Employee Stock Purchase Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Additional awards authorized for issuance (in shares) | shares       3,000,000.0        
Incremental compensation cost           $ 300,000    
2017 Employee Stock Purchase Plan | Employee Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Maximum employee subscription rate   15.00% 10.00% 10.00%   10.00%    
Maximum employee purchase amount   $ 25,000            
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Plans - Restricted and Performance Stock Units (Details)
shares in Thousands
6 Months Ended
Jun. 30, 2020
$ / shares
shares
Restricted Stock Units (RSUs)  
Number of Nonvested and Outstanding Units  
Beginning Balance (shares) | shares 2,551
Granted (shares) | shares 3,642
Released (shares) | shares (602)
Forfeited (shares) | shares (222)
Ending Balance (shares) | shares 5,369
Weighted-Average Grant Date Fair Value per Share  
Beginning Balance (usd per share) | $ / shares $ 7.43
Granted (usd per share) | $ / shares 3.95
Released (usd per share) | $ / shares 7.72
Forfeited (usd per share) | $ / shares 6.82
Ending Balance (usd per share) | $ / shares $ 5.06
Performance Shares  
Number of Nonvested and Outstanding Units  
Beginning Balance (shares) | shares 547
Granted (shares) | shares 509
Released (shares) | shares 0
Forfeited (shares) | shares (94)
Ending Balance (shares) | shares 962
Weighted-Average Grant Date Fair Value per Share  
Beginning Balance (usd per share) | $ / shares $ 15.09
Granted (usd per share) | $ / shares 4.82
Released (usd per share) | $ / shares 0
Forfeited (usd per share) | $ / shares 14.26
Ending Balance (usd per share) | $ / shares $ 9.74
Certain Employee | Performance Shares  
Number of Nonvested and Outstanding Units  
Beginning Balance (shares) | shares 64
Granted (shares) | shares 0
Released (shares) | shares (4)
Forfeited (shares) | shares (12)
Ending Balance (shares) | shares 48
Weighted-Average Grant Date Fair Value per Share  
Beginning Balance (usd per share) | $ / shares $ 7.05
Granted (usd per share) | $ / shares 0
Released (usd per share) | $ / shares 7.05
Forfeited (usd per share) | $ / shares 7.05
Ending Balance (usd per share) | $ / shares $ 7.05
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Plans - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Jan. 17, 2020
Number of Options (000s)      
Beginning Balance (shares) 2,027    
Options granted (shares) 105    
Option exercised (shares) 0    
Options forfeited (shares) (274)    
Ending Balance (shares) 1,858 2,027  
Vested (in shares) 1,372    
Unvested awards (shares) 474    
Weighted-Average Exercise Price per Option      
Beginning Balance (usd per share) $ 7.78    
Options granted (usd per share) 3.74    
Options exercised (usd per share) 0    
Options forfeited (usd per share) 5.71    
Ending Balance (usd per share) 7.86 $ 7.78  
Vested (usd per share) 8.69    
Unvested awards (usd per share) $ 5.50    
Weighted- Average Remaining Contractual Life      
Contractual term 6 years 1 month 6 days 6 years 9 months 18 days  
Vested 5 years 4 months 24 days    
Unvested awards 8 years 1 month 6 days    
Aggregate Intrinsic Value      
Outstanding $ 163 $ 81  
Vested 115    
Unvested awards $ 48    
Share price (usd per share) $ 4.01   $ 4.22
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Plans - Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total Share-based Compensation $ 3,634 $ 2,992 $ 6,000 $ 5,263
Restricted Stock Units, Stock Options and Performance Share Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total Share-based Compensation 3,331 2,848 5,443 4,993
Employee Stock Purchase Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total Share-based Compensation $ 303 $ 144 $ 557 $ 270
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Tax Disclosure [Abstract]        
Income tax (benefit) expense $ (1,145) $ (1,143) $ (1,825) $ (1,101)
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.20.2
Information About Geographic Areas (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
segment
Jun. 30, 2019
USD ($)
Product Information [Line Items]        
Number of reporting segment | segment     1  
Sales to customers $ 26,058 $ 28,196 $ 53,675 $ 58,307
Geographic Concentration Risk | United States | Revenue from Contract with Customer        
Product Information [Line Items]        
Sales to customers $ 13,400 $ 9,900 $ 27,500 $ 22,400
Concentration risk, percentage 51.00% 35.00% 51.00% 38.00%
Geographic Concentration Risk | China | Revenue from Contract with Customer        
Product Information [Line Items]        
Sales to customers $ 3,500 $ 4,000   $ 7,500
Concentration risk, percentage 13.00% 14.00%   13.00%
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.20.2
Development Agreement (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Collaboration agreement, up-front and periodic milestone payments, up to $ 11,700,000   $ 11,700,000  
Collaboration agreement, term     1 year  
Total revenue 26,058,000 $ 28,196,000 $ 53,675,000 $ 58,307,000
Collaboration agreement, deferred revenue 1,000,000.0   1,000,000.0  
Development revenue        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Total revenue $ 3,000,000 $ 0 $ 3,000,000 $ 0
XML 81 R68.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details) - Subsequent event
Jul. 31, 2020
USD ($)
Subsequent Event [Line Items]  
COVID-19 project, budget $ 37,000,000.0
COVID-19 project, initial funding $ 12,200,000
EXCEL 82 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
-X^:^M"Y_V.7JN.&X[S2C0@+J18IQ@ M5>E*FVO\NG;\!C=*FFGKZQMQNHK1 EA9;CQ=CC M8]>##P\+6"091SI%U"-BMT^P(_T195%WIC ]MJ&V(W!]YY#TNMCFXIGS)F3S M2B8;BJ?A>"W>B,J MA2E3PW.XVT@TJ3O'ON!VD3V=.#$E6M^7[>KX^&3!X5W>AQ2\42W/HUL',V0: M0&#Y."IAK[0F$Z\_@I[M86?T(0@P]I'=1*H[ ;_O1HITA9YO=$TFU#%#"\O& MZ'3Q@CW6=<:=9T?!Y=H\KA1FH"IU_0)I=]OWV[1^MKR0UX^_3TRN<4*!G*^0 MU1Y%."3)^D%5?VBQ-8^8I=#X)#++#;Y!N20"/%\)H?A<@/WQ2\J*:8UI_W9D+, M#WN]>CQC15(?5'-6RK],*EXD0G[ETUX]YRQ)&Z4B[Z$@H+TBRE$4"7_^RO+J\?,>W'OYX5LVG0GU0^_X:)Y,V1T3/^:W7'[K MK:RD6<'*.JM*P-GD\]X7>'@38Z702/R9L<=Z[3-0KMQ7U4_UY2+]O!>H&;&< MC84RD.\=.8^J=F@RO^5I6+V>2_> M RF;)(MSUGK$%'VQE5>-_^"QU8VV /C12VJHE66,RBR+4F3E%-Q6>3;.6 WVP4W">:+V)OAPPD22Y?5'^>N/NQ/PX1\? M03U+N!3+2O!]5BWJI$SKHYZ0"ZZH4LQH,RY2E%OVA M6Q_[]$=N?>K0[\G8K@*,7@+\%3D-7B?\ &#X": !9;Y#-SJ-]6#5 ^4.NQ; MU$_*OZT*T^6I0OHULG?_H^W\_K7W7VWJ=]T7W6A8P_A%4CAQA[>!E*RPDD7.0-_^%'J MKRNI#"X$*^J_'4.'JZ'#9NAPR]#?*Y'DLJAY8.6"V3;04ITVZJJP>CA&-"!Q M$,BD/ZPO5HM@#/O4$!R9@@33B!B"EQ;!& ?1NN"&SV3E,W'Z?,6FTN<)8U;\ M)L:H81!L'9.NQJ3.,6]YE2[& CPJBBG%,Q",%[9=YS8#P3-+N"/OT6H^D=/0 M13%/,BZ+6J&H<5I5Z6.6Y[8%L+1#UN+Q.O->B5%DQ/1UKETV-AR,5P[&[B17 M=0UDLU/Y99/7LQ=F4W0N;H['74:_$*/8Z:MKH!X[UU5^YVW>ZNP85=T*6 M)@E/:_!CGB:"@;^&3T*=7NXEPEQEM?C;QG1N\XMZ?YHD\T,]S&J4Y2 2"2G$ MUZRX9]RVK'^;^8UHP4"7A8%SQ,&B6.1-K;?/)A-Y,%,KHY1'MT0'LF[G .21 M$WROYMD88$3!@+,T$T M,#N"M$.OYQB&,+1@X; 575\P$*,(]@W14YNHW>J9 M351B+$0F:MM$(T3#P!"]L(G&"(4F-9E2K8^9)63_+3 MO^5B4D3E&E77.9#L?.7H@@>Z2Y7?B+!G[=#K"+L/'2P*=5D$W771H"J*K&XZ M?8.J%@H%KK,R*Q:%*RBZ*('QSC.B2P3H9EFYXIKFJ=S1H+K/L^ER4\^;A6C= M6&Y[WF(4:3I&'CJVA#UY\H0=:7A'<-=A1QJ_$?JU8??8PTW8:]?<-+PC+[P_ M,"Z:TO#$J(LWC6JP0^'.HZTQ#[D/=[<)!W\FN?TPB\S#':%!9)8E9ZTD\4J. MNMC<]$5#*')#Z!TKLZJI*U9)NJF$C%HJBQ(4X%!5'V_(H$9!%.T\@QHCD?OD MYLZ@>7Z"]@1V%!QU%;Q!YN%.'DNP@W:0AF;DAM*+4C"NRD^N#FP2'4J59VMC MRVT('43$5NON@J.N@M>MX$:(G*L-:T;";@89/HUG M23EE&^#1@LU[ :O-3QWWO'$FI^PNQAW 7>KIACLII@WM\G.L%E[X\"R=RY:P?5(.EM=6-,3=A?I';;X-39[CKX\:H;" M;H;:RLLGS;9!;]TVFB9P?^<7!1K80S>PN[;-(+0 .K$MBV%H=L?LDF>=)4== M)#>]UG02NNFD\YX=> R1 ^32FBO9ZP789LV-=J'.^^^A!K70S>N^^_U3!B'41B8 MS=SST,1QA!&VM'TMDICBV.Q07UHDPSB@:'LJ-3F$/G+82&6G!DZHH3_<>0,G MU/ ?NHOT[XP7M>+F>?+@A$\P+Q\((9<&_KAFC\)3MO MW1"-M,2-M&\(N,<2]0=*\M>GIL>?M-1.-HL2-?9:H>_&*:C2DP:ZC3C584D_OXZU1]]CS MMYJIQE+J1L _Q(SQ#IA%-0[2G3<1J 9,^KX'I[ZV^AOG9&N/R2)(L0EM%K'7 MH$;-W@6&%EN73EN; =$@3MT@KJYPY%J[$]78=>]-UYZ8HCM/KP9/ZKL'5,?W MYD*J[86 K!05&"^]K)67X$-6MD\%?[0]?TG-AYI@/Z3;(JVQE;JQ\'<^NT+- M;GADTN>PF]AI-[$SFYB%W"UBU&R<7E"S3V\1&W6;VV6W0:\L8N'V*R"JR8JZ MR6I]5TFF^L4W0I&FM6CGM!9I6HO<-/0K-F-DZ;OWR;8$19K6(C>MO4K0[VJM M1YH5HYVS8J19,?(\Y_+^3)U$)CFY,J4)*G(3E S $CA9*J,MHY(Y ZYY*MHY M3T5KC_%Z>.HW803S^"B MG' Y7];TH@9YDA6NLUFL22S>^2.FL2:LV'>=4(T92^OE8[9Y\W)&S83(&S>M MR-1:W#CH$%O<>VMO#A:,3YNW;FO0>+5\26;UZ^K-WB_-^XVO?O\*#T^@Y?4;N\LOHIHW[S/>5T)4 M1?-QQI*4<24@_SZI9!W1?E$#K-Z;/OX?4$L#!!0 ( )B#!U& X]4)KP0 M P5 9 >&PO=V]R:W-H965TM?5! MMD!R2M$G-FO7W$)&"%C:I/)2P+R M.=VMHU:WT&C/^(]X2X@ SU%(XZO>5HC=I6'$WI9$.+Y@.T+E+VO&(RSD*]\8 M\8X3[&>D*#20:3I&A /:&X^RL1L^'K%$A $E-QS$211A_G-*0K:_ZL'>R\!M ML-F*=, 8CW9X0^Z(>-C=A-XN4(9(4-\"\@^/G@& MZ50>&?N1OES[5STSC8B$Q!.I"2S_/9$9"$DL6%20 M90110//_^+D0XH @[>@)J" @E6 ?(5@%P>I*L N"W970+PC]KG-P"H+3U8-; M$-QLL7)ULZ698X''(\[V@*=H:2U]R-8W8\L5"6B:BG>"RU\#R1/CNSP% 5N# MNV!#@W7@82K Q/-80D5 -^"&A8$7D!A\2D>3* FQ(#[X*K:$@QF+Y [8IJGY M1,!G%L?@;$X$#L+X7!(>[N;@[,,Y^ ""NZW+(DQ]>.1(63DJ7_#*Z*&;M M]"^82SH\2I]W]@Z'&OJBLW]81>Y.OLVLP$8(' MCXG CR$!@H$;S D5'\$?LIC+U+['S^#/6Q:&0-:O/>;^7RV.[=*QG3FVCSB> MDDU :;I%ICC$U".ZO,Y-.)F)M"T\C:$-[:$S,IX.TT4#ZUL.1'787 ,;(&3W MZ[!%$^8B"!6?RVX^5Z>,U;3KE]KU6[7+JX=7JQX!E>\$G(6RBISKM,Q-]@\C M475L0CY9IJ6HV 3U;47!)@2:BGP:5PBYBGA-D&/KE7-*Y9Q6Y60%.Y%R3C-V M"[GI7JM)I8%I,G.N@;G(L14U%AJ8)C.7W6);G71:D\XMI7-;I9-[7YY,*)@E M7%8'[R>XYYC&LIVE9Z*)_[?LMO*0)5I*PZ#T-'C?FC0L'0]?7Y.&S;9;R4\8<):>YLZ!W!K7](GD6R-N M25%8-6SXSAT;5BT;OD'/+FP<"FRIC:8#9MF.J<^@:ISP%W1.J.N+ECJE)NA( MP855LX*O[5:P6>L;@6D@#:W;S-2#K]H%;.\7ISYWK@O9/S=EKWNLV@9\Y[X! MJ\8!WZ!S0$W!'PSZZGII4/V!>I;5H1Q7.4 MM*B!JZY^%X^K4[;J7X)5NT*_ MH%VA9B=J'&8U&,UI5H-J'&&PO=V]R:W-H965T?+'Y,3-\CV_$ M(6<[J>YU 6#(8\F%GGN%,=4;W]=9 275E[("@3,;J4IJL*NVOJX4T-PYE=R/ M@B#U2\J$MYBYL95:S&1M.!.P4D3794G5/]? Y6[NA=[3P&>V+8P=\!>SBFYA M#>9+M5+8\[LH.2M!:"8%4;"9>U?AFV686@=G\97!3A^TB:5R)^6][7S(YUY@ M$0&'S-@0%/\>8 FH[)"\XQ*U#[(@VR!RM&VKH8J;DCBAKC=%LP^V-\T8V3%@9UT;A+$,_LU@W M\A&Y(6NV%6S#,BH,N\-X;7#R$R;EK=2:K$ UGN2/&S"4X?QL^;1;/CTG MX<<=K/%Y"#\^DG02Q>.>[L=&R2@)3^L^Z1A.!AG:#Q?W53R ,NR. _F$9Z$F M_QZ/#6SGM%ML>DXJA\&^6 3GH7.+XU##<#)-TY[2)\R"TSJ'!P4Q_#]*5UWM M*^D]7.P*B5-ML?JU+ BC/93HK/)@7W["^$SR(#X^Z9,PZJ?!L=5+:; O9>%P M+<,T2'[[@P_W924[8M_@-02P,$% @ F(,'4;," MIUCH @ W @ !D !X;"]W;W)K&ULM5;1;ILP M%/T5"_6AE;I@""2T2B(U2;=EVJJH:;>':0\..,&JL:EMFN[O9QO"R$IH-VDO M8)M[[CG7Q[IFM./B0:88*_"<42;'3JI4?NFZ,DYQAF2/YYCI+QLN,J3T5&Q= MF0N,$@O*J.M#.' S1)@S&=FUI9B,>*$H87@I@"RR#(F?4TSY;NQXSG[AEFQ3 M91;"=;(R!*67- M^8.9+)*Q XTB3'&L3 JD7T]XABDUF;2.QRJI4W,:8'.\S_[>%J^+62.)9YQ^ M(XE*QT[D@ 1O4$'5+=]]Q%5!H'>4?AU-WR.XSWT;U=4=W,L#5M,M8B33-O;H!7OH M#<)V]HN:_>(OV:L.=EJ^6\]\F3)L'NI]W_2D MYHF>MT9!^(/':;Z M]P,+$Z"_;SA7^XFY?NH?FLDO4$L#!!0 ( )B#!U$2Z5]%C@( %<' 9 M >&PO=V]R:W-H965T<>6]?)7L@G M51"BT4O)N)HZA=;5E>NJK" E5I>B(AQV-D*66,-4;EU528)S"RJ9&WC>R"TQ MY4Z:V+6E3!-1:T8Y64JDZK+$\N^,,+&?.K[SNO! MX4V"VZ:5'A+5D0_5DL) M,[=CR6E)N**"(TDV4^?:OUI,3+P-^$G)7O7&R%2R%N+)3&[SJ>,908213!L& M#+\=F1/&#!'(>&XYG2ZE ?;'K^PWMG:H98T5F0OVB^:ZF#H3!^5D@VNF'\3^ M*VGKB0U?)IBR7[1O8L>A@[)::5&V8%!04M[\\4OK0P_@1T< 00L(/@H(6T#X M44#4 B+K3%.*]6&!-4X3*?9(FFA@,P-KID5#^92;8U]I";L4<#J=U0I6E$)S M4:XIQ_8P+M ]7+@Y5@6Z@7NAT.F":$R9.H.MQ]4"G9Z.@=A2\^#/>_O(6[8&'G M8]#Y&%B^\#T?K[/GFBIJ??Q]!VOH5I-2_1G($78Y0ILC.I*C3RTVZ)8K+>M[ M(<\1A^."ESR?"]:U2Y MO2YFGISO6&XI5XB1#<"\RS$4)9LVWDRTJ&QC6PL-;=(."WCYB#0!L+\10K]. M3*_LWM+T'U!+ P04 " "8@P=1["VPLPT$ "M#0 &0 'AL+W=OJHP9O%4'3Q<*6%*!,N$%OC_S,L;SR7I9C=VI M]5*61O <[A31998Q]7@#0IY6$SIY&OC,#ZFQ ]YZ6; #W(/Y6MPIO/.:* G/ M(-=RD_&YOMLEJXEM%(" V-@3#RQ%N M00@;"77\J(-.&DX+[/Y_BOZA2AZ3V3$-MU+\S1.3KB;S"4E@STIA/LO3[U G M-+7Q8BET]4M.]5Q_0N)2&YG58%20\?Q\90]U(3H &HT @AH0O!00UH#PI8"H M!D0O!4QK0)6Z=\Z]*MR&&;9>*GDBRL[&:/9/5?T*C?7BN=TH]T;A4XXXL[XI M-8YH36YEMN,YJU;O';G'#9F4 HCD&T"N>%[ MSG8X^UIK,+H:_X@C7'##09/7&S","_T&(W^]WY#7K]Z05X1CL%26&F?KI6

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�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¡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end XML 83 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 84 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 299 411 1 false 83 0 false 8 false false R1.htm 0001001 - Document - Cover Sheet http://fluidigm.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - Condensed Consolidated Balance Sheets Sheet http://fluidigm.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Condensed Consolidated Statements of Operations Sheet http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1006007 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101101 - Disclosure - Description of Business Sheet http://fluidigm.com/role/DescriptionofBusiness Description of Business Notes 8 false false R9.htm 2102102 - Disclosure - Summary of Significant Accounting Policies Sheet http://fluidigm.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2108103 - Disclosure - Business Combination Sheet http://fluidigm.com/role/BusinessCombination Business Combination Notes 10 false false R11.htm 2113104 - Disclosure - Revenue Sheet http://fluidigm.com/role/Revenue Revenue Notes 11 false false R12.htm 2118105 - Disclosure - Goodwill and Intangible Assets, net Sheet http://fluidigm.com/role/GoodwillandIntangibleAssetsnet Goodwill and Intangible Assets, net Notes 12 false false R13.htm 2123106 - Disclosure - Balance Sheet Details Sheet http://fluidigm.com/role/BalanceSheetDetails Balance Sheet Details Notes 13 false false R14.htm 2129107 - Disclosure - Convertible Notes and Credit Facility Notes http://fluidigm.com/role/ConvertibleNotesandCreditFacility Convertible Notes and Credit Facility Notes 14 false false R15.htm 2133108 - Disclosure - Leases Sheet http://fluidigm.com/role/Leases Leases Notes 15 false false R16.htm 2139109 - Disclosure - Fair Value of Financial Instruments Sheet http://fluidigm.com/role/FairValueofFinancialInstruments Fair Value of Financial Instruments Notes 16 false false R17.htm 2143110 - Disclosure - Shareholders' Equity Sheet http://fluidigm.com/role/ShareholdersEquity Shareholders' Equity Notes 17 false false R18.htm 2147111 - Disclosure - Stock-Based Plans Sheet http://fluidigm.com/role/StockBasedPlans Stock-Based Plans Notes 18 false false R19.htm 2153112 - Disclosure - Income Taxes Sheet http://fluidigm.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 2155113 - Disclosure - Information About Geographic Areas Sheet http://fluidigm.com/role/InformationAboutGeographicAreas Information About Geographic Areas Notes 20 false false R21.htm 2157114 - Disclosure - Development Agreement Sheet http://fluidigm.com/role/DevelopmentAgreement Development Agreement Notes 21 false false R22.htm 2159115 - Disclosure - Commitments and Contingencies Sheet http://fluidigm.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 2160116 - Disclosure - Subsequent Events Sheet http://fluidigm.com/role/SubsequentEvents Subsequent Events Notes 23 false false R24.htm 2203201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://fluidigm.com/role/SummaryofSignificantAccountingPolicies 24 false false R25.htm 2304301 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://fluidigm.com/role/SummaryofSignificantAccountingPolicies 25 false false R26.htm 2309302 - Disclosure - Business Combination (Tables) Sheet http://fluidigm.com/role/BusinessCombinationTables Business Combination (Tables) Tables http://fluidigm.com/role/BusinessCombination 26 false false R27.htm 2314303 - Disclosure - Revenue (Tables) Sheet http://fluidigm.com/role/RevenueTables Revenue (Tables) Tables http://fluidigm.com/role/Revenue 27 false false R28.htm 2319304 - Disclosure - Goodwill and Intangible Assets, net (Tables) Sheet http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables Goodwill and Intangible Assets, net (Tables) Tables http://fluidigm.com/role/GoodwillandIntangibleAssetsnet 28 false false R29.htm 2324305 - Disclosure - Balance Sheet Details (Tables) Sheet http://fluidigm.com/role/BalanceSheetDetailsTables Balance Sheet Details (Tables) Tables http://fluidigm.com/role/BalanceSheetDetails 29 false false R30.htm 2330306 - Disclosure - Convertible Notes and Credit Facility (Tables) Notes http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables Convertible Notes and Credit Facility (Tables) Tables http://fluidigm.com/role/ConvertibleNotesandCreditFacility 30 false false R31.htm 2334307 - Disclosure - Leases (Tables) Sheet http://fluidigm.com/role/LeasesTables Leases (Tables) Tables http://fluidigm.com/role/Leases 31 false false R32.htm 2340308 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://fluidigm.com/role/FairValueofFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://fluidigm.com/role/FairValueofFinancialInstruments 32 false false R33.htm 2344309 - Disclosure - Shareholders' Equity (Tables) Sheet http://fluidigm.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://fluidigm.com/role/ShareholdersEquity 33 false false R34.htm 2348310 - Disclosure - Stock-Based Plans (Tables) Sheet http://fluidigm.com/role/StockBasedPlansTables Stock-Based Plans (Tables) Tables http://fluidigm.com/role/StockBasedPlans 34 false false R35.htm 2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 35 false false R36.htm 2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) Sheet http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) Details 36 false false R37.htm 2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) Sheet http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) Details 37 false false R38.htm 2410404 - Disclosure - Business Combination - Narrative (Details) Sheet http://fluidigm.com/role/BusinessCombinationNarrativeDetails Business Combination - Narrative (Details) Details 38 false false R39.htm 2411405 - Disclosure - Business Combination - Net Cash Flows (Details) Sheet http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails Business Combination - Net Cash Flows (Details) Details 39 false false R40.htm 2412406 - Disclosure - Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details) Sheet http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details) Details 40 false false R41.htm 2415407 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details) Sheet http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails Revenue - Schedule of Disaggregation of Revenue (Details) Details 41 false false R42.htm 2416408 - Disclosure - Revenue - Narrative (Details) Sheet http://fluidigm.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 42 false false R43.htm 2417409 - Disclosure - Revenue - Performance Obligations (Details) Sheet http://fluidigm.com/role/RevenuePerformanceObligationsDetails Revenue - Performance Obligations (Details) Details 43 false false R44.htm 2420410 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details) Sheet http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails Goodwill and Intangible Assets, net - Narrative (Details) Details 44 false false R45.htm 2421411 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) Sheet http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) Details 45 false false R46.htm 2422412 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details) Sheet http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails Goodwill and Intangible Assets, net - Future Amortization Expense (Details) Details 46 false false R47.htm 2425413 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) Details 47 false false R48.htm 2426414 - Disclosure - Balance Sheet Details - Inventories (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails Balance Sheet Details - Inventories (Details) Details 48 false false R49.htm 2427415 - Disclosure - Balance Sheet Details - Property and Equipment (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails Balance Sheet Details - Property and Equipment (Details) Details 49 false false R50.htm 2428416 - Disclosure - Balance Sheet Details - Warranty Accrual (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails Balance Sheet Details - Warranty Accrual (Details) Details 50 false false R51.htm 2431417 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details) Notes http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails Convertible Notes and Credit Facility - Narrative (Details) Details 51 false false R52.htm 2432418 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details) Notes http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails Convertible Notes and Credit Facility - Schedule of Debt (Details) Details 52 false false R53.htm 2435419 - Disclosure - Leases - Narrative (Details) Sheet http://fluidigm.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 53 false false R54.htm 2436420 - Disclosure - Leases - Supplemental Balance sheet (Details) Sheet http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails Leases - Supplemental Balance sheet (Details) Details 54 false false R55.htm 2437421 - Disclosure - Leases - Schedule of Operating Lease Cost (Details) Sheet http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails Leases - Schedule of Operating Lease Cost (Details) Details 55 false false R56.htm 2438422 - Disclosure - Leases - Operating Lease Maturity (Details) Sheet http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails Leases - Operating Lease Maturity (Details) Details 56 false false R57.htm 2441423 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details) Sheet http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details) Details 57 false false R58.htm 2442424 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details) Sheet http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails Fair Value of Financial Instruments - Schedule of Debt (Details) Details 58 false false R59.htm 2445425 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://fluidigm.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 59 false false R60.htm 2446426 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details) Sheet http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails Shareholders' Equity - Schedule of Stock Options (Details) Details 60 false false R61.htm 2449427 - Disclosure - Stock-Based Plans - Narrative (Details) Sheet http://fluidigm.com/role/StockBasedPlansNarrativeDetails Stock-Based Plans - Narrative (Details) Details 61 false false R62.htm 2450428 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details) Sheet http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails Stock-Based Plans - Restricted and Performance Stock Units (Details) Details 62 false false R63.htm 2451429 - Disclosure - Stock-Based Plans - Stock Option Activity (Details) Sheet http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails Stock-Based Plans - Stock Option Activity (Details) Details 63 false false R64.htm 2452430 - Disclosure - Stock-Based Plans - Stock-based Compensation Expense (Details) Sheet http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails Stock-Based Plans - Stock-based Compensation Expense (Details) Details 64 false false R65.htm 2454431 - Disclosure - Income Taxes (Details) Sheet http://fluidigm.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://fluidigm.com/role/IncomeTaxes 65 false false R66.htm 2456432 - Disclosure - Information About Geographic Areas (Details) Sheet http://fluidigm.com/role/InformationAboutGeographicAreasDetails Information About Geographic Areas (Details) Details http://fluidigm.com/role/InformationAboutGeographicAreas 66 false false R67.htm 2458433 - Disclosure - Development Agreement (Details) Sheet http://fluidigm.com/role/DevelopmentAgreementDetails Development Agreement (Details) Details http://fluidigm.com/role/DevelopmentAgreement 67 false false R68.htm 2461434 - Disclosure - Subsequent Events (Details) Sheet http://fluidigm.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://fluidigm.com/role/SubsequentEvents 68 false false All Reports Book All Reports fldm-20200630.htm exhibit10510q2q2020.htm exhibit31110q2q2020ng.htm exhibit31210q2q2020ng.htm exhibit32110q2q2020ng.htm exhibit32210q2q2020ng.htm fldm-20200630.xsd fldm-20200630_cal.xml fldm-20200630_def.xml fldm-20200630_lab.xml fldm-20200630_pre.xml fldm-20200630_g1.jpg http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://xbrl.sec.gov/stpr/2018-01-31 true true JSON 88 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "fldm-20200630.htm": { "axisCustom": 0, "axisStandard": 30, "contextCount": 299, "dts": { "calculationLink": { "local": [ "fldm-20200630_cal.xml" ] }, "definitionLink": { "local": [ "fldm-20200630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "fldm-20200630.htm" ] }, "labelLink": { "local": [ "fldm-20200630_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "fldm-20200630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "fldm-20200630.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 574, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 8, "http://fluidigm.com/20200630": 2, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 15 }, "keyCustom": 42, "keyStandard": 369, "memberCustom": 31, "memberStandard": 51, "nsprefix": "fldm", "nsuri": "http://fluidigm.com/20200630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://fluidigm.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108103 - Disclosure - Business Combination", "role": "http://fluidigm.com/role/BusinessCombination", "shortName": "Business Combination", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113104 - Disclosure - Revenue", "role": "http://fluidigm.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118105 - Disclosure - Goodwill and Intangible Assets, net", "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnet", "shortName": "Goodwill and Intangible Assets, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2123106 - Disclosure - Balance Sheet Details", "role": "http://fluidigm.com/role/BalanceSheetDetails", "shortName": "Balance Sheet Details", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2129107 - Disclosure - Convertible Notes and Credit Facility", "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacility", "shortName": "Convertible Notes and Credit Facility", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2133108 - Disclosure - Leases", "role": "http://fluidigm.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2139109 - Disclosure - Fair Value of Financial Instruments", "role": "http://fluidigm.com/role/FairValueofFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2143110 - Disclosure - Shareholders' Equity", "role": "http://fluidigm.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2147111 - Disclosure - Stock-Based Plans", "role": "http://fluidigm.com/role/StockBasedPlans", "shortName": "Stock-Based Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2153112 - Disclosure - Income Taxes", "role": "http://fluidigm.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2155113 - Disclosure - Information About Geographic Areas", "role": "http://fluidigm.com/role/InformationAboutGeographicAreas", "shortName": "Information About Geographic Areas", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2157114 - Disclosure - Development Agreement", "role": "http://fluidigm.com/role/DevelopmentAgreement", "shortName": "Development Agreement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2159115 - Disclosure - Commitments and Contingencies", "role": "http://fluidigm.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2160116 - Disclosure - Subsequent Events", "role": "http://fluidigm.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309302 - Disclosure - Business Combination (Tables)", "role": "http://fluidigm.com/role/BusinessCombinationTables", "shortName": "Business Combination (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314303 - Disclosure - Revenue (Tables)", "role": "http://fluidigm.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319304 - Disclosure - Goodwill and Intangible Assets, net (Tables)", "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables", "shortName": "Goodwill and Intangible Assets, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2324305 - Disclosure - Balance Sheet Details (Tables)", "role": "http://fluidigm.com/role/BalanceSheetDetailsTables", "shortName": "Balance Sheet Details (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2330306 - Disclosure - Convertible Notes and Credit Facility (Tables)", "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables", "shortName": "Convertible Notes and Credit Facility (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "fldm:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2334307 - Disclosure - Leases (Tables)", "role": "http://fluidigm.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "fldm:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2340308 - Disclosure - Fair Value of Financial Instruments (Tables)", "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2344309 - Disclosure - Shareholders' Equity (Tables)", "role": "http://fluidigm.com/role/ShareholdersEquityTables", "shortName": "Shareholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2348310 - Disclosure - Stock-Based Plans (Tables)", "role": "http://fluidigm.com/role/StockBasedPlansTables", "shortName": "Stock-Based Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i79964bc11d7449879f38b03f6256374a_D20200301-20200331", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LegalFees", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ia57d96b6556f45b99a15fe298d823b86_I20200331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)", "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails", "shortName": "Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ia907c060122a4109879c9bd51737ccf9_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)", "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails", "shortName": "Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "iec4f943c16e948f5ae177d15edce4e05_I20200117", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Business Combination - Narrative (Details)", "role": "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "shortName": "Business Combination - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - Business Combination - Net Cash Flows (Details)", "role": "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "shortName": "Business Combination - Net Cash Flows (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "idfcdfbfd038741b7b0c3fcec98dfca56_D20200117-20200117", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAcquiredFromAcquisition", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations", "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)", "role": "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails", "shortName": "Business Combination - Schedule of Consideration Transferred and Identifiable Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "idfcdfbfd038741b7b0c3fcec98dfca56_D20200117-20200117", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415407 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)", "role": "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "shortName": "Revenue - Schedule of Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "iaaf1a0a993794cf39c4e50a799782a93_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416408 - Disclosure - Revenue - Narrative (Details)", "role": "http://fluidigm.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417409 - Disclosure - Revenue - Performance Obligations (Details)", "role": "http://fluidigm.com/role/RevenuePerformanceObligationsDetails", "shortName": "Revenue - Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)", "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "shortName": "Goodwill and Intangible Assets, net - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i924050c445564aa7a9a44dc0b15c0365_I20140228", "decimals": "-5", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421411 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)", "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ifc1d0d398b5a4e73aa1fa1ac8323aff2_I20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422412 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)", "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "shortName": "Goodwill and Intangible Assets, net - Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425413 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails", "shortName": "Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426414 - Disclosure - Balance Sheet Details - Inventories (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails", "shortName": "Balance Sheet Details - Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427415 - Disclosure - Balance Sheet Details - Property and Equipment (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails", "shortName": "Balance Sheet Details - Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss", "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss", "shortName": "Condensed Consolidated Statements of Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i513be9bea3864f238b0628fc7e0b2209_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428416 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails", "shortName": "Balance Sheet Details - Warranty Accrual (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i513be9bea3864f238b0628fc7e0b2209_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i6e9030acebc24a57ab2608aa9c15e38b_D20191101-20191130", "decimals": "6", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleConversionRatio1", "reportCount": 1, "unique": true, "unitRef": "rate", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431417 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details)", "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "shortName": "Convertible Notes and Credit Facility - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i6e9030acebc24a57ab2608aa9c15e38b_D20191101-20191130", "decimals": "6", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleConversionRatio1", "reportCount": 1, "unique": true, "unitRef": "rate", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ie858d56305824d51932d9d9017b325d7_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432418 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details)", "role": "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "shortName": "Convertible Notes and Credit Facility - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ie858d56305824d51932d9d9017b325d7_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435419 - Disclosure - Leases - Narrative (Details)", "role": "http://fluidigm.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "fldm:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "fldm:OperatingLeaseRightOfUseAssetGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436420 - Disclosure - Leases - Supplemental Balance sheet (Details)", "role": "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails", "shortName": "Leases - Supplemental Balance sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "fldm:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "fldm:OperatingLeaseRightOfUseAssetGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437421 - Disclosure - Leases - Schedule of Operating Lease Cost (Details)", "role": "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails", "shortName": "Leases - Schedule of Operating Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438422 - Disclosure - Leases - Operating Lease Maturity (Details)", "role": "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails", "shortName": "Leases - Operating Lease Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441423 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)", "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails", "shortName": "Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ie858d56305824d51932d9d9017b325d7_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2442424 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)", "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "shortName": "Fair Value of Financial Instruments - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i56c7e99db69245109c90dd582a9c9e51_I20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ic9e20e797d99498ba1503308c636860c_D20190101-20190331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2445425 - Disclosure - Shareholders' Equity - Narrative (Details)", "role": "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "shortName": "Shareholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ic9e20e797d99498ba1503308c636860c_D20190101-20190331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2618e3ce045d4dc08f1f826b91042438_I20181231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity", "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "shortName": "Condensed Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2d58b5e1b0d543faa6108f82f9a1f65d_D20190101-20190331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446426 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)", "role": "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "shortName": "Shareholders' Equity - Schedule of Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "2", "first": true, "lang": "en-US", "name": "fldm:SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2449427 - Disclosure - Stock-Based Plans - Narrative (Details)", "role": "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "shortName": "Stock-Based Plans - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i652f00ea65254f6b94379cb5ca9c63e0_D20200601-20200601", "decimals": null, "lang": "en-US", "name": "fldm:EmployeeStockPurchasePlanOfferingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ib34eb58e5178407f8245d1ab10b4d6cf_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2450428 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)", "role": "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails", "shortName": "Stock-Based Plans - Restricted and Performance Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "ib34eb58e5178407f8245d1ab10b4d6cf_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i513be9bea3864f238b0628fc7e0b2209_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451429 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)", "role": "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails", "shortName": "Stock-Based Plans - Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452430 - Disclosure - Stock-Based Plans - Stock-based Compensation Expense (Details)", "role": "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails", "shortName": "Stock-Based Plans - Stock-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i2ce9d5e802d94e62b7b4cefcfe29156d_D20200401-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454431 - Disclosure - Income Taxes (Details)", "role": "http://fluidigm.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2456432 - Disclosure - Information About Geographic Areas (Details)", "role": "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "shortName": "Information About Geographic Areas (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i3321d0ad94d34ac7ae2e7a971ed11206_I20200630", "decimals": "INF", "first": true, "lang": "en-US", "name": "fldm:UpFrontAndMilestonePaymentsMaximum", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458433 - Disclosure - Development Agreement (Details)", "role": "http://fluidigm.com/role/DevelopmentAgreementDetails", "shortName": "Development Agreement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "lang": "en-US", "name": "fldm:CollaborativeArrangementTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i1b0c85e1dd244ccea70e1a6cec958d37_I20200731", "decimals": "INF", "first": true, "lang": "en-US", "name": "fldm:COVID19ProjectBudget", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2461434 - Disclosure - Subsequent Events (Details)", "role": "http://fluidigm.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i1b0c85e1dd244ccea70e1a6cec958d37_I20200731", "decimals": "INF", "first": true, "lang": "en-US", "name": "fldm:COVID19ProjectBudget", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationAmortizationAndAccretionNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Description of Business", "role": "http://fluidigm.com/role/DescriptionofBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102102 - Disclosure - Summary of Significant Accounting Policies", "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fldm-20200630.htm", "contextRef": "i5e9e7ad2324c47d9baf72a0a74d2b666_D20200101-20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 83, "tag": { "country_CN": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CHINA", "terseLabel": "China" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r544" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r545" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r546" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r546" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r546" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r547" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r546" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r546" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r546" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r546" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r542" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r543" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://fluidigm.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "fldm_A2017InducementAwardPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2017 Inducement Award Plan [Member]", "label": "2017 Inducement Award Plan [Member]", "terseLabel": "2017 Inducement Award Plan" } } }, "localname": "A2017InducementAwardPlanMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_AssetRetirementObligationsIncurredButNotYetPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Retirement Obligations Incurred But Not Yet Paid", "label": "Asset Retirement Obligations Incurred But Not Yet Paid", "terseLabel": "Asset retirement obligations" } } }, "localname": "AssetRetirementObligationsIncurredButNotYetPaid", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "fldm_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Assets And Liabilities, Lessee [Table Text Block]", "label": "Assets And Liabilities, Lessee [Table Text Block]", "terseLabel": "Schedule of balance sheet information" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "fldm_AwardsHeldByOwnersOfMoreThan10OfCommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Awards Held By Owners Of More Than 10% Of Common Stock", "label": "Awards Held By Owners Of More Than 10% Of Common Stock [Member]", "terseLabel": "Stock options held by owners of more than 10% of common stock" } } }, "localname": "AwardsHeldByOwnersOfMoreThan10OfCommonStockMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAccountsReceivables", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Receivables", "terseLabel": "Other receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherReceivables", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_COVID19ProjectBudget": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "COVID-19 Project, Budget", "label": "COVID-19 Project, Budget", "terseLabel": "COVID-19 project, budget" } } }, "localname": "COVID19ProjectBudget", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "fldm_COVID19ProjectInitialFunding": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "COVID-19 Project, Initial Funding", "label": "COVID-19 Project, Initial Funding", "terseLabel": "COVID-19 project, initial funding" } } }, "localname": "COVID19ProjectInitialFunding", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cash, Cash Equivalents, And Short Term Investments, Amortized Cost", "label": "Cash, Cash Equivalents, And Short Term Investments, Amortized Cost", "totalLabel": "Amortized Cost" } } }, "localname": "CashCashEquivalentsAndShortTermInvestmentsAmortizedCost", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "fldm_CashPaidForOperatingLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cash Paid For Operating Lease Liabilities [Abstract]", "label": "Cash Paid For Operating Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities (included in net cash used in operating activities in thousands):" } } }, "localname": "CashPaidForOperatingLeaseLiabilitiesAbstract", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" ], "xbrltype": "stringItemType" }, "fldm_CertainEmployeeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Certain Employee [Member]", "label": "Certain Employee [Member]", "terseLabel": "Certain Employee" } } }, "localname": "CertainEmployeeMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "domainItemType" }, "fldm_CollaborationRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaboration Revenue", "label": "Collaboration Revenue [Member]", "terseLabel": "Development revenue" } } }, "localname": "CollaborationRevenueMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/DevelopmentAgreementDetails", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "fldm_CollaborativeArrangementRevenueDeferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Revenue Deferred", "label": "Collaborative Arrangement, Revenue Deferred", "terseLabel": "Collaboration agreement, deferred revenue" } } }, "localname": "CollaborativeArrangementRevenueDeferred", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "monetaryItemType" }, "fldm_CollaborativeArrangementTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative Arrangement, Term", "label": "Collaborative Arrangement, Term", "terseLabel": "Collaboration agreement, term" } } }, "localname": "CollaborativeArrangementTerm", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "durationItemType" }, "fldm_CommissionCostsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission Costs [Member]", "label": "Commission Costs [Member]", "terseLabel": "Commission Costs" } } }, "localname": "CommissionCostsMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ComputerEquipmentAndSoftwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Computer Equipment And Software [Member]", "label": "Computer Equipment And Software [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentAndSoftwareMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "fldm_ConsumablesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Consumables [Member]", "label": "Consumables [Member]", "terseLabel": "Consumables" } } }, "localname": "ConsumablesMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contract With Customer, Liability, Increase From Cash Receipts", "label": "Contract With Customer, Liability, Increase From Cash Receipts", "terseLabel": "Additional advance payments received" } } }, "localname": "ContractWithCustomerLiabilityIncreaseFromCashReceipts", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DVSSciencesInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "DVS Sciences, Inc. [Member]", "label": "DVS Sciences, Inc. [Member]", "terseLabel": "DVS Sciences, Inc." } } }, "localname": "DVSSciencesInc.Member", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_DebtAndEquityOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt And Equity Offering Costs", "label": "Debt And Equity Offering Costs", "terseLabel": "Debt and equity offering costs" } } }, "localname": "DebtAndEquityOfferingCosts", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity", "label": "Debt Instrument, Early Redemption Cost, Percent Of Maximum Borrowing Capacity", "terseLabel": "Prepayment fee, percentage" } } }, "localname": "DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price", "label": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price", "terseLabel": "Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price" } } }, "localname": "DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee Stock Purchase Plan, Number Of Six Month Offering Periods", "label": "Employee Stock Purchase Plan, Number Of Six Month Offering Periods", "terseLabel": "ESPP, number of six-month offering periods" } } }, "localname": "EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "integerItemType" }, "fldm_EmployeeStockPurchasePlanOfferingPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee Stock Purchase Plan, Offering Period", "label": "Employee Stock Purchase Plan, Offering Period", "terseLabel": "ESPP, offering period" } } }, "localname": "EmployeeStockPurchasePlanOfferingPeriod", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_EquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Incentive Plan [Member]", "label": "Equity Incentive Plan [Member]", "terseLabel": "Equity Incentive Plan" } } }, "localname": "EquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_EquityIncentivePlanTwentyElevenMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Incentive Plan Twenty Eleven [Member]", "label": "Equity Incentive Plan Twenty Eleven [Member]", "terseLabel": "2011 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlanTwentyElevenMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ExchangeConvertibleSeniorNotesDue2034Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Exchange Convertible Senior Notes Due 2034 [Member]", "label": "Exchange Convertible Senior Notes Due 2034 [Member]", "terseLabel": "Exchange Convertible Senior Notes due 2034" } } }, "localname": "ExchangeConvertibleSeniorNotesDue2034Member", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four", "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "fldm_FiveLargestCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Five Largest Customers [Member]", "label": "Five Largest Customers [Member]", "terseLabel": "5 Largest Customers" } } }, "localname": "FiveLargestCustomersMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_InitialConversionPriceOfStock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Initial Conversion Price Of Stock", "label": "Initial Conversion Price Of Stock", "terseLabel": "Initial conversion price of stock (usd per share)" } } }, "localname": "InitialConversionPriceOfStock", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "fldm_InstruNorASMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "InstruNor AS [Member]", "label": "InstruNor AS [Member]", "terseLabel": "InstruNor AS" } } }, "localname": "InstruNorASMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_InstrumentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Instruments [Member]", "label": "Instruments [Member]", "terseLabel": "Instruments" } } }, "localname": "InstrumentsMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "fldm_IntellectualPropertyInfringementClaimsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Intellectual Property Infringement Claims [Member]", "label": "Intellectual Property Infringement Claims [Member]", "terseLabel": "Intellectual Property Infringement Claims" } } }, "localname": "IntellectualPropertyInfringementClaimsMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_LaboratoryAndManufacturingEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Laboratory And Manufacturing Equipment [Member]", "label": "Laboratory And Manufacturing Equipment [Member]", "terseLabel": "Laboratory and manufacturing equipment" } } }, "localname": "LaboratoryAndManufacturingEquipmentMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "fldm_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "fldm_LesseeOperatingLeaseRemainingTermOfContract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee, Operating Lease, Remaining Term Of Contract", "label": "Lessee, Operating Lease, Remaining Term Of Contract", "terseLabel": "Remaining lease term" } } }, "localname": "LesseeOperatingLeaseRemainingTermOfContract", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory", "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory", "terseLabel": "Percentage of eligible inventory" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables", "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables", "terseLabel": "Percentage of eligible receivables" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default", "label": "Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default", "terseLabel": "Percentage of interest on obligation upon default" } } }, "localname": "LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement", "label": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement", "terseLabel": "Number of months over which options vest ratably" } } }, "localname": "NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Lease, Right-Of-Use Asset, Accumulated Amortization", "label": "Operating Lease, Right-Of-Use Asset, Accumulated Amortization", "negatedTerseLabel": "Accumulated amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLeaseRightOfUseAssetGross": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Operating Lease, Right-Of-Use Asset, Gross", "label": "Operating Lease, Right-Of-Use Asset, Gross", "terseLabel": "Gross Amount" } } }, "localname": "OperatingLeaseRightOfUseAssetGross", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Options, Performance Share Units And Restricted Stock Units [Member]", "label": "Options, Performance Share Units And Restricted Stock Units [Member]", "terseLabel": "Restricted Stock Units, Stock Options and Performance Share Units" } } }, "localname": "OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "fldm_PatentsandLicenseAgreementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Patents and License Agreements [Member]", "label": "Patents and License Agreements [Member]", "terseLabel": "Patents and licenses" } } }, "localname": "PatentsandLicenseAgreementsMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "fldm_PortionOfStockOptionsVestOnFirstAnniversary": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Portion Of Stock Options Vest On First Anniversary", "label": "Portion Of Stock Options Vest On First Anniversary", "terseLabel": "Rate at which outstanding options vest on the first anniversary of the option grant date" } } }, "localname": "PortionOfStockOptionsVestOnFirstAnniversary", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_ProductWarrantyTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product Warranty Term", "label": "Product Warranty Term", "terseLabel": "Product warranty term" } } }, "localname": "ProductWarrantyTerm", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_RestrictedCashAndCashEquivalentsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Cash And Cash Equivalents [Domain]", "label": "Restricted Cash And Cash Equivalents [Domain]", "terseLabel": "Cash-restricted" } } }, "localname": "RestrictedCashAndCashEquivalentsDomain", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "fldm_RestrictedStockAndPerformanceShareUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Stock And Performance Share Units [Member]", "label": "Restricted Stock And Performance Share Units [Member]", "terseLabel": "Restricted Stock And Performance Share Units" } } }, "localname": "RestrictedStockAndPerformanceShareUnitsMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue From Contract With Customer, Performance Obligation Period", "label": "Revenue From Contract With Customer, Performance Obligation Period", "terseLabel": "Performance obligation period" } } }, "localname": "RevenueFromContractWithCustomerPerformanceObligationPeriod", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue From Contract With Customer, Terms Of Payment Period", "label": "Revenue From Contract With Customer, Terms Of Payment Period", "terseLabel": "Terms of payment period" } } }, "localname": "RevenueFromContractWithCustomerTermsOfPaymentPeriod", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_ScheduleOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Significant Accounting Policies [Line Items]", "label": "Schedule Of Significant Accounting Policies [Line Items]", "terseLabel": "Schedule Of Significant Accounting Policies [Line Items]" } } }, "localname": "ScheduleOfSignificantAccountingPoliciesLineItems", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_ScheduleOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Significant Accounting Policies [Table]", "label": "Schedule Of Significant Accounting Policies [Table]", "terseLabel": "Schedule Of Significant Accounting Policies [Table]" } } }, "localname": "ScheduleOfSignificantAccountingPoliciesTable", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_SeniorConvertibleNotesDue2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Convertible Notes Due 2024 [Member]", "label": "Senior Convertible Notes Due 2024 [Member]", "terseLabel": "Senior Convertible Notes Due 2024" } } }, "localname": "SeniorConvertibleNotesDue2024Member", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_SeniorConvertibleNotesdue2034Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Convertible Notes due 2034 [Member]", "label": "Senior Convertible Notes due 2034 [Member]", "terseLabel": "Senior Convertible Notes due 2034" } } }, "localname": "SeniorConvertibleNotesdue2034Member", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest", "terseLabel": "Percentage of performance period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value", "terseLabel": "Unvested awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number", "terseLabel": "Unvested awards (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price", "terseLabel": "Unvested awards (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1", "terseLabel": "Unvested awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value", "terseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price", "terseLabel": "Vested (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One", "verboseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount", "terseLabel": "Maximum employee purchase amount" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock", "terseLabel": "Percentage of voting power which impacts the term of equity incentive plan" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_ShareholdersEquityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Shareholders' Equity [Table]", "label": "Shareholders' Equity [Line Items]", "terseLabel": "Shareholders' Equity [Line Items]" } } }, "localname": "ShareholdersEquityLineItems", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_ShareholdersEquityTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shareholders' Equity [Table]", "label": "Shareholders' Equity [Table]", "terseLabel": "Shareholders' Equity [Table]" } } }, "localname": "ShareholdersEquityTable", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value", "label": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value", "terseLabel": "Stock option grants exercise price minimum percentage on fair market value" } } }, "localname": "StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_TrusteeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trustee [Member]", "label": "Trustee [Member]", "terseLabel": "Trustee" } } }, "localname": "TrusteeMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndElevenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Eleven Equity Incentive Plan [Member]", "label": "Two Thousand And Eleven Equity Incentive Plan [Member]", "verboseLabel": "2011 Equity Incentive Plan" } } }, "localname": "TwoThousandAndElevenEquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndFourteenConvertibleNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Fourteen Convertible Notes [Member]", "label": "Two Thousand And Fourteen Convertible Notes [Member]", "terseLabel": "2014 Convertible Notes" } } }, "localname": "TwoThousandAndFourteenConvertibleNotesMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndNineEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Nine Equity Incentive Plan [Member]", "label": "Two Thousand And Nine Equity Incentive Plan [Member]", "terseLabel": "2009 Equity Incentive Plan" } } }, "localname": "TwoThousandAndNineEquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndNineteenConvertibleNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Nineteen Convertible Notes [Member]", "label": "Two Thousand And Nineteen Convertible Notes [Member]", "terseLabel": "2019 Convertible Notes" } } }, "localname": "TwoThousandAndNineteenConvertibleNotesMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]", "label": "Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]", "terseLabel": "2019 Convertible Notes potential make-whole shares" } } }, "localname": "TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndSeventeenInducementAwardPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Seventeen Inducement Award Plan [Member]", "label": "Two Thousand And Seventeen Inducement Award Plan [Member]", "verboseLabel": "2017 Inducement Award Plan" } } }, "localname": "TwoThousandAndSeventeenInducementAwardPlanMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndTenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Ten Equity Incentive Plan [Member]", "label": "Two Thousand And Ten Equity Incentive Plan [Member]", "verboseLabel": "DVS Sciences Inc. 2010 Equity Incentive Plan" } } }, "localname": "TwoThousandAndTenEquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]", "label": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]", "terseLabel": "2017 Employee Stock Purchase Plan", "verboseLabel": "2017 Employee Stock Purchase Plan" } } }, "localname": "TwoThousandSeventeenEmployeeStockPurchasePlanMember", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_UnderwritingDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Underwriting Discount", "label": "Underwriting Discount", "terseLabel": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_UpFrontAndMilestonePaymentsMaximum": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Up-Front And Milestone Payments, Maximum", "label": "Up-Front And Milestone Payments, Maximum", "terseLabel": "Collaboration agreement, up-front and periodic milestone payments, up to" } } }, "localname": "UpFrontAndMilestonePaymentsMaximum", "nsuri": "http://fluidigm.com/20200630", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "monetaryItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Americas [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Asia Pacific [Member]", "verboseLabel": "Asia-Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r60", "r111" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r118", "r125", "r200", "r351", "r352", "r353", "r366", "r367" ], "lang": { "en-US": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r118", "r125", "r200", "r351", "r352", "r353", "r366", "r367" ], "lang": { "en-US": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r118", "r125", "r200", "r351", "r352", "r353", "r366", "r367" ], "lang": { "en-US": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r176", "r294", "r300", "r515" ], "lang": { "en-US": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r316", "r318", "r452", "r453", "r454", "r455", "r456", "r457", "r476", "r512", "r516" ], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r316", "r318", "r452", "r453", "r454", "r455", "r456", "r457", "r476", "r512", "r516" ], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r176", "r294", "r300", "r515" ], "lang": { "en-US": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r172", "r294", "r298", "r477", "r511", "r513" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/DevelopmentAgreementDetails", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r172", "r294", "r298", "r477", "r511", "r513" ], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/DevelopmentAgreementDetails", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r306", "r316", "r318", "r452", "r453", "r454", "r455", "r456", "r457", "r476", "r512", "r516" ], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r306", "r316", "r318", "r452", "r453", "r454", "r455", "r456", "r457", "r476", "r512", "r516" ], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r173", "r174", "r294", "r299", "r514", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539" ], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r173", "r174", "r294", "r299", "r514", "r530", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r178", "r442" ], "lang": { "en-US": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CALIFORNIA", "terseLabel": "CALIFORNIA" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r119", "r120", "r121", "r122", "r197", "r198", "r199", "r200", "r201", "r202", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r366", "r367", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528" ], "lang": { "en-US": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible List]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r20", "r179", "r180" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable (net of allowances of $101 and $6, at June 30, 2020 and December\u00a031, 2019, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r39", "r239" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r64", "r65", "r66", "r70", "r71" ], "lang": { "en-US": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized Gain (Loss) on Investments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r23", "r68", "r69", "r70", "r503", "r524", "r528" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r413", "r414", "r415", "r416", "r417", "r419" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r67", "r70", "r71", "r115", "r116", "r117", "r396", "r519", "r520" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "verboseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r63", "r70", "r71", "r396", "r414", "r415", "r416", "r417", "r419" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustment" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r228" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Acquired finite-lived intangible assets, useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r21", "r354" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r115", "r116", "r117", "r351", "r352", "r353" ], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r319", "r321", "r356", "r357" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r263", "r271" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "terseLabel": "Stock issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r321", "r342", "r355" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total Share-based Compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r27", "r182", "r203" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, allowances" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r100", "r425" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discounts, premiums and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r100", "r225", "r234" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of developed technology", "verboseLabel": "Amortization of intangibles" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive securities excluded from computations of net loss per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Development revenue" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r109", "r158", "r162", "r168", "r196", "r393", "r397", "r411", "r482", "r500" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r59", "r109", "r196", "r393", "r397", "r411" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r190" ], "calculation": { "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gain" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r191" ], "calculation": { "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "negatedTerseLabel": "Gross Unrealized Loss" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r188", "r209" ], "calculation": { "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "totalLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r187", "r189", "r209", "r488" ], "calculation": { "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "totalLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r322", "r345" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]", "terseLabel": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Operating lease right-of-use buildings" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r315", "r317" ], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r315", "r317", "r375", "r376" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r385" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "verboseLabel": "Purchase price in shares (shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r381", "r382", "r383" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "totalLabel": "Total purchase price", "verboseLabel": "Total purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r381", "r382" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Non-cash consideration common shares" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r386" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combination" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r378" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r378" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r378" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "terseLabel": "Other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r378" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "auth_ref": [ "r378" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets", "terseLabel": "Developed technology" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r377", "r378" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r377", "r378" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Fair value of identifiable net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r114", "r149" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Description of Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/DescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedContractCostAxis": { "auth_ref": [ "r217" ], "lang": { "en-US": { "role": { "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.", "label": "Capitalized Contract Cost [Axis]", "terseLabel": "Capitalized Contract Cost [Axis]" } } }, "localname": "CapitalizedContractCostAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalizedContractCostDomain": { "auth_ref": [ "r217" ], "lang": { "en-US": { "role": { "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.", "label": "Capitalized Contract Cost [Domain]", "terseLabel": "Capitalized Contract Cost [Domain]" } } }, "localname": "CapitalizedContractCostDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r407", "r408" ], "lang": { "en-US": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r85" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired from Acquisition", "negatedTerseLabel": "Less: cash and cash equivalents acquired" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r36", "r102" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 }, "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "netLabel": "Cash-unrestricted", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails", "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash-unrestricted" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r36" ], "calculation": { "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": 3.0, "parentTag": "fldm_CashCashEquivalentsAndShortTermInvestmentsAmortizedCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash, Cash Equivalents, and Short-term Investments", "totalLabel": "Fair Value" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r95", "r102", "r104" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "totalLabel": "Total cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails", "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows", "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r95", "r412" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]", "terseLabel": "Total cash" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "auth_ref": [ "r387", "r388", "r390" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.", "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "Development Agreement" } } }, "localname": "CollaborativeArrangementDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreement" ], "xbrltype": "textBlockItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r50", "r244", "r490", "r507" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r241", "r242", "r243", "r245" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r52" ], "lang": { "en-US": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Number Of Remaining Securities Available For Future Issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r115", "r116" ], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (usd per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r263" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending Balance (shares)", "periodStartLabel": "Beginning Balance (shares)", "terseLabel": "Common stock, shares outstanding (shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2020 and December\u00a031, 2019; 71,283 and 69,956 shares issued and outstanding at June 30, 2020 and December\u00a031, 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r74", "r76", "r77", "r80", "r492", "r509" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r144", "r145", "r176", "r409", "r410" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r144", "r145", "r176", "r409", "r410", "r529" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r144", "r145", "r176", "r409", "r410", "r529" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r139", "r497" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentrations of Business and Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r144", "r145", "r176", "r409", "r410" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r144", "r145", "r176", "r409", "r410" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r238" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Construction-in-progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r273", "r274", "r295" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r273", "r274", "r295" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue, current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r273", "r274", "r295" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Deferred revenue, non-current" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r296" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "negatedTerseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r307" ], "lang": { "en-US": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Convertible Notes" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r48" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "terseLabel": "Convertible notes, net" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r81", "r477" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r142", "r176" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r16", "r17", "r483", "r484", "r498" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Additional interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r17", "r254", "r484", "r498" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r47", "r264", "r267", "r269" ], "lang": { "en-US": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Initial conversion rate of notes" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r424", "r426" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Par Value", "verboseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r406" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r46", "r256", "r424" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r46" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate on notes" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r48" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "Redemption, Period One" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Redemption, Period Two" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r48", "r112", "r264", "r268", "r269", "r270", "r423", "r424", "r426", "r496" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r423", "r426" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedTerseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r105", "r251" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Convertible Notes" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "auth_ref": [ "r195" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table Text Block]", "terseLabel": "Schedule of cash and available-for-sale securities" } } }, "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "auth_ref": [ "r194", "r210" ], "lang": { "en-US": { "role": { "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions", "terseLabel": "Number of investment in unrealized loss positions" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r425" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Offering related costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r40", "r425" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized debt issuance cost", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r360", "r361" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r100" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation, Amortization and Accretion, Net", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r380" ], "lang": { "en-US": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r294", "r298", "r299", "r300", "r301", "r302", "r303", "r304" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r294" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Summary of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r358" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r322", "r345" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense", "verboseLabel": "Schedule of common stock reserved for future issuance" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityTables", "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Net loss per share, basic and diluted (usd per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r105", "r132", "r133" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r412" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of foreign exchange rate fluctuations on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation and related benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r344" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Total unrecognized compensation cost related to stock-based compensation arrangements" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock", "verboseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r341" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock options, restricted stock units and performance awards", "verboseLabel": "Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Operating lease right-of-use equipment" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r115", "r116", "r117", "r120", "r127", "r129", "r134", "r200", "r263", "r271", "r351", "r352", "r353", "r366", "r367", "r413", "r414", "r415", "r416", "r417", "r419", "r519", "r520", "r521" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r406" ], "lang": { "en-US": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Extinguishment of Debt, Amount", "terseLabel": "Debt extinguished" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r401", "r403" ], "lang": { "en-US": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r400", "r449", "r450", "r451" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r399", "r404" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r402" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r307", "r308", "r313", "r314", "r400", "r449" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level\u00a0I" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r449", "r450", "r451" ], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r192", "r193", "r204", "r205", "r206", "r207", "r208", "r211", "r212", "r213", "r214", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475" ], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r233" ], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r235" ], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "2020 (remainder of the year)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r235" ], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r235" ], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r235" ], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r226", "r229", "r233", "r236", "r478", "r479" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r233", "r479" ], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Gross Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r226", "r232" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r233", "r478" ], "calculation": { "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r478" ], "lang": { "en-US": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Weighted-Average Amortization Period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-lived Intangible Assets Acquired", "terseLabel": "Finite-lived intangible assets acquired" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r105", "r421" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r100" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r100", "r257", "r258" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on extinguishment of debt", "terseLabel": "Loss from extinguishment of debt", "verboseLabel": "Gain (loss) on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows", "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r143" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r218", "r220", "r481" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails", "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r105", "r222", "r230" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill, Intangible Assets and Other Long-Lived Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r100", "r219", "r221", "r223" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Impairment of goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrantMember": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Award of money not required to be repaid.", "label": "Grant [Member]", "terseLabel": "Grant revenue" } } }, "localname": "GrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r113", "r158", "r161", "r164", "r167", "r170" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r363", "r364", "r365", "r368", "r370", "r372", "r373", "r374" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r110", "r128", "r129", "r157", "r362", "r369", "r371", "r510" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax benefit", "terseLabel": "Income tax (benefit) expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r103" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes, net of refunds" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r237" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets, net" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r224", "r231" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Developed technology, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r78", "r156", "r422", "r425", "r493" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r94", "r97", "r103" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r28", "r216" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReservePeriodCharge": { "auth_ref": [ "r56", "r57", "r58", "r215" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.", "label": "Inventory, LIFO Reserve, Period Charge", "terseLabel": "Provision for excess and obsolete inventory" } } }, "localname": "InventoryLIFOReservePeriodCharge", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r55" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails", "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r30", "r216" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r29", "r216" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r438" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of lease expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r82" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "terseLabel": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r430" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r432" ], "lang": { "en-US": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Lessee, Operating Lease, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r439" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "verboseLabel": "Schedule of future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r439" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total future minimum payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r439" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r439" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r439" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r439" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r439" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2020 (remainder of year)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r439" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r431" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Renewal term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r431" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r441" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r43", "r109", "r163", "r196", "r394", "r397", "r398", "r411" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r109", "r196", "r411", "r485", "r505" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r45", "r109", "r196", "r394", "r397", "r398", "r411" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "License [Member]", "terseLabel": "Other revenue", "verboseLabel": "License and royalty revenue" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r17", "r484", "r498" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Line of credit outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r42", "r112" ], "lang": { "en-US": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Commitment Fee Amount", "terseLabel": "Commitment fee amount" } } }, "localname": "LineOfCreditFacilityCommitmentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r42" ], "lang": { "en-US": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum ability to borrow under line of credit" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Unused revolving line of credit" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r17", "r255", "r484", "r501" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Long-term Debt, Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Estimated fair value of debt" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r259" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-term Debt [Text Block]", "terseLabel": "Convertible Notes and Credit Facility" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacility" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Long-term Investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r48" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r48", "r252" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityScheduleofDebtDetails", "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r307" ], "lang": { "en-US": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r95" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r95" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r95", "r98", "r101" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r72", "r75", "r79", "r101", "r109", "r119", "r123", "r124", "r125", "r126", "r128", "r129", "r130", "r158", "r161", "r164", "r167", "r170", "r196", "r411", "r491", "r508" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows", "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss", "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Changes and Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r151" ], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reporting segment" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office furniture and fixtures" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r158", "r161", "r164", "r167", "r170" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r433", "r440" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost (including variable costs)" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "verboseLabel": "Minimum Lease Payments for Operating Leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r428" ], "calculation": { "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "netLabel": "Reorganized lease liabilities", "terseLabel": "Total", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/LeasesOperatingLeaseMaturityDetails", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r428" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current", "verboseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r428" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, non-current", "verboseLabel": "Operating lease liabilities, non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r429", "r435" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r427" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use asset, net", "totalLabel": "Total operating lease right-of-use assets, net", "verboseLabel": "Right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r100" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Lease amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r437", "r440" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "verboseLabel": "Weighted average discount rate per annum" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r436", "r440" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Weighted average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Leased Assets [Line Items]", "terseLabel": "Operating Leased Assets [Line Items]" } } }, "localname": "OperatingLeasedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r62" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r73", "r76", "r391", "r392", "r395" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss", "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r64", "r68" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "terseLabel": "Net change in unrealized gain (loss) on investments" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r84" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other non-cash items" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": { "auth_ref": [ "r93" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.", "label": "Payment of Financing and Stock Issuance Costs", "negatedTerseLabel": "Payment of debt issuance cost" } } }, "localname": "PaymentOfFinancingAndStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r92" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards and other" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r87", "r384" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired", "weight": 1.0 }, "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "netLabel": "Purchase price in cash", "terseLabel": "Cash consideration paid on closing to former equity holders" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r87" ], "calculation": { "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisition, net of cash acquired", "totalLabel": "Acquisition of InstruNor, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r89" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r88" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r322", "r345" ], "lang": { "en-US": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r405" ], "lang": { "en-US": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (usd per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either June 30, 2020 or December\u00a031, 2019" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r34", "r35" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from convertible debt issuance" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r90" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Proceeds from debt issuance" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r90", "r346" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised", "terseLabel": "Proceeds from stock issuance from ESPP" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLegalSettlements": { "auth_ref": [ "r96" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cash received for the settlement of litigation during the current period.", "label": "Proceeds from Legal Settlements", "terseLabel": "Proceeds from legal settlements" } } }, "localname": "ProceedsFromLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments": { "auth_ref": [ "r86" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the maturity (principal being due), prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.", "label": "Proceeds from Maturities, Prepayments and Calls of Other Investments", "terseLabel": "Proceeds from maturities of investments" } } }, "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "auth_ref": [ "r86" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from the sale of investments classified as other.", "label": "Proceeds from Sale of Other Investments", "terseLabel": "Proceeds from sale of investments" } } }, "localname": "ProceedsFromSaleOfOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r90", "r346" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductAndServiceOtherMember": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.", "label": "Product and Service, Other [Member]", "terseLabel": "Other revenue" } } }, "localname": "ProductAndServiceOtherMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]", "terseLabel": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product revenue", "verboseLabel": "Product revenue" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r248", "r249", "r489" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r246" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Warranty costs incurred" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r247" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accrual for current period warranties" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r39", "r240" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r38", "r238" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r12", "r240", "r506" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails", "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r11", "r240" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r11", "r238" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r105", "r181", "r184", "r185", "r186" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r359", "r541" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r10", "r102", "r104", "r480", "r502" ], "calculation": { "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Cash-restricted" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r10", "r102", "r104" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r3", "r10", "r104" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Short-term restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r8", "r13", "r104", "r531" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Non-current restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r22", "r271", "r354", "r504", "r523", "r528" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r115", "r116", "r117", "r120", "r127", "r129", "r200", "r351", "r352", "r353", "r366", "r367", "r519", "r521" ], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r154", "r155", "r160", "r165", "r166", "r172", "r173", "r176", "r293", "r294", "r477" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenue", "verboseLabel": "Sales to customers" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/DevelopmentAgreementDetails", "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r144", "r176" ], "lang": { "en-US": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r106", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r305" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r275", "r276", "r277", "r278", "r279", "r280", "r283", "r284", "r297", "r305" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r281" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Remaining performance obligation, expected timing of satisfaction" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]", "terseLabel": "Summary of expected timing of revenue recognition" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r70", "r418", "r419" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Components of accumulated other comprehensive loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r375", "r376" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/BusinessCombinationNetCashFlowsDetails", "http://fluidigm.com/role/BusinessCombinationScheduleofConsiderationTransferredandIdentifiableAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r375", "r376" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of consideration transferred" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Summary of cash and cash equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r389" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityTables", "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r226", "r232", "r478" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails", "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r226", "r232" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of finite-lived intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r9", "r31", "r32", "r33" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.", "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]", "terseLabel": "Schedule of nonvested performance-based units activity" } } }, "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Activity under restricted stock units" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Operating Leased Assets [Table]", "terseLabel": "Schedule of Operating Leased Assets [Table]" } } }, "localname": "ScheduleOfOperatingLeasedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesNarrativeDetails", "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]", "terseLabel": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Activity of warranty accrual" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r39", "r240" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r379" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of consideration transferred and assets acquired and liabilities assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r10", "r104", "r480", "r502" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of restricted cash" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r322", "r345" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r327", "r338", "r339" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Activity under stock options" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r51", "r107", "r135", "r136", "r260", "r261", "r262", "r264", "r265", "r266", "r268", "r269", "r270", "r271" ], "lang": { "en-US": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Estimated future intangible asset amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r150", "r152", "r153", "r158", "r159", "r164", "r168", "r169", "r170", "r171", "r172", "r175", "r176", "r177" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Information About Geographic Areas" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreas" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r83" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service revenue", "verboseLabel": "Service revenue" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r323" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "verboseLabel": "Granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r334" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending Balance (shares)", "periodStartLabel": "Beginning Balance (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Nonvested and Outstanding Units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r334" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending Balance (usd per share)", "periodStartLabel": "Beginning Balance (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r340" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms", "terseLabel": "Weighted average remaining contractual terms" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Released (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Released (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r345" ], "lang": { "en-US": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Maximum employee subscription rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Additional awards authorized for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r325" ], "lang": { "en-US": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Securities To Be Issued (in shares)", "verboseLabel": "Awards authorized for issuance (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted- Average Remaining Contractual Life" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Options forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r330" ], "lang": { "en-US": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Options granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r345" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r329", "r345" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Ending Balance (shares)", "periodStartLabel": "Beginning Balance (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Options (000s)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r328" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Ending Balance (usd per share)", "periodStartLabel": "Beginning Balance (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted-Average Exercise Price per Option" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "auth_ref": [ "r343" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.", "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost", "terseLabel": "Incremental compensation cost" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r320", "r326" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockbasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Options exercised (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Options forfeited (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Options granted (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche One [Member]", "terseLabel": "Tranche One" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche Two [Member]", "terseLabel": "Tranche Two" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "verboseLabel": "Share price (usd per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BusinessCombinationNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r323" ], "lang": { "en-US": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Award vesting percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r324" ], "lang": { "en-US": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted-Average Grant Date Fair Value per Share" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r340" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Vested (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Purchase price of common stock, percent" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r15", "r486", "r487", "r499" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short-term investments", "verboseLabel": "Short-Term Marketable Securities" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r54", "r115", "r116", "r117", "r120", "r127", "r129", "r134", "r200", "r263", "r271", "r351", "r352", "r353", "r366", "r367", "r413", "r414", "r415", "r416", "r417", "r419", "r519", "r520", "r521" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r115", "r116", "r117", "r134", "r477" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations", "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-based Payment Arrangement [Member]", "terseLabel": "Stock options" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r18", "r19", "r271" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Acquisition of InstruNor AS (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r53", "r263", "r264", "r271" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of debt into common stock (in shares)", "verboseLabel": "Issuance of common stock on bond conversion (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r18", "r19", "r263", "r271" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock under ESPP (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r18", "r19", "r263", "r271" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Shares sold (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r18", "r19", "r263", "r271" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r18", "r19", "r263", "r271", "r331" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Option exercised (shares)", "terseLabel": "Issuance of common stock from option exercises (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r54", "r263", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Acquisition of InstruNor AS" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r54", "r263", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Issuance of common stock on bond conversion" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r18", "r19", "r263", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock under ESPP" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r263", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r54", "r263", "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock from option exercises" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r24", "r25", "r109", "r183", "r196", "r411" ], "calculation": { "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Cumulative-effect of new accounting standard for Topic 326 Credit Losses", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets", "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails", "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r108", "r271", "r272" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r420", "r444" ], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r420", "r444" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r420", "r444" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r420", "r444" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r443", "r445" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Details" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetails" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r192", "r193", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r389" ], "lang": { "en-US": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/DevelopmentAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r307", "r314", "r494" ], "lang": { "en-US": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "US treasury securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r137", "r138", "r140", "r141", "r146", "r147", "r148" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r434", "r440" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable costs including non-lease component" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesScheduleofOperatingLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesandCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Operating lease right-of-use vehicles" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r345" ], "lang": { "en-US": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r345" ], "lang": { "en-US": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Shares used in computing net loss per share, basic and diluted (shares)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r195": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.L)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r243": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r245": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r259": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r305": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r358": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r374": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r386": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "808", "URI": "http://asc.fasb.org/topic&trid=5833765" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r421": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r441": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r445": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r542": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r543": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r544": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r545": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r546": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r547": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r61": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" } }, "version": "2.1" } ZIP 89 0001162194-20-000093-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001162194-20-000093-xbrl.zip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

    Y]T>5;%5+*;AXH=2A M.2T^>R(8VW(S?O1\0^>U27*7H\W]K,'&VZH,[%V30:TF$GF721TUV[.R588[ M=NQ8$V+08E'8,0T4!<E) MO>>8 $_2[-FI%1MQ93*W_9J*RPDJQP?% M=CZ$O,*7\?=JGL^B7%G756CX\:)=KH-F]-87,2Z)A(RU*H.NQ(JDT&VUC9E3 MJR;7;4R][]-5/0V\M_4^$O2\FMPW\ MRI'PCC5JGVZ6%DX@Y8(GO5,B@^/TQT)J]N29V>?(2:A7[XEV_-AX]Q/E7$%> M<&U3@5K:X!;"O2J9!T_4V JJF^@O]1('?.2#Q0>F@4KK+JO\R,OK3T>'G3U^ MH<5,-EE#;.LO)PJ<960V!QF,%=W-2G!%FXYN*WI)5,,%R4U7! M#Z>B)D1-]G<-/>>_W;;OS@3?8'!G&K[X&MK)\G3SQI2LT(/:+OVZZG?WE,"Z ME(,?GA3;6Z(+)W M!S:J0*X]*"KH?&.P"7CLY4P=)6_$/?]2U-X]T#DM:^:15^*BU*-NZ M(0N3-JMPR[__-=TPW;OBXS=/&B$K#RAO,C:EIZ?Y;/+K(?8 =)VHX7JJ=PL MZ^D8@/7.> H.XX@GNA =B204P07KZ(1'H=U!+];.A#96E#9VF:ZKP[E0>])) MI76=V8Q)=:]H;:JTMEYJ^ZPW# !LGB309S>CD#TI9/"2ZEH#YEYD2RFW!DZIAO6"O][5:T>>T M,T /T*$AG1EH3B(2G2VQ9(JGF9,;&@2S ^8 "2""_YP!0< 2P )D@ )XTH:P M>L[WGJ-]$YY,F*6,W8F"PY-Q!-J4X#4+K3>5*3,<5:/VIY-9L'+N[U9NYDG& M$0E>('05;7V>9,+<8L#%.I'F+RQ>+WY"Y"?WZ;>A'9WF67$K-MN8;A)E^;94^L804$,D>*D37P+S!5#$N$/ ML$WX/_;;1,)861/(!L(6>#+P7=F$QPC^"&[AA2?3X.:^>&W2@SDPJS<632:2 M]%!DU+QTF+N8>\U)![4^^ZU+8P+6F?RCZ:U 6?\1W!*-GX&;D]#:=O/@96@2 MT=/6%0MN+KA?.(++',3)4<:.\,#1!IVK9 YKYI4B5&:^/\M@*M?3.CZ#EHE]1SS$^[ M7K/P&CI NV:9&P>AC1)?-L-F8#YJH_4=HM6- #EG9[ %#WXRS@Z:@<1M ?4$'M00. #.((U(N "_CF"Z\(!!, = MK#F!4!2 IM4M $-@$S!_N!:4[V#4F:&,?]%AOGQ3)0"!@J>*)#6)PNA$I! P M7HM.,IH,FUL85?R_$SU@D8P"F^9E>88,BWE1I2V:T0N/0V.];/!;J(<-L@ / M ZT-K'"#?TRT"V.][^9F:AH:A>&M5=XP)TP+"1"(:(6$ 0, =N)0KMCR8).6##VTA#JNU>(*7 MJJ^&$&UR5;!.!P2PN\$I#:'91/CX^ MLCX(62+)!1RKHB(G#Y>#PV7 'C)>?@0RRE>&X"4\-X,>U@M-PM$R;H+4:Q08 M,9(UA(1FI\6@YV?U!&,]VIP8M!P6C_7 $LA>(+M@Y$ML,Y_W=N+&I+)66"]B!02&@MV%_XV6-^;_"N#];W!=Y+L.BY=H9>[RUXC)N@W/)Z8/^$EV !V17SK.)<*_Y/N<\VSR\:@59V)) \4R&R3QZ:H8TS-54U)GB1401JZD9#"(3(XG 8 M526$$D(![N0L@U%14I)1<%92E%%!HC RSHI(>3@@@84EY95WEN M @LL 8.C'G9=/,K+2T.(EIJG"@6HWKZ)LBI5TC2$YK L;+,DHTADBJB, MPX.]:)E@VOR@Q*L:H;QL<%XX)SS6S!M+HF7U-80,4'@O[ ^Z6)%0!"]/% E+ M0/MI"%F1*-\Z;34'A0@D$"8D"%*G"F+#4-!8TOSN@8H/CW,BH4A^@N#64??Y M&T=I61I0D$#B$-_#C75UYZGVLC#<)&BLKZL(4U%4E('+PJ@*$11B,HZ,Q\[J M1AT\>;:&QU%/A2H>10#/M*_,;+)(2/.O[@"IR\V,!*>0^S:;W')^('/R*D@X5E'!60;AC(7)*""Q"!EEE#(H*DI8)P4GM*(\ M' LR;V8\YJ288X;Q V?*;9;"/&(60=T9@X,Y(&:0"$BZCX 17EE%&PN1E M0)NJ#'>&*:&Q2/3<>!]7+&%6=\B#1A9I):^B"E-259C7'3/=O(C.9!]02G5< ML%1IGI% XV]'8EZ#(!9JD)G1:%>J8("^@QQMO;^W*A5%D,]H9[@,6@G\4)!7 MP,J@5! H&2>D"DP)I:""4E# _F!5/]:(_ZU5H8D$:NKUV\K HXX"'2$L"90" M9ZJ\HSP]\3@TBMJ=:H $R<0%(&\"9M;DS(ON/^"A$AR)47)6EI=1DH>#:ANN MZ"R#4D8HR#@YP141"C!%! JI_)<\5/Y[//RI9?D/RH4"%HE44G2B+@=GBG*E^KK6>+\L8*T*$C5!Z01G%]%GEJ$9H&N/P)2"#B00%/0 M/<7-,'S.I:!.;(X'0P/J8R]>/W K-'7]4(3O7+39BBF*NF;4'QOLL'@\T>>/ M\$U4?V^QJ_=MP7^@8Q9FZ8,BHUT-J7> ?TC='X-S:I"G2KME3)T*=,YG?%#! MF9D$:5,)?==KQH67%YK!:3CC%*/ F/U'/A:MAQ=MIIG9;5UQ9.SL=!XT3QKT MEV>OR;29S2W,=/4M+6=A).J6PY'(>0JP-$F;!SCA*=B9:[F_P$ICYJ]B12Q" MBH MP(F _R5*JJBA2DNW%QEV,_Q4@_=/T6KA%@H4PCEG^/=A*?\LC0K+-I@!94%>&$* M?RW+-+RSZN37A6O1%LLO1(U0^6O4&C"DH*D&3%Y>T$Y#15[0!*S^*@DPE45\ M1RRDX6>KUY '*5"A$J",! GX9?S4;5V 7U%A 7ZDPM_ KTQCP._A5UBT?I5% MZ__)*:/A1U+Q4[?AMPA8)'^P><"LAOD[%""0O[\#R#^(GU"@A/QG%"PV-C"EA6I0Z6="H#RCBN8I^'55M%@,%1:QX&=BH$(["/.J M /&/"9!?I(I^8NJ_[8'2;QW$>?,^AU]YD3F _4P,E>7G]D#AMRCX@^5?>!!A M/^< C0"J+OHM(40H+29@H1#"X7]+"FGJ^/3/** = M!T7D7+2 ^ U97*24E!9%"S\+EV@4*'US5)&_+HN+U-)B&_TS'B#G*:#M@M*O M.^N+H@7$HO2;_(]RL@M3@W*+\HYSH.]SGC]/3AJ24'Y>0M^!9[*1L-_,1LY8 MC#FK#9/_=0?RG^4(%Z!7^67LBHLT]:)4AN+?2:7,85?^9>S*BTZF\D*71>5G M5N)[[+\NDC#YQ1$L;''T\BO,5_QU N!_4(Z+?+9?VOU?UPJP/R9R%KI+,.2O M;,&OF\AOX=I\^+2( *5?(>#7XV=J=+3(6UJT!;\DA/!?=QCE%\D ?)$0PF&_ M0L"O6V@X8I&; E^D@>"_)H2_C']Q#F'Q/0/X;.#R7[ -FV@_=ON/6X>9@.9W M,WW_\&X.C0(EY#_)]BY.\BSRI!%_)]\-^P?Y[C_<58(ODI"?G9#%B;Y_GF5: M2(#2S\SD;(KEMX-[Q%^;::IC_]<$*/XS_+#%62;%19'$K)WX_3/Z@YO3BVY$ M_]EP"ST#VJ"Y)]PU!9?*4EDJ2V6I+)6E\O]?^?8;.2P!=%Y\A+0TI]^Q;S?6 MU74$?1L#XRWZM)_VL1MMP1&(=,L P(- )E%_=+'=SEZ0Z05 ![ C , %!H M+T]32P,KVFM+]'4%J;_, !:4X=J9%W]4R1B9"PH"OU:6HSU)9 " F(-U! ;T M;,#Z(;".]R%[4N'4MVKP.+E3ZW34]VGPD$ "P?IJ:MUEIBY-ZS-3UZ;6,1X$ M#%BGTNR)\O58%T$3_' @77JFWYX/+ H M+P"@O;%#A(Q%NX)U>>H[/DA6%KI@71T F-E=OJL[?5!P#E(9 W9[[!G"X"0,YA %C]^AM,Y!H M<('[EOWRN_6LI,K+=S]ZQ&'1LE2&SI>?=O@;Y3M\LM3IYMDC./<()I5O:- ' MIY $O< S@16462S$OSWPQW1(6V"=L=1?36$%;4 IPQ%_9&-(([P9YOX MF\,6E1FY!LN*&U, CZ,LL.PE#P#M+0?H5[ !T)U7P1;(_+YM8;$!J"?/5J!C M1NYIY0X']P!'@)' &B N =' #2 1 M2 4R@!P@'W@(E !EP"N@!F@$W@)M0#?0#PP#XQ (A G" 5D!60,1@(A"I"!P MB#)$$Z(/V0*Q@-A!=D-<( 0(!;(70IY *2 .D M%=()^0(9HX/2L=/QT/'1B=')T2G3Z="9T%G1.="YT.VA\Z<[1'>:[@+==;I; M=-ET#^G*Z&KHWM)UTPU! 2@;="5T U0&J@S5A9I![:'.4!(T"'H"&@F]#DV% MYD%+H570M] >Z"@](_T*>D%Z&7HU>B-Z:WHT_1[Z(/I3])?H$^BSZ8OIJ^A; MZ?OIIQ@X&-8S2#&H,A@S;&=P8?!A.,(0R7"3(8OA,4,-0QO#,",CXTI&<48E M1B-&.T8WQ@#&4XQ7&-,8'S!6,+YG'&)B8EK#),6DP63&A&(B,QUANLATBZF0 MJ9*IC>DK,QNS #.S7F!-97W,VL0ZP,;&)L2FPK:-#<>V MC^T"VVVV)VRM;*/LW.R2[+KL.]DI[*?9X]D?L#>P#W!P<(AQ:'/8AE@4MBUJ6NZQNV=#R%RP_M3QI^=/E'[F9N,6X];DQW(>X M8[F+N-^O@*X07J&[ KWBX(H;*QZO:.-AY!'G,>9QXSG)D\+S@J>?EYM7@=>& MUY ]^U*Z$JQE<8K\2M#5V:LK%TYMHIOE6R.X1G^-^YJP-3EKWJRE7RNY=MM:G[57USY>V[..9YW:.O2Z M$^LRUKU>3[=>O+UP_Q\?,9\GGR7>0KXNOA7\FOS>_&?X[_/G^G MP H!30&LW&&V@;(C9\&+#N)"XD+70 :$T MH3?"K,+*PL["YX0?"?>+"(B8BNP5219Y+M%1T1$Q+&XO[BR>)-$AP26A)[)*Y+5&]DW*B\T7WCE8VO).DDD9*NDE&2+Z7H MI!2E<%)7I"JD&:15I G2UZ7K9-AE=&2\99)E6F57RFZ1/2";(_M)3D3.7BY, MKE1N2AXICY>_(=\(XX9MAAV Y<&^P"7A:'@4O!K!@3! !"/N(CXK2"E@%:XJ MU"-7($V11Y&/D).*2HHDQ53%3B41I=U*EY7JE'F4S95/*3]185#9I!*LDJ\R MJJJH2E;-4.U3DU%S5TM2^Z@NKHY5OZ'^7D-( Z41H_%64U!SM^8US;=:&[10 M6M>UWFD+:V.T;VIWZ&S4<=.YI?-ID_PFTJ:L32.ZJKJ!N@_TH'J&>B?T7NAS MZUOK7])O-A R<#%(-N@W1!H&&#XP8C R,0HSJC/F,T8;)QKW;U;:'+BYV(3= MQ-+DDLF[+9);2%OR3.E,-YN>-6W:*KJ5L#7'## S-CMK]L9 6>RU*+5<8>EHF60Y;+7)*M2JT5K"FF+]R(;+9J=-HLV(K9YMN.W; M[7+; [>7V:VUP]G=M6>RM[&_:3^T0W]'Q(ZVG70W1AMS#M.)U<"&8SN< M-9S#G3^Z:+B<=>ETU7*-=.W!Z>(NX3Z[&;E%NXVXF[G'NT_C;?%I'LP>NSUR M"=P$=T(QD9_H2ZSPE/(\XOEVC^J>B#W])!/232^(EX/773(/Z$R54R0HARFM MWIK>4=Y??6Q\,GV7^Q)\R_TD_8[[=?@;^,<%T >@ Q[MW;!W_][60)W F"!( MD%/0HV#AX$/!;?L,]R7L9]WOOO_Y ?D#X0<&#]H>S#O$=VC?H?>'#0\G'^$\ M0CI2=U3M:/0Q^F.X8R^.(XY?/#YU G/BV4GYDY$G)TZA3ST+@85<")D^[7SZ M1:ABZ-4SC&<(9VK#M,(2PI>'^X>_/VMZ-ON1BI$1I]G/4\Y M__;"E@MW+XI&].K\TPR7B4J9R9>D?T MSN6L%5DGLB'9?MG].:XY;^_:W:W(W9S[*$\M+^N>[+WX_ WY406\!:'W6>\? MNC]=Z%\X],#S0<]#EX?O'SD^:BS:7E1=O*WXQ6.3QT]*#$J*2G5*"Y]H/,E_ MJOHT]YGRLYPRQ;+LA7K%_4JMRH=5>E4E MU<;5935;:RIJK6OKZW;6O:W'U']LP#=\?NW]>KQQ7Q-#TXDWR]Y$-J]OOMZR ML27MK>+;@E:]UO)WEN\:WZ/?=W_P^C#1=JB=HSVR0Z C\2/\8WZG0>>KKAU= M;=V>W>,]1WJ7]U[^)/'I3I]V7WG_]OZVSZ3/TU].#:P9B!]4&'PT9#[4/.PQ M/#YRXNN:KPFCRJ.E8[9C'>,^$TP3%R8W3N9-F4PU37M,3W_WKCIM8.Y==9"_ M*'2S7PL*=&'YUA4TV']H_1N%]JXZ*".+*A2R_+MWU4$DIHLAH%L+,-)!O_-T MF)@9&>A9H*QT$( -!#-"O[VI#KQBH(_G(&;<0/3"B& &<:C Q?F9=FV:25*!+'*8L_^U4YAHKHQZ?UB"B36-0\K MD.*MEHH'/H=?U[/RTC=0,D1+6-O8KLUX5/GN"^8@^>PA;&QF4=7[COW#QTHVXF_$)B4EWLK)S[N;F M%3\N*7WR]%EU36U=?^CHXMIY),?;<= ST]/2,C@P=( M\G+Z#=P,,$9 :(7.-B8XBF=NW*&^Y"YBYBUW M$H:VSLKS+[K[]IX]H^VNOL_:Z:VSAZ_!:WK?DC>P:^5105S">1ND+ZGX3\+\9P!AXL&G2L'JP)#DS M0,D)+S$AYEM%^719ECOI)FP:D+1"#HA4I6=%; BY& JLZ,6FM@3ZDQL>?9D& MXBP,V[6O38RM(A4*>I6JF;S]GD@4RM MRW)%!2='>,9=Y/+''86Y\VX$B+M;5: 9C%K1T7+Y+2N/J$TZQQD_SC4O#74* MT-1K275UMMH7;)H4[.0V>>0*9D1BLGARI%T#_JG?OB=]K=6;)JFG\=7Z;K*< M:?IG2@)Q-7[#+@//>J73FBR&Q$U[GD=!I1[S6P9@O]QK%$<_JM$Q/+':WQ4C M8!X^^0PZ5*T\+)$YW/5R=T,F-.,TD0T>+^RL$9#1LHYV#Y;4N7$D?64X@##?[]E VY9L=;4#R M-$)7XZ*'+%YREI\^WB4L6'\B451:V=GZ$9_6?2P^V Y=)^2=OW^Y\@ MVRW')-P\HL+??MKT9-!K[@!1-A_6*^L!2J+FFLF"0_W*"O1G/$9BQJ,\@L;' M3;'W2?CE]@.[*J!1FV+0)HV!1+E7FP.L@X1JPY$K-VZ/Y3UAQ^=#>>3 MXWC3CH"-H2]V(^I?KW^Q GD\^4#AJO/%'SHC<_C"2VTM,@T55CSJE+8H>>RP M'1[./!+*;2@"5[!(M+'0H3<_(*_#K\>OL?<+85W@5%6P9DW>IN$1Q4IUB\=" MY\(W"CN%KC_V )XG+_GL :_@ :FJ^#QR:%K R*[NYLFZO)%"RJ>"OC7/&GOJQA./J M7S\[$XO@!\1?W]O!UEUULW+5^4G)L^-&/ +1FYJW?Y#UZ;#+Y]SV6DY)+(6K M:D<9/'$J2BA"IVOG/D9C:-)$S\L.IOYN)[_.X5H7/^]L U'*]FR#VL0;)2?" M'I4JHOTT91%\4QF5M]XU):!+TS6BA8AU"@C)!UHW:[32*4%%6S-\S@6]NSH^ M(';1QSW (5)X"VA.C6GF=.W]DQM.U84H#^T*O#CQ95QK8T=WHL77J?7S)OV:EPM +0&;;J M$A^EG-L;._E&/=KE)L&GY5-:O?F%7J'3E5J#<1_&XO=T6>E5M^I>32[-#+X@ M4+ZU?OQ8CE( 49J@&K-+O*CGTJ7 _2<57A99F'$^_]ZQ MOVDP$K]?*$K >!8-F,9-S!3N][[@3^]=O2>LQ5ZX^.;@Q6>%^E M2LD2/5)776JW3W_?42D5^2SGW@<2G M 18O17'\D6*+XIU),F\$,%5A^ [ZM7J/P'%?'V!=9' SVPABJG#[ MSH#WO90XGS*C(8)WF)QW*[W[U(?B)+4T01U#;>3.1]=DG$.X/9X$/BCP=/Q7 MJ8(EP!)@"? ?-:X5_ZN,*V/!P:8"8S V3V-/@K@^&9BV)70FXE MLB)@;^D"D[,:^]*V1BGOJ0A^L6JUA?% U6]MVJ_].X]M;DK'1^28FD MDB][=SJK36+C[&8BTY.:NM3(U/J[R+1#8O+QY'"[*?S3*VIDZORIU=Y4\[K4 M-L\'8])'$+M$]G3ECR-&V[V#+%^:5%]!9GKO94_C\3/MN_"L;V=$*)LU Z>( MT\;6,YQZI+41-%.Z#0>:TFUIJ6MU/^X3')>DK)C(>Z9I/O4IU>Q.E9):WXAM MN<06[S!#G,"8Q9= D[M#DD)NGC$OK3L;HLO7M>^H\W$DX=T.&UV&S4>IS_L>+>M-L-YD7X&Z%*?5J?D^9L M*1?-EJKGN"LDZ[Y[D[SK:4*0(.&2M6YG:Q) CY>K:FU_B#IG)*6E)AZ*_%, MV39;6_4L))([IRLKO)TROWH+2YTIN%_*YV 7W#E<_1PY#7QH\0FA/$GN MTIX*E+I]L"LM)FL:"#(Z.37X(/A\4MNP3+<4[0CD %/&CL_5)D71G@*<8O)1 MN7MVQ7U5+FQE4Q$F094,3!VODB-SUUU1>4:$GAN.*GB:K#M8 M^Z6<9QHP#MM\;4A:&RJROV:O-W'@Z%?B[:EWT1[.(Z%XS'5;ZZ-H#[>DG:Z) M.PZ=WOOB"WZG =S#+]%F#\$*]K[^YLLS?@?:CV"-F 9?QP^+I=7C:DV^G&\* M:-%$5\EV$STR]8P2[]VU"=3$S >GQ]?[ITZ53_GSQ9P;J!P2V-+S)GHFV=L. MO]<(*O\L3_-W!OQ7UP ?##5_;!/4:!?',53T)' 9O0!VZ_7@\W:Z MSQS?O'^V\I)SA\=8U^AAEM.5$KWH:6#S+K-$;_XX/;W3/"HTPWUHHJ0W5'W' M^8*12"4^\[053HKJ@V^"0Q0J@Y+LWC>$51AO6T-_0/+&N; B;HT3'BH[=JY=2>[)DAB!7S0(24W.>)W_NP4]W.A^\\>ESV/'G,JTS M3'&I[Y$I0_9@KO&@QZ+?\;)LTIX&4!N&DYY3' 1'ZX9=8I3$=TR:(>P-/XY- M \T\A1/C%U3VZE/$S'@C2FK,=,-*, F2 M*Y..;M#9L:5,!%$D*1UFLH[1 '+N &3$4"^,G00\>W" .4'P[0'UAP-\XOF9 M=YID1&\7'A<_0';]<%J?,]R@R[JB8K^-H85UQ'YV%OIE_LWQH[K3 "*?^)S_ M_M:D7OP57JZGJ7E%Q0UGIEB5QVW=MQV*,YT\$F3OVK5-$28 FP M!/@/ *:K_A^RZ;/Q<#5HPM]\;\*A?V+"%Y$GBLB@&X*:J:4$OIO8X=(KO[<8^WR9/U#BB[\!G0,SS)Y/'EX M+25\;^*(R$CIA3ME>3L:\9^I,;'=X-BQE,-%T,DUZHA="N]KO(>) S4]/?%7 MSR?D.3KW?+7;)?'E7CVVK6\RUHE,:ZMP0)^&P+G.!U)C2=&QT=B3. MH/"NGZ81'5=&O)U6V:U+;5J?1MND3.$#J>->_O74N[599M3T\GG4P+;E\:SK MAW;Q14T4!6&&7U[E>]H\7LI[^LHNL:(>7*?_.-]PI:.U=%DF^GKD=3@+O;7) M1N$C(@&\=E_BY>I?%>%/&4;5O)P@W)E(K-WZY?R;V/KFK97CMK*-IJ#]/H]* M$S"?T.T"0^*.,;=]_ !Y:[)4,AQI6?M!LLL]V0T#KZZI-9.QMM9+&;MQ]3KI M14^PZ''-ES76JS:S0CZH7O%H/?":-R=;/V39-FMM:^@KB#;3$VJ"V:R_^XSF MH*&M#?C57;5OC%(NX"\<#Z64@19][=";R>Z4@UMSH7T.RESQ._>/7%?U5-I9 MT)W\N;MYZ :G0CCT7MBJG;,+GQ/3VE'O9-MJ\$ M!BB" 42FD^5BCB/56ULN2A:^15>H#@=7#\S+FIS_OG)6]FAE-E'&S MP)Z]SQ5]/#H^IZZ\?B+O:M=3:0*[E^7+=1H:U@K/*LS8GK(G?+ZWT<3/Q>.N M?4'$.Z;3.@:6[5I/#)<9Z,2LX6/,+3T[2HP>W35^UN]^A5SVFQ*Q([X8OM20 M=N880P/(^S CWP_686L<= 1T!-I*!Z8!I[W#G6Z!-;K#ZP)R%/=:K;[:TOW$ M1;3?[^EUH6A/E-"52W;R#6;KSYH_>WP*GU'YI$^:O>_4^H:R5>J9=U?;I]%' MP+02IE:TI?@*[)1_V-V^JF_'"+K=[)[978[,G>YY]7UE3[,=EQ^/H7<[X 18 MY^54)\/W00^<%4HRXL4KU>^XM>-?I:26 $N )< _!!1.5_][33UCP=&F-\;5 M=Z(#&B:CTE6G& _''QU_DW?[[IJN6).6'AP<82BCRRT]D^KV'BB: MY\>/L=I'X^@.#GPT*[M\]H5ZJ]+^9_<[-]0Q 4SUMC@7K>C[R9 MQN"KG_M6A5HW-+2\=,_\2NZK=:$%-\$C9!1*'L1T/:\ M>_>%7J?3-5J5Y\]V.1Q]KF=P6<*KQMN;.+!L]'RCIJ^/W-X^:1M%BF\45[I+ M7'>33Z-QH%6F;/GI$_;'GH@LMY:^<7IU6(^=R[.]!6A=CB08/]&.B_H@EC;E M[/K$$?RP[MD[]QO*:JLVW]$4?>5>"H;F8Y$1YJ-3EZXQ"7(>?XZE.!LD^?<< M=C -]-@2(F.*Q7RIL;;:W))DW"5.37>7&P\')23DF9MS;=A?W49D7_DJI2!# M>D_"]:1]24S7Z/9QW:;L$PCH--*@1N.I#T>2*+N;"[R8FA.K8@K\/W 54#P# M_=OFFCS?>,T$\%!: $\J+""_1787^G>]H0;VMS5(U''[\SJ"_3L?N-<5=*<, M?2]*%811-CM7[Q)U@3K9K1GZ4U=%CC";C?.1@K.'B5FR#E,/I_CCTMQWWSI_ MWO")0>R M-G75=?+>CH2@Q<@)> M8EQ:)(1X+.CZ@:*E2SRN):6:TVZVV>-J=]>M(_D$.\VB/;W/\J3X3 MV^Y]^MT1N:IM6UZDK-]'G[#_7>*)SYL/O:L=S6C&KSO8.Q(K%8'JS[O*7B@\ M$:+SI+NML'D:P.:6U9MY$B;O=Q@E2C/M7)$@M*[,643?"Z)NHB6%A/;,+)?X.:6@(L 98 _PG =,V_QMXS%ARF!>XT\WY[;.KRHZK'DWUO M?+?0UVQ+F0;>\LIN=FV[X^ZD=Z;SU:=FP9T[!*'STAH M:1YJNO=T;\OS*M_U:5EO"!SV O$'[#9%=\(W6O/''0,PERB['*(G/FBNQ@MH M:#:^),HV/-5+O?V'*[@V/% MC[B7'-2PM74)UOCT_)E?IW]PG"+AU:'DQ_RV0QUFS"Y59XF^-=):D=N/.7<\JB2A[" M7C_FRPB.DQ.O5N.Z="Q$V;PCJ:NGKUUJ0"M[;_^GK:/-RJ?P79_7:Q9=.I\& MFP8\Q+MO1(U?Y..I67[&2"@59[P>)@SZ$K+;VAI95WML.S;@_\2]N]E(X P? M)EIRLG'R;!N'7#9I\DYE"M=Q[[6?A[B*->/BK#2OK@7-/+1"X59JRE-K,\>P M6TEIJ4EGRJSM=FQ;$,)+%T<[\>KK,^\#E"'[JUM .W_[ULJ$])(#)Y+H$OCW MZP,"N[N4-4>VGCO2?3YO$#3:]\9'=C!>H>7C!;;F'OQT@_PN!XS;4R\S5:7N M&JIYF.;0TI)7KT -]K=>YJB3#^R.AU M_81_CX!_UX.JU-WC-=08GS8$O$@! M+QS&ZVRZ;P>.)T.[P0%U\9 A]ZEQB?9^5;DQKP*U ML8BK$VEJ55DX3OX\KMFX\LS*(:T/?%NO-CQL[2%M]7V*"'IL#1WM^L@UC*T^ M^0?IK9@&IAP*-49&'J3VQ#7?W>-P5[60HL$ID)/W2?7,&8+'/9[2QY&/#1', MU\O?JX>_#$EPNM85?LEPNZ3H\.KV5+NL=H?\QJ?Z%R6=@EN)NATQ=^7'F9_P MH<6;HS]5E&GY$8G1Y_ONV/>MU&EKE#M1W?A"^Q9I&1*94A)A_,KFG+'UEC!Q M1YW3-WL#]S=K>-T)0"?G\''VU >\YS*[U-B0QZBI>@)W_+2;6P)_I66-Y>8, M2QN+\F3I%:4B\*0GIV)7I=U*S>[.E4Y;=B/]DKQ6UQ-AP5/+=%9WMT.OY$I= M+,AKO_?)N&.=8493=J?]QM8@R:(-YTZIDS;:"849&PMCR:+;N84"3%[M^%>I MLR7 $F )\)N Z=K_25_ Z.JCGJL%71XI82U\,07#\;OP/9O=GWP*[(@N\7<3Q7-1+O9-PKO&Q?7UQEU,3+DRGPA"Y82_;T M:$#DZ-$HI>W#FK;IT7ORS[\]TBQ^R69H@["-&Y=B' _FC&I=85O.A$3+-=7& MKU=KOR9F?-$8RFL=L#2\GR.)\7:T>E6=4N&V<6,2MWKS;N$#_*+QUXY7'SV2 M7CT>.QW_1)]YW3QN-L'OX3N&/[*8!]QK0'QPWD!*?Y1 M'+'F4=LW[VR!CR'H/%*ZE&$!1RW-^Q.[SHI/$5H4[AMB25\]IH'F=0=QP!C-M5/17PX>^-K1+F(HU[.(=@[ M678;-]\I3*B9DNW:[_@Q:9\O9Z:W5IY QOTF>]V LO'UMD&KZ8S3#&M-;WF> M'SIH<#C=D56YQOZPE2V$PR.0L#G5?R(":[,I+TE7QM3#0R_+FL*=TQ7I?[Q, M+7TBDSLPUJ!6-&?!4][C3-LA(WGD!*K)M2>_)>0>['-0 MYO#O:\[+<0"KV_E!@!4U*&>B)>2I%I=O053>SI4W^)%ZD7<7C-F#NII404LN MG)Q,*1>@=#X(5&T+]N]Z6Y->SA4/$_\JURO3'EV(/FSRGNU4A M]=)LO27@]_[FJGE$+]EO>KJ^FM>E=9]97GKZVMA:_&_BZ M_@JC.U-4Z39L?\,IZYV\7\M3I82W9%V8B%3-B[BT\=I5<6.G2$7)KH?GSNB, MA%0:?%;3EY!\9B1X8ID!L_"3@\64 ;]@5$!6BVDVP;R@X/F]?-I/S%2$G=+6 MQ0)//CY(E@*L#C G=):^437^GPX'E@!+@"7 /P0X3M?]#]AT\LXIO;TY7UL^ MZQ*"_>YK#T^][/8WQK4EE+S[DM6>1NFH7'?4(2MSC]2VB"=G#"+')57HHFNM MO'K>N[1-=@1'/7@MTXQNU[Z>-N:B8#WQI$MO>.0U<4]!35.P-XFQ8L_=NX)J MUSL/2/9_3A792*\96QSFWK8K*V:4. VP6CVK#5[Q.II=-06V3 I'9C31.ZO MQ=1[K;G5&$@\<3$Q1C!45,/ XK[G,^TH_E.LXY=R@QO(#DKKGVK&ECXZ"NW! M,2>.'M[VQ:MNLT;<5&^C4;Y,7;-#70D>=KOQJ=50%?)]@O<@^8#$1T/LPS7= M.[8.CLJT!(OEF! UQWH#.UZO>3N 7!]U7D:D/E^!PI'JYI"3@]/;WN.@MMS+ M]'3<$:F!ZU/M'FG8U]E&FE%N.48K7AH]'W?*2<40'P2U-"+=OX@ MD]2"SRF)8=^M?L@3=]/#J]+5,BRYK%>9EUI*JIA MJI#^TDQ]BX61\_&#I4+R'Y9I"X['2NRV/JS331+Q,JC8#!6F8U9G5A84UZ5JC]=M MA8*A=NT5U774J#WOT]1DS?[9J'OHB0 E?BMC]WG0$[C'U))WF_KXW1M-\^^"WL:G F4N MT/5(HKH>T#G7XS8U03!4\W"P^X+F$#5/($6E:%?R/9+--+"\R:ZKN\G&&6XM M&;Q6[):/MM8#.F!8ZCA9+_DCTU?59R'7N>)>IZ3<7?TN)%C^FD!'E5R.*NS/ MO>1L@RGC:>"YVN3RMO[@99JZ! T-V[LD*?VJJ&Z$M:M_RQY,%R%*2LG.W(.? M35CMK*&:O/W:>,EIX,/9S$J]^ZTDESIAXCW[H S69_N"76,_[Y]P4PXMUKHA MT71EJC\X-WKH74E'BYE[BE2!_BSR>6IQ):]?GJS@A.6M'ER*?8#KUG MTWQW_VW078U_@W)9 BP!E@#_R#K_-W_G;=WQI6[TQH3L5^>+[$3<< $C\;:K MA7:!2>V[:/]A1/7U+AX_:0?V1)-CWNMC7:1NGU30[J[2_-'OZR@Y=^(_"V>_-BU85JM57TM"[>#7JW5?&W,^!Z_+-C6\=%%IF;]#6Z/=6H-\ [/W M#"$TEI?HV:%L:U2TM>5!'CH;E"T MQPO]^S@?-?EIM!;Z['K?W)B)5$DJ)P0V1CTER#R,2$2A-0UAYR/=CE]M<@O? MY%&:Z]1M*,6?(1FLV[-FOS.DVSE#0-7=L[$=MK)Y^LT]=7 M@RVWJ53A]S=.F8R$'B2: $5G--+WT.W4<+9AIR?^8/LM M9?EQK0L);_UO\Q5$EQ+P^OPNJ^3"(S,T[$WS;V_)-S55/=GI^[JK:/+87<$S MAU[ESABH;IG!]64?QUZ&TAKH8;Y7',Q/ZW;S'-U MMP.[9YJM.E_-!/W\]T924ZCQN0WC%:^9F'\653F5*]#NNB#01?C 54CQ]-\? MF3+%=^)IW5F4;FC*+9$I!B3"U&L:$!E_+9O+&V@D<&THKN[K';FO% 0':&E#2'\9&_>! MAWW*N!"TV)+O^AVY@D"+ M'1BUOS2%RZ2OO,:ZO4>C,"0^/V"5V@YSPFC^7I8I';4KUM4)Z. O=Y&UVE.@ MP:Y0(S;:!YU<^VS?7O;@U0(/2H]-B&NQ]+:*CQR:+)\&$GUR-,<#=N!,K[8- M?(ROM$I;IQRKQ^,:+8#L@+O]Y8O F4WE\]"?1[O#)?Y/B60(L 98 OPCX MO_V[\6K_O+PM@3*F@8'6&KPMS4U@8OL N+$R@+F:Z-)6-]#Z MU?AS[->K;^H;#\1^2,-N\[OFD%M=<\<+_TSRXZ>5ZM, [H5(B0CVH/#E39B; M(8=O["<&DQSE JS+QYLOII[]&*-UPIP2-KGZ=DN?/^2+AO.J+"V2@)]&27\. M1Q>D[)[7JZ]USQZUGAM]C-D(4XCA5\DQ6&.KX=;]I6.T>>^[4%=S,FQW-%N:H_0;#6 MJ Z.%,VKJNMC54TDEQ_/2U"*:/.)M/7#A+TV%@F[^"'<4/7*F]3 M> $>/FP&SIKU^K[=D \:JOV:$UQ;#]9J!_;%0VF!:.<#_WEKY4^-6ZEWGJ]P M4.\D=R2%(;F2?,U@N0'RFO8K^WV2M;B7,11KG],J5G\UF6];40#1X'>-.^WZ M/E+6$7= 6;! YJQ]58'.+C,P]A/;7O,K$#]#5BHG49W M&J4>#&]3UZ7N'D\# ^[9Z'LW+=:E&MVBU(X0/--"X\=YS+PNZF1.DA] M)_CU\?1E&S!*ICTZ_VR*=H=]?,2&EDE/K"FBN@B=KP)5V_H<=GYS"FC)=:\_ MI-HK5V6Z!Y6B/N'2B&+*%=- QR/R->')8V=?1R%KR <['!NN'LJ/X:KV$KWL MHA#HV =0?QC'R50?=2N"B7;;GDR]A[#K,E/JKLF:'QONRS 5_$TFJ9 7N[\@ MZ_?6KMM@&%&,_4SQ>H5)]]M"V53S"K-GJ/I61I$Z]W43GO3;&"S[C65<>:HB M">@SC#;TR_1UF.B7MS._4S4-P+KD-ICF$& BPR/,%64\)_A5A"F2'S\^2(Y- ME'SVX C] >;_P]Z7QU/5M7_O;I5&*FDRG I))9$RA%.I3$E2AH0DR9QYMBM% M$D)1R*F0><@\GR3SE'D^)YD=,^<" MSO.Z/?:(.AU[Z%JH^*SMO>17'VY'\,D?VG%0&!WA)+W@C,,=*3YI'8%%;O:S M91NAK)[>)<&.%,.Z"^5M'NJ9#?47F[%5$3IHT8@"!NJP]UH,#(_O"=H-9$8E MVDGIO[=N/*>K])H X%;]UUV *X05P@KA_XV _O\5^K[_%&L::3*6D"SG2@A> MZ'1S2+=:G\*7)_8!W)F5:OLH[N[W$+Z0X(,%_K=XG@@[R+Q0EW*Y9F3HE'-# M,.F1BJAOL:J2,.4^_[@4L]PI5B'+[J;<\K29EA=$HC5E2]>7F0I,U/ZUHMQW M7C#Q/F@MT#N*[I5'(YS;YC^TS*/2TG3(^7OIGG&BR.TL#36&9_S@2+R!O\3K MK3G[OE]W=3T:)74B.::[I!I3/4',LY!XJ&J\N]XSPTE^CM>>OTN#IU9.:VA< MC^@VVR;LZ(+*)7I_[ QE,V?Q\6GE?G;FY-35>WPQ=B=8-T1D.BWH4"J*;KG6 M)<3[Y)\"3ZBF?T#5*K7DG\OZBMNS1DLJ8_I-G+>A(O$1MN1:2'!RM(5<1+=+ M>!:+TD#=],/#3;/!Z[:;C0OR7.3O-U.C.F7,1OFK2,PN_]AVF8)9VY*O$_& M&%;EQU"[-SFMY"?"0MF74! JBX>?\+ MSQ"WI2_@,)#VL_W,OJM%T20!6Z$??W!"# M90A=.@;O- ->=QKKW$K-JKA^S\QZ]],]M]"! ;POHU!3:_D@P)& -KO>W?85 M,6N+)(PB=KZ28@3*9<2#]>7O[[%^7,6EHMCS"]^7L00-L(5;>DL0@']QVM=) MJW6Z$*/RV>X2LC4M),=CB@@RMU 2V38YQ#^N7\\Y&GA&=:,'YUS+5M$7>-OT MP^>EA'A%(LO&H@7'7V;UF1 TGG +K-F%$*:=%7\HLFZUT=MR26LC09?'5=G= M(74[O%VR)H1%CW_NVQ2S-XZK:TEDZKK[=.@XLW_]C6V0E@AK!#^ M'PC_RU'R#98+NV>(?1I?:G.I0PL;NT^=2C(^$!,,-.ZD?$42_* MXW'+'.XA/=I$OWF\6_5T[+PIK4,GW!O1]FAT#!5T36M/ HQ#0>]'I>OWW M,)5>O:L']C,-1OMGYP='[*D)8[EU(LPTR>IXIBCOUOZ8V*K^0TP"?Y@Y'SL\ M<6\ >YM'1XRSUBIV>DK_$WG/V4-NZ\XC^*5MD9WU$_A,GY)N:D\W1>VAF=EZ MNAN]*]9^SM!3]!U74$!$9O0D&"1-G7&Q.SDWB>G O(E$L1Y7KV]8OS?J5-'_?XGI0,7)=2YX.RN=/R0(0V8< 7^7[;HA1 ;[5J M]COV\'IW2O 8VMK>\O.+N9(G,K-.ZJ%T\].GW"F=GQ(V>'Q!"#=\'W4O41[P M)A]Y]%2,Y2CO]9:3:GH7!3F=#H:0@@Q?L4:V3W')I6;UWC&/:D8QW5M J,S: M;;!1_]1U NMO@2P=D$8W2"DBIE)BR^3YW]DB# O7/)C#O:3",TR!#TW69DGZ MJG[X(DCTQ?$L&OK1W'0// -.3_?,U_STS+LS//.+J#QIAGO^';PU=!_\4CQ> MD3)!MRL"Y5I=H&L([WR-Q^A\!1_ M6E='5N-K!S+SO'.P=(IG6D\W:M\>#T(P/X7I?1EK>L2'+;],+G;+[2]V(U\7 M8_\8 LM??B 75+Y;5ODUSMOTN!CDD6)X>JMZH\B"Q=FC'U[?.]5GW%+C']K) MX;<.K7/BROLT\37?7N^/>Y3XM>Q3I$N'&7&\D$!NZ.Q0G[W N=O=8.&IQT-G M[\(Q@E&0VSR!--LU8>MS58SIQO%8[A/150_WYSWP7\_#^U!F-X^1-X[S&>O7 MKN]@E472@G=COD&^9"3?T)<[D60IPA_)FI=<;EODR:O.:LM:JWT!+>)?OE', MVZ]M6;^*Z1'=C2MYJ :,R&=O)71\[XW9> MCJS\/GQ'\:)LZ@#'*>USSY"RPJD\,CK]W$:#MU+T+:ZPT7P%KT@Z/SRO1WV? M71_7U,6:[Y7O/B9RPQK3_K6]$%END6!IJO)=SE!(G!M4X8QR>M":! HA>R]@ M!5S\YS^TSK=D3^OMR9*F>_&W21^='>_VY=$]\'QHYMA1AA?_F;MT_$T#LM/: MO6*Y?2%N(>WV/<]>(28>SOJ#"IDH$1QD>ZMU!)JSH EJS7Q#X?! MC:7OIM+7!(KM<33!'&D63TQ;U^UZ>4-3$BCFB<=(>^7,A)6#%H65A40+B[NX-E^&NGWJ4]YC%P+.>308G(Z/[ =&3K)F&S?$+N+9 M&;EC?J+;?^+-?@>?,1K%#-:WY! O_C'F)IZN=Z-MOUGJ+CFHX?\EOV%N@_5I M>H2:BN:F"5D+P]AT\=R"$R^N>"EUEXL:-0E*C0K&\5ZY5CXGM<7,+5-40?2. M&#MS%+%5G?PRLD-G0^13U^(9GJ\> 2WWQS>W^&-V*=ZHD\[P9GZ:_"K5^*ZI MJEQ$L+;VL/RAUCTO$K11^AO#'+)>E$% )Z[\'1^5H=5.O;$R_+@:P6O5=8B M!K@O1%9'R\LTS=WG7ES*H@_]^:*#@6$$^6$#T2 FAZ\MA 4!S3UVBU"]19&" M/6^ <";H.%;B^D[EIS,P [\VIZ8&X5TH>3W&+XELPDL==PS78+Q;[]$29JU MZ+;;):9XA'>-%^EUO,E@ 3T%R/2QY,$5EFJT0#)<"HL0G88AD/ >T7P5OP# M"NXK-VOZT:B;B[8/V26YY)= QV@L22QTL6)@LD?[+S_/!&;:#0A B@U]BAB- MZ9EOT,MQCG10./-DG%;P].T1%P^F3>7%X25RIXZH#EJY*QPHKRF5]0P.EM,T MX7HA6.N:;E[3Y?1@."CZH@I%<-AU3FPM0G\W4Z(>N87:X60Z*3@^.^;@+.B0 ML&5F/*349M.7#24"0/KU;N-KK\\K/@\Z%.)]AK3!3L_8[.@8KC:ZLU _9UCL MSA?L+F?7P>ZZOO!7)L-#>0J;IG*VG5%3.52IHJ$DDIAZ,5#V$.^3*N&'A+HA MRSR7PU\$CMQY%E,! 2^X&9%[TJ[%LZ@#LT+9!4UNE:Z]=PG:P3V'9:6.BB2* MK-L?/SPJ6[X_,/!"]?[C/'^<8S5VWO2/\*JN$%8(*X2_1=#[?P_65TTX+" \ M]_(:'G^U653TZNRU5O56%?83?'1L@.Q3E8_Q'_4&G;78")-^C^6H71H"(]4&;2 P)V@T_- M:[US#LDHVQON#%W3]49)6^YHU?MDOUZ>>D+FV):[F?>XGFM_GJZ:R'-$2U!4X> [5WMU*G"5:TG,'>1.6^$ M5?6R<;AAWKQU8F(W,[Q.7-<5,8A[&O$AV._FI?ACXFS8HRX:5>'H#T8^.'[$ M<)#J?62#_[<;_=MV>TW;-8"FM.&(>A>K7DR]$1EGI8B(+=JX/X%5/"GNFYSL MRR-IBEZ/"M6ZJF8J9JHF>=..2P7*EV+D;.)Z>G)Y(Q20:A-R;__P2/R@>) . M+E#STJ6;N;F7V;SO_8J-ZW&F&\"9&*V?%OBK?_&R_XO68L>O]$:.W3TWNE(^ MS7@D]E=&V\67/=+-QMJ=0IQ\N>EV&.L- P\A^8+@1XCS-PXYSI185]-B=VC[ M:JRS--\Q>NB>_B<("!J3WCJ[HW+'PBV#[6Q\%\UG9]6H.V;G1&6N#I-46]4T M&IM:&^JYE/EN"#>KJ;"9^-TUO#Q=X4M=)T9@,S2\E7A0COMMKD$P1OVAX:$* M^;W3JV_Z17M,O, 5_\#R_PM0X+]S6?P"8/QF:%@.^V==@@Y0R0EV/^TU#$,, M(Q @Y9Q>%LZ=F&HSMKDQ5%%1%#'JWNIY,!J!/R9!.)"J<])[-HX:D^C=_\H= M%9SD%;;6@-;1[C]PR>.Y6SS/.Y-LNK3VR_M!]X6\^:VU^+\&+O&D1?7TL=>! ]:!,T?ZW=M(4:'9A[Y'CD4H7+I9B:I^MB:?MGLZB^J;U:3(&"5 M% O+Y@M_N,W3AG> CD?5I?HJ/_+>P&:>9..1#2FY<_?@3,ZS+)'X#6,6:KN?QUS/V^0GD_4Z M5((>-KC_5]C@A#_;J_XU6@JKMYY=5[S::8NC7]$](;.4DUV5]N.?^1]^[^F4 M, A05.!\4JK#M6NMQH4U6II_1&TYS1-'PS5:_%/4K17""F&%\)\)_^-X?UO/ M,=U:7,2[SM=?7O HZ;Q/CU(7VT B@"*GW8Z^#V3M2VK M*:*(9M\E=XL2P M/U^:9/##: L?-3D%-4ZG[@K?9B]OX^FO%8M@A(9J]_))L4X+B:>J1@PPPI,Y M7O=0MTQK<7:N.Q"0I6?%;8NE2)=W^V1V)/FNS_:Y2'PFO>NA^;?8;TJ7/C6+ MGL8GZ%4+#:K.\@^^T;FA@^W6RGL3=D(N(BCAI,?)^E&*ZIB\BT2Z? MVZ9:!OH3X[4#AK*YAXIT^]VU!AXSFV2I'NP[3*QRSK27,'0P#66P>1^ M9;=9;"Q9$A"ZO\+MEX+K?VB_7YV7>P'PO]",C)"\G^Z.90U\2W./X MSLP-!767WK'VE0L:9-P$[U\!"(*/1<_Z, ($-T<(17>.)]5M.+^+\ODI!,B\ M7D5T]SWSFP-H^9L6G4;)B\A,CU\PS47,)B[!0S>?'M&X_,>E+0 !O/6#;V@^ M::\07N ^(G=$9EW;!V2TP^"=^ 8[ LBG2M;>>$K[LMFKZPM8:GG=V)K-2O,H M2N"]9BO^G!NO\4^Z",VHQ/=I;Q%[_,N8IV/GO;[OGO=RX ,+^">,J%;IN41L M9Y?B!*%"SR[=V\9EDVE8A>H%B]XSI.$U%OMT3$G3 3*]W-_\72_5W6]+[@U*\]B,D :G2%9SZ7&?BXGW%XW2[&P*8?6BK7: MT=J1\RBVJK]CO>K>=Y$O^(J?QXH1'-*L,0LU#@CEM"ZI,8$K:[::4BSN^M Z M'KOF<5HCL[IG)RY\L\0 MO9)E.NNS(#=],4JZ>91X,&I8>[C<]/&R+-0"=/O99#O(7N>P&II0/.\]D M;+V?(&! ^O!$RY"2FCYCUWX\5\N1M>_"*8X%Q"Q"J*/Y3"T%3<[JPXWOG..3 M8'HH/+-PV$IOKTE.J9R0H"#I;$C1!&SM[\ MGUE\+,DP _#TZ4X%ZI)3X4^2SU)>P,LBF1YRK^+WNF)=:9RV$]FS>@F M,PVZ MFF&>FW9TN)+/^GY+XB$^U2ZC4ZCFTP+FQSY/Z_^LWU0IAA;!" M^!O&_;^;"^!Z+?C9WWG@L+U>F6Z+HJC D^Y\QY7]?WH\-3] M#1"POE+*@)I$0WNW=7 T9FN0G9#;ROZ(UO1U8\H.0IJ=N.F]SHF[V:#L9=KS(V M3J*ME;^8#0%Z\A"@W87+%>J[(E.B-VMKS"IZ#LQ^XA_Z'"Q1F9H+3L29]RA8 M"U=J^E#S)&-YT90= KMYD6-L7=4N9AA;LMR%KY-=9CE";R% ?BME!HE2,"FX MI,&M@NTSC1VGQH@SZ^4S M1(N7?U'>_E4#UO'HS+_U]TPXRWG_OY0+?CC8)9=U_!?/@( LXFC3(O:0H>#3 MU6#Q[S-V.:Z/#ZAQ79YKR3C..]<4T\*%W,2Z1E-'2X5>"TXEJ]_W]EF_0ZS< M<5:K=P9/FEOG-92N6P##K9B?2' A>AX7WLTNVL#Y8L^^)"]E&?5')SK]4@7K MGCL)*Y#>&^ Y$5=25W'DJV>^>/?-$:%*LQIJ9B\R9QL+*>N\U"]Q@<8' >+? M2MJDUHU8CO.?YV+HU,:_[0Z.P?C'8$:IOOG7*I,6I10Z1Z?B$NC!C"T/?I-X M4G3(;>J]BPSUM^>--'*DF[J7Z%MX3YH[ED?"IV/^68)_-ADA6!B7IJPA+V-' M?3VL4!7@)B=,+\.'QJP"%XCO65@_JFCM86 2WM/S&?Q5-//XJV@V*G?I\*)8 MX";Y&W[@S_!'-#>LQAIF/W\#@DK:+7Q>+O7FU_C+1SR]@%P2$Q\?NKY+) MXDR_7A4U/?XZQF]-R[Z8>96.!MWQ0O,N/G3SQ+8UW(HB-6[LCJCL^[-[;6TE MPVZ7-B_TH N%V?T/D+JT7.]\^SP!O.-8__J+^@$Y+BTO[Y0^QSN^7'?$7'P> MOGU)0!3EBC5DYOLWW;N:$KO_$2+#RM(E:^3U)BO\?,7F$=:JO1R"WP M=QG/1DYT^X)7R.8E7Q+OW?;I>WC=R?&KJ/6#?L0[CTZ6^X7_I,MUA;!"6"'\ MU8CP=S,:7-M*F9:<)<]2BDYM%.+4=4Y.Q>@XM-M^?-S"'W,ON:)""3$WK7IG MU-"&]DZ;:FDME[D3K5!WKTQYS6>%W1#@-,T\?IMI',=3-!K6-H%R'!NO?(\M ML;$ AW:_D1N<.H@0D6QXCG RN)17](L%+O$-NB7< MA9_I67ZQ%O^\\6RZ#3ZCX3X$C(=U^8A63GU$H)1NH0N]R *:K(JA[G5>%HG4)(H3)= M"FQQDW0R<[>A;60WY$.W%DPAJ3:$F0F],E0J!"10I/>4U.JJE2XD@,_]9^9" M$D:I'4HVV[?;C2)%7P;$95-VI)X#VUDMD_#Y5KQND926X4YN@Z[;\QU!XVH0 M(-,6E7FGI]Y@PO3>PBYV][03O&4(4OC]=Q!P$X/1>@<^?D AG?"DU5F.#:C# M^"4('>X7"_OEGV8T%C/D2?[2]_^:M:?X7\$7%\%ZQ8OU M\F UFXOQOR)I1B#@!*QT1R>78NRZ^$^MO1)V(R/0V$/@[)YJ[7.U#JKNJ[U) M[\&2>VY\#Q0<3+)5=W7Y!\PA1_L:=/$9Q86:F8FOK%Y8]EK.1;;T.WH,BDA:$;#*'KKY:+1=JO'O\I*0\R@^A1XKV?XS5O(W MN\GOL9)SWWZD(UXJ*C2Q&,>@&\[<]M:R,,&]R\"M<,Q:XIF;P$Y2HBF?51^) M:1T]V%$_,]HB87@]!/ O.'.377;ZH.>]J!O$++O.00#*_UP-XM8A.TFZK6-9 MYL,?C;_Z7)XSXDU^NF:6Q60L%BR@QT#0<9;]$B0W, :6_"QEO 1]FK2D)KWX MFUS*]C8RXDL'F5W8R]57[KX-MWD8^<]1^;QSU) M5SB+?+@O^$[Z-?7N.*Z0C]]?5DM\-C3TV5I@-35Z4G,D07GS ME?T/E5HOE3^8$""RF3<<.95HP$JR)#Q]B7P5"P$FD@-"1"^RZ5Q^%)5@^;B"=:7B0<$&);IV-.<1UW?DV8JT %^^4*]*LN'))^ M,],R.3%Q,ZTP:;5-F0I)QT!C_+J?9T2W);)E NQP>-^ICB%TA$/ 9\JU;:QU M(B6SN,'Q27')\106NBO;SNZ'*_LW!AGSRW^LD>0\AG#'W6SZ75G\0"J0X=\' M%I5=5F?#FSR5YP/Q)7F!K/,>$]6\WK"\H3]R0\SA&&C (]0N/R*DU=IU(7G@ M+F^D#=Y9,JXOF]2@J,-,7DV8P70+O7%O:,B0*LXM+2WQO\!$V>^U,!><.-)Y M(;=\,'X?:42QZNZH)755\(ZG6-PP$N?BYK"#8H+D49F=,V45K4)F/4',1?GW MF]*X UO>J.7&31BC$+KH#LWX/;M52+BKL9$T)1F,]CS'=_A"U:B.U'0*LW25 MWRW3H$KQ1E:_XTB00;A&3OVA"TU'V$3U_6-YMLX1O.X-2GN9'A0[G/-62$>&Y_&!%TF'+[$CLM^[ MZQ/5NB(NWU4+=4A0SNE>*^SC';BM]^"N6.NHD2.9<['#VHAJQ((G!&!VN3Z# M@ ;M/)"$ZG# #P6AAX?,(4!"@T)E]L(@VK$DTY-H\A$OVD,<>M[,?Q#F8XX& M,\FT*KW0<#;O$%DL-SL M)@@H$%Z 1[[/MH4 /+(0U)4X1?.SAX#9EV!]D\ZN0X2-!BI:YIVT=) M0[[2H_:&5-13V?,C(2".VD::KL3.V63#FGL"S3T?'^O'H),I* B0.PPN5*&'1DLF=XZI4$_DZU\'@C%T% M>"1ED!U>O^&,$+Q^B^'%]>?/@%3.) A@;$ ,,^9XN[^,12?ZQ\P,X9FED$N0 MBS.C.A)3<&A^^(U56)IUR@(IAUQ&WCI4VZ6Q]))J&H?0PB/XN^RF/(5[Z>0A M<>5Y$*"S($OS4_^Y81QC2)28N=Z/#4M'OE*A]L94H.D;1BMP(>*[7B"'!Y:6 M?L.MCPI_Z0]H$PA(JP"'C^:R#KRF?$9.;I8Y#PXG]R#P?3U@[GRL?*2;Z M$W;20JD)2U^Q'QEL.0N+6 6B"_#ZW^?;@FW^\,*MO7XM/,&_P"L5/=\)JIH]V$ *(G>C]Z3L/"GS0]";99J,YV+WM+2"HXUVZ.7'P+O'3T M*S%J;TH%BLK>]6/IX+*E]U,?PDLO,8:7W@XOW1/S;EZ(4FS_TE0_'T_KI1$I,^33+X05_Q=T/IKP&A:C?(< 5 MWED,@JHPYD.JK4;/O&&F#*C,XKE87=S>PO-!F<'SZ0))K,GPTO/T<0&2.(RT;@##!8(_CW M$=.%',O"TCQPS^?/S[+1IL%"")C3F( 6A1\"(6.0D"5+6+V);*^I;R05@\! M32J9\+/-T50S>(0U;4P%/[<,:;PQ\.!I(XV M<"R0\AE>]*U)/>H.#L:BR:3*:@B8"5M<]<=)5+HLS?X-?('"AQYG= /=<6#! M _[:I1@TZ8@8N'@\_$,@8.#DTOG JMR1HXR?TJ.&P#^LUKI<5OCZH,\K_]>\ M[&@?9Y;-2UR:0#"@A28E++U$!YZ>\BP3;=JG$/RQ^$D<-]Q;(!6LNPK_5.&K M1T\/OLI&XN&;C;'Z]GD5^@A_^HB)2<9N+0Z ?]SGZ"-@#4P8 I356^ ;MQ4^ M$.GO3\PBX_)-8WC:-2V:<6Z3;6H3_/6WIT7)]>:&6?VOY:W^" U^;[*ZJG3K MRULF;].V%P5^)N00#@QTX39_JN9[5GE,>>_PS>:D2W>5#U]*8V['6/5/V)J7 M$5\X*.G4FC]2V)<5(?'HCK+9NQJS3J5UE4!CAFAOPW;F]M WMP_^IXC ?]E8 M4L,S1C[]5NE6+<%SA&PYWETWE'S1?MJV@,!/MSN M]]GTQU\;^K&W[8./O@9+P,2I3,\&,XOL]:M-!T;+&^2VN==G?+6U.,E_13\K MQ6M?T/2=XPG1K4X\A9LW>:!F=O%RIB(5HO;DK#EK+?U<1T]!6O64Q@(JF])S MMKNT?B>Y+D%;L=C"ZK1+-WC1GX?"PWTN^^R\3#5I+5.;.[Z51(>./HOY[Q8:' M&QQZ0"UZX@4_J\M(X4NVU0B9K2M4W7MK>(SO!^O:I6\U#>Z.'= M2@VY*[NU%%9OD>.>_OHP*F'#UK:Z%Q^55B>MKE+]^M+PYAGUM8^V6*\3W]O/ MG>[2IHS_ITG)*X05P@KAE\[X=]/GZ&Q9M_?^F1U[9]8A+\O!%U*1,6H?"9\7 MA#Z5DO!,=SNNKG5L\^M+;XW5([O"XA/898^ X]MDMTD9S40AG)K2,)NKC3*[ MU[K>-0!KG[.1U^-R;KPN9+DUP)7BGN2>UH@Q(%1N.\4TN_JYN\%;EXZ0LW\J M2[((0AY<:ORL:O9MJ9Y9_U(0TZ] Y)^>Q"H:KNE^6U(K$=7;_#']:K!=% MX"L$H''?66E[W$HA(-^W<,*5H$60)WD6->I M<^) N*^K40 AM0)IOHZDM)?V^)K7WJQ1FK@+SX1EOPQVUG;=(+=S6J?=]?8K M+@\\(KX@&WF\$9]CQO=^"[O!S;0U^R!/N7[LN_?12MMX=@8:"QJ<.%=K'U _ M$!XT3P*DGRL="3J9NUGEQ62#R&H&XF)-^Y?AWL$ MNJ+-P=993#XN07Q.<]*#^&@[U[N!6T6KTK6D ;06##;7?^ M;T>5K!!6""N$?Q]T]3]) ]/JB:YS26'6 X]-X!P%:F7$W-7&DDO*XK2=+GWK MF+/MJ+KO[J5[/61O&P+'\5REH(!01,0Y'6UF4W]48$1-^*@W7ZR;5T\TQ/A- MC@VV)G=&?*VWP JQ& G[5QWPCT]C[G[03&']4SKF70(8'&/AH >=;![U:0*^64V!$2' M483Q=2BT?C*N&IQ5G*4A+5NK:+TLJ1S_A,^3R0(!CT^!Y?AI)@C8+-,'S[T, M0Y0A"]*^3R!&OD/ ZC?V*N0$?_+;(>3"DMEW9/[Z[?IEAD/F/+>11[M9RUO]C=7XKV7G+N9 M62$E^[!@6G>/GCS/&=P7U&GQCPN RH5Z_;D)?@M':RTLBY%HWNUSMP6?O7UN MO6FK/-*NF*2PM^]A;)0)KYBV1VW'3A,(.$ZS>%>G/Y3?TW0MN4=SKSC_=,Y" MP)0'Y9![Z]ZF=ZD(PS>K'M CJ.?H&*AZ1OKX'BJ]ODO^(D+;YJ?/5'RS M/Q$+#J?TMY'$J]6I12V34O*=8X%5!A^\7/1=Q M<6QKO8M1ZSA"_6&*F1V8(6ZUH.]?Z?P91.MEH=N0=\$D>^'1PH%*F;>7K_E& MY1GDJP[O"+@A/*/)L1MGAKZ'NJ'\WSX;*X05P@KAWQ+0_Z/,)*U1R*E(]P(S M2QN*[?C=WC^D>UO#(O551 Y^C,7UU.7./QH ,RISY<]V/W_$PO;,GW"6^*5S M,NL[F/:2%P+"O6-H'\'X0MOC$_H%\]V9!6.K!SL'!3XMW#C?&^J:8(XZZ^YF MZLF:6^"7KJJ]A"!=J@D)3]ML#R.$0V,QYN8,'?0YMPCZM%M>%^NWW-LMQ4M1 M.ZTMB*EPR_E9&74(Z*UO1I/CZ\GE$.",[DY"4X]@>_V3[:@DL#_N)V^KEOE& M2^7_)WR@S$UTWH8B4EU/PWJG4@X$$*VR"^LQU6!.OA?)$5W,K_.:F_?&[OD/W"X=Q&O[J_$K(<:O!EU%<[AE=]34WM%TAONB MS/J,G/A@Y$S>,"VKO E-D(< !V1,6*S+UK$\6$D[Y-V-B9 =AP"Q,RPWA[0W MAV:USD5\,Y"7C@4_E-23>&3R'.1N%:6QT3W>V"Q7SK1M;H5/@M49U./(^HF:: M-WP. L8CGC,"D-0W,^#%DAR_:98,5#(]P]FG)8#.",[2:*9+&^G1/;^AX^/K M\=R0LJ'4W#WV#:IG@K^H?Y#ETF9RYQ:(5-@. 9>E,X\HB"IO>A__+8[[[=.M M"WZ!$RYV?OBL&V;D\%O:ICE1GII=AZ:K'O/*SAC>8JW %]:?MA_D+Y+42\IW MV=RKJ(//M.IP#M7<'2%UQ_AJ@X740?O< U[[V*]Q<(2]JLPEDE M/.:.N9SYNO.?[SJ=A6$A!?A-J._@H!*98V.]/:BEA%5&Y?XK_?1!41"8" MW4*M6M3Z;-1[(LOL79MSA>G6S(G/*SF$J&K&SDV7$4[2;8JK?D]ZS4@LC6=D M3V 4B?+X#^DE7E+;&%$;7(&!]*7*R9D$; KR05R!@(@$YB2C$08!U M%@3,I8.>,KE8XM")'@D;FK$N6#Y.ZC#MYFI=\T_PU;2^ Z=B/&@0@'Z"F#=V M0- F3A)S(:!#C[CS'@2H[)SGQ7U$]]PV3IT-HCL>GH\YM.?!^!\&8U\#PG-[X MJ>>1H_*$;K^ H[F;@9&P?)SVNCVC,V\U=L".J7/,G!&OTQ1X5% MQ<91I$/U@_SPZ3:?=V!L>IX3/9H(I82GFHC0#HFE.\OF-!3-V?22I]@Q.?M.([8MGSP MC-MZA@_';S!'9"-[9]T-YFH5]J**D<\KHFJN@IE?[+BB(:_)PN^EEYU0GW_TG')<5P@IAA? 7 OBW$U4P MF)P[>(([WZ*.I@?R3VU5>_HT'*F;?5--RTZ)S<[S3E#J*.]]JNPNX:!]397J MAB1A[C)W#(;*+#$^RW:ZT=&(9A'W##S)I111,LEC0+0QR#3P/5['HO&-4.OCAL)-=EG40OM#H*8]_P?-_I%R0Y* ; M/AGV3[INZ<$(=NQ,H+%Y00"W4=4D18(4! %V6A#@2)TT6F;UA/G(ON21:M0/ MU3#B&R;UU#]!',E<#ZN&TF Y<0H"(&#ST26[YW/NJD7=$(1U0Q\:3HTV[%1- M\ZH\NK; MCA"N2ZTBB/+G'&3D?PNZ'8GUL?Z/+[#+O4\)Z0ITK1RYQ)HE*<2\:!&@ MFP*TET7-T+V.*8S$4UBTG077LH*8O_RWU8Y/5(P@!&5G!$AI440LN\!67:UFZ MHS,U/[3ZFTAJJ&L$JX">5Z5:&&8#Q5"[0?VLQ:JYBF<%_N4%Q*=7(_A"CU^[ MMPL1P(ZH3N[IO%'J8,[5O3;N4$(<7GW5 ZK7AZ]NV.C3C-"U98%LRPLLD>C7 M: X]^<^BFLC0,QCJA,RRW,!S=.6"P9X[T_\59R4OYZSU"#0_Y>4O!=*FFZ.5 M^9^@$;2^A8"IF'2Z!@DOX8<*6?" H,* RY30X3)(HG:HF=0 '2[CP(#+''.K M$\4EO/M]%U!^Y1H#"?O*^P3XDQ-CS; M$)O3TL[1I3V%X8)6MKT\NKRAJV@I^[Y$<.U)>MPHJHEE47-X8GVB[V+ K2W> MPLV^)*^>[,9WY0-@K9_* MS^\6/P5&TU;-SJ,;IX:+X^,/O3\4?^CQMLP0NLL0L3]PKXP,#PQ9*G$Q?'6Q"'0R:\J-0G+"K_K6;8P,&[_B.Q?K M6R>5HE^";A#P 0*\\^6X7B2Q:Z-C#2'@//F1PO[,B^T4/E'KL;&@,K<_86H> MY#8M8FJB;&COJ3%]B,EKHC.K[3ZCBY!96)S;Y#5\2[CS$8=B\N<-+%]G/NY4 M]?B<<(_7;7\H3["PXI4LV3&^UD/_*(EZA;!"6"'0"7\[?<%/PFPF[;:THW/V MD&653C3AL]_:\?'J_(,"+VWEUA[^R'OI\Y?2#32>ZS>BS@K3/F!F#0)20$=K M3ZS-==2:RZAP\ ,8N@??+G3'(:"(K/51;[3Y?)25,-[4N2L7*:VZAT+BQ92Z M*5 9*7&<_UWZ&'I5NSP\HZI=]O(RO,M* C#R_F?!]^^C;RCBH&LR RB*)%Y# M$?TC"!"0J^U TD*7(&[@R5.A$^'Y$"":@NPC4,T*)S;A5CO_MV49.N&RWKS: M" 2 V)))BF@^S+4=.!PP9USX&$":7@:09BU2W#':'A P[QR/I^]LKH,(GMDGU\\O:[1^TU)<_E]ZWJ?<7QA^Z_<'\OZ8%+(&=.;C"=NSZ?X9)UR2+G3*HY9OMW MRFS?=9[,G%+3C+INF\S<:?&T>.Z''0!I-U+5EJ+WJYKBGR4>6,8I-&US8-1C M_"V+(#UUT%],"S\C_T<[D4'U;O0(IR!P&"NH32!K% KSF*95"_D%>V&1UA!7H*5U4'.2LV0O4*I2!ESE'8Z]?J&PH\MLU_O]S M\=6=2)S."^<4"7N5V%AV ^.CKR9>.*^)TMCD&KRVS+E+MGM?&_L_XKBL$%8( M*X3EA+\=/_^3$,U/.;@QN:QQH=@'[2 RKI&FBU*G.32^9#=H@1S2,>--%:LN2(2H^8DQBM0Z:[ M_*28S07F]_)QXDA])UY*\:CO.%4&-:D[D)SFJ]<&3_02++!36Q[@EW*^_G:= M_9;\!%MH9T''$*;*T$/=\FP9;B(ZIS/7AX#UGR# 7V@ I'%2%2 @+Q$""ER( M^=2J+G1C+6T7:0B-=6VS'< N1#M! "(;!\O[]_0T!?X)4LCUA^!G%+J// ]? MV)XAUN!$GP6Y GD;W:U33I5"?@M*+@;M8%9G*]6WI-SEX]1##TD6/+XJ>E6T MJ?5:L[C?!N>[&.-H&^H+WU7\)-2PA,S03L/S1\KN.^-;)"SV93VIO5>\];P2 MVVF91F=1EXV1-Z.G!L1>*<8'?)"_9R7NK"D_ #ZI"5?$MO)*(EN./SR]+[]G MXS7!5*1/_B$E@WI]T9AYLXIX\'2.]:S[2;U>?YZ[& M7>_/^QV$_\3[SD1OW7H$8+H/I!(4390O.?L]>S:F4WE$64&"%R7B7$,76$S; MW/&,K'ZCGWXY?/]CVCXZZ$J#7CNP1]MK2=*Q7I)T]!BF5"PCD\^2IL=0^YI: M>^H'",D@<]XQ]G0#FWQ+8=]Z?6O1\0^1B."2U@^R'+\P-ZKC<;<4WM\U9-=8 M(X]??=F_QC;$NFLL^TU6GU%W))NVSGE>D;(.5LYXU:^4UYH>,]*6#Z8A(-M* M>K:QQ[1K7F_#EXL7YTQ M,ZU_=X"I@;3+[>WPYG_"^5PAK!!6"#\(?S^Z\"2;S*7H(+* GVLT>B087LBG\!QK\"=FTUXZ>-IM.F<9A)XF$+"% 0FS? H?3%"CYM3\\M3>9QO+K1[N5D<.K+]=?NQE-5. MQE8)ZG(OC3L_A"MJS+W> 0%Z1AQZ0I,N[?:=@K=SMC9I>$9GC-(3R;R+Z?C: M]L(M9ZC.3:&_O_;#D(WVE8=JEFSR/"(F![G#3]PUT? +&OG*#@$L090\].1Q M&20X_+D$;*#5@K&N0Q!PH=I_H:QG$_J;/;&>]EJGFE:)HO2XT+CX%^P@ '/' M%82 AL>>$!!))9.\ZL YLQP("#=O0W^S(S;17BLO]G> 'Q] R8. 21$:$@*& MBTO@430J578(23IY ZP[B0.G)%UP$'#QPP $W*ZG610R1N0C_S) :&D =DJ" M_'- (QB6 I9$0L#1>G(-VA\"2,?N0< <6 BJ2E33?$,0L[YY6 J++AELXL\% M.XY#0!BL\OSYX%$NN2;X/=_7P M6ERQ=QURSOS'BJV(?;37TO6TRML0(*8# 27OX0E-_FF$S\\1K1#PS9(XM#@D M"AZB"P%>YVDZ6.)KZ55P9V96") CM^%WAH/#7; 6+]Z5! &?L)/U5!%M%#6P M!#FMBTK[=DF)!4QB6VV@'1#0%,1FC47,4$2%#B7\B;I'=W!/]#;[UEO8D4R9TS4[ P6C&,H.[:!9*0 M&'1L-RS.7>BBGS@7VMH4$!P)Z(: L6"56;O)>5NA 5C.<_+_BB0=.T;_NFA0 M=0%-\TV' ,;W$B53X>_E!Y_9VVD@X_M^!4/\J8/(,^#PIZ7O*S<(GPTQE1^; MV3"Y %O9&TA($T+6=N&[OV*# GY=R/JZ=N#PL+-VV(J/_?S :4 /2F M]]IEVPDNE#EC*9L@P)'U9W<7&B<$+,!2-L; =N?/'7*WA'<(GL'L,_SD_.ZB M*>15I2R^P&_YA';1IL"Y\HF?$R(N M.,/SN36'H'G-,SY9'&5LI(U^+C,]_2W-VFIXD#&C1]S%5TWY;IFL=PP8Q?^U/LL/5IJ?-M&IK>C MAISD4+>XSFSSIXWS%O9I7QI%SS,)[(GESEC8\)1::%L^L;XBXAM9K1J^5<<_ MZK97.YSP?BAQTU;D25\NR]6 T_$ZLHB1#4PMY\9*1]^\5NHKM=#)%C1[LBWE ML,;KLCVC0?A#G!6KK; CG/:ZJR3#6L;<;/!$0:VMMC<1&U&=U?3F]((,&8;6=X\&8DUI\V M0W\ M$^8#CIW*\"%!T1Z,GIWHB6]MRLTBZXW$'/=#3EYQ>9>-FN<@(&;M]#,M(GT3 MT;.^\!?ACCHZV.5K+D'A89IK>OE6++NU-:CG(AO(Y%X"7PWV$TIE&+V%,NP@ M3G)HRIQDHQF,;KITX1D$%"+S7AG2V,BLZB2.WK+=2 P'I<=HMZN2>WB$= Z: M/:/<'U?BDN+%/X5J=V[(R..\!1*#:!;IR66ZF16:^P/R!MD<.OA>\,W6$Y M=>:V9%U\*VD,X3[ZC<300366)2!G0':60/Z+\1]+&4*;[I,8J(_\18#K(J*E M8^,"MP-V6C"[ ^0\?BTTGC @/U;KOSU9JX[UL*BF;Y^_EVI:J?+UNR8!V[?I MIME+L5H)Y73=\=;OB=P%-H$95]]1RM[1FNVJ$9/,A+X1!YV8GE/KAD.4YG;> MWN3XT3.XI3Y!8:?O;M[>F\]8I/7:-[?S:7L<1 MQ0S,E/,O/_ I?M-#!K>*K#EYJ^'V(1Y]R]IR6$H,5)B1[?L2)"WEAF^<4=EU M0)XMP_Z4\JXK[#YEF9V/O8%N6*0<,?88\\OOGN#ITB8:3NS>TZG&G'?/RJN5)NMI4,)H^,C M;3K>"KNN-#H[;!@S>_01 E38=UA_T$".LJ-;B7QD)9:>$ =JVT1M=/X>P3&Q'?T04(O>+371;_AE-9C/_)9_F:&TM!2GP'-/ M*DE*A(4>L1CJ G@8 J:&1U6HS4/4OGJ8S4^H]] "+:?*VY#NY OY*"&P]G#] M/!6M+>SR,*_8[S\;2IO2:>RP#(YP^%Q/$3L%ZV?V+FH8!90Z64PWH3W2N2Z]!?]!2QS9>@!4P,[>OL7,X_%C^5POM;D4,>7? M+HG]VAYQK SL%%K(J\L/NIJTV)6==A./J:>"I(2HQW>OHN'Y\^:W@'_0BMO0MN/\OHG\-/,8*E/S8XQV M+GAIM-NGEBI1\VJ(-"V4QV$*?M,C!M LDL@AAE)FWY"S)D@2I(GB=;;CA[8P+I0BJ RM=IA\UO P2/=_%370AOP M:YU;6^X7J3 M/(FX#HZ97@V;@5>! /?-+T&?F/SA/NA/DEB\7HAXF#P$&)&E+393@I$A2 N\ M5BDE9V%?6/>\X%#X)PTU.W_5>M%7H\]V='?;'@A-L+$_<2A>(BDA!IPY(E5P MY1U;BQ!FU_?(!](E@]4;>[1W?(UO2&#=IGO"$+G)Z"OW$9FC3%G1.=Y$/+G1 M6D,\$5/EHF5I::5O*7*"U@]8B4[)1#^LC)=[S.'?DGNCYE/Y^JD34N3=+MYY M _7_*_9Q!*4% AX_=# J189 #]-I)>V'7]GZ@L%G"QJ':FQP%7:UXV7]HOQ ML>I87N^)4PI++FO\;NBWWB3PA3*O<$75LU+9+4)TFT,Y!)PI=IBD?J-K.L/# M&!3U#OUEZ&'QH[!25; 6EN^I7!Q-$)#(N"*HS&NP:.+]'OA:B(QT!O%A]-E! MP-MO^43:%$<,K)S96JK0TNDW"':.XT#P>3F+) MGRQ0L)K54(@DU=*O'/#K/1TRK#-MAM]$DA2#'Z3%6"^)92,:G%R5!\(*S84Y M",")T2^IE3G_FO/H* 0$:% .IJ2#86U5157SN$)WD;%+P65F2/^PH+PXXLFV ML_LVB.UO9V2)1,HZBE/W)2Y6:1"4_30.WEKN3RBMB;Y3XP@ MZ1@ZS(ARR#(;#&ZKQ\S,&V46\=B5W_U&\D,E&+W'2M!JN\D.@J'2CYOF66KC MKB?*G-JMNDG/_*CA"$_#<5/YE[4^6Z3;\I)9_P<;TE(! 3PI\ZH0G>ILRI8MN=/)8;MVBID]=V^/UH;X\91">TR+U_H#8H?]HWUOO3Z> M=K%I_<;#Y^*W>_*ZI-AEZ?TON@[C7]-LP1H/6_#0Y./=K"_S91.FN I?O1^C M>J3N-)I0+@GHVE4ID/WBI;&,_("P+?Z*E\>XYQ.*NOF%?FWZCQ76KOX7CLI7 M[9CL4CDC.WYUPC5=&4YE#7V[N@HLNWB>$^8#BD,U_V3M46>84VE7=OPGK%@0VR(B! 5$"F"2%,08@61)M)%B J*@'1"A]@0!>E-0$!% M>@Z,XSHQWF>>>^WB^XSV>'_S8A9UUM;7.\UKK M6DL![C(JIX>\;N]^/R[D?ER.J;"XHW[JJWLUSU//A?O $* @._Y*>]N(3. MEGR)Q11UW'B,J)[1A]OGI*3!W"SU_ID?;BV&-.,JP$\N<13HY52VWA,7,^2YEIUIO MZ# .2;S:_EG.=/%MRY9@XL(Q_LS,Z#<,/0\](X5=TOQC>2+Q4Y+ M/0UC!Q.#NPY/FGX8XL^^Z,IWZ6+ZL_<10! K 1K'.)G_QU4A4H FRE7R.1#+ M0'@:7I:2?JF,D\M['-YR$VA "XF<'H[A"A!1P( ?W2;-!&BB6F**!=?Q;E;(L"L!?M^"@H\ 6[V7U80*;D62_X*.HUT1O!&_A MW1M8>R>>.;QHI?BOGK=^*3K4A3FS;FI/(A.HP(.]D;YY4H.LVS%W:ZKX=G\/ M/;&GC$/J^KG-W9YZNSL\?$C.#UB*R@,5Z"C9+9;XFEE:M+6\DK-F(OKBHN6 M[X,TSM&%_I]3IO:'N".H 1-YW"QZ!%&3'? %^]!3IT0\EF6.K7C9D+LXC[NX M-+>-ZOL@70[&GYLR7U"T[*$:7"YUU5%8Z:DX^8UO9$_2D"D3A\7]"F3B+)W]Z^5NR'?SF^@]+V.'==/C2=9B M'('&6+G)EA<(T#@]^9]A*,[PC^]+SEJNL$,JNNN]O2UHGR MJ89D[V38-"UKL$>K1;,EF:J=?QCJGT*4&'; $%Z;/N11? 3;&L6HH#PH&X^V MT%1NCKDSZ+84)ISQ5&I@*^U])A#L[8'3N/ M]FK5^^QQFTS\#.=Q6E0*%SQF6*G6V.?IK2AV^U9R?9LR>N9T9MUKJH6=.]#. MHE="TD[LB6_$4RI)S\.376A,@.BQECUC>;S$Y\BC<3?]Z^[WU(")*R)K'FZ> M6#QQ"Y;Y+ 0< 1WL%]A!KU-+%74"YJ1DNZ6KH;GF\3ER,FY$@:A _D2K*J/+ M^O&3GF W;/U1S7O[!^.,QMIO[>S@;NKF]C*O/LH=_*6TPF+/)D;HQG?M6A,% M#6^ZP4Y4ZDC#QH[-VT]$F<-6TO:'Z8A_SMM[D:=\JAYM>^.Z/OD"!VMW?)7@ MEK/C!XZ&H?=:0>OASCB"K!\_;X3?.-Y/J(4%POGM-@^I/BW%96@@IDL>ARYB MY"1:%EU.6IULH+CF(#>L(VR3Y@7_;XF<#ZX\3;+9%[: "H\\,JX'M6]N48Q= M7G$23XOC+5N>>W9_]]6 2U5;<3V[FGBNGE9Z6%W"B-6P,@.GQPO,8=31P(?8 M$T>QE1@!6O2D]:1XDZ@BUMK*OVZ=*!,H;SKQBX4S_(J9-\_ 1T$1X,2^JQPG MMYX&1[NIZM^?3!H,%"VZSN,8V6#.<$1]LX4)^I/)R^4$^R5IN=LW\W2.>U@/ MI+U[=RB0TS L(<#\6H!*Y^L+SP+?*4#6-/ _5Z6%'@Q%Q"?2-29PW#ICRM7> M78*U!7:PQ%UN+Q'SXD5/_K30Q5Z?6'LGGQN$DP%G-EWQC18T-<@MWE-_/E5H M$"&HGRZX)0[?BV#Y;X19"< 5,%9(CKE97=7IEZG;\<>1UW.<=*" C/9(]0C#2*F2HTF([O_!4)M\[)'\V M;V*N-ZIKW,RO\4*Q57CN_JR4#T?.N*5.2CSRW<@B+ B!FF,ZJ/>-J'!6!=/! M01"XQRR^.6BSK<>Q3*FEYI%I.\?T.?8R[ZU*YP/2]P)+L*0E%E $ [(.C8(- MSVY4G18V68BLZ2WS)JBVYC0/+@<6B1>KO\9UWO$^O7F]@)46<4]_E9DPS["O MZE;%0L/U_*?6@HA^-/[@\(HB9SG9RK+HQ M)+[-NQT5R 20:1;24VGQ$0$86===7A<#S9[GNU-+GV78/'D1X ("196,]?1T MS<_8;CJ.Q':2P%4LJ[NYU,D!7-*SNR[ )46@^8%"N#9V7 ^GNTTND:;C6#N< M&''TEC1&&9*!Q3K.6"#QJ%P>>LODXA"T);:X4MAT\;>MH,EO)X8S98M^C'\S MN@HS+@15Q\,^)E 5.5?!!+8&)*PD2^P[21U@C%CA)@ZM) .F$L&W^-6-H63 MJ%FJ5Z$):>WB Z-_;E"2$32ANTP 6SJ 8'#%@BBU5#Z5R >5JK!#:RQ\1MTW M+GE [TV*,9-B @U&6,8)U_:D:]1JXQ+U;_'7=M\S9_T^I.N'PKJ/?@N(_E[E[.X_KG+V]0+Z)QJ;'DO&72KNAR>K'UBI>K?_6T]> M^YIJ:J5\X$0I]U\5IZO*&8%]SK?:TYO35FHJQ<<4/7W:YD3BR) M<>PUZF/'0H/?1U7LL'&T;S@5M\_1%@Z?9P*!V3>^Q"_,Y=4F#\X=]B%[1/E\ M?.?4BM[-H,&]),KH9OD\]<:7ZTJX&QV\L3T!PORQSWU1/5["=K;)B_.[E-ZU MMQ#8ISGPP;%_6Z3,#L08*Q.P,6:8HLAO80(HTNQ-"+]=5?AO!+O:-I+/B]'? MXH>5&(=1H(V8.8W,!I]C8N/^^.:P(!/8%,4$T&.T)B:0PN:/H&VDPB#N2EG] M$NX9R00>,P%7%/&$%O3@/OP_:_EDE8(($Y"Q&368*1_?3R;,"Y=*._55 M[F$T7ALEB4]9YWAO\U=FTU_2=O78-]B.UPI[4._;J0CK M!I]NF#SFJ-6GJO?II]6""*@ G88\4H'\,3M1I0-MW9^2DMG"TU#I1WAL6#>@ MD\0@GQ::ARQ,PZ$BD^?WODKV&2159R87.7@C6HX,)!QY1N_BE?TWI 5E NNC_<%56=%.24-V?X,\:&6*HND;&!NX* M:#OTP&KOC',P@0UF3, /,7\"7!%,P =&#>R"Q@2'_FLV=.\2R1X)/X4<'29D M34]9Q;1QF^6/QQPH=OY$[]G3FU\XNZM__+'V\%R>$F>$V4$AEVUO\B_4[;HP M=RP5%$,)-VH &LPCW7)>=XAZ3$!$(?^!F]Z'Q>,4C!KIT4[^TP4[.AYW+,9? MRF\>%K;>HZP6U)/7E&%_*,IV4?RH"G?1 M^7,M0]=ZBZNX#._X^D69.QE__)BIL'.CNK5RT@>3B4&^D,O#H2 0UOIKG7M8 M.FNJ5X[#[H:,5W5/Z0,SZUZLX6Z57TJDL\QXT>C=;+RL-"GRT[Z#%RS,DU1B MCU4(Y=!@X+]9<=+>@BOD"K9>8/!ID7SH'#(%8^,XLB^L-;_F2_'N=Z1/''LR MMN,V]TA>JN]4WL4153G^HKI5M=SDRJ3I(ALX@PB,JZA/,?VP>?@'K1::,R'% MCCM_]_%A&9:JK,: P%O."JP'?!H04CR]$:ZI^8YA0VT*2M;M>BWG-CT9?J0X M&XB5548)!N;D'MP5Q8E*F;OCL9']++5930RVW08WB6NW0I277#4,;]O3F?37,, M2B[T,CH$_#("$KC"$FX=T=!;^QF>)@'.W9>XO].3>LY[W3-OG;7Y.P!@63);V[N?CZLL)^FUWCKJ)Q".H>N:843T>IC-EM9J6/! MB5F=2^7FMMTW#*NQI@7LGV6SKNA'@MK"Y$?O,T(92SZ'H@>CZ@-I!C0VQO)S M&T@I&/THCT4";0 5A:[;VDO1*V0"(55S_JGG* Y8.]MAA8L>CQ(S(@*Y9E'9 M]KN.#EM.I#IS2SKL4U<4L=*1]T*6F5,(&K]J\\[JUTJ(DEB6Y=CK^J M(&9_(^>)DE;TRSC9J==(3G.>!(.:QM<9(+G7WPUG[#I-\S;/:;+:XER?E?JR MVV9ODQ+Z^L160A6A[5[5TU/DH7R3UQ*?!OTA&]%J!&O+0Y=M,P-N$ZX#PL-V)FWNBGPB-6]P6$I3O M*.FQ60GD_2M)\U9N- 'W-ZS==GKMU6TN^Q] RA-$$=5>;ZT3B)_PDRTY9Z3O/BZ#:^![QN32.7.#%$^4*58A]AO*9%*G9 = L2I_2 MF)=W@H>1;' ]V87$:ZV]W:?%J:9/]!] )4,\U^ 0MV(WLJ=V(#3<)T8LAI&X MCKX2I'$L=Y)@7>))[V.AMSL@:&W=H 21L1:F;&\?)1OQ M?NQ*%G/7UE/Z#WQWD^./%;QSBQXL'_XI0_%8U^8>KQ8J5N"U2U+,JWDLW\^AON'UWX\I+GBUG< _;/< M[NWG2[DW8&BV--S9%AED7%O_66/K_8PC_QQ#^?\H0OM]X+G["(VN- M8,"G:WFN6T0MMQNJA7P8%9%._ONW7^NX)#YI"[\K M=)H#VD9OCZ_C9;#'S-L,2G8[9'H99SHW*#Q,<+OJ$>7?%'8%'EP*WU'X)+G< MZ:;QZQYC=C'QU[V"4FIGUWH?:]7<#,(TS&/L&GB47@5J5*/=+%_AT-*2@'N2 M]%Z),NFM:JC2WM3VMK8T#Q<"-2>]>WI\&L]W2>_V5%PC:@7C&$53]&".!L0\U M#3>'^LD+]V__AK8AK1\;C_C !$:D"B:ELVZXN&>/>#EL%5Y2JCJ2')645&WR M,L/'6,;1:;3?7XC#:J!O4#.UM;P&_-33"NXQJ$1Q'S3'OAX%'@4G]C[< M5" 5DK8?@9Q.Q_YGVLMQ$2US:+"SDR:-[SI!:V_KY7+F5W[630VUOFF9XTK; M;7S_NN;I\(I;XB'G-56TUOKFG3VY0S@!J'WG!VD&)&X$7-&;" 2%5S&6CAKS M>TTWEN:II&Z-2W M7D@!P'>RG]NQ_GY6"%)Y8E3OD*EB^?#+W+JW+A80FD$)YLZ[&\T(U>"0&0#*HOG,"H_ M;A_+>V/?7MC-.><1A;;L!RXWLP.-V$[>.F[I$H2ZIH*N/(F2E_>]L+-W\JR?X]4P?&C_;4-*9]$%G!Y3$ MUH'K)9B+3$!<=':*0"QR7E+D-M#%TQ.Q]GL.?6R64BP6;,8ZG2^:0PKO3-/@ MF)FI?1^R&W+;:('0]DY_3DS""-L<7[=[46NB7R;5#,R[ MJ&*O+[3#A1_7F5CJ#*0DI=Y7/A"W43/DW"W%=@40E/@3$#HXK)L&B<3 MB.@H3QE(OW_%W-AOL$/%Q'+'B:!*@DI0U?57*?=/L;W2OZFD59NS'QHXB_"9 MY,Q"TEPR*(3N*(;%XVSCR 1&Q"-QTN.3B>?"D)D]EQ]W>X'=@K19F5.?:&;Z M2+1B2H7I3 59ZJ;EWJ*CE%#5>=5;K@(DX\E^T!AHP5C%87SPB-T4HBH[[V=2 MX/M]A3+#,#V;+292//T?"9,BF3QRA;:MG;[N&NLD!@C/#Q[%;01[Y!0"XN4NL7W&UVF9[AVBF]AO)$7V M=1C3;?BOW+?XC @5K8^2)ZB!- MQ^DE@[+%;6&#PF"O?(V9_2.X+4#3#HV#%EALQ(?!S:W$!$J>,X&WSJ2JE9/P M:HP]R^\T,*E98W5,8/XB$8*YMZR3D(UD-X_>A7 MA'[J]^!]%>/+_@GP?]N$3W/L7RD-57:<+7MU\WPUPK,;>_O_H> M@;M2RZJDZ*L@+U<%,#ZRK$;@+\$RZ.5SZ-=G'T(4)'&("P_W2=W\' M[TLL(7A_U$K'[Q_!^[4DEAY82D?N';%E5X.;6K.NN\[ V4*/DHNV=D4,"> < MB"7.V>E+-IVEV%D0WQ_Y)_@>5:25=?%OQ?SY;KI9:XLCCUC67'%G*8^/8_O'YWZY M%O.2S\BY:^YH:;-;.#QZUC"Z:4.P9%^##7(Z>S/C;B E 3HR-PNN_9-&((%M M7P&>_W?_?_6^,6R.C0D\)-+N,32Q1]SAP_ [SCAUIR0<#L4M(Z/RN5]VGJOL M]OPN@Z=C-PEJL^N-LXQJE#1^2;H@33\GFC*R6,>YYL(-$.]TF_V)07C#![3@ M2R"/B(8O_C(+:J1[4D!S[8O+ M9P*D,2VHMR8X?\I]XN-IHB8,46P=C-$&XA(L22 =^KT7\:L+=BM#,WYI$3$" M#K3?P*P8$T 5;H8$L<[^F8PL=/ 7CV7G,8%9&%&,/B8$"3:C].,K=\QIZ? ! M&=Q!5#2N4M6G9CJ3LJZYUZ30CIY04I*GAL;.QHQFRQW2LK@^Z^J;$:V"OCV6 M3'75$MZAN!E?(O5N-[:$I L:IU-*$%M_6T4&AR1.M .J%_\U .]_[\$K'=1[ M/HSM0280[($AIU[JVG-/)Y#0)=5!#V_;NL.+;;@[LDX1LQ/3K5U:E)R8.M.1 MQ$I3$^_>*^D):6U;1;99[HP5=: MYXU.; Z(.S'FLSL.WVO5_>_3^0$"K05.&(/5FS$!#NP("&C6;AV D/2VU:FX ML!E45Q(@^%)/_1U?#1:/8/%+@#6L/Z5H\/;G8^=-<#S(UH+M; MQ>Q:7DR,PUC>COLF+RJNV>9JZ.A( !<_KE6MK*R -*>PASC8#<^8@"0N=('L MW]AMZ'[30P8_%6;;1B>ZC@BD3]4^=:R($J>?SF_//J!V.?G1JQ[D<5=@+1-( M9079(0@L]Z$&.&" [-(6)*IF*YFR;D[&3FM#@Y.WT=N M:/ZB[Y@MA#EIO4/\^O6/$%5+2R7KS?05G-2)W\&0T*FZQ2,;YS-9T_Q)LJA) M]'" $LLRJ!#'.?K@M2C*-9OQFWY.*#&8M^L)@58>C-C37GF_>E9$>M7S#S?V M9ZC0U9]4G:2?@J;.)@*6K*HQIT5(F1Q!^8"+[%FJGOY\F7*7)SJ/[Y4H7.=0 MSP,9Z?7]7P(/'2!8>FYDZ75/LZ+L!!5R,+FWZ$!&%CE]7J"HI.* N5E2-WTH M?RG0=D#@66_(?9'1>BZ%/-_-7T2:6SHNO'"+T()BO NJH#0%&Z\QK.&[S>>B MZ 6MAC8CQE65E"2K\ME(.[6WSCN:-Q? 0]-EV$4%'#4NU<+M]ZD?*MY^3U.8 M5:0/WVO95"H=,/7%,% L'_WI2X^AF+/5*BF:@-&3=?U@U( M;#^KI7:LQ\+W=KC/,'3(4OZ/LSU3CF*,DB%&XFH#WZ#*Z"PE3" 0^6BHIEE[ M"5W5,*1GJ-?6&ZZT[<*AM(C[TD>>-+S>M,,/'K!1:W=8P'4=I9&$2/![Z<2Y MMPR+^#W8:-(YY1XXS#ZU\MSF-2A:?VV3*1@ETM]X]T-PG:+ MKZ+35!5O/7TFS.M[ZAS[)9W+6N!LOXGYV8),8QL#39VU%^,&G)S![<,$BI2A MQWXR?WRQ;DN+EAK[^9-YY9IK7UI[A;OTC1-! MO\U[>CGJ/0.RA^JH 4FYEE_*4"%F[SES)$X96EEA&CM=:R\\X[2CT/-[2T/N M8_86E?/S(&=U4^!I)X;<@7<0Z@D%-?#U5CDF(-"+JU'A:N-\:MQ+$/%Q=6Y@ MNS*]I4=3P[O<9KFLMW7;G:E*8\Y4R^ )<_LC:O)GRMC//&N[=U^3"IK))CW& M;00O:D"/"=0VIDC'VWG.I^"7Z2.S\TEN$O9)[WK8GPT9//1S MK2M9#K1N->DX_$3[65>73K2XE-QYD2 U_H.-H,UM1NT7&UF7)WOQ%6(TM1LK M=(#2.9,!M-$,L*S22:#VJWVWK MI%B1@2]+WA2BE*6:I1MPW)MB_ZIJ')QYY 40^Z7VPN>3:YE IS 3R-=C6.0S M3-&T:;@&#=3:("2584 .E[^4._XW?_4)T(K+X?/]I^,#8C."?MD]BS_2F),< MQ?% LR,FUJ&) LZZVTDC>;N''^Z_*L )F_*>+LLB66?=".>CO5:#+_K1=?!R M7A-<6+^Z[L)*=:MIWN=L8;/C5;6%%*J7IZ4[*/[V:;NA=H0P$H>UG?@D[\16 MNL:XD%5V&M?2M^R*6$F?ZLA39C,!)3P:=L/3V%:"*8G)R[@.7(GGE;=09E*O M;WD#5VM+CS%V.C !'D0=C"8K"X5W@JUP(1 CJ>%HU&LH%_Q=G*>$46,D$Q@- MQ]&\<)E1]'?TZVS_O"O,&\"N2(03B60=)O (Y\X$IAO-J34VI4R ZE^"2D*# MF*/7<8A:QBK=9_'M%#$Q4^4>*8CN>'=E_^"FB7?O-BVBD^>L&6H5MUDSY[I'"MM9G(*5BF0MD]#KN"M;UK?I8]Y- M;3&Z /*1[(D8=M\H5'69E)0P"7-\O!]F6_9^V=]]ZWLFD!P><1/.$7R.=X8B MP>9WEY!J+>6YA*$JN2UCS>2?ER9&.LI%C&Q&%>_359&#$@,6T71=6QF8&X_) M>Z,]7Y>]][0W^^_DZGPB-O^(":"S4 E.?J'KGA*.K]/O@0 M$V"8@+#=C(9@ KWMU)5C= X;AD7 M!CVJU?OQ)9(+.88)F.;.@J*R,X$D+*G7!#(EU^3_)BEFO1E>3&")(C8* CB_ M7T"$W,L-G25(6S7M[83XFC M\$$\+9<)$!#S7$S WJT4VE78N&H]T F3OU&B3*TN3/ MI/R,ZH;/"U%!0KZ=,<<$^NR3(5:^%O5C0UKQC.V@&K(.ZL&2B[AK0,:JT B) MWO'O3]ETPQ'$G!O# "596&;6)29Y]]GDK:FX M0@_U6R\JQVKV(9$A'].6$VZ:Z8)?T=9XCIKQ?/'26Z_+H?/1)%KNI*WO&DG30CR)B!- 6*CLP'KY ,PPY_:: $DK#*-Q$ MB=&G2]E&L*>(F!?5[=JM+00:X\HCD:1W?67-SV'0>U'FKB0E=ZJCA M.W W]J"-!BCXD^P?FY-S8?_]TVNWG.ASMV0#U*/L8@E[&5 M"1SSIRKHF;;6!'3%&,[-BHY/6KH6BDDESW>M@JYIV]F/GWI'E:,72'H:&@SYGK>3] MPN-A[.N'IZ;\CTU;#_0-.+YM+"T5.\97TWJ>[\4G\9D&UK6B#4MO@@YLD.\H M@?]T??[I!A^T&18I\QX1'W-%+7.N<2C>R*GS(L>+#]93$0)D^$W"[3V1:VXO M>?5:J#+$S\;SGE4*NO!Z_\:$8.OD7O?,O4P@RH;&ZU#H-LA:W@6OT\J==$=; M7*[2"HD9RK8V/5HDVOOBWAHU_D,54\=#_%CB"ZH?!0JL%WUI#I5NO# M%N;#S3JMRGM:7Q\M"=(H(5T(_-;K2CO[G^LMBNP9G@R]D\NK7G&QG)@=>).TXZ:MMI-;U7O20(3AZ>_W'8Z?<)K11(L:?-$.)'BN>(:5YZB[OF MM(>=%+7(7DN=S;IU2D^F^G(::K@5*/@,_'[DS+"@GH[DU_#3(XZW6RY_A#9; M6N(Y&,J+8O6P0+KF'")!9I=[0KJ[W^TADE-[#=L^9%A3FT5R3;]$6+ %3_S_W*P820BEWCJ@<_K6K?U"*1Q\H0O0?C!" MP(:LI3=_SV94?.[=@I[*M$,0^=XL0B[JW9V2YS<-/&2LG3ZXS5!QZ"_O/'2T M-C>,5/VW@5SMD^?)BM,@CF0/JK>&M4F%S]_/. MBZ@W53_=<)./!VK^FP*&)CU78$Z.88KCA8?@:FAOJ(9#5=7%OX9%H*^OH MB =6M[K=C_7/&A[,M]6;>*Q]Z_9X2DZ#4\!ATFZAM*C=2G5:U7WXWCV@>;OL M_ $7"N.#?$'\L4V?Y=D[Z15H-\-AT.3WQ!9$XWM?1O:0^TK>F9&@4?,O4P,-( B8+&FWB=QE/&.3 M?8-=G-SQ);GH -E:E[3WC?Z-UX5&E*AWXD3S9#TB1',O%!B MU/ZM:(8)HF[-:'93M88YFT3+4@YWI2L*VR:J\?K$\VH><\]V!.F/]R;:RQXF4&\XS*&( MVJ_QT/4Q6N^&4Z"9E57GO(3;=:F;3E6:4V51>CS#+[M*2Y+\GYI>?R,ZW7-I M4GE_B,_.LSN5#0V.2$+[Y&N8 "O73!W#Q0"$#+WPF0[A2RP-/ MJ\6O+[0AU'P1XZ@.=+%/ISMN391 GLF3?CCQ0JT2S11K($_2Z?6/ESS0'^FT<_D5:KQLNF-&-P_3%Z>*SW2<^6W: +$.AS,;G M*@9#:O%=P&DU\*@4! M5XXDWC*;K(:EN2)$4#/CD_"5'%#9&-1J"JCVM?0%^'#B;V[N!IY^ZYS ?^'F M'@8'2PM5A9M)_M'+S02'[U>O M'2?1$"_+^C&STU59R!]-]' K^NU\VLHCZ/3@CY[JWR>.^BVEU'QL47=E'.L5K*WQ'V/\/VV:?ZF3>VDM%<-I+FH0X780+WR]@U&KC692^A M+YC3!! T6QF5#.?31-G8(X::CRH%EB*NI*:9P?#\?'=\&$F!YC!D(>+A;EHJ M S;OJ 8O,A31]S8-6_;>!+?<*99O)W1:1 MT4P 3ZY:[FO&3./&;[-T63*LGPB0A 9RS2W2YYV.T,+$R&Y7ATJTKEV:.#:4 M-J=>F#]\C/W0V/(;QUN[X/A=:+*[(C6\V_: 5SG#;4$-+C^_BVR@>X"^%C%3 MF$!;WEZXQ/)+@;U^#V8-BT_E\"Q[JZN(I^.>28V2Y,P7*5?2+GJG(,52^72N MJ7@JO7%0$1DW"?<3_G5#:N)6MM/T*KL>&7>#.VBN)_R^IJ9(T2Z#J^S7+S8_ MW'$6C6G&.[:WKC\5!8I:_3F8L MP)7TI*.PP+33LI MX=DJ@>8E!_X[52<&56@#6 (>5Q_(!#@>#!,9#!$L1!M\5D$?)7[&AXT,A;6" M'(H!,AP0RI*0&"A<<4'DO\9EH1MS(*OW5F4"W?.,VTR@E:4RF[&6'@BY;CQ6 MW[XB-._DP!%FL4<1^/!3@Z*GXU\(I_P4 !VW3)J@'T')FV%E361D& M>@3B!'/AOS/;?0J@X>X4\0"%_8B:R*:3]"%1]K#]35)X7$?%8^D8%99\M,@2]A2 M(ZT6 ZKO#ZBW6-+S5.A^.>S'%BS*,H&'5N!@OI818XBRV*.(;/G0&!7\#R8P MJYQ[DELD=ID)V"(U7)"%-82L@E[)RE#;.U[EW?JQ'85YP7<]+FO?R!=7V19] M2.&B:].YG.JUP;*RZ6R@U1!GV,!F@BYF8@-L8 MABBF=O%N@^P"XMI8XISNXXYG,UR^B6GZ+%2/Q'.9ZS:"$IPEM!0X*U3V1!%B MRIRFG6];TS,CLM]96V46STJ1N3^B'9ZE1234#.0_N_K:3KM91ZL^<-?"?&4> M[_V,%RM942I^;$H?D;$37%.;=F1TNJIYTPH5[(A10D[2NAY>G\D)?7+9!YO5 M\NQ#2S[WNPEXC5KJ1U1H%U^TR@R*)9X6#.3DW;M1$.X#+43Y_ZV X;:U*#AQ M3*(0&T:L//_JBX[^4U*]Z$+5J*T1RQNAC_(>7(H1&S[R.)>@'TD;G1JRS13* M4H@PY>4-%M=ZZ'8[?3@9"M]7+I-)(DQYXDKDUGA-JWZ:Z:-VV]XDZ8(B^1W0 MBFBT5JN)R_*(LSP15=,NH2*OIG,N3TTR3_S6+;XX:,T@=BE]^X]"C"V,]DB\PW\*X[=Q[> M^F4ERG.A@7$>-?/,.IML=#8?<]ECNMPJ"T=!)OG9$GARTJG<-6WP??@-5Z)9 M]+'VH;;375IFD4*,BYLVOMOS)L+")2\?A+)HW/],$Z?OI(2B#L=[PQO$LG%W M:,'XQ_NG]JF+OGJ0[4XT3=S-4K0\K=3!?](ELV$PV'*V3OA-R/5C,VV7Y"0N M[+_HOS,9'%G1^-%>VE.&$1,0]!]NZZ9R,R(4I*WWE0XMSP\7UGS0_?@F;Z?J M5"N734[NUI:Z0H?&/:V'A<8BXEXUH]@R,[H G/ MJ*@IT=8I>EU EQS,[-K^G#V["BA@LJ1#S%,;(?5GAV24FA=P_H6H^X4?DA ;DX"G3+A)ZIW0F.SRNF. MTF-)J3M<"MO7UHE(GF[CR7.*/W#2[N2$FAHXDUK_X5&,?]M#^-VW_P$U((#] MQ$8/%Z4R@4<,8F;+$I;'2W4ZS5763R8ZL\5_,CZH\[P?9V#ED^3]6H/H9Q<] M[N#M@V_NN*^C'Y*&<0"G5$O\_UQGMR?$SZ3AQE@8-9%5!V9\7CEK=-)B*&H% MEB_[BCVDS/S$6F$\>6*B7/*1!@.R$WFEJ4.I[P>C%(M2=_+K9JZ=;;K -7] M3S7MOTD05UZ] FO82='U,&-8QFZ116'LVER.=!2,9C4XXI!6MP59KB%WXS/N M'8S#LDJIA>1S&@[>/UFY(_$A>W 5U_K[>7$!>3&0I2TTJPXD:[+-&23ZI"F< MH5VK0]!Z[<=O!\%Z$;XQJ@7"QT\@U MW;?BULKFKW0UD--0,.HF.CE7F6-&=>R=V*BPW]3=M6)Y/GJ+K;F'SBV?A\UN M*FM00RQ/E03LDZ%U8Z%PY\WHR/GU( L:KTI/ER0C];N54=[S9=8XIJ0J"(A5!JA#UUVMT03?T.N:U\(53N!'2 M'&H-^_&X9+:.S"^2?;&7S_1>CWH])1MU'7X)9_,TBK58J/[M_=.<[N[N"_M& MKHM+L@H\0HU./JN:O]Z:,%6(I\;W/1V\4F&%KG-S^ EQWA4&P-VLZ&GWP MY:2H,N1A&2-/^""&WE+;5^:.9[#@BASGT$:H>R1,'*MQ*:G?O*UDQ)V*[FQK M2W%;X6N9"'06 [/8DM;[]:QBMC%H5[.)O;+9ZN!2.KE!W@K)!#86,H% X9'( M'X*4D:1&>MUJD#)(Y6AAA6R41.>5'>I]&AN5R@!1W@ : M!Z/F=WG-F4Q3&4/6\1.93*!RD1%JKQU5EY:YQ0J*AVZ MU]]2X>P!51%X^GG%6T&HC,M@/Q)XIYW,R_T\[S*!B-B=C8W[L.MW*(8M'X3- M% ;3EHV&,++#,)6;SD>XX2,@UVHP0$%]? DW3R8+-YUD M#!EF4Y_<:9AWVDR[:S.S4%KEN+L^L;FMP.!Y3&!K7MM9E5] (BEHH@=;E*0J M4@OJ//:+C2! "!7SRI7^KB\QY9[)8X^P7'K&!2;P=*&X:C'K0Z4YU2K;S[XP M7_<#17HMRE+W?*(,.%O,C9[QH;*=!\3_[>W%3*@O9\G81EN%_\967XFT4^ M&!+_;G7$(LL@+S+NFQ>YI$C>VH"6Z+[?"?9>%)T8?2NE!OE)RW$1HZ[HZ:8. M$^E\RK>?1UOI2;7)$+BB4HMR]F]Q&:N#OQY5?K9IX_UJN+@B/2/#;3 2QQ*! M2H^C6CL,-KBU;/BV8T=Z8)+6_%[W/XKI0')(4S@N W5 MC33/"_*+?HH<$\#Z07ERTP96EQ;&C':@ BI-,PK^/4)]9 +T7ALHA-9S\]_E M5OLY,_F_"-__IR)\/=6Q URHI0E6D-#YW>N)IU9,@?,<9-N>_\$<-FX%1]RCC^@'_6PT1U.+^22-CB45F5+0%/(;9S=[5/C.Z?7KMC M@\Q:V].P,] #S LF,!,)'T-JS;NGAO:3:C*[+!EZ"PIMOEZ8/L[E7E=K^L33 M@_R[D,CP M:L? ?":W&MD:B:N)+'Y<$V)V='!$"@43CSSY>)/#;:C/YVB/(4 M)/ D*+%(_[T>*)3GX.K17\P]U,PC%+F "4C$+P>2[4"D2T^$\"S5\Q]]E,,F M G6X)'# IDJAFW*ZS[7I+EXTKDNG-$'^I-?NFIMI.LT^OQ0XT26)>QO#ZDT/ M)7X<$O1+B4A[Q2?R(H('.C (?P;_%##$,$&(R*F,V" [JAVZB4*MW8869PVD MC-DREL?8)8/O9!5V#5ZZ=SO7,3MQ6+\I+; MS$:TDV[=NULRQC.]G?6ZG5W="!N3M#D*X6-1?GC-TXIK,T5I[*Z3%I-I_ &; M7 XHNG*':^^ PC,[VI(9.P=H]YWTYJKP3\VJQ8+TK^Z>I?1^Z?;D$@M&)M3? MP,@2,AH$*!H&4YM&YLY1S&\X[!YNU!*?ET[;),BZ244*!>J9X_^AR@V6#V[O M1?7(L2$74193#05?/)&8G((8!Y>IV &?5XV$S)H'U4I#Z94W9SEWA7"^NFYR M"Z$"U)X]S OJ84^&(;8:WH^;^T!DS%'8FEPR:XID?,QT50+PIE.;2CS?@]9. M=HQ7;5?G- ;_]LVD1=*5R2:Q&#'C.;V]:Q-?F,>?MU(_"Z[GHG\ZB_XMMYMS M? ,O174:]BA^'SPROL&X^&7M3P#M[&Y8]&^+1TP/F>-4P/./C>L M1 I,)EM4BLS<>C_>-[O9/WPX1"J0)U"LA*3ML]H_?!(J&B):Y2)!&FN?2$J< M(>S+J>-B"=!_?6937M"F'!F68.C%3!3M4!7EW5E:'8;W8[M\6=%0!L5[UF?G MPZZRM,Y-89S6K5\JX0/= J6"0T&3<19O_,A>0Z9'AFHJ+4RW?0QY'0@9BH-_ M_4#^*S/:.P4;),<<@1S;#1>1B\N0[L$_YT(!W;L6;9M'J1RHFV+G\]SP5I2S MQOG"5TT>5O,BD^YJ&!S=M= B"X6*7*/8S<6C,9:T $)VF-%$[(GI.@*]PZ#8 MX?*Y6U>-=_N=^4R@)Z+-DUWWQK,_JOJHXE>I%6G"+;D]7:[(S 8Y[1>YJHE? M,\['U_HY, $I7/2>K26US2-V.*[EYX.EFX?[%EY*-$4]92A[[YOJ@BHN$:5\1J8/;YL M>UY^JP172=IXRN'^+!W[FNN(A*" MWQ:*&C*.&+983',GABZ '-V.&KA=F@?]V06.EK"C++UJ'IF:'BP-''S25M7U M^BC#)+'4:J'TUI!-\>G9[NJ0[.7;7\";V<\^.; BT/D&'NLO[]0(+1\1GJ'L M=7 O1SQ-=Q.J=LU=J'YZ A;H.K8E]:2*Y*VT_FU>Y[11HJ5K+!VX&]XZ'XU^ M[9N1W*;_*]N4O-0#PJ>(]5#>%2*VG30=J[>(QR&RL8YDZY)EU&,&AE25'%Y" MQ*6K9W=T Z.8<==+N=_+ MS$83>KV2NT6#P>4YRP1*U9*)A[R(V&EI/",:1]N);&&;IDIV%R+W_Y3^8"4^ M\8=@Q6^'2J&(Q.S5XZ+/#^=V[O,CSRZP%\P9=QU.-4MS9P)J1X5A5J6O-A6O M(4A.YO4:=OOK[1 Q:7LF1KXPX1 P&5=>8WZ4D-:%A.M5RRO(7&!D!MK8PC*I*_;!F4P8N!Y6^Y*@!+^(R=4'[*K,U7@SLO@PY MJV9QW#EVYB?4RL,R#W[PW>MVU3Z4#G>?5L-^"5SB:5:8%V0T %1E^.AX',J6 MB-C=/AX_X0&@A]_W>B=VXTJ",C!0L;2^ !U=KJE>SPH@+B /C MK\%F/7#T_FCB2]_K!U-190+XR">_ M"-"4L6]L))L][A@2^!8T%88\G1DCJG.H)"?X@+S\&D+<,Y8L^M=*/F"(*[WM,[E M#M8".8%URNDMMW9:>79HOJ:S[;E9M(_A]:#G_+1_/-6OZ##C\!=&)8+"!+*L M42XL(F.1Q9_8F4"8GZ A?=0=R03>A#+8% H%2=L7&S!_.S-:04Y\V$]I0"*ZMW6<34'@O+4@V0<2/_]4[-&A##ZFJ#*3I M,:*9 [I#]YMNOMW]4HE!X7*!+J'L<\T&"+K39B HR-DPU*^A\X6HMX?Q$YE M*YB#"!D-D@XZI17JJ67%GP[^V!@3V/P,BB.>JV("!:AZ&WK-)/2#MP56$T=6 M8,/,Z&5Z%)#G#9(]5, F$>Y#DG2G_TS(TTS@#A.H3Y_"TI2H(/EQK85BACRV M_^A,1&AEDQ5Q])*S]N G^YT%&#-4."0ZXC^N*MX+63;34U5(98"]:<]LAIQ7'+ROY:'E5MOD3^=E)$85MFX M+[?@X9O%HQ=F&C?S?5;F.\:+!IN.73TIF#X46:W02D[LBS6/$5;5-V_>5EL^@' N=Y72;-#T7'G3()OP>VAZ!! M0WLY+2;/'R [M.!$ENLJ I-Q1?!\'-=QW2-6SE>='JW_0J#GV%\VN!J]=\0I M(4X_P2)-4-!25RH@$7*/N?Y#S^U_A3]YM(*Z (%M.)9:4J?@=NU+=K L;E5.='HEF5\[ZY-3JMI\_Z77'<0L& MWVMN]N-@+A]G N\UL2'\ I>G,M&T1L8E K]7QY2J2 %\YY)T_XN]RV.9\V&/ MXM0GLEZG&RE']83EG73A?>U9>/"L=B9?E.2N.%!9L?TWE.1/;Z2]8+BAEL:( MH[R@%2K_@J(^A (LR?F_TZZU."[,@072)^*PV QZ$.UV'7P75.MW4$>P/E_< M?&M=^D]DIL8GDV<+TY>R*-T[6X5%3JB**@IY^&]YFK@E>,.(\@%77HB_JR)D M,1PDMCDJ1:T;OJL4R[U$KZ1L#@\%%*Z=TS9=DM:;=U)FY^Q^2;Y2]8\ M[MX1>M"7?26",'HE@G"U/\YP:"'UKCO'F]WAB9GTS SMZXWLI*+7Y2Y)MU1\ MX*\>0TL/51^28 ]\8*!]:JX:HYR(#.!CY(C]/C_M3;H6:FBITZ%PD65%(,G#G_7M-DLVG M\I7WI*6DN@_;G(/@.C)Q/ MAM$7CT,O6)?^>]/VKQ=,_*ZPY6Q&3W>8I2LX>21VG8DA[+?N[2G-NQ^N=&$Y<65 M(*\\EYUD G-B7A.+-NIE-B NL2*V+4Z,6)>0,,_70YO2Y=D0[2#BB9ZRV>IQ M=BX7WP9O97GT#*8]M\:D\2 [HXD)N#"2N^TOI@8(I#4X[_OUN48RA2Z[/47\ MS;/QMXY-=S]X#6>:B"33,YE W]TAFOQ+5\X&PU=5Q2$F>L?G>&*M0'RY<11$ M/(8C<'KV--X$:XO2 M1_Z+;58;*($3=H@(U<)ZA/- 3;>84VNR2\>H_B5,X-NY*305&TC-' VDI(.Z M@KL4?SG(<]A(=CS%^EL0W/?4+ZMY8-HJO@?A_9:3\:<1>2MN&D_9[U=0 IQ/[H#E*(O>EOK*CMS]GK'[Y=10(VGO8V'BG)*8_0U[Q\6U9WJ/#0 M?.V$Y/_'WG>'19%T>[>B8L8 )H1101$4,2$*PJA(%I"L1)6@9$6"Q%980[Z*D^ M577JU/G524*Z_#S\V=6'-\\W38*C"LH[T&2A]KOYN3[]#RC&T%9?V6+37?@. MS?+ULYLWT)SCR99%%9;B4&J#T>VROD":$^60_UO4M*91TT-H-[S2DQQ3N1[3 MS<4ED)VEDL!%$UCO--#6F4^67R1KA[P@>/..FJ2-*,PWKT/OUZ Y\O.?]EEJ MG&0EH GOZ "L^QQ #8[$F=]WVZ1A7HNG/@;KN_A.=6UZ.S+_,J9:_UG&;0W? MDV_082!)K'96J^VD>_CQ[[)?W*G:OW&R6XHZ.26ID,O:021PH_U5F=2A0IM*MB M*K*ZM>(-B?_>X-)E=_]W)2[M<:KC;V% N))+"/@XSHG6G#^Q4DGT]W%O MZ:HZU!BA8S0V:N=X_H6QXL:];>>]&EO(YWCU PG#<+9[/0;Y.XEX4EK"4.Y0>BPIB0&MMU;U&S0(]7^WXZM* #T'8 M]H[:4^B#+8/:,_UIQXA_BVEDYC!T'[] ) Q)P"IJR2R\PCG?Y"HG)@%>TI//:.\"S\ M8B8;*QW0F$74#[+T]]> Q0343G B6.0LV(>=QT&4%"2QF^=?51FF^"2V'@_A M#U,_@#.WSJ HT:\1OZ9+*P1T94';82RK;SLG3P=8L'=A9%D7CRQQPYF?GC9H M]*)F!54+#$;3DB%=<$I>#?G89?2WOZNR4:/1DV/8:ATZL+NT3P>"M:C="!5= MVC\CD(ER%]+7T8<57G2W#J5.&:&JQ^<'=3,<_'".#DPVL(; /3+DH4EN;0AF M:J?\!?QL6$\'-J9#UYA!GGPE;NJ'XHNFY^LK^7P*5*6]1]_WC+Q/GXIXWM$4 M9U?S,7!^'%**:)L?(2HW;#N<^#%5]J!A1,!>.5@_=JCX7J?7@-?\@P0ZU!*_ M"S)4HQZ;<'P_7\0U=R7-97=V=%KB,<]VD#.#N7R+A]8U_QT9H!TWPV32DQW& MB2G09K9?+*GVZ59$EG])]/0"9!BY,.3?C9.3K@S'@?R1;Q[-?Y6@M_ M?B\\H3AJ'3B&[JV ^A>0"US,Y$_]VQS!L_6O.AZ2+:C;R6MGL6?O)3WLV'E/ MUF.,NO9!\Z[QJ2T=!SK"[V*ZPR7]I:VKE"\K^<^L_O)95$4X^^.RU?:%.1L^ MC[+)QBR55I05RE9?2"KNKS.C=>59S.6H:MR?=.\::6:S'7BV,;(7F5;MAUB0DH9\+C'\5)2,I=E9$5%9>4EQ"3D MMQQF8^,\U=C0H-A8?C ^+B[^ES7>YS^OO7I]]6, 0/Q5)?]6Q]X?)OC?R&.I M8QXY*$0'S#(A=7#Q-6H+'5ADLT:T[Z1C$',C-5R-[$F]20?DP[ERUX(U:(\7 MFXOOWE.\,\HP).26>)LOM%OXRC@PVX1[[Y#GF,X68U[(PGPRZE6*/^(\Q]6B M*JYGI6=Y)R5E8V9FV.G,B,N,SHA!\-V* .@\ ^T J3UTH$V.@%^X5#!LZ9A> M81X *_5+D0(O4QJ]QGP07[+=7F]V+N?//!"X6/6D2BQ >H-S*9N8PS"\5^-_ MZH/[<]) A.:Y MAYQ9'ZP:]6TT*I1J;VAPE8#[&^S]04"G X$Q"^=;H/_ M_ZR/;X%&6:MPR--/MYT.F]8TL[\,CVZY<$^'+4_H36)2B*9*Q\LS1]",1Y6/ MN5'%5!$>X6.[:5/TJSU%@VO.Q4W*O6H+>FLK* M#P(@CU]>H&K#Z;HI7FJSP@\.0:3F<;G\);#,D> CEZR6!A732N.# M\L?]")UVMAKIZG1 C@EK.8O1C)8Z;.5^]J[?)^6KBC4U3D^4+1P7/V^,"&]Y M;:1[N6&8)>>#8<*G-KQS=M)E,2C" )4,;3P/Q="$8^TC/[P2MN,+7HB_=AX^ MH<-BW9\"/(_?7%JE#+S>"@".C+F",NHSX[#0*F8S(?U$Q^]D(*A1_& ]/!;) MC? TTEY)H\N'=AA'M<.G>M-*:+?_3.H7P%(_!>X4VRL!L3K.?3,S0 3P5S-# M0_J[#7$=M2@DJD;(IB6FA_(IW^K+R:^Q+>S?97S\V?4.)Q6O:EH;F9:X%U]$M7GF#E;AEKPW#UYP+()UV*- MG;J6B%HR8*!RQ4X)Q%%VO>+BL]<+#I2IM.F0KCD1$!@YYZ7VVP/N6\L]$B ?I'F M#J8#X_S8BG:![CNHMC=H4T;R$D]8I$D K>()GG9*A0ZL2Y^&P8"#3?MG0Y-@ MG3.^#XQ3UOD[,T+Y 5?3H7:%20[";L8>%50VO))4-F;9^@+/%\Y'^RE6I^C M>E1U[)!0HB")-:8B=]1(4YW@%YQ\,,&G6DR5@*( CT&W;'/P$573)].%RL8B M6RLT6;ZO)P%ZMHG:Q$!=TOK1+#K_JVZE>##U*PGMAYK6)-!WJ MJ>&\RK[^X=9@I9(U+B4+WDO-YB:#64X[H@_"BE(,&!*E;=3:,Q2AUFEK-$X1 M_M!N;T#>$'6ODIJCS'[ G3B_O7S@7N;BV.;<?\.@M-3.TX(1/%72 M;]$G+S,F%H\WLOV#"OY!!?^@@A\;[@6%3X:@O^?C[>(=E76N[FN:^\M4^TH+I/4P^23EM=]&,THRGC(MR<2XYG!NZ"QKO0J%_-O*_W 0QEPJS>@*U+Z&3AIEI)#N:7BQ. MQ;:<1RW*ZZ_EW4_9ZH01D)1 M]=]8(\6WE/=JQN4UBO(79SE/EFX\ZU][W'/'^2BO5<=K)#>^UHQ ]D5Q#?J3 M"_GA=3K RS>(:Q(6>UE:<;FKRTN*T9+JGN+/K.FVI(P_GV\[U*YR>M;!_BX; MV]9N,=69[.R IJAD%2G0:BI-_N_$ G\M./"A \B8;X'3R7P#PU 5HQ.F_H1S M.]9P)GF@93R)#DB].,[+[JDC3W6NWF"1=RE[>LO95M.NJ&AN4>.*=9>/C8)W M]IZ:AGE1_R8_C=R(DT/G^8JR2_LC?&<2\*?RZ;G/' .YM$FG.KG/W,3A[931 M:XI]VG1*@8VQ4G.I5-B$V?LJ%XFO3D_=6^;$&29)E7MO6>7-E>2FFA8+ M141X-+5/ORK8,_KZ^.^M530?XT:%[QF3GW#^5S@B] MX?I@7N]G[\PG?)S5.72L6RNV\4;^HG0FSLQV-,X[ML_2SD&/A;CAD/+ATS+P MRK\(]G<2_M.62:*>I7UGYIW][LL M+[^1\WKI#IY#/$F/ 63762"<4Q(VP$6MKYNF Q^Q;2"EK07!_ =6>&H^##ZV MX/.V;3?B'U 6^1X6UXGER*I:_7OE,,#_>O6I7\%)%?C!UVY:>8+@*9RQ]EQD M3T<(2!Q2S5 +!0O?Y;-5/HX+H@-#^.E7 >7H=OSX8CC-MZCQ(8C9.7/<8A44 MF)E!):9/L.ECNC2LI@D8QR"?!;]201]R7#VKW\*B'VZ"S2A@'CX@ERB?S+(N M:Q?9==,:JYJ6P_4=*C1-S>W'QKHETAD(71=9XZ]9LV=QTH',_-OKZJ_W/&M< M>@QF@^_!#$QNM[+<14?!^1"I]5.5\R/B%7?NS23>"]#\"!"WKO+#)J#&)!:9 M%@26*%=FA5Y!=1Z'\_UU\:6-U?$B$C@:-O_!^.5\$HX&DK#V:[PC5(GC.*B8 MX()$0MRM7Y3G@V$'-QV8[AF3I^',F.XS%>E,R>&A8"3L?Q=M$MTYZ0,9=H$5 MK[\:'Y[\R72:PE@O61;C]@&DGJ/TTP'K,/EN.<=N;*D+R"[>\^F/^=_;?1>9_%TB/DHMI;&Q2D3P8ZVP4JC%?MD;^ MK!M-SW,G-#/EJ2)VHS'Y;.*^,3]GG]#7D"/O@RY#K,5+V2/-U4_-&XAO-YN8 M, U(^9_B12+FA8DQ(+/+;/WBL2\.'5"].2WV@Z.[%:HU9]31:Y%6S#.?8[)H MH@X:WDT)CK.B \ZQS!8'T?/3]A)'"$;8]09?0^;5^(1,M_<=F'5T!^B US8P M1*;3O'SL<$.;Z1<5XP4^M-:.L D,V$C;C6X-8!_K;5"<(N)MW3T.$U=D&DUBNC> M016.#K J=%K#U\I(-OZB6=A?5#LM6(Z.BH:! M5;?6/D8]%GELKQMSV2<2\3M*^S6O 6(:*(#AQW+>.MSO2P\@>&4Y).=KU(Y< M^')18%RRRSB.SVFLR_IKM,YR/07BM^(*X33$=*!-2DM=]D'[L?88[A@%I[:N MR(;0I;&2\HYAI29P6MH6.P(^/\=PN:R!YK><>8VI?70@!-2#\;3\4SJ (AW/ M2B&V3OK(9LS>U4Y\:J/57)W1+ET0]MS VUDPF"MX!^/229)G9]?=^8L5-NN9 MUQ)],B^A4 >3(D,T>2GELSBB4G?Q[8[MEA6\C5I<<6%E&DE\\\I5U^T,.:JC M8R;$+4DG(H?/FW[^[^D\:?..I M/'-L4OBN^F%=EGHVN(VO.@-U)U-A M577&0>0P?"0NE""$3#;_C,;7=" 7'%)9T($X:(-TH' 0R=%6O![Z?AB)."J' M.=1U, ^.48B=*?_5>RR*G0T]&TZPWM^HC9FLLK/R[>8Q M4O]T+F6FC.USK9;"P8U3UQ OG>B?KJ8;9NX:'<"\ D]%4K5AR1%)W2:$I-.X M*KHRF,]\T+9ZF'+L$,S1"G1@*YJ$RD:HPIK_GD=*E)1DQ605;MY4V'+X,.>. MIF85Y2I?I4:ERWN#[9X/^3Z]*K8V],5C@#,,^4%O+[5:1*7%H9-,F"T8Y"0& ML;PK[I@R;0MJ,U76XV<.UW^:Q*J6E*%(-K%2F,S?K,+=*]9_3H7=;ZKH"]O* MQ#B!TR^QOVQSZ(2,'5&B>0\XN)OQ^X/C!V"P6RJ,?NF<%I9R6AGLW,RF7K7Y M=*SU>'))A9(4+[7)6/5L9G('3/E;OK]58/RL82P!'1%)RZ.0G\&P[*TU"NKE M0KCS^ _O8>IGP^%EN0GRHJG7F5QA4;>UX"'B240'X/]>$D R485+S3&^%E+K ME[ S_8215[59U_#)E+?14^3\.'=_8J."9_VML0$)BF;$B=SE/%3*RWFHBF,0 M-70Q%SR-?DS#4'.^SLYWM9EC$36OT[=[M MU0G>N1'GW#/7!,MGI[FF/1TP-'R%R)+G*SA#"%N=-7P7UG1.,(6P*SVBQM!RDML6%>F>".O/8;VI=E M \O4Q)0\JQ1W']GX[L@S?T5D2Z/^Y89\8*"L:J-_5>SXU$>>I(2",Z=Z@ N< M"-T#'71@HQYTGY=:47Q30&J^90@&0FXPDS^T#2]X.URN$E)JC;OWQD2.-"4P MC6*1W<.S&)[%??KH:ZGD@_?H@'O]#O@+*2M)%-[8O%XZENTD9R-QD^HTJI5^ MLY"BA!%PXM";",^[>C;'3)?O^J&=+4UOO\B*R>SQ3RO.O?.V44F,]VJ-W]4) M85P^Y0H=.,8TV-B,KR+U8C6HVN,98B%U_:\AHLWNVZ7BW,>$9-Z=R?;UZBU, M"G+S,WSBNM_IT,LKM;+><3%/VJ4X;)'RW;M^M2D:D&%!<6:N$#W#!\N_!2LD MJF+]BM3][\==_$>5KI &E;74V?P)0OH@H77OL[ZY9BMKXGC:QUA/;L/SG9LR M,G=4T"XJVU:%:M*!!%48(G0&3 H3&AZ^.A5P^;Z_.-CM<)FB?E*D.XY0T#)* MP716WY.*ZA:[R$CK+V>8NQ?(%,IV+X_ *SCRV/P4+I6&1C)Z'2/B<$B)JU"V M1\=.;7R==6K5%6VG@! MBG$4CO/OGXZ?'.7$9$^ZH=%SEGG/.9[O.N^GZ[4NZ.KUI.@E'I][M5*)H^R9 MY3&X-#T=/T+S6 ^Q@LI4--]S=CQ98_03:2I<=1ROX]3;6-6U;/2 #R$?M4$T MM)]-"CXJ)TNFUI)B6H;-Z8",P*+N^.;B!7%, 8K:B"2[O]Q2$=$#96SZDW1B M[?")":L!%;W3D4@^,3(=Z(IK) 5$VD226*U6THGQ=3+#GYNZ2P=>!J-F.HIS M.!F[)9327+^JH$_R%?JM(T:K1\_7%KU,%5^2D?=*?G1A:=>K(X_1'S&YG.\P M/OU6J!>C%PO"G^9RA6ZCMJHMJ!;QS12QM>8L77N79'*'/_6(!(?D*U#5W2\. M">J&ODCEMW&MXUU@@-2W>A@,U08?W[ I@G&MF#:=?I0.HD'@-RUEKHDL"B MG8YN\<6)?"U>G9MA5>=S8^U><'.WXQL$;WQT@>(B[^%M\\T?\T J:%@S#(BJ M)#=:!FQ+$A?Y(#]W%M+BRRC2P2T6H4US'EB<;J_5V1\J_@YJGI7E0Q/K MD;1?+6OR)OM6RJO]&OUM^5.;Q6])K(N60R&P18C-XH?J9D[$YD5BJPBQI03) M=/TU\1J"#Y8?>LP*$%1QZRM:^7W1,Z3GKX:4MROA%5]3;J>KP6^OA&.H;6GY M$ODI)!/TFO&F[+TY0F_=$3>TR9[#;RWNX MZ4:D$EN-\0)71_.8O:=@R=9_PM!)_X2A_Q.&_O.&%):S3<1L(K-5X+1*@TH) M+[\*[S6%>GDE^8L&W*-C!P)9+*T.:^W9=OF !_++/C9J4_$1@1+LT,%9?!]1 M>&?_ N$F:6N/&38NX.:#9HW*._BNZPU">*5P3& 9^<:.BR^Q\?"'DI?5R^7; M["F8+XP@R28'$\@"M7T\-HTBC.D2SD9] M45PX9+7/>M MAIK3W7585-81IO+SG5ZTYTD?VE+39$5>/,:QFEIF<=8%F5CWBN^G>!36A-8G M+Z9O+5]TF54;K-/=[S=,H;P[5:238Q3_R]G^=#N9S49&QQXTOIT7U0KOW,MC M%"@Z[F B1NA'(%H^YG\C?%@.L2J@ ]/1J,%5$M3/3@>;S(I3WC?">*+?&BU0 M*"B=%G$TZI/UN56]+&'5TA?=3Y397F:Y3/;I-:JVPOC$6WBP<&]MY M:DSUM84XI)0N^[Y.C'#/=\W=8&A\-)E;_Z1R@TJC'$M_L("J%(?5YI3U!Y!Z M7PDK5&(8Z< O;\#SZ 5%"BQR?;7)72C#F<:!J?$XL^1: ^.S_8*1 ^<4[I3= M&2UL].6>T?AX6.1$@H6?7@#J_+8*?H=:F"$:*_Z5<&F)0D\G\R$IK>HK;D_K M1@E(M%&#R5(YQY1 @Y/-$1Z[A&/9H9?D M&]=. Y M" L54E8J3/3GR[_RI #,DSZPN.,C^\%[!?T$7C4E)+BM9;SXW^*7_ZS<"M(@ M5CJT6\N[;3%QEB\M.&PJB73WFO4)@>WKM>XN+K83^86L570JO8L%;9F=I"E" M@\GXKLY2?7OU]<.>D?/Y[\W;<]@V7N!X2*NM$](>D0MR'=NE2V/:+@HU'1Z T/([*R+5D'_TI M02@_2Y/S2IK=MIE'ZII&K@RURF(1-OL]:*J'AR7I@"TZ8'*_?Q8M_*#_X)"( M2V.\!>^GA2Z[UV;YC-U+OV::M2FA SK=[V"EZ-VL<(JST$U;F!_# M: C#LL86W=]"EH>1'Z,B.%5PG_)$>)0.6)RC _-9H*O(6QQ!T]@^$XQ94GQV"S_I[9*L6LBX5$V/7D135'G,\:Z;6K$]/2F5L*CPJF73.G M'F'H7Q"2,O=EK3AXJ+UAP/KP?A)F*8&C)D:"YNE4WF!/+D)31<4HG!R00_K< MV+T0PI>Z'?VDJT>%=UFCZDNXR/-%%>"'!TMNV^,7=4#]C#(G'XFF,+,(&9_* MX..O[X ?PRCB$,G,@@X8&J0NU%1 CB-)YL5NIS1!\VP.&L8"-5W6.$QCZ'A+ M!PA',#:0APG,R5I%.5 A*7+V<>1<$'9D:P =*'$K +]XHRC-_B:=8D G&HD X$KJ$#KU+IP"6K#%)95P7U+:P%98; ZHF6#=RX M:")/J4R%47Q4QQ8Z@#.WHP/:QO7D2_+D*OP\HRK*P1$/><*HHDV&#K2DP;+N MM8,U%VV@99(.?#&%Y>$XI@A,YQVFON:B#I@O,20S%8M/H0>?,M$"L33#<>P2 M8\5M.M!];8I V]5J#A78DY9FN\&JU6"=.-R5()ZZ5PA#V[-"D3!"$1FA*+SK M!XIDZLF7Y _[:TB0! M/UYI2P>.=&&7>*=A(6Y-2B?V(2L'@\Y77LC*F2^>72%)'B&) #TAM6)) :P8.B!6 MC*(#:=U$J% G'6.G/.#>2-%9"GL/1T(7H->4%Z>))UYIG)8)2\,^>T;!&+O M]]\@FB_RV\#?$%WY!CSLF0R0<)B$#!O];=CF*\,6MH>VF/9#GMN^'[:3-1]M MH/BW8<.LL?;782>#)>GPJ)U_&W7W[RA*)_84?$\1=O&<3>1W%,&CIL"C]N_( M^G74-*B M#)J=GABUW7#ZM UZK=AIX.?T6&[H5D-:YA),/#L$3OP6)P3 ;JN M!%D(T!A:Z$!/1SM,Y$B[G)N>9'A2:=[8N1GMP,"B-SAB M\/14H:+.*$FQ4A3"$U2%P(R%TAM=Z7OJ!R.G+=WE-/&'%E-?T1X+4"TC K/# M0LQP&A-9K>H%-!$$^:]4/N&G9/BJ%XVX>1U MJP)=UVANN[P&O"Z1*SGZTM?)\2&,R&\9(R#\R7)*=*O[OT^7#@/W&1A?4U)= MY'Y6GFKE[^-?_Z[\6U5O4EIZ,\QFG-Z5T"@UM\I$_?FSZ$FSG,Y'=NJ.=JJR M)3GZ;H\^UTDL>%J>#;W*,$[Y!>^\V79*):3)9)-E]$G)&#H0:P2+)R\66OCM M>KQ]4++KW61^Z!O MV5E;+Y^\1!N14WV!3L$[&]ZH4MF1ZP526$?;A/;H^ULDD:VQQO<+?)@\Z^\< MVSFOTC<[+^5;T12_*,7\K)^&6%4O_KU6O291:-?#3L4)<-"KV5'E\HU;:5.$ M((U#;MR2*,FTMB(P\R&EGBM18FS[$,=[?A]49,)N)*QC\OLN*#+@H:GG'OV1 MLQZ+6W"'GIXB$O$HZW3#8<-")\%GF-VVA5W-KUSSJ:&]B?65:T*XI&09&I(8 M888I^Q_%ULL-_U8"Y\DY:CPXV:)3#>\+9H9>+!U@2.N$Y_4+C.:^O^7#T8%> M=6QE/6W50@J^IJ!_J&7:LM[6[-X]$6G3"5Z6A/S^PC,6[1X95.:HSW=(@2$L M#9F_>%Q(C% ZHAW!#']'>J7$FF9?L*2>]SV]1W'/&V[$/F^_P.%_KLE??/Q. M2LSJ]0)(G3@==9]%69VYQQ[D0*JD1Y*]BT6%QMRF/HAC4P[E0B:_]$.V5%SO M.@$]&TUN;IR"PO4,3[,!RQ-*A_?#86?&&9UV&B<%1N;>X1^/T MD8NHTMGZP=UFU ;R[@Z=HT*-%SMLMLS[D0YSXU#5VK>9Y"T1PI6J&G%0#N?4R.3L*'XZ@0!K/'DTG.( MW<&H\K: N46]VAJ_?J$SEF?C, :65BR7WP;J=>^\&3FC6>KN?B.T)R+?71SN M9=SMOQ-8]K=&$_U'1760!JUM>[9=.N"\_E"/2\D:)#.-PV>1*\1Q(I>3C9KJ M"T\97'AZ*^N)-:NKFL+,K9KOW(OU6(KQN^JS%Z5RP)NI<*3-''PTN:O C;*T MIY.6\CARR&X,P9 MXU>-)\.:GOWH^^YO%56+[ ;M:8ZX>%&K+[M(2))D$^(WB]H/840;"!*4@)4P M(C>4799&5\!R&-'67"'2>N)SX;_5^?=/[K=Y4(%KR]UTX"!! M9(&/?+"-#M2N!\?:B?.ADY5TX(5C!MB07PU]B1K9PM@6+WIK)=VSW7?)G>5> M;6FJ,AIK/Y/DGYD4E.ZH3-SQWIQFOIU]Y)/7#.#T!1=Q/O9C$NLDL*Q&GZ!T M!UHS4]+O']").J>>>\-MZ/JC0_XH.+R!U;#T]@&>>P0($WQAKMZ@6@AJWJ)J0ZT.U< M0\8//;37/G/S?C1L :JU,]HQJ1I:W<5M*$2Y(V]^>FCD^1*M3H2+@0Z<'PJA MC7=LR>[:ND^^%:QCE,3[D3Y!#*PT3PFJK1H,.^Y;-6LYFTG>T35.5=DE'8R# MTB_R8"?#VJT[TG=/.WU@(MM)3TF;O!.R(M.-&J MH:GD>FYQPA%O?0RQ4,_'Y'0F]4HXQ[W!9PUB/$ZW?*:)1^%5U_B^_NYR]!-) M-17)(=&X[$N(A#]9WBGFM+X^A@IPW-W:T,3/N[5CHC;UB)FEZ>8"X\/^U\Z- M7,=/WAASC\WHZ:[PT:/00@A;@L=J-H9X9=.!N-7PAMO'D$#IJM. WMGK%L_V MG<@[81*_W6?1XJ _4]OI@^..Z8_2<0Q__7'[3SV?/V_XIY[/_U_U?/YU,/11 M=*\9F]8ZW=[(4J>1D\;)XX0 (8]4CH0-B:^C)[O3TCJ)TAIC2;,F2?;0ADU. MID@?83\HE5-,U%0;:G@L-4=DE?7:JW%&D_73_?V.UMI7K';5530]>GEML9F\ M.O?">R[_M9\8$6B!^D--QK_2RJ:#UEG4-(/NP@?3";.T^- @PWM.,H2)(N&Z M4/7\:'W3K@)^; IH'JA#9IHA(SAOA1JY=Q?YG?IJ>Q>@$QPB\D)!%;T9GS=U M&U'#U144K_*"S1P)2P@UA =O%UR/I5N+U+2>YYRY?4ZDJ:- =,N>Z\X75=L_ MBCZM>"W6H[YGVPTD0,HR^7_^Y/ZWDA[&KB+RJ@&-F=P100?0MS5Y!W4R/Q-D:=%A*W0E<6>G1OR[+#O MK(/6C7=8Q7\,FM]RRDBSO*->\U5L7VAHV&-@8#F8*$""RNU&?H^>.T"^1SO5:!^:#*&H MZK4&N7B=>J]D7K?)B#K%UM29SLQ'3-YQOH$.DZMZ;7T#?:;(@WN/-)[NM[$>G>/=['K_&&' M_LT>>O]1Q1>D0;;-L_B8>9]%Z,24N,?V7S[H)EN0/7.EXW@N.O'M]HHSJG&] M4IQFD[:&N^Y-,Y"Q MM^+C]&11$9,YLP\ *CE? NN]V%WOWS%\ MY(T13W1T6>,=8P$@[J@7TXQTDNVL%+/'P/.[-UZ%B'.=LM6N(QD-5LNFD9_X MB\Y$H!@ZT&7= M2UIM7_]]IK+A[IB6.3TZ(&5%!]A=4KUI'X3OZ/P_0A_+#57V@S#7O7I!WDD' MGN,P:!+VDWU]EP2?2^?X?*"H9QKR1\J MTUCV"']7MO,/#\O5;(:6?V/QTVHV/)(S;_4,Q+55 H-N@>^]'2F,C,D][NFO;9\*5M@&DDQ?M0Q*8;N M9>/FMI=Y>W2RK^L"%Z9QRI,%.PD1.;$4E G_T[ 'GDXWZ C#%+"G76\FQF7 MU-.IEMZ!@47#K2GU ,2K?)DXX8+%[AN M!?1*R,^GX><6T@(#L8=L!&^HWCZI CC*GD^/T87R;/5A'?0VC%->HS>=I+E1 M76(4[<%QD-\7UHVU\8<<3\RW/?6G RU?9.1RZ8 _[6T' M-_6TTQ>H7C)F813[V:RB]4LCV0W=,RHE,[OS7O5M%<_ZAHRES!)1A6UT0"OX MC09T;:'4A,30JX_&4+L.!730NL"LX"/45M3B**H^5IOOW<()U;A@[V L!ZDY MH%1&XNH[S1Q9+5FMJ\X\=D;W'DS7U'/D;7R&X?1=6[GP4C9WC/_X^^MZX9< M85G)D>+^0(&.&^V&NK+K-YUYY)>4]$3Q8P$OL)=S>J^PXZ[\3??-3'%?BH3S M!-(X^)]T7ZC+;&WC;7/M?#16(V[#FF>4VW4VK_U:VID#&4V73S?O%2V[:'@H M@HTE+7J;P+TW+I;O7-M"Y75I/MS$]7 [L6*A-CK#QPNB_ M%/(XSV>FN.&@E3_74X,'.\5'I$\'-HHK*D,[Q)BNX#,AY[\6L7\,(9>"'3AL M* KB8ZS$TZ@WD:LUM96 E6C00NWNXBLO%I=9RUO^/R]J[+ M+:(!!9IN,&E+3CK7R8NZ>VM.2G:AWC_U8$++#DA&6O.0(4E[[#T=&.'"#H?3 M =MF7SK0X+ 830=:$>><(CIP69@.7"10ZE+ M>CY2Y"@L]#<@IQ_X61ZL%X+FD@_2@1CRC 0=>(MXY-E#SO:0+9X4?I.)QE7O MCJ8Y(X<U[0+NFXL6&I-#97L-_&43#Q\1\4]Q* MA$4_.+STU&_>ZXC+[_;YZ8GZ3T;L;PW_9,3^-QN:"Z!=#+G1,&]S.;0H]*N9 MAL[*1V..7U,^Y2X=7S4Q=RARPC_/ !Z..,?<#RZ)$VUT8 .I3O8=.H!O M=BD]X?ZLTKS)(_Z#'JNVMG6193'70M!!WG[,/F6IB">KYQ_X]:\KGCJG1@>> MY@[K)Y!+9AA-@@O/^[A;D5L;AAM/]$]V=HL8Y*1^*GN]!*%;$ X-6@FO\R1] MN+A9(WD(_*B5<5YI73]9^/.CO2X>;SQ.M;>^>C](E<'Y)HX0T@ASTV82'<:6"4F*P5@M#_QLB*[5@!SJ2YAH+&SC,)/S M?9-$#>!+#)4P5UZB.'!.:,R1OP74JS\G<\?T59FJ M69;]E\D\PUFB4+VUV1Z]N&W*0CRB\CO'@="-SO%P/_F_O[7Z"Q):_+ KH@C# MD]28MSJUNKUI:@S9#]Y5Z00)HW89@PZF72Q'(ORO!>LG?"$)* S.G@FZ,5,0 MM_&>H4OE(0EY7U?G3/'IDK,6B%L!H9,5O) ]UU:4FG^2+%R49]VB]/=S3.6W4T=?[@@ M>PU.!]*!@5&H$E_1.Y>%/8=I=WA!%LKA9M*Z-:=L<#%=WL&Q*ONFB:Q0H]R; MQ"S6[-AS:H=820?>7'/DWG:M;;T.O)Y%CC_;/'\W^OR/ZO(L!R)\H@."Z9'8 MCSRG45N6/,YM86'^C+:?.JXO5J;EL#5'6?BVC,J&7'>;#0IA&Z5./TMH373/ MY HO2AN@ 0_/#82BIP3]WM\_[3?7$\F#>>D7")7;V_;RS.7.H1XRS#\K?7S^ MC*_#IX\Z/.]2KWN9/B&=5TIY\ZV(S'@(;IR@=9XUC5.CJU0-,4#A=8@T?#Q+ M(DZ;UEB2_&L\V1*1D XC1?[Q)VO U*GF=!@*OOU::N8N]M?,$9-@4R0EK5.D M!VV'[O3"TH[C>WU21"B-^[I-L*,GL/V?K3*&WTFDR/T/&K3_Z C2WV#G@M M'P)G!!>&(1*9R98.9#"1)/3IP%E8&"4;XQIV8V3IP($M'E#0@LZ"%^K2+9%: MP7TNWV=,FSJ:6L>6V]D0(G(W4.KHMHIZ.W'B[GJ M";QE)RD.COMN9F>GZ(6ZN4=EQ#$TB:_+26S!+0052IXE\_*6736^QG'[/ V\]VH'ZC*>IWCESPGQQQ:9IF#QMTCGB4%N*"V&;-NQ P*:5RGE MCC-D0C?Y\.#DZ^+::JL#ZN)T(-7R=6^ZOKIQ^D?>!M^#<>E[O^B/#0A7:-VN M_^M#D*3 5P*T(GO$R;QOV@'6_O%E(8C_G']O)?M+T8H7O53==#,FQ-AQ7KNK)FR(;/L%'F\Y%7 M:RHB%X^*NT@QX$==>@7]1 ?6%T/K6=#7!NC#J[0-[(; M9M&[,+S1F;M !Q+H@!N*XM...+KA,7]8XBJPUV3324@W\YK0)"UE.B4@ 5>^'-QRX0]!$R[D49@_(K$O?*!CC+?IP-2.9>-P M[0\>9 YT@!M/L0J9;82[ Q;-Z<#[<0QB&0)_NN/G"F$98@ERH:?$A\+("0Z/ MVO//>1,K^Z;1? MU.WS$1#KQ>S?H?C25FY-6?_"&^V'FGE-"KI>V;?:+3KY] MO(TG#\DB?#7]6Z^:_?Z2>E)W;-QOA.MY2[;Y2PZ(-WE[YQYP7K6&=3FF+!5% M/1)-?B]!K80X)9J*2O,4,4-,99WBNTVL-4/WQ5[P;AE_&[TW@Q+'$CB>D!"J MNZ>V:DPS39P_*>1CJ. -A%YX/#47CZ+#;/*&A:&'2]EUO7Y)S& MZ%W J9F(YTLW$.:UB<85:)+3$VQ,D*?FA8+A=JZ(OMRM1E55"/R).%!.9VD66A&D9K4Q>=:5)?=\_'(0'](XJ^ MQ:AW]M8L/F>R\I^OZ2]3NGSMX@6O+Z@IOC9:SN9/R4%22O!\)"\E124=2HI* M4%%9I:(B%J0B :R:1Y1OPD^UQG7FOI%S:*%2.K"##L!*".&N!CRKKUU67FXP MA[:C8/5:!XGCW04RT('B>%9DV^-^JN/^H>$_J\>BRC1WB8P7G1Z/#]N4-3YZ MA.!=&Y563J2M[4L(,.H_;FA1Y!$08_^$;:_NK@M'%+-:6.9E-K-(1]>)#G(- M:567Y:U1OW39=[KET;,2HAFOW*:A#=JQ:.,+:\GUMC,$9:_B)M<7TS.L[A_B MF]_E[55.$SVM)B6]-#81;F4@?_BFBM^G :.Q8[-[-XX]-QHW3C8:,G+/KZI* MK+Z86D[;5GSYS/KKKR&-@#; 88?=E%4T9^D6 V9I9F808 M9K@-> _<8CKQQI>IX/[HM*-@_Z?[\!OUR MZ?\21F7]+8PJ@X$@:6R?20=B\GZ+HY+X'U9Y?V@8/#7[C [47:,^A\^M\8Y( M"GY >)[A#AWP9PNA?G:#4M-U)+J[(LF B0H=B'8,H45+?-[#E"7G^GB)^+6" MB]T/-HWO:U(NIRB62_L6_;^B^/XD5=AW#R[?J\M;X66X1<&S+W=!@C7DYDXZ MP%L_D-R%/QOSP1J)EM@]BO8**.3W,WLYQN+C8"V[_M8DHWK/[%$50WT=^9FQ MD5J>L2VR++92NI*EX<+5'1?N\7MYG3 7/^O2MI<.N)Z<0Q%RIJ!#06MZ?;KY M")&5VC4IG3G5[.S$&F.5D\=4VVO?J012*IA?I>\[G;X6]<']9)(P0'[I+Z]YG<34F69%4GHQ,!1A MA_5?FKIV(EJR5[I);,V5YYME- \!&Y+/Q1O%1E/Y@4EJ M889)BFMRO]/GSM?\4VJV]0J%V_.H)],VH]_#"N18QQ^6YR]5?W'87M-%QCAR M^O2<95"V;:3'38?5(K[\(NV3KW+%Q7#&89LSPW0\Z,#SY8OFE5L\3ZZ/7C5A MQP;OELL.'O\0(1P[NS.6=#8@H^%M'&/&3)[:"TS/47<2?=F7V['KIU#SWT1@ M%["AZ;1"'[(+V$>@PCL#/Q>)\/J!/^U&(PW\ .LL$]E., /WI?=@2>/]""'S MKW[_ILIEZCP=F*S'U\!:,XO+6SI VH"\.6/P ]8L!@,)M/QJ,L+TCY&PSAZK M#L0VAH9^QAJB"^;J$W*#XT4S35UO0.UA> M^;RV[UC?&M3^^=G\7>*JBJ(R7^ESU2&U/;//SVH])O]3N4(F1DM&0UH$!:M@* M2+1"(E#JG#HAS4C>_,A!-[FFPKS4)R^VF:7&\NME/S*K'']5RGN$-)[Z07?K MEA-R/HIE9\0.QB9)&[6&3''?UH?9KPG;*ZI35X0-X[*;",?(Y5.!91^ M:;9J:>U4GG2K(6RM['QQ3[^;]KSP?H84IZ&2I-;;\\_4I:XR?Y97V!FM-\:! M<$[^RO[QVOV!#CP++YTK&, I4E5'"M$S2SHP2UW,:L(SYXNR M+5 $4LY1+:WRJI(>':PC%/5JXQT+A3995J[]&+J_S+Y6[>1F11:]N,>'SVXK MCQCO8O7YE[>H?[L^_%^M7F*Y@?J,4.LR$Y9@ UI8BX'MD[3D2]H1SKL]]4A' M+.)F;EN7;]W+-*6J6A]WM&)4#'*[I*)_G'5^4]$F1Q\"$S8(NO MVVPE3&F7I^R\:R-L3MYU>@.GB79KQWQ,V2_MK9(Q-.; Z^UG.8W\B/7^V6H-J;;UMN5^D>S;R]5G M@]Z)23Y5_YI9X1( F#>V8:[PF^5C!L!PG6NV"=;/5Z.J#1/:X- M:W:W*$2D'L37#*M(V91QRC2G98^PU7Q_QV.7YI)YI';[9!$A7F5I')__B/^\ M%2%^J9O6.$8^">^I,^\;I"DMUO%0&?.=E)I[ $5^@N'Y^;TCZ>"0L$?0 M.5NR2ZA97T9FCN)L[9E?O'8/?9PY\D19)?29RMIGC!;R@ZG4)[EH.3H 3)F_ M#'PG4CMYU*F#VWGT1<3FBILFTF\,>QU[CS9O[:^\:I(JK^OYE/@X!]8PKK\8 MKHN8Z#(37.A6YUVS=XO AOV@:!V_"'9O18FO[7:2)V71W*&K?Q;,,C_2D;LO MIN!)BDW(L??/UNUKV#5KHODN[M:45ZZZ^]$>[_.WO0ZZ,DM&N7/>Z'<_C[LB ML>^P<])C +C!=#^1\V5$WL>:NK).?ZE$+LZ CP'C.+3=6-'?QQ]_EITW-Y . M_%(%5L8:[9\M;<^ 2 Y_-P;\D$8J%6!4,Y7"^IZQED8?88S53+1V)7H #']FS'W M$CH 0QUQD@1'9B/I0.I7X^SJ5=1P[+#HK"@=D(!IIQE_-;9N8QJ8I ."*'_4 MTL5X>,-_,_Q>>@QRF9,_4WWIP)=!-!U0_VK*_5]'\JW(ZGCR7H<=D)IP>I%0 M6%^Y0,X()HXV7A6145^)M=\AV^MIFJZ2=ZHC23GFM9W@@_UTP,8C]I"IP:>] MIF/P.HWU_91-_O^YNH?5_8TT"?.!\7>6^51)-J!)$Y7OR M5VVJ/X4W2&*V0[>MR:9SVO<9O='>83R[!78SH?4_SCQ&MW@A_V$IEJZ#<(?OI^1IO0L@ M(@N*_TH1%$V@\@[G1'VDWEH4^M+]8!A/([86I2Z4T,1/O!EOS7T<'LTXLG6Q M(45BX D9^4T=U_>_)DDOLK7,S@^7$%QI4L+'%)2)/F6@3\'JS"#<5=^6R:WQ M'WN,%?4ODB^^O> ;(:,9(86L=MK?Z5Q#A;=*A0*M7Z+@;FY@0E1B?$AO4DQ03P?/2 ML%]0SS5JPYJWU:Q.>V^L9B(B7^B.CZ-L],A=WZJ=MS1JU5YWXJ_%52CFRT((>MCQ'X*C! ((?A"&ME%_(9B-$VIK9\T'57=; MV+B9+J#-IS:?V^@4O>>:G/G_8>\[P)KHJ*"T@0$I"-50(B $'I$>I-.:$E .J&W$!*2_PL>S_7,+>?.S#ES M9^:?YQ&?)U\^-GNOW=YWKW>OE4\(,EMM&KU:?;YH(G'N?D*17"9Y13Q!R,"V MU06"Q^Q.7-V-^@PC-2T Y'8T07>"OB^)OXY3Y7 D_'D8@\D4<=K/.H;^JY= M/!74YWD+\@X_7\/LEP^SK1R[(8&#R' /,+K4,NVY\O2\S(LKR]X^Z=WU 9X( M9^4?H0K^U1X.V@-UY$H913,62LPE7QG:DGO]+4]B"PVK\:0;A6PACGZ^RA*D M))GLG1'5\-@DA*XD* ;I'/RT2E/PZ@#NP3)N7+B_3KLYJ+ECHT!"H*,GY(2=U5J7 M]-U*7?WT!Y&)(B5L-H>#/PDRUH0;IUEZHTL'PO_AH/NS)2S_GNPIW59-3>+. M+(92Y[65)"4EE21,G9U-EM0Z.CHZ:\PSL[,SX[)DCUM\6):;9=)@E-N%B=#I M8]LI+P@R"7,#B3?.-(2P^X_NB?8'[5"3_PPZ%*:RHS<\L14\&0%K8<6*V9F: M6!U[)UI96>1KI(:(3.##19],;5J_+!,]6]/]N/U;Y]TS9\18CBJIJV57X"VD+6Q&ZO+*(3A)A6$6!@2==>C>04( M*GNW+VBO8]<9:*?73P@SOT2Q$670+X;"/$9ZJIUKGD*_50[1&TI<9Z#]]A,J MR)-@&Z>=8>!)4,EV#R[R ";,"KP^9SF1@M[:#H1\=CTF"4V;?LX4 ]O&=KQ#=3M;QX]/U MOWSU/1S0DY_" 67\$K;WIQB^4[\F_/CQ%>U%+]D@*U_AF>VLVB.=O[YH<$W3>.E #$?+^#/K,^*F!PT49*S24U](7M^[8BXZ M.Y1FE[56+M^G>5Y-"/D.^CFQTR[A=8WZ>V8L%53NBJRLM?'ANMJZIA>7I8NS M>_)F2*&&1[Y&KTI52M!7\ 'C'7Q*SGPE/?QR2#!XQSIL43EU,+$6B35\<<9[ M:9"4<$:WE53.J9;?JOA0]99QWE-I^KWM$"F?T@!5LQ -Y(92D! )XO@G8VM,;\1];I X+,$\#, MZ;IL-'<@5<:TVM5<-9O@:T1O;&&.V8RRONYX,IF)/=D],- M!&B5W?.RR)/RYX>@QWQN3+*%B5F$B2-5'F1W= [=>[F#AH:%#?^@+MWX1 5) M6&>9P>/ *T<_! 7P0KG$=AV7/]>_*,0_/*;W'BR3P88;::4Q@JP?^T3O"F[1 M;T@PG(!KR_E\Y%1>O%1GL;FG8[ZY:X)MD6#/1G']#>0$;CM]<3+Z;]7@?Z?6 M!A&52.8M&].$FL.O44JGO#1=AXPAU[S^1G6<\="827,5Y+5K DYV[&!;OQ@![O-$D9\YQIE8@R5M0EK6/:_=9;6WG(PZV- M!G[3C*9CG]/:3H[.2%>@2XF>OQD*+;C%1-MUOS&NY4<;X'+(AI:)<(ABIU.D MJ<%:CYKV*JL9(N/@\> *SS MN9L60M@IBC(Q24-/V2=_J*G0T&T$I0L%:.22]B*,M+9$ WN;RO^VO*PDB@=\ M?7)A M@F7U7UP4G/MD%EP6^:CH,VN5(PIF1@"B[=A#!308NB&I:!#S/;>M4/;(A*J&@'^TL_[?%M*W[LFQ 6T--'UWQIAD)W"V$R.A_:/$L]3OLIZV=A5;&0O M/70:G;&_%U<+CF(8PI!"Y KT/"W%CV4&9Q]#'IU^I-/],#6_4O2%W,33K!R: M)FCFP>\:NO(0[CQTPL?5C\)) 68K]BO-WR7Y:\2V5!R9#4II0$W(4G@I=%20 MM[+(MJ/HG]-I_;L2N MKSECJ6/0 GW_"Z'N*!?E;J[I4+\3IP2.3J4G0ZT_BY]WI/L1J91AN M>N)4>+1SM_#9:QC@OUW*Y;*K0$,I2)33#( L*RB5A*Z14GPHA1U7O+J,-#@* M]\P1M6"_1 ""S0$D\?5A@$S>(4%)LB%)5\%F%8>JUKX?GV_^ M2!CW]OLI^4^2:M]M.<]V"@?#>+KM1''VVQ_B?OKP/;D#8&81M_? M6V;Q\#SD>A$9%AQYFIL[*RN+XTA7E[KZEX.-M%NC29$FC8\#.;/('>=94&E>M*]]AB- [O!4;:8CV[D=[,%:7-360HE MKUD'CGT.D!;2B]XQ(K#+]M.>/9^%#*I=9.K[*QY^6A0[ABBJI#.=K4"$^#$A M78KZ:SM&/MZS=CJYU#FZ]&E?J R2,_8.YFVDT;TPA\Z9F8GUD7D$AZ7I(RTS MCCQ(:MQ:(V;2 T,,<$KTQ.6:EI>7&"VW"GP*DZL/$,CC2#RO_AAT''0X M(W M5?!?1$#^#X#^XP/YAB(P-=^"' M%Y]C^79I%@*8:(FVFWH]_OFD"V8%'K/IXW>Q6_:E&,2&77J&#]XHZ#7P^IO>MG_(WC4C@JZEK/"8$8%\:LD&/@I M0(?:%U2BP1=$+ER[ZWRI9KPL5D#[I5P#*NU2#(>R"L@1L)V3_(]S(&]@VQ@Y M+,:7612R&W+C2T0^(B&=3"\N>CY\^, Q-L3!;/F:/_^&UPG&%XH)>I<, MQ.Q?=W75-E>?[3Z#&CTU+L?+>]/I# ^6 HE$8CESNO II5D59&S M9/RAC+G",8?7I!WB86WD;%:?&O;PGH9L^)##N.7K(RT6+"5R0[0"\.Q_IB IRG6T2 MC98=:BTH>[2[S-BQ8Y2MHE58A ]IE)D8HEBB.8;?X8TNQ?Y1"6/^XF]*I8*> M/X"2'S@M\ "F;UQ96MS@X8]O;G^ M[8GW'WW;\>''XJHF^-?.IR1$YL98WD\X?3P[Y=IK25I#ZV6)>#@W?1OY?:6Y>2GIJ'Q$ M _GA7'JS"T.=P;2^>;:0'E]VA..6:W1CH\-E9WT_P+WR M,DH)&CF_U&1J GZ%"O+=0I%K*-IKLK6'(U.@6.6:UDM#S,G)858?P/JS9W5T M*_!]@V]KU)5.< ?H)PNP"2E.'+BX/S/S.3-0R"=<#?15O.1BR"A\B-$ 2M]]^), MV'E6%2_3:8YBP>OOV$3K9J2E%23WE-L(AAXB;YFOUQO3!.=3XS69Z(QNY",REV ^T;5WB[[BQPA-W@?!OF#EE. MOICRE/,%TP'_G>]/@7;Z>B7?V)!5+7&=XB\>IN$R/>ZSA*IRF?B0A\T!O>GOC,Y@RJQ$P MBO2"-R1G&JU%T[>0YJ;';2NJ"/,LH@SZO+)E#M.?MW,:;RNA:9?TEDYN>FX+ M8ZR7J*#]$]]C=/XEZ]T^0ESOJ!VT@Q:BDY;Z((1PQ9P*D@>6+U8_6HP< Z.% M?Y'L9?M!D\#X:2HH+H9XD@IZ.8B$$X9-)%;!#ZB@L%_/>Z4-L8G$'=;P540! M%?3);7-GU?I#Y1\@<3_$O'F;P;&V?[P/7[.(]J'=[]^^"5*3FE7QBXG M$Y\K9*4%Q-N*".F>^#T?E\7J[>6'W[>,/1;4TS,WXHRJ(?FZS]_P&QR=ZFQ- M2S/F:!'76&H5XU"4KUS9V]7L(D,%N;R129 *N$$Y;LCKTW*8XXEZ^[$AF-,- MKH$$0Q^3R8#N3X\U9%#'NXJ9%I/\7>],GMIU9U>6S.T]+U:AS:[$:TXB5:_T M91\L,-6[RC9*[E02,1I?2B&5?,Q*"^XY+J'])(=^/>VRD76KG% 7O8R [*&V M._S&\1)-F)+,F*\#1;VPA8^>J:SY'T?Q22X,$K?WX@.I(#=P!4J,U,91=K@; M9C$^TZZ;0LEI\GU1'N$CNK3(^#HS'<'4+M_3ZAGD41/\7WS:_W\!*'__@3;7 MBL\,85YEW)+\>7,SX0W:Q!'.Z%E]Y5FRQK*$X5C_(&.!ATV,!7I+(_J0][5, M,B/#Z+9.Z,K/A?4@*8Q',>WK(@P9>/89W%H(-"$-;FGR"P8<6VVT5"Z%N MHY/[O U/VF#$547:/ZF=V]K- *#"@#_ I)(A+BZV[&FBYD6D*'MQU6&/\ ^N M"V838_%D^W3V!S:Z%3UA[@G?FLZG.M9]J]Z.Q^$K\Y _=.A&8!&<7YW35N]& M.*+%E(=3)!+!'I[E,3 0S;"9R>GRB$+3%RC]\()6OD,M!AI^B#6'\V"[9JUF M8$PP>Z\B'%'<5"L(ZEKH H/-!<7?W 7N9F]2GX@<'HSUED0!!,[Y;Q[[_.\4 MJVL#>$D3O;(O?>,)&;GBO?_3HVPI#%3$ZEJ\V+.TM+@+"J>[G.RE-+&QH2ET ME%W=QEF77,I\&V\$6<(/1M#.+1E^@T1MX5\$*L]T.U%!5<$8HF?)TH401W+1 M;,/BX+7T9# F*J/T!EZX5[@R4OZFQ7/;B9RACA9_P:8W3OF,O4JL>(SM7WGI M_WC8_1(F*1WQ+J=V+/,2?JF?^T[,H>?T^O(2?#9,)GPJFO+JNQ]GUW-8-TQ] M?KI_.YRGEQ"PSLC6'?+[LA"+N^3#AU;OD53JW.JJ6$\8"$,V$F[P^9(UE^/M M$L*;9Z@@1S&?#&;#U'#GM\R)F0!"BO_Q9ROL-I2OM!9##E-!0FTAI%B'<6VF M7HDY">TZY:[W"?"BY/3/+AAOSLM=+=IMYY=J58(P&F7P\SKB3QL5Z&5Y'*N! M%N2=_*.7VO\AI\[;#[2AK22BF3-N17W#N)(B9FLW\A;26,=;-IHDQE845U[A M/ECL<=JXJJ>[[8 X[HNCQ;+1HX]L)1XWL/>ZYI/2PZ# G[]F4-:->=F^E=+' M/.%_4>#!4O,C&Z"#H9_IE6TUY-R M3)V<8$31Q1T_B22%V\C*KIP&+>A7%KC_]#N\HI/CED!G#417VBS%%I6G?TE(#[M*SYZ9K=G^N?CAXF1"P M481GZN%(]VUG$.9JU- (GQ*]UK\>BUEQ#'@XB-8H$*)+.JO OZS)Q.M-%XV_ MM1"1R$F8;(;,8"3J4686Z*B@G0,;%9(R_D<'Y,?W MI7N\O/#>E(&'P?UA,XDEXXJ-PUR1[TBS2&S)1MQ6I53C3=4GO3:.J"M]RW5M M)[I,KI:XIIN\)BOC[$#0 X]3=B5/KFV2;DS)G8GWG*9=LJQ,U$*P%H?"U[8V M6'/I18$Y[CL_O#IEM8:'J[@@E+,WUX:]21E/MB. XU&("ON9D5(".TVO@30L MI()H,@T>9_0&V&=ZN ?_\L2F)\;;HUC"#>SSJ]1ZT[D 3>9*I$C8O0%Z#+6M M1P?;0\M1@W,_8E<:A6#O]2Y8_ 675WSQ-J;[Q[VC<7)%A&(:6S!LNSC-DE;H M0;*RLTH8^NS":I,ZU,];N"-%[ 22_H[E^Q=7'[>RC1\*9)WH"+M.-Q3>X!5@ MT]J+=A4Y)GZK/\6PG=[KYD1Z90PT4;V^H+*]CQ3]H!AGB%&PY37U4T%)OF+9%(!F9*-6SV,25UWS)C=;YF#+T5=(3&8Z'.#N -^_FV33$'E*(N@XE60U10 MN30:-74."_1%.7QF86N?J_D6RP(.+P#8MLD$M7"IIQZC'<5 +K2%3YXU<*:" M)/<2M+=&J2!M^)14&71JP9.UQ4:6/T;%21B0 6U M2\;W -6A@GIPFT=HM/X#3M*,!*Z$GR9EL#L*>DWEJB ?Z E7KZ4 M#[0C0QOL-*\+7>[]7BYZ:_=I#(P0L@74Y]WA62HHI6)ARTP8152*VAH719'W M>P%ME7V82*P_:?B3B7.H(+_O;Y. MQ'?WW;PF1;/=YLGT&I!"XFUU_4WQO"A M@G2"LBGJI@#:4$8 \T:$#]Z!Q5,<:FE&_CKS;XS,3S.R-6#DWGH,+/RM]T!^\N;/:CAV^.)FV(8^-?KI0N4IP?F$XF++']I&7[+S 5%5*35 M]2/IG6-]PH(SK3?PJ,U]7*7PR<_.KI1G8@648 )B+7J "AH7AA'>S. 6SRW7 M;[',HR;/PB;P>530@?W;Q<)HQ>)_,<&/8OM(28Y_>1DHEWV[7#A0+F*[W!A: MN=>^EPM>1FVQ7O[U5>8?KS+37EU8B_WUU>IYSZ9)BMY)&$GC[35I6&0A= M-A6T>@X#W^Y>+!KHWC!:]VJ!'U5JKV!IQ=(2(TKN),B2-U@!<[?[ HWMP*Y1 M"F)AY'0%8$CJ47;E A LI19-'O5# .7&_[9<%/S#Q*_E&H(?)6A#E_M*@6%C MO]8 __*8E$+Q8@!^?TH2>#:UX %T;RN"HLY)Z]Y4O;R@X8%1&I+[@-Z[%EV>[5?$2Y&FBB?%_)10( MX9SI%VQ!@<)T*Y89\WL"?!VT:1=L=89SI?[[15K3XX\#IVOV,DY_8^L M7[Y$:5>?D9P%"&_U/?<0P@ !?O3.4P>ZA1V$RC$JR"+25G^\@KG^ZH',Y[I% MZT%X5[8S472T*];TVU>LL2JC(760D(W8WN*O[Z<,?/W[8N_XWEXS>B7\OM56 M'.$O!1G&1,^$];AS$V\]7A-2R],\>/S!>;E1_7M89&O7VRMZ]ICT:PUNVB.J MY(LI!U+:&:(S.=;J(3Z$8W'>7R?VWX@%4./Z]&)I$/M+'M7C_*\X5!%AYT Q M!5:.+;(H4XF='O^">_C_Q[Y__X&@[:$3/$[#CSS-Q>19?(XY&%V[QUM["#61 M[:#CP54_=HF#"K(,.\W"L+$=WH:E#)]9X+T?Z]W6$1O5N/5M.A@]J_R^S=UX M2>Z1A&M9MG"P8CFL_X*5" ?-G>5T[ ?YQ(I0C@HLA]$CENG&VZI;L+=EZ6R= M*[L6Z%\JJ5^5VSL^HUA3IN=FO)07)M1CPE_V*CA7.@]R5N_J1QF P\)D_HB$ M])+@Q?2V\+M>YA1EZ$4ER.V[MKF4C$'8Z2(O&17PTHTR8ZX1W-M%R9+*K\E# M^=,@G'30FS ) /731*8_P?ZOT :&=V,;T^1XRMY9T2RMU";;PY&I\_JE=V*X M*21404]%7ZCVI8+]]WVA>R[)KK'5Y+T6O.>)<+;_FYX](I$*^C(!_88G QO! M'&P%H!&.'F5 M77W_S#=QP7:H:&=)D478+>58$9@A)+NTQJT/O.WVMH.'X2N M<).N4$%'*.?WG0HB*_(5:DR1?MOYS,8%2+/0Z-MS8FIY+79!,*[S(:JSC(Y>');L)AC MR84T:Y6[<];/YH*^]AJGY?F=+[::R&HS.5H5=C+KSK4%)@YA@N%,\@^+'$X\ M#9%89VAF>%TAL(3(F@+PPDA;F$>($!H>Z/NMP^ S--6EG]1/%"R9TK$R[EF=)W'B<. M?FY23A "AF1JR"]%YLHM'$L-+9/EL$:<]:]E83F:1GT/? M5H!7+E+T,9(#[D--8Y[5V=.7-J7&I 57/D3?\!0Q^I:99#"N]>S%I9*EL+OF MY%=/^264E*XQ=N?K83RS$_[_<\?]^N 3@%>>VU-!7-!5Q,=)BD4B:Q$R*E^T M8(^4/_$!\NHGCRQDAL:#85U>.H=7'JI9NELY1^[P=G_XT/9B\>O"\>MFC$!E M-&&+;VB9X5NUW;E6]BYLY1!@K#XBML5&T^5[;0.TQ(I\;AJ)NQ\0;WB:=%35 MKS\M*3?B WLB;[=]=M,;]WUT0"N4_HD3B5^;_*=?#?^]]!%?Y-E?W+@0<_O5 MQ="Q2!T6M>NCTMW+L=-ZJN9Q8>F[HRUF9KB%JDO92\=-; ^U/]'PWN:T&KB^; M#\ZK4A!]WLX 0P@:VI%5;JS,!@V]?F4EF7(F+F^].=V?2\0P5??/DE]P.-*F9(1VNU(VUPFYZE3"?H+V&S]Y.ZP!6 M+EZ&]A+N>Q3;5JP1[#V<=>,!,(O&;GH)>2Q@2Y$&N$T26HL>C\ZQ6T-A*Q8R M(L@AAL,TX1GA<((6/E<6O85".4P/8RNQ"]X7V?.282.B..6 M\%X95!! 4GZ)AN0]\5-2^3SMA0L/73_!4XNIH!"IWGJ?$4A>P.^,4H#,/+\S MD2V\8.)UO'44)VTHB?&\Q9"/1NC"!@:*H-DYS,][E-*F(_?6^'"@'*^;TE+<9;]*YBG M*0?[(&L]3[ZG/-O6O,7_D@8-'X5RMBVCPY9^%)PN$'I>9\MKJL5^Y4Z$DY!E MLASNA=;9U([KXRP,F2SN=)CD,#D31AD+606^*USY\;8V@PJ(712I&8:W4WXN M7 9CZR=4ZB^4EO/IE=2.[[PGE]*S7JCK)M_N+=OAE^E6K&H:_\T@3>:4 W@< M?#E=(L3+U_5I2I'F1E37A(0&%729;H+5=\Y4%$J'_D5EA_A+-Z<\81SJ, MAQ-KB>^"QLS(=A:-J1^^/GWG>KV%>2RV#)[K@3*?IR=6$C0=C8LHO0,;37%% MQEP:PV7[+EW2] \6I.==@;S]%J0K;\ N:\'+\[=UW0\*-V;]#8W.;^@R,"Q5>#9;? UK\8D328S(R9)(SJ]6#@O ML#ZJ]-9-H^:I(">O_K0J%U@ZJ'%PX[7UW7C%.IJE[ M_7HQ[-Y!&$ES?R!Y:7ZM=QQA/>[8KCY7S*ZV& MT$LDF4Z;01^K*%?V)XMTM0^/N0M?/J5^U?5\?_+%Y*<71UX(OCBER@8L M'<:O+J88'*T_:WD_*PD$.K%KB%7^0@;'6ML+,Y?+$ZECX6'RW^3QB17.N?^B MZS^5'*BOS!1L!4UBL.0&4086VF_- ":*?ZQC-I% _ ?V#N O88(_(PD+L&I M(%<]6H [V*VV/]-7_=\B1-3W[5X 6)F4R/I1H^8KSQ;$UPY?'5V'-^94Y%/D MYK3D/E5)F"W4"_?-ZHCCIRW3,&[6XR8!U=S=,O>.-"W0HK'\N 41$K)<2PP) MV]BS@AX%-Y\1_F MJ^FB)6Q#DKS%,O.(1;OTTGA_1:9?QO/K81Y!J-<-.1=- M[Q>R8:!!A[+U^9&J>0SJ*<;3F$\R85 OD2%P2,SS1D!F<,'IZ*J)]^&< M+YN-LT8X.9\F)]R;>"'-<>WJ?6N:GF[I/SE0B)7P+YT^MNHN= VH$-RNHF#8 M/#\8[%*A[;".X>,=R6RS<,DYI#$(WA_^E*#[0:;_V1C;?=#5RM1)_P..54V]?DPVN)/,C47P,?>C$ M66_> K2&W.E3YK 4VB7:GQ_/]!"*A+RW%7 (\/.DU+PL#=%D JU]!H M%A+P:L7I>7P\E6F<[H9?@K'D18N:B:99[G8N*[\M&\@'X<0$C%O25/Z3A)_; M@ZNG'"T@YW$;E@$<1="G?S!!]+HE@4[)2SV$4U%(HT>Q]=6\85^=NP;3O5 ] MR]&L9,>SC7'/NT^-&M,8 _COUOB/#*&U+5>"DT?(F]]"[B M-,NI[)W[:5-?=LU:-TP.[6KDC2X]\F]IVC^X[_!GYLO^O2P# M".1*$G&+$N*R9E?CD]9ZBO!UL;8.4YM0KV$9:S7;DG,]+-%$4O#"M$'TDVKT M3LE73R($D=@7KQZL-[^!Y#]HT7M%>6.^JA$25+5!!76^V_"&0?T$8(7BT6O( M@RUE,3Z!LJO'0X)OPC]!.Z06-XL1PU^SBFCZN#:!B. M)N3&:6<8$BH3Z*?1E2@51 4MZ9PG3F6787&H'8"$/>FR7^"'P*YT&5+J[ " M'LR(R$;[K'5%( QPV-(^07PO.<1GNL?*>6$1*$1K%9^M%TKC,UHT.C,DZL1: MY$X%/5L.L*&Y]#;LG;DH>"1=,3O6CL!N1P4IB&P8XYDHRQ>0GK*;"B$;JQ+6 M[O.,^-._<]ZK9+>A&47V >]'4$'B:"\J:+[+DM385H8F!9520>E(*F@WQAPU M]+&S_BU\(BV1[#*98T\16[ARMC"6N]3N-E8_\DB9-Z=F3VBR A64I3HI#>Z4 M6H-,;,T,)!F<(XH0&8A0MS,L9RA;&NE*VES#T=@ 0-BTM=[A M<2J> /?8JO#$4U HI^4*45HPKB,> ";[*$C+U9"][2#H#@8*C*IP&OZA=W0$ MR$0Q3;SWJUYO"OA$R,VE]YBGK/5692A%?[@LX&#,G7?:0R/[7;828PWYVL?Q M"\_K+TYYR^$;( MG0PX]E6O=-VT:/[:NGM-:8.E\G0KB7Z-K<5^5*CN6N^QY MD&O4V]E-%_DHH&EW?L/?)!IN5[]!FR &BGJLQ+T+>]/F(GP$J:"+:^KD8C"W MWV.2MO*S'3_+!Y_\E7QP=5CB7OUGV'CHL@+QJ6V50F^?RGR&YC?'HYUVMG,8 M)V=5ZYS2DXH1]V9OI;\4N/& >6_(R5MHM8Z8S,SSKY5WZ./:Q+BX!F#ZO!29SWS[@;4HYS@TBMJULOB4Q79CA$..OUW?K<=N6U^;=S M+U*N-0C('/V0*^A<":^"C52V&BTAE+K,37#L$4N1^>Y5$]XS6] M$1-GD.7V1/))79M;!6$2YX&TRY[P##G0=.$"MHY1:V#'9Q:A#_E=]((1C]1. MWE+=L;%^=.;DOR)*P/_QAG_O@W0HF7=T1'$K;W$P'6)EHZ^G,0]]%;ON'=NG MKBZ)MTV<;\H2%[^A_ZSAH.@W@O2%$PDQ J:2$5EAHZ^QP,;2]AO1VMVV#?F3 M*S>3B?*+ZW#?^-CB,)^-#8>7:2G]_.CNO0T+L" F(4NI@NS,7;$-@\I9FH.: M\F?V//4?L6WC6#X*M!F3\!_O[0!P"RIB2V_1=93N$3EK7O%IA[5R;+\[2YN. M3.'5+A,1R,,NR4)AF?TS$O1A7TTOI-2,]E1<\/!OCKC90G-=!)#CB/1]B;R4 M6P2N1L/^AD-1#PCF#VP-OPQURJP(,3%I#3=(: HS' DO$-0X-0 _#&79T_ B MYE0R;)OX[/A!GXIH#K)G]N1+4640;SM<5&PXX\HLW"_>79-UX$/"7L%P@NRC M=JU93,5QF0>CL;-%,[:ZF;\94; M<14VR@I\4T8_ICWZ;MRT5_>%B^J!"U*&" M+G]MIP#@_II'U[<%@QP7'KJ(+,H*@>&!>D=,*21GFLRDP>5N)_IQN,9*L/D$ M]*C*)#/]O,[$Y*)<5$K75KM*:VZ6CS6UIQN7-%Q.BP %U^"_%WQ_B935R?,]T-M P2<194 MF[^C;U2IV'^3A@IEA;;M_?#CQGPWR%.U'_VP9^M /P'^1DZCE#N MXP37%[Y\#P):OUJK*ZB_H32-FX89+U.&FSY M\B(A8]=Z C3"XXI8[)B6(:)Q;W=M]4M_C!:*/;FH/*2Z7A&5=YH*HEL.,;]J MG9=KJZ?=<-\'RT5TNE0PWJ=>.M><*/UYJUQE&6\-WE"P=>4O]B!,2/O8L6N' M98OAW]]5T.:1'PW9V.O\[&[&=- .CFA1D0HS-Z M%6$\)09'/N:< '=<9_L+@5%8.GVGY8*R+Y\DUZL"%DUZ [$5 M.X[+S%)/UK1.:L,:.%@9R@/"A&($F!9[T6E/_"!RZ9CS9$VY3 MOL8Z434J\.G":C^W1MR%I-;=J.3DZ 9*M]K>(%0-^+[[B 6G!>Q5XD8*,7#M M.$:OT=QQO=-!2N63.[CE[BJ9HUG"NN6TT;$=N H?=9?/!, @?"P9RTCS.>@[Y/06K2$$]M1 I[\$C* MIIWR6>LIM6Y]X!#K=UK3O[DSS8!>UR*2:SC[L)J%OF/8^35VQ#E2N:/X98[ M]N"(?JR*J>C0H'"4(1W9KQO,WW%X5KFL<98W,6BM9R0+\_7*1<9FMA#M@1[+ M$2[)-; ,:]JW$>E(UY*CTG"PO'-0U-S1X-N?,9 MZ>D9STZ&R9]]?ONN B-H=Z*3F8;:O,5>^>N@PQP)12NRAVP$/QP]PECS&@32 M"%,&[>*(V]';B6H6H!Q#EWJ>)*$P<#&+?-))(_GU?@/4TG)"$O!?0L3@_-Y]M?&Q@Y]CUZP8Z6MW&5==[U2G4W'\XI/N[MQA]G>ID,^6V3K4=+Z)CG.L\OVXH&755GS M$GGKEUOP$FE/^@S<"S^*<9G:6'M=SRDK=*F[''+PZ9?1)%1P.#@HZ?8KH1+> M :W9F@+&%OFZ[.RR6+Q?67EH6J24E@MG=$@F%U>N@2VI#H^:5[<3P]1$N;H> M,M1)/O]/@/9_@L3=2ES,3"3YP%O!FX\W>H#]-3&/MK4B?H3B MR4'"1T[!UM?FVX$I>6ZN;8O,XDDKY#WN#Z[2U"GBR0[F7>,,4JYT]8:= 'XX MAL?B\3G]O8/Y\2<$-$_P.(^,US2&UC5>9.,>$ ZUFK("]=#?=FAZ=FTGC6%X MD\LVJONA!RF*!//:A*%DDM)6IQY)(#]_A>.:>L?DQ6D.)KU'KD;L;Z,HX)@Z M)=FH>H'-F)CT"^<8:1$> WZT-P6VZ#LAZT#>393L 7-O7N&^*(+6MMV''ZO5 M;+Y;S((OQ-]MG\<\*9V>[M>U-C-Z,I&"GICL"?F3DY%Z?0)7Q>;,Z59[JXJ6NM,>WA52DL'/=2JC9E\1'6T M%6-V.VMTJO=VG4S+?"$+V +_[[=A+J/\6?Y&P4X.U=M!'/D-3:'U9RYGA,D^ M!"7ME+_P>?OP-Y$*.O"$XMP-A7KFAG]CJ,/T7H,?A8C.QY0&]DY7:WXHMMV< M+_=Z] #OZDVOL3M-"_NYEE-9S*[!KUZ;MS!ZCV52S)-O0#GJB%\&N0[;*YWQ MX'WL89;IH6PO3H6F1NJ8V- \G8XM-8]!)[F>T.J9CU@^3#%DA/.AQDNZ,/*E M>9<"Y[&-.IYM8SO+V41G(,VS9[UY7W[BV5_"@+RZNE&^NRFWHU":\_92GS+M M'.'1WQ2K;0_=_^DAQTHY+O+6<+_G? NLT/IA*C18J*L%EX!M:%16;RQ)E?M< MI(+X6GL>SZ)>7RZA1_9!.?A?A-BO(>XH:K['Y\4[W&!4G5=JV\]+;T5T<)L& M'7HX\ZR[&X#[7A@"9'(H%NTPB7RQU#:!-)S#W @,'AD:3'08YWGDZ6L_6BXJ: MLTQ'ZP*V:=:F^64_B=UL;D FI]56HC$N6_>LV>6GH)L]',%"8OFI#S/'3*3- M6 $S/Z&"0N'+3_O!3=K?@BYW-.8R.Y(3Y_H^D@K&HDR,.\R?9D"5%"?I>\O4 M2J5U#N^RR;F]NAI$\&WK@348&P7!F[A\J>?[ ",4_BI1FF(1_F4^F MW$[/"Z/_YY46#M+?3(\M$J;<83 M^T5YWQ3,9"18X( _&,#0@O#'-"]JCV58D?46X@X.DXYE(5ED6+,LPNR&!U/H MKC+%&GO96&7V*,GP"-Q<-+EX@9NY]J*\VHTPN2Z,9W+U#_'BBK6M=WT^\@(. M*P:5B!H81%J9Y7F&6]O:H$*S:\R+UH>_:*4K,,1^&;=@O3&=-6W%'NSA/N+L M-J9I>O\S32#KK08P%0G<8E)%!+G11?C8*+0Q<)[.E#S7?TI2.<$LK?H!1-%F MB'-O:3PAW_)Q\#[7XU?K5N;Y*I1!YV&.Y](9. M677E'L%'3)%7V%XRR2.!SBS\]79LZ20MIEBS[ 24PDTY2 7Y5 IL.UG^ZCQ1 M ]RF0AG:(M? E^Z),5!!]K10N[ 3=C^_-SA)5 8F] =49"+E(ETUG$)G4$+; M!*B@/^T(U5>D0868& _L]B_A^500H2"')M+\-PE/) E6ZR\:IVW+,)B,OI*W]F(")B-9 CHM@47F1Z0L MIJ>FDCA.9V6E6TQG7NI""W;*,N[\2E<8Z_V\=]*3Y7D8/E(]39:HDK0S-?'< M?@G>P=G+2(6^6=XH_?RB"/ XY/&!,#?0?G'1]LD)V2;,W,K!OVXTSM-HTPO/3:WOE-V<>SB?7(%-G03W4' MP3=Y.OVUY$_)GHF$/*8IIA[/M2XS//Q&?K-Q0#>^6@.I"LWR/96SBHHQO581 MLOGV:6(UQ3NFJD"%RZGFW%8&&=>V/"7U,$^_6::8C9^D,GN* H^2GGRT/K\Q M1)%+;Q*^]F0>ZC?BVUZ=NJBETQ.XO!/R;IR'TBD1KS=7]-KD*P'0($OFO") M>[1MLWKE/9R0^-6S#ES.0$HL@K?>0(UVK#U/]#QFT&5*!<5H@Y)<>%?34M@ U;]:=/\% S#2G M@EA*\*I4$*(\&"]2[1XL$6XGK#!D&>LNT3.>#75D8#\*VAQ&G MLE8Q).0&L,\, Q).>9=A&0KE_-$2#8=Y3/=X.*.[L)MN(C3J"8R?!0P$@:>E M3(]W8:APOD]+D>AL[S'Q/8PO@W,9%I]QFG$2+?M7S@*XH1 M3D(.;\*$1T+]^%L/!JO=AJ0Z-$ 6CH<K\_76F;I/ QO\)9< M83GRM1H_E/"E<2,-K>V7[7J]/$F!MTD"9J.>\2R>;@:6PJ"V9+\'8)NN++^* M^<*]D-ASW17YB+K*1/Z9#*(]].H&V&JZ8]$V,*,6]5*"M,*5/U6*&*5\:;3C MJ^9ZFB(4!NJP,8CUBX0=FZ>?+N$"VX6D* A'1@2&7UWLDA6<#>4_006UZ,GR M]L57N[V]'7?A-;!7JZ-_7(: M7=JOFCAFIK;J6(SJ_SLPPU\?_$Z"QIP5Z,AA\!+-^\%/!9$%*%>HH'F\-XT^ M3NG\J=Z^L4L :0! %G*2W$$%O6<(@I'WDVBP6)?XX_U!5\K1Y[0\.7,,9+7# MM$1*56C:7K49]$?)5GY^D',./@*#-]DBD*7-^\FMI5!K;RQEFG?/Y38B]&6- MVLG<(8S0'GG*S+JONEIN9I9PSNUE-5,S[GD'H:.M[/4*?C1U%O'+SS7+\2/* M4$$BT->)32IC9[T3>QD5*D3#W16":@E(*5/'\/8YVZ^#@HX?G^9'VN?GBM@; M:^FD?IE(>3YPPOR%QN2<_XR;HEN#$UT[*S*C*RRY[+LP.1B@H M29>YY#CX@OM88*6IZ<=Z9BOK![[(<]:/G5^SN-^IKBFS1XE)6HFG7H"6/.Z? MQUJ23:;\;\7-9(5B&MJ_7>U[=:8\78_O379&_2B_6XNWF"9ZS%%HS3I4I44/*AI]ISMEM$ >2, M2;H/.BE4-X2_-UY2CS7ZF'73P:JHMO-:S>E95F)&,?++ ,&P0/_<,0/-%$8$ M.<.*8DU&I1,?#8H]G*?PDR6&WN94[7;7E;K,50"15*^)CG^2/R+O%YP+;)!CM'9*/<_K_%X9.110DQO0 MB5%@%KH0OXHXM)[H&(?H'U25X*_(&BG7LE)=<4 ^,RR^( MGGF/F!A\:_KB]8*FEJ]P^\D5H9?!-0^NO@UTE*-.;W>_I4G2, M0V#>:D.OMGA%<%[M8K/1%(<@RETS'#"2%>QW!_OB.L4R<7TE9$( Z'_<\@J M(>AHQV93_K_Z46D"R-- )Z')7^$ST)%ZRN@Z[30'.?)\M3>:D?*!A;%&N6ED MC<)EA=U!>X1ELI*O.,]7*D;/'G[TT%Q S/C1@^585T>;EB+97<7"%,>GV4PQ M59/\3"$AS0^6-TK'Y*>S,C."Y;@O34B[C6G)WOU,TQ,*_EB'[MI(])>ZG)@: M'!PTL16?:,?J*0@%#7GJ.=O$Y=@R.-BT5KW(OD-6MJ.+KBMW/E[HU%47+JFZ M^]74S.E[1VB;1&4@O)&.PF3ZL2S9SYRL3S$C1>WOC6\]HSHLK-T4,R+U>(;2 M'JII^7Z*Y%;#ECIX&OV-^#CO&_?7%)'%_EM\VL"X1JKUJ&MUJ?=V:$AJRVKO MUM2(<,JO5U725%(]%7G@E?LW3D,1M=,L\KN/2)ZC51KZ[U_!#Y;%EGGXC2+U MYY6Q"X9-_=X*O6(RKWOG^990KGO%;.9FK*IQF] MN,%AJDY3[3XD-@']7.2*=.R<3PQ.;-[IW=QC8'JOL$^I9QG!)PO95212>"@F MD_O^]"RGW+$Y?:_&]^E6.=J",U/MTGXQ;)U MZ?RF9H:WLK-JJS,2BXM+4WV M:!H8:!S/S/Z0G?FF55U34YW?/$R>)1J#"1!@E*<=A,S\:.5_,UGD?^0,^L_4 M*/Z=-#*Z;G"1D$34;/TZNY.YUL2S+7!/?_1S'W46]=R ?->U$Z6BY=]:CW8( M"S!GZ>H;QJ;FFF73L\DK?6MDL'67(O!%+>BMI76/@@+K3S? PH4/NC^1KJ+7 M#U['OT$Y]E/6*G4-E*\RG!J]<7#9K,J._WG5WD^H-<*%Q1D5FH8.Y3 ];EOV M2V(79[W<"E*&KW8NAX\L&HOOJ")SB]/C(4Q\_GI&F'BPT>ELX^+K+3;9V84A!/W0+TZW M<Y[WU*E:2"C3D: 1'H*?/I:7M%C<2A38]C(&U$T0C\7E+JO/!=I MSNQRUAW ,!$9H8=#CPX'4D&:IE%DYOXA9EYYC-@)B.\N\B31B;VP[_X=H>:3 MOWS<.5[@'C@G_Z%E#._HO'<]+#]9ON5^[)N7^M/2E%>/=VQ)Q-:>M0_BOZBZ M/"6]V_Y+Z?F[*>T'G/K7UC+0R#I=^CU&.T-N$%Q$6D!D1F=LY;19MD5" MJ64!&V$>,8@*\IN\2P4M0.,(@3 W,$$,V"!C'L'K4_"'(&OI9>FM5)!@+G1T MR;D(6NZ&9_R=Z:X$IVDJO:F@_:C%P87$K0&;*^XW" #+=D#"5@%N.!S[ 4^* M/<*+7-H2@V[,M>F&;,'1E,IEL0\#6AFLZ<;Y3&Y9F^(1Q],/-!UXRSUM"NZ+ M29#DM98=TW=DV&WOW=-A[>D@YI#[D?X*^+-7M.#IECE5UW/H'5DXCH M&I2O569XOPQ].RT%MUYM_Q&^<+QJDY:AGA[-N(]02KN+U8O: 'N.=+W".*]N MD@@JVI-R?)7_5AZ<#/T* M?'9OA9#9XMO6VL"L&M-IM=P7.8*-S/8-U6\GGDHVR?EU!Y?[SB_=62P.$[@E MJFGN[F!LCQ1N38O:TH D$8.#S)<7*;(2V2L"CXJ(6,_HTM%O6"X!3H[!;PFB M'D%+J+1W;^!'!\L8Z-5R#MGMIX*XLEMZ>=2J+[&=>FCZRL/--VYZO@C7?,2; M\X,/9+C9 #SE@/:5J[Y0?NOPM^L1N_E!I#9"_CB JX27/LW9>[M>E7OLOY_M MH'UUD8+?;G[Z)8Y]MP-1QVY_"!YL(-MNH#H2&3VZ3G=C]GR\2F*P&%U5T;J8 M(G0ZIS%R:9_Y$#,2JJ&+X(1=O,N:GJ7%_QB2]KFP\R5Q?7N)%+_.242OYNO%QN136 M.X]W6K5J0!P%S+I*B@X[Y(*&'1>8&VQ:7X_ F5FLX6>_IE/O"" MN?6\OHP(%.EZ@N?\T[;A1X*"_>(0NX-1J5X^VD'28DSIG#X MMWPX$$:3[RP#J]WS W!.I0YR-D6FVVX>46VRC-I?AG,PP?\_]KX]'LIU_7M: M*6LI=%"24%'.=$(14ZOD3!)"C")"C/-Y3"B5,"$4H1QR-LYR&)/(6=)@B#'D M;##.,\,A=?CMO=^]]OZ]O_W^]OM[UQ]]/KG-/)[GON_GOJ[O=7VO[[5F MZRI+L-Z;Z[5/L\9,O-.LZHA,AF8HVUZ=\FG[FV67#L17%QMVCIZW -S&BM_? MG!R6*\#)/YG*.>"=OTS-ZNJ);M1(^T M*[[3D'8M\ZV/1W>'A"ATB+L'TO96>-?TBG'(/$-B9MD$YX"8<"8D8>:_; MCJ_D5TB,OK+R3^T#[OJC9:NS?7T#%N/]YV;:TG]=QQ9\^\C9&Q"< 8+;*(#)< M+S38V>JN_9Y@I^WG:>72B!^*0N:?O/JQ'[C8J^0E9V"V>>AMS+OD%Z2#XOTC MC^J;LSOZW67>?^JYCH?;JQ_;H]_EI4M7G[(=X,IERPD+38KCY9?2O9N>]="^ M _ =UGY_ARB%Q6DFC$"BM]96^L(WU0,Q*'H^W7;*FPFWRMXONX$=R3[5 .%8%E[/OD,(+)@M4; MY^0/\NPW+*T:0]>>WY\HCQC-@5<3E"B>/0;9'&'YMRO&\W*?B5V6.1)X-"/T M0"H .;K^[J3]OY:/?-+HCSQ!#((=N)6/?"8DRSRWHNIT5F.B?[VJW%.'BQSY M#1O%P1DC8#4VG6[&7Z>E*CR/ '?.:V2,T'P!>LSGR[/1PL1MX7-Z<7[YB<>T M_:MD[W9[P,VTS/8\LUM,P)6FOFE1XT-J=EFMMKN>J!*_\\4,\*,-:IR1'TJ0 M+SM:O$_U&Z2?\C,8-C:S-DI)F%DSMW=3+C9&):T&BQ/X$SG-STPUA+:7HNHT MI9L//T/@*WL,W.82VS'E7%9><.7&1$(_VAG?$=,QA^B(:[*E<+F)7E^;+CH7 MUF.D86]O&UD193=F:]4,QCRT?T_0?:/TMA)6RKRTZOEI*@)%8G1\%JY8FC^X^O.9CVPG.9%HCM$G!OF:H"U4H<^2Z:+ M:N5#8P/X.1RXJ:,XE=NAM;=4 M!>9F)QBT?*-30#PKJ]D/[5'R-XL(_WH["1+;3S,'7>@-R 4_I@5R_L(P_29,A3;9P2%YEMNMQ[-6P(_5="=_&0[26\NT72KW+9LUW7HXCR M:," _=>^OR@"+61L>!&FI7_)_)*^LH#C/NL].,/.;ISFK:ST[+DZ4JFI4,>W[6DCX]@EH5[CT$1V'R7J#%2Q?> ME&IP7_7.^Q:QP^:TJCTC:G;X]/%WT)P/?.))(,%"A^SC[6W*O.5ZVO_*S^WJ=P M>712D$2PF#QR_\[AH"UL_$'A(2'/^3 0+,CM8/H5X MB.*2\/*R)2MCBYPMK,-:Q*86^4-2$H]G.4OODSHV%IE;F IX1FB/3/32#N \ MC/2_,37MW_.1"<-X1-'4>O4YXL\JV1:(%1-\/O>:EF[;4R44DJUIWE'!YBIN MG+'KUI"'I!0?GW$PL*HAV'/8EPKMW.,*V#BD?^G<;&LOMBX[.UL^MB%PI)]A MCE\P-#^88+4R?D U_ U\_XL[>?,81\VC!RNS'QT$#@5WU=\?,EIS^=.?FN;F M/GPUU^M2$G);U;M#;FN7)_;U"]D,D]SZHUUL).9NIS30K9XL&14"*PI_=NWSDV]J^;G E-K"_](3^O\U8_LW M^ESIJRT]H]&8#U?-]1ID,MM_K#(K=,Y@'+8I+!4:0R#QM!N:A^ZY_0SG,E#8 M+2ZDHB[VM.T'9561#\:K^.=0'P(GQ=FT_P/Q;=IM#?;D]ET+B](7XT],ZZ]. MQ$"]"9QS# FP.@,Y&[,C:N'I>KDKI;L-U/Q@FB5IYJAAU68ZMY?Z:$Q)_0ZA9VC-VQK' M''<'-8Y*?N:MJ/EYMLTKBK-"U2 IRRPS.\X">C!C*LO4\+0&?.K;520W;=5Q M>_OI<;?7OB[0<0&!_GMNS9>^8 M H^[+VI>95PS"@\K"J;M::JCLQ=GRJ^;^6=WK0$>"G?K&X%\@JU#C&EYCC5X MB4NOB"1LA4'*, 3IR6"A'2A+BL:Z@\UB,8Q>(8LD=MQF_2() M#Q;N@6HIRR0W,E4336_=$/P)\.!F+M$ZO#]2@E@0M[(.6H8"W5>E $^^[E Q M0US2'&%">:PN_! M@NC F3]5?D)6=*;'LB#,I ZFDEM/FA )@/J1!)M*+-B0=GL&5YA78_L874G: MH,3A3JF@=:G%B<+ECS$ALH,/8($33Y#0K^$7QC!1%%$), MTDC@2L#,^LMR/ZN6(OC>+UH5#@*Y@-?N('?VV>EAM846EU Q18(#1K>NMTHO MU].FCS3[Y$%J?P+4=CBS0,EOQX6'XI,G2W8]OJ6CK=4L?*/YS)?3&E)A7]3; M9MI<9!;GOC&GM5K+9:5R35XL %?-@5CNW.G1G$?T'/":_8*8\(S)J*CPC%)S MDFJS#[C Q9$2>'W;5R51QVN50]XVO?"]C=PW5OSZQ M+9!B,?T1.GF4!9DP84%\:%^%UCA61%D0JPTKP&"#T4E0,E0)P,D7+=)8D)F- M@A$6Y#4 91)M&1,3=Y&3DEW)C AP+HC+NY%+N2Q(-7V6F['--YH%*=R@K#&# M9)D>R93DQ#? %]'7D*M*X.,A/ZNR()^*F4M+)=#E?=-ZS,:-1.+:CUA:#W(P MP/,1,PBCP8+T@L <5*_E94$4.]8[/GUF03X;9T'7!<"%P_Z_>N<]AD MXHD:/W=RF_G'Q:7J7JLPDS6-3TW70%R]$ M%&NQZ3;<<>4(%]D!.E?]?UG"-[F-=FXA+HUYVQUN27>C<186)C[L8L0]C.-\ M-\^WK_.,S &]L$]#12>9*]L-!*X6]EBY\K05&UR_$M50&P?Z+,+("2@]:IT% MH:E1>")'W[2NVGXTI[W,T8VF;=4*EU0S0N7G"V)FTE)@VR7=KUW(-15.21;> MHVR^K5LB*Q.XE[2_+%-T=PJ0\J?0$N>CS_:10V''JN!IQY.R'%S/.B96D@SN M3&1?A43-1=0TQX?M-U;73[,NQ 4Z@6TXRS2H8/+T'-/*W$'OXA/:MBZD(%/; M2MSJB7UQ*G?\5%)]T>"EYD&QP5&W41PQ0FO@0$NO9CD M^0+D*$UKA]8V9'-U6-#JV]2I'_?8%F!BBO@RA2>FVD"IMPO[Z8 !S$%*STB= M;L03!56LR;EA=[5%3Y>N>5E;3B!GT M"Y C=0K6U%)?J@"UT &&9F). 9_:; MNYFG[,C;D!Q$<"C,_J':G1]5M6[@YAG4I+YL>/T>X^G%D@%$W;E95XWC MH\E@">*[WY]*X>1:%B182 3Z HYTA$? #JP>LY@?[ ^ZG-TVEKT_)=IF9;PK M],WA5OBG^@&71BGO-M5=D?[1BB7%ZIU?OJCJFYSG600# ,-,?6*+\6OD\XQ& M=<7DW/W2(U^K:ETJDJAD[5B9@YRM7\W*(MA-O2TSN"6M"@YTG)D?FF]6RE,\ M'ZVYU-/5?;U]#M.=]\>G9W(R7<:**8-M%6)V \ MGD1#'';[MR^UY=V/UO @F+"M8$&2'BW=)W2V[S>F/?%_DV92)YE8V-O'&7TT M9(UJT_?TPD+RI-4=85#'*<6N#WNJ!N9UT^#B0+($4WVU:]^6GA3!-K),!_'9 MIZ* TEAIW/-L(_;%'R= 1O/?U,_9D#DJ9$&D9$>;EXQI.? 'C>XJ34JPC *: M^J0?^ZBMI8'Q-\5D6XE]OC.([:K"IR;<)/G%43\]TGB[[9M]6>I;M^M)) )" MC06)45BTH#ZDO_6=6C _%^1((:PG[-O&?9?^;+!W>O^,SKC',54C7O9#%NJK M3.+>E.;MW$)'C#IWX*\;=]5+Z%52C&;_<1,^/$O'06[!APL+%Q M#6_43?[R>,L RGYPF@7YB*:]8D&ZD'4H1N,L&&2#_VT5U+\B%ZE"D^/HQU$V M_@O,5?\RJEY$/\9QZ7"=P4LB(H"L6KY&&<5XT9"MFOW%'>Z;G'RL5/N/!V\[7;*<\X9:AW4A,6BW(@ M %+/BPI0!([C 96?'2?%"K$2 0<\].SL%FH-*BNU IRD<@A@ BW.X,=7Y/QPPY4YX,;#M M^FL?,04O3?_0?C>#D\SZ[I<":26V3,Y]!NAU8SRP%W]>@=+%1&FGNAJ^--)K M?94-K4Y%7EW_$*4C/+W_8.ZU<_#5^Y78.N"#&M5DNAB>)C;;^U7[44=^<::A M^67+,B]GIY<_EJ&US6R=# NA0SS)C>!%50T*D<-F0LUNUG7Z,OUS@L39J2/= M*0GYE>R%A<6&=H<05:L?Y?&/89/GHT2I_6"ZY>F@T'QY,NK%BQP[IH*_T)ST M^M66A9'%Q+[>*MFLK&&W#X;=M^3/*+6/&ZZ]V%]SM XE@5"KI%S76?1C[NN@ M]ZT/2H4(Y10S+BVH.1J)E#1A%/#SM@K/G^\).JC8/MN_UW90\2D_1[7J<175 M O$W^\*:S<<>IP1[VZ1$7^Y.L+T]LB\# MY>@X]B@"WS-S4]#-F7<(#;#46>%*(;<=6Q( ,B MX*\_)OS^@ZLTI@%VE20[EL&"A&Z9)[(@@7@GT!%C0?X5),*-@:'VQ;U,VPEO MY#?8#)8Q Z 0M/NN7UE%.L"K(PPXNT^9ULAO'4-(2M<(:!,JR?_0'\'^1>-% M=VVFNW_M5^1.7Z63O17PXA;X3>R I6*5K9[X'B<$4?J'TK%G]]"NIS(J"FWM27K=/3ZD>2,WY6'++0;VU*X;"H" MD[#'GKUH/Q^XBRU"[IWZK7"CLZF&$7+7#?5C>CS+5O<7]IF*J:=?.T<2G9D=*BS3TC+\Z9"E1. H^UJ1=W1T4I1@MWN) MA0,0/'(!$K?6# MP^LND*K6\6!/16(DF:"8IUO-C75?+/_.F";"]227#\TY=??QFS7O\[10;)F< MXU+8][:FX.Q:HVS8XQ3X?/QE%?S%4RY#0*9 M;C3CE(6*FDM.!UD0$7[[D&1V;:?]^:^/7Q)1^WSJ"6^M0&.7]P"JSD\QV";0 M[9P,XBSW$N"K? [JMPD4AWB)[/AY-GC[P@_)4C+FF M_,7:J8;K,3N=) [L4FM:F&Z2MQC/(*P[\"9E?$$;0C2_>BBLFU*13D5)C0GL M;.DT,4.L2BWO5;F2V1T^SBJIK9D?5@DS3H-]] CNS//<,R-+:,TD[A*ZHK7@ MNUZ4YTAWG4?O9B.?)K <>JM''^^:WPK837)D>0BDZ..-Z*C50<;J\G2YQ=I& M#"[#8LWOG=S4&%RWBE*#-ETA,-9SMNIB-D1Y5TC$(<2&*B]E';^.WPCFF0/; MUF-#?7<%%-[%W?^E\SS6=YH :F45J&!D?/OSR^.8AT%:9[$^@ZN#II_=5)H']?G+,WF$W$;3?WL(M40FBUA\OCJ3X<] M,-@/L,=52L-H]5N*'5M67^ITFW_[Y&FT&/I##'^5=X=NEK$^?PO;DXOJ[%]' M['JY#TGF!2:9C$;OIN6\E*E(]O"C91=&]$8W[VU"OCU_@_;*&<*EYY<^)S\Q M9RNG53-HI.2>Z_DY^O$M]JT'3D$_2OH4OIZY#AE$YSOXR\+/'7 '\.6>^Q)GD7>U(WJ<3&9D2D;<,85*BFG(J:+3PCF2.?ON6!K&/.^+>;[X(U0? MK%3^3^X#[^06,QJ'?RO3@3^:OT+^TY[4]!KISK']R5[T6&*O?7=_Z0G<=:JK M=T36^Z:N):?<(KO(G>Y1C9?TCD[FH],]GQP#'FS:BU[%@L26?X2./>E\'K0I[M.*3/UR?7NNK.TUEWZ7*1^O/G MGY^(X &T0?O';OF_06?V_Z3\?L3_/!.6?*H& =>;DZU/1A$"!TP.^F:*GWXY M("-WLG_'W=(+W(<2^@N+.[2"ZG*.] 0?>?8D[=#E_!X#8+NO@L&!W1TX@IG\ MP"QJW*!F:2O>=H7OXX M??_;!LLRYGXQ<3OQ+Q/:5R]GRWB#"%?SG^S)\E^M1?NWP;4*4@X^^G*^GU9X M#RT$GYT@#5+??X,)X&''/#FW[51^6G9-V>#JL,*9/9/!KI9&-E+4L&B+$TL' M.;)_&O?IJ*3 3L+&O>CA-9XLB*1Y;523Y^K[A(*UW450Q[( K16/_6KGNOL. M2-@N6(E[N7DS2?>LQ[HB7P78GXW2*$WGU'&W&U)*4Q4%QZQM'V,U5M0-O/]P2 M97SY&@@^OT%CO.C"&= 7T7 OWB7= 7+YR8M91>ZPO;YH5X,N)XYE-DVQ*F29 M\RD-/57^&VE43-YYG*)B0=LU3328+"COFOH4.PU#F;N4*0:G^D[8KJC=N->R MK6$V'%7H?)W?#W[;+A O67<1==DXR6>'CJ&!3%9&3))=6I2Q+?#D/_UOG^W_ M6]VIWSI/?KF$)!-2N_LEW5:/T]L[9]L3BPNZ*V;KXO-O%UP=R3QZJJ5V%V^4 ML7S$CT>-HDSXA,--U0PE[LW*R,ZE%I?\O*A9:ZCV$CHD:/UJ2W1$POH=/-9[>*"MR-7HH;WSY+2QP\E]30AAB4M?E63>5"]RVV')1& M%P]GRNK:"X>_Y#]B\=YP].VV4LT/(G"V71)WO"06Q[!2LUIW! X:S<6P($^8 ML$X+#N73]4E%L%C/L^?\G,S4)ZV=IH2H" 1NWVBYA1S,S8S8YKJM MY0D6RM"99+V!J9<-UWU2"!6#*^;PI?!YCL\2UA8GQ!OMD(G[?C@*8IK=J M%FO(QY0A7Q]3C!/@./UD")@7*[#Q$_>G%!9D$'F.S!"DY2U.RJC%&XZ#NRQVC.F;"&H>FUAO\, QG@I[H M(KVT7PJV(J#GV/YA*!X5*E94R.1%7//BWOFTF++/X^D?E'C_-P_ ]L F.,%: M4Z8UDEHM)(JD+-P!C^2;OU2WE;>Q( _.(AM9$%""<+Z#BF5!JO(V-.[?V/XK M(,"O \\RZ!*V3&+RDAKSM8H<&%A9%R M&QN'@OS9)+37VP;;/D*\9NBTCPO-)$$]3J3S-2@)8[H#_),/NH'W7S8HYEQ[ M'??5Z_Y)4Z]N);T5[*<2M**)5^)X^4XA/LV1SKXQ;W]R]U9):?&A>U2JLJGK MGNP-Q:NM>FQ=.!T=@YTE*SR+S6SS>OP?S^R]/'[N5KPXY Z($^X??@K2'&__ M8T[6:_^#3!UDFP/M4<_MZ0 %NN.@' ;Q+#/T7%4Q$E=^<[ETVVF5T-#>\M7) M&Y8M""RG\O$?%-?>I^U[Z_ 4N!0&MO@9>)Y@NA85;Q XRYUHEA0]+NIH-1@M MK-=3\GS?.G+$LZ_YY\LU$@,")C>3R OJ-7%MC'2VSL*(U)UTL&:UC/;!*D>"E4WNOHU"&33 M)G\@4]4[%C]2\?+\;I0T/\HXTG+$E"-+J#0GVLY#PCJ+MN\ ,ZWOVA71P J\ MZCNW<][\DTV.8*XGP9,=[&Q\W5%*OG::$%Z\UG][]NLMM?)5BP_]9\V32^;= MGS:EUSL2,-N4!9OZ%8^NC%L?9QL?NQ7#)Z!AQ+8']#6S M>9<. JL13M]/,U1Q**@1N6-#5>OO;M:/3[+&D^.BN@%3@ L!1LWDD:B?6P8G2.-NBL;]-^_1HS\_[2E+M0"/2OS0$IQ_%GC0\ MOM1(9>89:>;5KI=1\[T)!Z$Q8$W56) ]ONR6[I\.IG#VC@PWS)9"JXI\AH[O( M$1\^*1NYR4GLT89'-^F,5.Q^8"8&; 3B'S[C_Y?EI;_UZ>M)@WZ"3DS-Y9'T M%^*R3]]V2B?E-BLMR85E8D0M5[?+&/!?;=3?74+-E0I,#6UL5+;TF3UZ44.V M^C'(B_4T#:AZ6;I>LV6JD$TJ45IR[?' M_DQM9L ME]""Z:<7*1*X+"F%FVAFO1_>F%,7LPQX>V 2P$+9W=$I((F!2]SN MEU!6=@6_J&H0JQUSSTNH;GY-6Q(F04]Q=&A+)\RKXVG*"7HRY<-<0 M,GF5*\QQ)M_IK$SDM#.T@UX):LX>'VNFB:^N'),GICMD=Y6]"M&)FW(1:3FB MA7K_.)**["CVEG]LU59?L3P$?(,%D4%)KV8"/V,7A2:8R+@+%FKB4:W7,39& M-6AA8]'IK+S,V+?79)W?C(G"*\?N^Y."CU M*N&\)UL9^M#*;AMQ+ M0B^4I0)J<.XOY "TQX #JZ*29U%YE 71\V//V$(*9T& F?^E&O0F&HFN!'ZJ M/$K<_#4:C6=@,?-3[P* # %;8%=H?@+"ISG1H,* M1*0J%@3F.UU;N8(!$U7@YS;4F4&AHS4F \Q380.F!Q1GA'RGAU9\D[3TQ$JHKZ3>6/BA!%0M-5VM M(SB:,/46$VYQ6*8BX MTDL&X'M7"+J.L[W.;/ZGVDY@GPCG#)4X]@RH+&#S?5?^W6#(7Y>Z]](![_I! M#E*R(UI@=@!V5.EH\6BE)[OWJL7*+&(FP:NLX&PUQUSB^CM[!7GW6X7%LU.# M'+"*K.C:'7I'+A?%W99!X"O969!)+N08-PLBR8)(09?=@6EKV"0B;4VF76)! M6@ /BYLAH.3&@A2"#ILI=+&=J2W$A7T^9_SNM-"^:257WT_DQIE7-BLLB,8Z MD;_JFZECL,'S[/V/W-XVS,S($+X.R\O4-W@,]MY4>.3NVMU:A M;,@[ ^9R;D;T-%[_MA"\5VZ[TJ$CJ(^&LC$F-PL+V4P;@:\K_&- T-^_C'D= MVUH\<3(WEW9Q03C33]C-N/YSER?/@7-E>O:G]N$.)G61:(5F#R.YLX[Z1U_A M7CVG #SE360D;#X4]4!IVG0&U8"--J@D3*.%P"< ;[)L"H\=1.V,=P=.^9SJB# MY7?\@R=E^?27HQ25B>\6]CEQ#TF?A*^";SB$#TK5;5S*K&^5DH-!JBR,'YA_ M.NV\XF0OW(ZU]YFFYWFUJ@CH2$" M:BCI;2JS25BZ;KQ\^=HJ.\$OM:X;.1^&'8^N3HI/+?03_6:K9Y48319?)#RI M*4\:#SRP%BY_^LYL=JY[;@J%^T6818_H-/#BEG/=!P[$2\LA!WT569#GT+-* MT(+;C H'^8XK*_F]TR_>>(Q-\7J1XS$#*R<+#[6UGH$U%*#2XHCZ5^/&#[J-#OT( M2_GB<_4G$6!^7194>7:KL>UNW'FB(?+23O7"CSSZF>HC$6<@$ID0R+;[0^#Y M]%7GP+KH3F/XY+BQ ELB^:L257%H1FPQ$7<(Y-[2S( MH00D*"O\@!,+^*Z"3.VSMIR1TY^F"??EVOR"L0KMITY@EJ-+DP_TT)WQ@ <* MW ? UC&@GS]7(4L:!RY5N5!;%1.NLI!_YO3U>$[A''CGJ*7/$+Z.YZDEH4^\=I^ MFD_@7M%3;D+LF^3 :1 ;75GZK_)C/E.0]&-[:2;TP+DD(CEQW6S1T0OON1K" M@LP2)M_)#+RW*GA:I23J:4B6;GCG[]_O:1OTW,BH?76^Y L/2C/NMIP0@/M8 MD']R28PJZ$78Z(YZ^)@OZ0V^F!UL85B_+.F'U7)! M^2+6G:\,H=<3 W20I8Z*7&B/N3RM__S#=WOXHYG7D*U>XR3C'GHL%8'S6W*S M;BV%W[(ZL6>%8M>E3G^4.2M3'K?[W7&.1M-&>=61;M>KTP[ 9?)9D"8D5=6V MUI&F[*0U@FH6>B8D2,JFH[GX/3L=+9;[SN*AX\*-5O8A ^W>^,D/. M=-!TF -;Z,>W-$;9L=S,*7@4"[+?SX%7]R;N8I6]DFQ6N:J_%;WWT=[]_"Y6 MUR[13-PT4QDFX+VZD\E4+:&E=[WC/F(UHK?\?@CZX>LB/WN-(H"QLHI*#KQ: M'6FT3NM>V2+VA/D:S-_FSPF-'J./>+:^6(2UXD95M;9_T1WL]Y[]&H?)/_8U M)B9;C1H,7P!3@@?U1G/H_2-Q'XBMT>,_N8VNJ'4FC-_ WKM/'-M][0 -F]$] MO98W S(DLS\@CT(G.-^)\BP+M=:-5N_AA_1A(OKMN:^^P^B.Q$>=9"H$0,'S MXY09+W/O5OH&\CM[J6P-P=2&]7>'JMVQ,%I^M.#=Q[J&HHDH K4&#.O&5?.;!@9NLD(Z/% MO58C"]4])T@BF*$O(3\(JYRUM'Z=1Y-=,GNW?BXR-:F*'6>.*%YS?9B(<+S@ M9E:3ZM-Q1F&YNEE/1SAO^?&-H!H2 9;Q$6P1WKCXA!HGKR2-Q^YO),EMJ[H'R$I<#WMAZAO)TOBU;O>F(Z"5J;DS)D;+1+: M3O(1<4*HUQDA42%!(4D'-244-;WKKR^7/"\9OG:V\\+URU=Y()"MP%:[]H_O MS"U0T0"E%4HK#$6H6,@I33B?Z$(PDY0M\(J>]7]^%O'AG537;8FZ1RW7+UY[ MIG=K,O*U,[0+?+4<4/\U_EV?58JBVUU_STEF/)6!;X]%/.Q$&. 3SQ7Q0\T$ MM13[+^5ZA@LV]^O$-]7Q_*1O=#?SUOK++P?JFK."#BNJ55)^+O]7H8E2%T+R M_+..L=/5%*/Q0;Y0UJ2I'1XC?%;SF6C DOMGSE M*3Q\XR8#W++)_Z1!<<&VPF@WZ)9,0V6W7H3Y@J=32\*]5:>5=&)_3-5ISZM. M \\^=0Z]Z?\2Q F9R$]?;>B_R)&>[%_S<][EZZR@8W*/R;]% MVW[)1%'J#E31HBCE;-B#'<^#Y!73X*O/V5B01U6-/%%E+[H*:>YT#9$,;+1^2X+341>6(+LB_[6;L ,VA3<^Z)BZRC\ M&:RP1JI$2*]6\%<:X1;YH.,L"+?JB)NGQ1(A27W1Y^5(2M30B)CL)=1G9,'\ MAXO/D7JG@443LMUE8F8VQJN2(SG<)M.DUD##*3@B<&B)X M@6E9IOA<]U0WW *SLBGLA<9$SB/)N%ANM_IS&#,*Y)$ M!&D%WRN<09FO$3R2M([7#1'.Z\ .2Z0R3Z+:X'25-> %\Z%/5-^AL"",3_W0 M\5?$AECU574:1>61_8*.9!V_*F6V*FU6K,I,88"&E>.<]#5Z_QX+8D<5N;U+'VIOK%VU2A7,4*YBR($ M7\7'BA FTN*N]2C=T&!^,74Y;%N'&GDVPG/UDB+>S_QAH7S+CXX;T M.#8[$A=K)-7F'86L7=P*L;3*-Y[KSQ^N<3(@\^>^=4B(LQ/Q_-;6D#$*&>*Y M*K;E F3+EZJO3D_7_F51FS\'_ASX<^#?;0#+ZB*<'C=NF8V9)Z5. M^75_V8_"M*-#'>/N)OM@S=0+JLVQ#]7VKM*VC*LO9I$NY7?- MC44=#-U;]5L39 M9VP7E,<\'C[,[[<5>!@U&7IXGQI-+TM49$$DRK=)2_*NE&/4EV[WM-OWDDE-:A9EJO';CP0/# F1DZ[,#L C\$_B&"B=TR%(RG!Z8MH"=Q]QBMD\EAGO9*_Y$O=U'7V-:Q*( ?] M88!1.NF47*GABBM_L[Z)OK1V1_O'L1?1MZB\J_"#*3+/(=P7(\*MO@1KWF=O MS?1BUI"_W"=X+%/F ./9OZGW G87P:QGU!GG,S=_Q($_QN1$?F?=Z4FND-&@ MPNP+P#QAW=>P%AM2M&"6++ <@P<^69?/K$:AU\GHJJVX[*YA/)9H!G+\=^YW;\@1W105$- MPR/(5!T6)(2(0,YUV/DU)U=-K(<#UO5M.0O"1K")(TA]Z0 \$3T[%D3@'4F? MJ89G8*O#1GINAY#J80PD!1L =K&OW,P2\J/--CLU3O 471)QK9\]5*C8?.BQ M9K6KL+W:E4-!/[+M)M?_(.;K^CI4(=E(%J]4JI#4U3C6*IX?'M J?;#W0-'U M%K;V- 3;Z]PF*,=0 '>!^>CVGN&4\V=1@&N?\$@_?\+F'OR@T =7[)0>=U_= MXI3'"@L2NJ[WY=CM#6:D2IX%,&^UFSU)B18@]4^.% BXP:4.WPN.7O]2!%2U ME7P3[!7I(SC;F+%EF903H+8.#T"C=7,\ ,>P"5QPC"(%1ZCS$4P"W2HL9GE( M#IC#GMJ,FS4U*[CLY2G''H);=95;P*QN,6GFF-&W03_<:8V@?FKH!;FNGN[R M4SJ2?4>">+B5=2X_4-LIMMC4\KAM#Y%H.EOF"AM\IYYRK:VQB7L^^OV6*/6M MHFEF#2OEKLQN%4J5YI&RLI\7SRUN;>(Z]B0E.S3V-L\/Z@)PQ#SJFV [U;:3 MJEO4_RU:M#*GVF2P==#EPK54+[CX5+>DA+#/A4@Q<7::S*F7]Q<^5/;RC25I MG-P13XLEQ2O88N-S#LP^.1^YY3T+HNU=N'1V"'*HC*(P(-TZ$& ;YU>5?2%& MZZY&_=7@P#!>9.B5):L+[MGWG95#?%%_X+S^.?#GP)\#_],&6-W<+$A\^=+) MP63A&FWX3?]U+5?':NYKMEZ\YO<2'V(.)_^DTJ$MHU](^]JVND7ON8WD=!;] MY:Y9_LM[#EY=5-/A+[OERBW2?Z]*1%?$V.^AB>#E.7RFX<_EG!S<\(-CF3MV M]UQ>3):J+9M]7%MWYKV2XH2AJBKW_'T74G20[]OVUMZJ.D]>[0:;-YF#(U3' M(^M2WK /(_(GH%$\$Z4@2B/R/8HQN[8;V_2!#+'?V7Q3S/ 6(;BK[&,1V;)R+]N MX:6'9$$&&.5,NW861!"5J[/>$C^GI$?')3.5A<#ZX9I"U-]?V9+>OU$__(42 M#?U]_7 ;"U+IDYY$8R;AP0+B-%ZZ7].GXBV@\P+/$"96^IBA$8CU[R)N([AI MPD88!OVYO].O8[V\,FZWB4R8T>A)?96R$F?K[L>-U]W>=]WX0)SW$'VX:EAE M2EUE2M UDDM\4(O+.M@^A&%R6!!Z?T W_1(=&]>1^EEM>95GIYK@?T=O_/&:9-@J$YC+;M*37X3IP$D]RXW^I267F M2?A 2L!Y17JJV'GVJSRE<*U;-=Z_H M05(-"U+!)BAQZ=NSGBO4CCG;<\RU:B69@972P*K'PU+!^V@ISK"C]GT'U2=8 MD$%V I)D,^FC=SNVRC&:F9KUL9X49'_VXW[#\R]7- ;.GY+I'S#HD?OW9\7\ M.?#GP)\#_^4#K)XB+%5?:+&>N3Q,8@8L!PQVOUL=VR:MT*Q<^B2]6\;MWN>? MG]_('\AX>]_>/NRFEH"@\_VOF;$<9;OS!*Y'C7(75R\,J9_3<@]H%.D_"=UQ MZ(7#9$-N\I?LB6N!4NM>[8([PH-H53>83U2T7:W6^4-9$,W4!=@?AU?1:PI]6@,]5L8,6 M%#"IID2]C"KC#$.&+X6=Q"02WP'W9^ZJ JJ)HO0D/4@ $@V86D%:5&*'-I1L M-^0WRG^1W^#=D-]H)K,@Z\EE($3&CC3WB#%&XZM"P'*7B0T$W3NX0,ZU_?M> M49X<"S)L!%V@^A\'S#*\!DFQ*V&,=A"6?M<"4W(NS6=QX M!M*'MRX78[1,&@ ]$?MY4L]W:0O@(6#@S*KDX8W*P4DSQ;@:2=0^C_$X$O/\ M6B;G3KO!MW)!(O:TG3C_1;%FQQ6"8S.9W_?]'_")_QSX<^#/@?^I U@6 MGE@L'-$XMK#2^ZJ4\[@>[_/4K$;KP@J.NPYBIPZL]1Z,+PHIBWI]QK5.ZEYG M,W^6T37#0#:4IYKW@ :?1,M%MH.[KEQD6N4'>G"T0N')F"BZ_9SI3))7MNMA'0.N3\TYC!YDMFL,*NO!.]SAN/U+ M)^U#MX>18GU]BU[&S)8KB8SS%M-1O>-+ MI\AE@@*U+ A?2" +DG;^%7?RMV7X!;7KQ)6A]2A%?DD//(XI21[P]8'AT0 4 M!9/7W\$,8$D8R/<;,DFDG'X2V7(-'.H',^+.#AO);A!O;L)+2>/-+R<99P > M1Q+GS0CPR-[*I( P3A?#!$7@:ZL;S9%YS/[!-1_8)MS[I?3<0L 7OW$5 _16 M.#4##'=7SN$!>Z(,P->-NNFU\@QSTP$4V(RZ' 1L-9L?WPAC#WB J7.HXM/- MU+DUF#KOZ$>"J?-1TKZ A89-DSS^FTEV^ .3+ \=-A):H-#_HT6F !89^MTB M\\_E_F:1.WK2]I>O#2Z>SJTT7B'AL?C!2F\%BS4_HF"2T0II0 B4,,^L\[H9IB'&2PPO;>A M?GY?;W)&$>$+?EJZ-7-.&U71+YY%NQ;'0GWXKPI^(I]8UD"7AEG;!AC-!>&6;Y9T;^1&F#'Y;/M M9I97N0 &V),;XSZD#-CD+%Q@Y$7#$? M"E>78HD>\2BW8]>^"C.?2)^-;*Q#?0.SY!Z*>#_'W[+DW.RJ?Y4EW_WSW\B2 MHWR\_F.6O/O^B>W;%<<]IRJ(9+.P_K*)(_'?AEN;9C^^#-=KXCZ\[8?[$ A$ MT=A/YPO7O\LY\^? GP-_#OS?MNV;"IRJR'&%>F8Q+6]A"4%'S$KHTX4\/C,: MV)UK]7AHB/#JAN)#\L.&SO^DBX^3E=,^!R0-W/I]AA)V'1 M0@)*I[\]\EIEO[@Z*/*M/ ,VGM[0U;HKIM!GX&:V1(%9QA9]B:P$H>@T;P?Q M8Q+\C8=-]ATS5OTD$.U32%Q]Y^6(*54]U>6;-=0R&/;V-4H_-%2P".8P,$O1 M$B/G<5H],Q[GCD]^<1;:RC?Y(V"19_I3#7]7C3D-]B=AUC!PPY4@"0[ VH#- M(M5PXP$X/ W 83#*#-/=&%ICSG#K2?JND#/P!,"^F9N!XB2 SQ ?+NE?M.- M ).E51O:*QL)[YID,*X]9K]"I@1O. *@= IF>=YITV>@>9#16- N8IJ VUG9 MX)H!+@>>8NGK889&*),WPML!:G@0^N=U0(OV6LI1'?VKTX MT=^#V7F%C!'B#<(?\-?O(3_D0D>^)ZS]@>OA[-:;DZO(Z^&5R.\):UZ"=:0= M!OF+K1?2\^'M,9/DVLRFUPR"*I+LQ"Q<;>5F- *-!FEHWX/R#LC'E!JPLA+; M.(EDV_1Z? M4,@:A1,YT#67M&NTR6=W3DIF#&L3^F1ZBTN(L&S]0D\H:08ABDC"VD M>C#7[,FI#=C\?"R>@BS."?D]V?#7@LW-),,&$T$$_(H?.]BK]#5(IB,]4R'I MON+\,I%7.>&].D?_FFB+[]5,_%A->6L3O:U\@><^>U9>CI-UO&W1)38Q0=_X M)^H1!_3'(F-VOQ"IJ2GKEQK%5CM'7DY_D7P8^D$/LEWC\,ZD2*=^3,C',KUJ MIZ@?\V8_5Q4N;OWL(A*_33_V-L_UR!X*]L>:(S/$$'.A!R1I['?URE6+I0WU M2A\]W2R3W]0KQ7^G7EF!?BE3D>KYBWKEGG="4ZC]*K:'(%OCDT;(\[?'LYNG\F^M=?A->^_57CNSX$_!_X<^+\<$O]- MWJY[#_(\:BQ2J#WIF4!M]P&>3)I"9Z_I- :C=TE7A04I\5W;[I_DEI=^,MS- MZ$.#*:.&"[T8+7\ 8!ZN7$K<7_=LN389Y7^_6B7DDE=Z8& M<.QN%%D2[X,'1$UA/V8<+1U"O8?VC1(EA.HN+1&B%$+50F\,BM_VC+B19J0A M',FOE9IZ(^C'PT$RW-4UVU-2LVAF;1ZH*3)"90,>;W0=-WAD@:4_!:TA+O]7 ML38 N&$-0(4W8B1@CG* 2\_,$>:U:^(T(1D('3 T1?(FX*>;*IC(U M&N2#N;^L:@A0HV0/]B.$@]E+E$HXS-D"P84\Z#KX T)H;O'&4C$\UM M48KMH3B!W"@WXE_%QUO_8WQ<%C'<#E_%;HHUE#504 BKN+^_7G:%+ @'\ ^% M'9;#3B1\)[++4@) (KO>\F=DD$418+/?V=E5 V"\;-- \V*KG[+G%K*W>9 S MJL# ,P7/0 8,XUH&$_TVU-4V*'GX#2L-ZMK]0M1:]_4Q>V.641Y'T?+$I5^O M.7\%WAC6;"\?L3^2!6G*,:5S\X2T-4Z&,5LI2O#,LF-JKM;(YP%6-%S*[#<< M2:KYXF!B'3UU2:B-"]7)ALR;$6I\_:-3%3OQ\=1G@AL8ZQ;2K58%*0!#ZE/O M?4E3L^\O3@_A'GT7/$> 10,6#%PMF(?>[&Z6__A_L??F\5#V;_OX=*NTH92R M3R4IDC:1;5))6DBR+Z.T6++%6(8Q25&2L812J"R3=N:O *K *_'L Y-^LE;A@8B/C@/;2 M3>0[RR7C.;>D!6I :JFV6CA5EV?[)7O=\LDM;=J33O.!:VQ=?:(]-#RDSITZ M?UO!GF8;>0#[=B2!X!$0K:246;V9=DCWUE,D[[=$<;4&Y)CPJ\2PXICQ?C%% MDE_&V?FOC L0@:Z H#0V*%DF\P:R@OX&'GF6NR-%!':DN"2RKQ=6NVQA\]<^ ME!^PHI6_! 8XJ%.9P "A$LTAL#"2GW9I@!6'TQ*A/AP^! -&RPBS,A4JC0A= MEB !CIMS$MQ!)D"1K3CLU)E3.0DV'$:KA\;. ]O9=&X]YFY6 RSU5S5N)570 M>^%>2MQEJTQ6B)^-.;!!5S)T-NL*[*$TZS)I8N_G*(%*WFZ4*,0L#]LO*9V4R,CEE'.OC M@IB03. #-IJG*&-M2"E\>1DP2.\%!N?!W!P*8/A-Q)/(EFI_;9G1J'B& )>J MHQIUG17(3C_0H6F6WK["*)'P5N=]M4]99\V(D4,AIB^9EN)TWBD/W)7[%QD* MX2S])?"@]NDK/UO&%#;JGXLL1M9!I!A/1HVE9M5C DC-UNI>8#]@6W8: MPEQZ%4,1%J\1F<5$%O4/IQL\O$Y!2=)]$IA6W8T')NY?HXTA35N'-YBXK'6) MT/_'U>!56 5^ T Z(HX^]K$@D+"CTM)C%\>KZ?==D+XGM>Y(A M9&K5ZXAW)7:>"C4Q.7;DI[ H:D&S4EAYC.3S-%/FTFL/V5'-:VI/V"!C 0U> MS*O&N0.+N["X&/S7*Y];O7&X!LJ4PY22WF5RW=7&=I+KW74$\PXZQ< M"')V2]FF])1;V]]O@L=Z^'8/9MTK&&:&*PE_R%6XU8RJW"V"CH]>#*/=+(E* M#;@O:[TQ;.P.-5@YH\P-HX>?>#6V<@L?=KEKNY\X66IH1 M24@LMZ4EJPFP;CP?D)K- M*8W,'LEXH]GE)QLO!#K+@."'NJS179DPK^>VAH%6=5HU=YN,E@\?)ZX$B..Q M9'0 MY #H^65*?98^PAQ.LIY*1IR%#?-&%=@CLS%SR00B52((QL4ZX:LBZM(;FXSRMUYZTDY4PB1W4,S7"X*VH'')7A0$VCSLX)Q6K4BZ# MSM3+S<)5T(EZZ=SE-N*,'E?^5 :P^@ XESK>"'FS%T#LL*4QV3BA]28\S(R M:)'HXH_::Z?4%)\O2FX\47RR_+FU'\;64PR:6K#'3[J6#5(:AL2I:)5T(1Q? M&2[BB_V:J_ULP(XJV=!1IPV0,QK1#)_U\VOX\!R*&: +Z*GU5NP"I[ J A@+ M;IY[ DO"$&7KI]55Q98ME3'=;8$5[N[EV_T5>[%G?"I$L)WX$H_W[, =]^E MZWF?%3XZB4V6.!^#3HK6LOU^:6]=Z\N.B_G+H^#.,XS>AH4>3%[^X)^2:5;P MC,V89G6HOV3_7&_,GMFY*3?]J5MIYM7(YGWH[2/O- [R']7B-3B@VC4A_S2O MI.KV9#RVXZ6*?&'N@I_H,Y["[!<;KL4&B&EN"-[16ET6H1@2>47J1$3MMWTA M/U2/5C^K+WU-3U5PZBG[F'/'ICJ2E;'FP9&C>%4E^2]43]QK]YZD8XVJNSR= MI)^F+JT9!+T%91J\ JL K\VX?"K?^1\ (%W_CNG-(B;R[N MI=Z7#++QX'H..Q6SF:)"="\TZ91%FL/=IV MR%E?1R_)II;1[?:5W@65-MMX('(W0\=JMTM[@B XWYY'$K7DYOOZ9H_1D+V- M4^>N-H3V?$PPR\9?W;>)SFOM+)E&%"O,]-GL/'@R9;&C.^!@/M6JIZYZ+Z9J MY$B;HU;8^[CK48[']C3ONU=+NGO^UFV;UR<]/? +.83.HHB#UX\=Z;L>',"J MV58QDA%46!0\+%1<:%W;MU7[#P'^<""5D>9C\"-_>2G(",U?PJ76'(H]J\X5 MQ@!IJMRFLY,V0);-LRJ!MC IW7RLEKM=72[ ,.ZM'!OBD&FIWJ)Y[IK8BH ) M<(?]6TL3Q2'34,!U9=FTEFN7$F^,L5P./N309R)0AZ;M*:3EQW]LG!5F64LH M3$=B6.>:%H9Y/]['='37W&CKV]_Q4AX7@WY^\LNN/?RZ:L^&9SO:M;'NZX^* M%NVEREEOD9IJ/.#DV^Q]B^[VI7S3!;'J.^#M\@>3Q1;UT%R@OG?HTX:"4+ =U2PZA,V(.;W]0!9;Z@]?[HI,QQ\+PYDEH,(1ES+BAH?/$V&Z1VM]:9^4?!+C;HM@:3E5?V MC<4LY##72%8^[,;DKN,)\^;.RP^ -*;WOV2#7AX?5&+YFV]F@SXF^+%!9E:< MYP#DU]BOG"]*LA<"8@5H\H7TG@1*.@991?$]Q@;%_Z>'Z-[Y^T,*:=_G].@+ MW:S[.L"7)!88TQ_&?1W(KP?Y_)<'=2RXQ>IQ7HZQ04@S-NB[#H2D9_83J4%\ MS;PTYZDP\UJUU42CLGJ UBW1Y157N9]199W#)W]G(K6B_6:D>-'E^ O*S:&I MQT2VW#*QXW.S2^_2,.KQ-E,=+=SU/&1X;[G8T4\;UV0E0W^*R[6R01.H U.^ M<9(#_*,SQRV$37U/W@&^FZ0WL",9CD_HJ6]=7+:BQF&!D!SJLC@_G:L_L.)J MP:$>O%Q5_3PP_\!8Y;,2@$Z3LR[6!WCWP&$DZ!C94B53%X74<8:0-5I"'V99 M>CN6[*TQM'?XJB@9R3B908QT-]B^_>NM0\BK"X*]CKZ;GSM,EVMW#T/JE^8W M$#(UHLG5>@\OH\(99Q=&)M2W> !+_O4:A."V$E( YS#M#M8MFE7O1BUW4'3? M\.%W(_#H-6/.[4S7,A]//T?=/%*/M.Z?*G+X:9XVHW^M(M]N!>UV+(B 6BD# M*G*],'"_S .>?6'KX3K%4P6JAWM/DHHO['VX[O"$[X.EE0$^*%4JD^RWC7&V M$[>%!MG8;NY[[;:2H>>S4YT^WP]LNNXT.:2NDFQYSOF H/2ZW6R0])>6;$EE M8W,>M=RO^Z7=C(]9NFF,4^<,;21R9")DPN9;5Q3DLR-3L/*1+.M(6'':F?P+ M>[.DGH@+7'&<4?7.>3NY:0UN071T^^_ ^5:!56 5^!T =MM_/:0!WS0K1'X* MA$3+T$PZ\W$J*I>ZS9: M-"0G?_YP<_QH<\VAR0E.56.1B\4S2R"CEXEOJ_OWJ=DL'0KJGX]DGMJK/6AE M0],);/0@HOFF4_J0@U83?"J< MHQ<&<0JLYYD)1*\M:Z-7]N[A_TD1MY+9MLA=,+<"5O$OAY8 J6WEG!)E)- J M#.V+0SQX&GEY:8/84?W/ST[JL'[^445[LN6B,U/]D9*(KWFAQEEP+K@?H^GX M";ISLK;O"$1AP:'II4">^CY>KA\>YW[Y4'738< 6&;=!0262?+C)>7@\@<8M M29!V:KFZ,C!G)^,(3'H05\#'5;*_I>8M$*F)M^[8VJ"^FE\2F+GLPF,0V^!U M?,, >#P9]74#&Q1 -R]LG*?:C_A7T@66BN9O%U@P%7^>4D?G,8,87X)FQ\L@ M^(7CHW[+:K]@H'/"4Y/%PD'A8VV 90MPI@16"3D',R\-9DO:_ >LZ@Q(:#' MPQU[O(H*%6J%Y':U&; M1CCE2)&I]JX]%U&MB'>X MKK^P$_1<"V;!"$/\+) V=NVXSY<@QG.\M8]$.8 MP#]^3$^42WQ0.WY6+GUSNAS_!JFQ"1&]PXG3G>\J25&8^3Y@,1*&7P3^5&VD MISL'?7KA1< 01 IM6-+#LP1A@Q3("]"3XM#==.B&/5-9]57G/8:EI/7L"7D= M(CO,GM@2-FKUU=^..4<9_&N^?Y(>^1U2[O3]6R'6T=IIF/<_S/<5J.D]2-+A M/F_GNQ$%.S,)=:YJ]0_ME6LDSW@?-YP]L24D-E V&/TEZZ"7S7#K0Z_99\>QO.QZDRQV4K:MXR(?"/KP^ M;K&MO7)W*VRNCN6)K#_L'&!)8D6JX#8>@@J7XA3",)T..IL5!:#U+UJW^S4'T=N MB7]^]D$?3'DVZ B+FDOSX?!RX4>>\(_3 JSS2R,S:]HD@!;["[AH^G]P]^"* MVFC9ZG "M26-A85S*@VY5T,LJSR>R74'#5CQ;OUK;%'7ZPFHV)@(H(+!VFII M] Z-.!6QK$DD&L^DMO168K@+\10F(.I:]@J#%B[/'U:FU8&890V=;GH+^O+. MPQ8$!Z&@P)\6\6="'U\8T>[5SJPGV?*>Z(IN_;,3AY5. :MM[3C 7\7LC0J)4YNW>L&JGR$@W3Z]"'B1 M/;!^#TCZ$)QR#:Q.6$D8&]^>Q$T5S'^SD4+5:$MK8FI AQ)LH"S]+:YLT*-S M>4JL#XCG]^[.3!HVBEYE)C(82(T@NB.^U4SJ32SG:W C:N2'0%=Y2-5?QQ(@ M2Q;XSUL*,,H U@QIW#5#,MJ0VQ5"0GUXT6W^I-)EM1_7<:5W19[/H=PXC';, M>VH,%>6P1?%6R>SK>UKGN[KQ&O+^PF/%M-%-U@Z($P?W3TY(EYHM[I*4Y< M#I_>S-)%UL][^LVG+!WO5CX*T8<-W^G>Q1N);M->5I7#,J+C]>UFE$U/>T^I MP83\#S:&[\YXUJ,W!55FC>>K[NR9+XY#ZOLWN";(+JF&2MKGWQ-$?Q C)+CB M7#KBC3H'DR?K6.FI#4>R^P1>1(0(*%XLV+R'Y 3Q&FD7I_P.A^A58!58!7XC M ,K&_^L*# #-?DLZ,^D9Y9;SQM;NO(XV&FR0+;GA;'-PAZ#"3_I=U&BUWYH6EQ3PY\OGPMO6I?>''Y9RSQ_@*)GUR8O^])>_QE]);GXQFR M I,[=DM&3^*I8K=_6G6+'@/7HA0A>X\@;1NA1_5BP#M+E?H3D,YD%#93ZV>/ M^?%]R,#AU+[H0QIS7?G5C074+(*WBSL[LC8AV/5\H>=KV_0+=I M*#VGBO6?>''+.Q'U5&P8#3YZ7G@W)>RUU9!S2:?T9,ZD:_@P^IM> [B[VCKT MV>UE]IJ;]5QHA3@?Y11N8.>\C80O!Z;_@'\W=IY6N+(V370&S%JXVJ8A)R[3 MY6X!(J%_U;:2>:Z4_6S53+P M^Z-/;- .8KA1;>R[RJN&@QOWDJB"']ZF&+"4HI*@,Y?HAWJ3IR=/A!X^S2%L M2RI:Q0W76C_\K!:898,B$^NYM'3SO 3GF0 9//37&60,CP,T\EL$+.EX(U(/ M&(-S&>\OH:X(\,VPGI6_Y/?+]!#,X3?4-:3:*=:+ M?%C%YAGF]BX;;:/+>?=/L4$&XN]>($/*&SUTQJ3,"W_6TK7!0RS^1Z7KVO8Y M>$!V:G._U<=A KFC"Q*OR M>GG!GB77_$,[W9(09L=VW@)'G]9X1-?Q<3J%7@0$%9F/^9KZ("75LN/D6,52<&DR:@O3\+#@M,YC+193>>""^T M_[CX7$%/YU!:\YMHK:C4H]G9#N7%G5MVS$5M<7,^UCU;WHK'G'\UGB,S TG] MT[&==VY$I>N^;C4]),][,$U3A''?X.E<4\+VA(L'5%XY8.,_=;R^E''2JH/4 M&Q3POML'E4I*H\#9 MWJ CZT#+1NWAJX>!56 56 7^\V&@Z9\/ US@$O1[PI*M/F-N=&LOC9W#53A<$!0YT/ZSCK0]H"?863%,1FDUA=2N2@XYR*-"+!\1F#5V-[WSC MZAB%7M-] MSUN/9>]^H%WV15MGA\I63:&UM[9Z;6L=#,W@.9@)1P'EL1<(^N5^%4W=5QNR.=>Y+>A3^-?F+5M4[5J!ITC5(&AN4.:%45I]V M^]FB%O(XJT)"<"IW/.HF:QNT@0W*5CGJ][5$'A@'^V!TY;PE2VATHFXZ()QK M!W84QRLX'^/C3$\.F;4T 0-]9\X1 P/X@7(N"A#1X0C KUR&LMPJ *3PPO6F M0L3-(YWO'#$8VQSQ+C9>Z8:KT/D$Z7T+;-#K^VG*G$OH7IA]>#IA:(11 M8NS@8AUW!_P(/SL'?CF>EV8WG/PA/OK]R<#WL79V(T^+;(UXPW^B47KVLCX3 ,8T() MS"P.!B3 \%EA6=1E*Y^A7ZWT,7QY_"3 [B7B'Q.@-2>[)\>_PFX5]%UXUX[W MGA$4/"@,)?4K/?+_]"&4D7##D8#_E/ %^I@-JAJA>[$(#\6&T &NE VJMUA7 M. S?[0#5FCI?+B'^-H@4X6^T:"H,'Z^X8=U 6MO&!],,?]*0^3%A0O6CWD: M#?3W;*O:I/;QV/OCH$G*9%:OG31EX%&P]*$&WP=LT$8UD,B^!\?@FYW,H^*; M;QP>*5(.%;Z>FS/+P]CWY@#W6P1Z/[CZRNOIQL3IN+L/Z)=3QK-F[JHJ>']> M$[KL>2X[_J?G^48V6/<\A_FKE9BN*\[7> Z_)IQI]$=]_ MI@LN5$FXBEOWP1VBO&!MTH]V?^3I\EJ\ JL K\+L#?E.C__ @[ M.S9H$YAEDM"C7@.=ZTXZN?#\5=G'O";?9]TO8RV/3#Z?C/I@=MG9KE(/]..% M=W'GP5R^V\WAMN/"M9T;+YO* :-LQ'6I*"4EIDDES4/FIV;DKJZ @^-1PDUR M!V?UCGA]..E3,*5).[?T@0&VGX&.#DR'YE]D@^"L\I$FA]87F59 _CN!YO+W MK'EU'Q)KV5V5JP_G;O4!AJQ US:<1(1R_; YC/SSLNG)BH2,XE2"!4I?R10> MJ$0]*APJ[E^()U0"8CTNI9_JPR__/!!ODKZ7Q%"@^MQQ;-#1$V]=K)5.NV22 M>?LVR6$-&V1F*NZSCJ S8%$6?VY@0AA<_Q;;4*Y85:O6."LL<<@/<#S!TJ^T M&8X!LNJ* /PYH%@;;=&V1)87+I/=/V5[P.>SNRBEETG*#-#%.@"M <-4;K4V M IQ5_;@ZP44?HFZ 1>B3&+@CIL^<\+Y<>+[9Z8"QG,3C* >%_MH:9+T(Z!5N MZ.V"?-?=FHJPE+1HMM M=_^6ZWE>Z92(!SI8K[#V4X)9B*/F1F,)W*%U2:>]VM.0DIVE#RS-\[2?]L]* M!=&P*G<6UGC>:U+:'H;8T,^RF97!O,7-WE_LRC%X;W_FBN#4/-F[X(\VL-:3.N MS3>7TMR%G)(=W_9;C+M6@55@%?@=@?^L.?^7!7*_9TI#%_99GN?)3T1E<8_1 MSM+&=2^ZQ=!.M\?:TT5>5PR/)H!??#$^34P[]2Z\.4-SN._AF@5F?L."YT9/ M^^%3>ZWKJM:97M$$'X'?/WCKH6&LH.&+AQM^;JA5]VW%Q3K/4GNA]8V#\>8W MUM8.E3C[BC+QS:4_J*NN7?9)MT) A,GH[*9#M\[JF0Z$JA0U MW4G8Z^8K3OR82=@Y+'MH5"W^I37$?\QP7M$L(HFB:I710"]TNA>UKD![BQ9R\OTZ<9<%U7# MU 48GL:BMHP#SBY,*HW M(HSHBP78!JW \YAI#6M!ZIB2I\P$*82D]2%OA'CXAEG:;C=7E(> 4,GHG#NH\#A8TKW,L0L-R& M]!GO:\F"Z/F,-;61B&2_Y4D[YZ0@2B%B84X2GEQ:7P2# ?;A@(ULUB*$Q+6< M'=U*CBMP4Y7_Z%*3ENMT71X>=OB;IF+J[#;4-,^Y;ZQM=,4NF>FILN.5GR$: M4@QB@K:/8F,0[.VTJU[C$S9(::19-)_U!CPV8;HP?\R(E [T"+C6JYGY7GQ$N-CR^^,/@O#RR=2H1Y1ZA%7PR:GJ'H%^%++ST>UAUB\[CTR;,!]/@_*?=*;]^E*?6OIE+V;O&[UQ,5-QI=U=6*/W()O M>OOM;'3*5=^\C\6G9HI,1JG%'[L/:1%X*A"YQD)P M8T%]Z95XE(_RNG2(/OCV4/RMZ4WS&MYG;NFWAPS106]A/1)^?/N?LBO;8#-;%5RD?Y6:J\MQ#O$RI*J[9N71" KZ&9\*B88 MO!\YH*4RO0K#00#^!ZQ>899]0V"_##N-.<61J]3A[F2GXS%F;!"@NK;_6TSC MWWO)W"#O\V(#*=NGJ">-E#:](A?E(L 0I_*)2WPTM1>5Y7 &WA+4FN0?/ 5A(CH]B@ M;A].^=3%.B\0R59 >;0$Z& D,B6/ ,+VW_T?^LJ,Y-RX%J8?! M&0.\?9P-PA,! _1"KD8?\%X#:* 'M%.ZX?ZV(D>$^K(V#_=Y]95X%58!7XK8%_ MI>S^QRK;G@^9?@L=>L9J4#!K]?TR9HD=F2*\[9[ OO:O_D$HS(4G;MM^_5)D M:/PV>,B7'I3%C)BW[%&6K8)4R]6J*;N%R#@VR-TJU**'$%W(1[NLN_?%DO'7 M?7V^ 4U]QR4#&0GES!UL4*G3Z_DD]236+@WH;N+7#[Y?25H./G5.RBOVVHIO7;/TA@V*67*_4G0E:^ "8V_"T*@+8*YV&R%M1,), M:TSPJ;B+4IIW#OJXB%)=G=%U)V0AN+W:E9L<9H<]1!ZUZZ)?;%=PJ M)=[5M\1N&N;QAYY.K)A"9H1M?8N\@,K97Z]^TU:@OY8N0(?TCYKF](P_?0L) MDIJ 3+!!0>][@:?JG(1O3?^/^V)<>^YR((*S'Q"@8]!XSBU:=.+.; '.S=W9 MXN.4+V0F4/>H+764\19D1&@CBX$\H?>D(_I9O:02?,IR8(\<[!G],?Y4'&E+ MAM_#'TWG=R1,"O%$J#]0;RJFZ9[MN=6?*@09V?-9MV.[&4,_ M"3D7;3+ !O%(EL=H3/MD>?Y6Q\I58!58!7XW /E/DM=_#9Q;O\[DCZ2MFKO6 M2F[83>=4PI$EQ@(;%'UT$=9#'*.C%Y92%O&$4UW%D>#G*0=#QT._9Y@>\W:, M''AB&R 2;IBPYZ'ACYRTUF;9O=?.M-S&Y/N2F3;=2/W0CI2J9M4,* U9KRYDJ&2,ZXO)Q#+R-7($C@?NJV5RP.R %B= MU^NY;&"6M:($P@:,>. MCTU74)IW4*'L\5J4YR_$ZA, M:?]QEF$L#BIE#JN)/')%4:[5##Y"5C(SLA/&IJ(:>0(6P'.NC)*CW4Y^\9/0 MVCZN #9M:M!'A*=IS S+[9[V^@,WBP3$:IEG_@SL_(3+3),)9:Y:@/L-/JY4>,Z3XO#18<8E@Y>,Q;SS)U MTOI_^[EN%5@%5H'?&<#]D[3T'P'W+8S'H[KY2^HMJFS0>Q^W#:]Z@SJ*#DX7 MPUT'+HYOI,CKRD$>IX9;:(;5&-;PP=:=CQR(WW^D01$A;UC^RDI\F:'LSQH5L/#H=-QHT\,3[TQ_4OSX4NRTDQ\RT,=V1, M3!^EOB[+:3"R:,[]7&K:IYR8:6\3YGO![_ON@6MA/0(&?FW%526FF3W*61OF MC,0UV2"9#^_F1E,0B(1Y^\Q?;;$@*VJV70W:D#;%(M< ]M,^3.=E7P97' M&Y%*V: ":A;7VHNASW%EG7)C>#":3J;B?,8^V_=1R!B FGJ;<1@IUPHL'8\EI<,LU5\5 ML$$EW2V*SRXPW)VOWA&5B:/]4] MY?>^;9^:W=D%U-S,V+I?CM49HU^A^"RRGP VH.4MA.3<>[?_2Y;!5:!5>"W!O[_!)[_#%R_._>(95Z4,,P[T_764454 M5"\A&/>BZF+GI^F,3D).?7N=H9:DW8T0 QVYM!9C:;7/[=NO?:S5 MZ)U[\R:Y3.##OLX>_3M6*LC J^K7BM'52<'&5P26?+P=4^8H J-?3P^T- I MAA&B3_9K!]LF7:T=-WRP&^4=M2/GFVC]]O7:H-3U;Q_*;I!:NRT,H?+*)LKR M[,$/>]^&KI7D32%.:Y!_/'8J*<3.S^:[+!L^5X0#33C"%!_<2Q%.YFZ8EL<9 MH:V64X:S,ID:Y=PE$E&%YT6.AF(HE]KH&:TK@WOV??JB09Q#QB1:"V0S513X\(>739AX8%7A9%^X"U@7ZUR[ M+";538B?(L?M1H MKEE"!KQ;7^^:W,53N?+E^Z5(4AB\-_E?;8*K *KP.\(X/Z/LL9_!,R\ MD)^>(J,5.J\;LT%')$.[B8-1]YOU&2^[A>%6!TG2MVKZ2T.C0]H7N%_0SM6490O=)7%!+Q$YW9>DQ M6F067K!!LBR;)MB'(%["&9?QL\#')W8&R*K]-1:"DNC4!O=I)RQK5KU'T8O; MS&2#,/.<"R^ZN=RO+)8XXO1FAVH,H$.T M W2(<2+%VZZ/S5[3\^!V'UQ"*G -OC$#K.$1"U>.=G(FF2# M#K\)]7[_@QDPN^LC]6*=<=LAX8F=FVW>\BT9^JH5@$]?\M.A/O%;M%CL&_P7E@%5H%5 MX+<%_ELZO7\)7*8'.5L7.O$HY7MJ2($3NLUCMH57.&W9:14ARC!RV/@RT=?/ M0"CB_0<^\5;*U@LS5[:G&IV7U>3M#OLF7Y:NMD6_*=!H_:,CBFO!>_DUQVLG MQ7C/GN'3%-<4%X J*0P/,(J/)]03!V%WI-9<"LM:9(.Z! >ID M3]I&*>MTV M-A^,&RC#-TLN17^UCK=]=[C!['W$1;/WYR+JQ4U?3U)/:7WK/A)Q_$%/Z2B:I!8VPJ[7L@&A?M(SN\!7.4* M@:R=OWO1WXN1&3!_#>" M^\Q&"$FNXG?.5FI"WQ3]<^BHW/92+HZ#5S$JY ZBS78M8:4!_@=R/&.6P,(\1 M <:Y 7CPM :UQ3\5;U2XB/(9:$GK]00**-#W:V$Z^P!Q@*+#44 MIA3FTGL?J+3O2H8 N_<^8*.&0Y:6PL&Z0TU%1J5SPC M_U!I1\W0$,NY_NU=AD"N1BB/\;('$8;+7U.L#,%1O M%:UD]B#&7*C_?!?%!F6FRMHUZ]&B M)*=1O9<2TD9Z*RL_Y=E"NK1$$X8%3.2GVO!M],=%1HU M6&WUWV6JO0JL JO [PA _ULBO'\$FE66>J?KL_P\?5T)B,T=&X7X="\J#""0 M9=%1LA_5$1U>==[K>WJ]YJ5-PT6U4S!HX[/ZVHI:&GG'>/7!LG/2([+DHTX% MKS9W[S5Z>*&Q.H@AZ_N2)]8@F7ZG_V2G1Z&^]XV@&867G$_:=^](PQ "5JJ# M*.[CZ3]VCCZ/VBDICK]\;N!!0]3KQ^: MG_TL2[/P^89-=\LE>"P67L%2JHX%&K"V:D<>3,N>W8TZG'+I4E%6G_D3/L// MVDOEYURD\&]CQB@+-WZT 720167=33;,7]">=%?@. M?UWYXL6RC!C)R+UO$Y/7LD'ZA^KZD'D[B2AWQ8-G>7V>#1+@/+D#_AP05NZ#P1CSZ9;P<@W7BWFFDMS[ MG$IW@RE,>A"')J):.%6OK7(EV-R'#H>99U4"U1LH@6TXJ97X5'R1QA2?\ORH M1ISK;@ZW(Z*,^3CUE*+BKF112;5ZP]O"'9DMB],Q?F/?_25IW= O'N:W^E&6 M5CT?A,9/E\:*3.J%A2 ?B.YWGD9UIK1 @MS^IL$K;W;KMUATK/P,@2C,^2&V M)6!R],ZTK517 LT;6.T!1ID#>&/ -:<2D.+C8]N-%L? DFEG_%>]%RZ@?8]BG1]PI7*176#D5T[[;]V1Y M!16_0>566^/JXMQ(;PZ7%[Y6DDMK56\=1,1+K6-='^VB\\^+_S8GRU5@%5@% M?D?@ORVI^V< HS WSC+!373 MON^',-BJ9"]*MK.K>5WMS]+GKU5:I.6P[H< MJ.VR=3TF37.^YKSKPAF?*R_D'.)U3J'F^*KHNX?G,\MN9$4^219 MF6]6^Q,N3,4]D@$KU#W4(4AJ=Q/LBY^N^5B"H%#"^AB%.NBL*T ML>U890'+Y44-8.FDFXGTX8:VLT$5@$8,2,KP6!^GQ@'3 _#^U!)W M(*846+Y$ ^;J@,@/D)-]:'//-KYF>+7MO'1*!CHV.F4_36?=N3LB85SQ6ZF< MD'5]]2UWVJFU*C,BX[F%DCL1I7'U-V05AK\87[\VOI=@V\P&W72!)(6/P3@E M=\)QRWO;:/W*Q\BV!7>EPC>7!&N5CXS%=&-E 4\Z8#6'"JSF +PM$TA8X>KQ MT>*ZAS&GHK[^BCB^WSGX>!MR-Z,VNN9TB=\H135#WT^21&']/-0E9HR M$W^@TT_4;W&4BV];FY"]*;Z\5,QAG7;^PC"Q6WDF)<"I_ZB)K%"VN?[/ U(U M+7Q28Z//O:C?.X?LAKV)SW)L%B(-\*=&7F7)_/J*)0E(Q"U_IS/C*K *K *_ M&P#]'^G>_AFP=68PV:!H&?HA1*I"W=3+;J)S$Z*EZ(YJ_<:GR2VH\:R.NN/M M;2TU>AM:]((:LZ.S'A+S]8QD#X("][][.IO>Y>3)I-Z@!]R']W8KV&Q_=5,8 M[%#S@'#;ME,%=0UZR!EL*M!L 6X+L4ZH3F2D5]""P5;Y7ZG'W.77Q_VR_GS# M*1B /L \?1?IG@(5:3-9YGU%D WB#_Z8?"%7WNA<[!+G(_VSZ)D$TIK%!8&R MF"\EGDM-B ")G5_W%YL&82XEV,&;%$DX^'A%"P:9R>KN#?"6C#,F92.ZT9JD M=E8\LV6UT+TIXQ5P$DD"N?G M.(QL$)G)7)9$$WE)+"*GTLT6_IEX'L='PC_!M9"F^DM<)(L(1*C'6$6OVW+G MD4SBNK-8*F=HGYL;O---5_NE='N#^2?T;1,M?]>V MO3O9Z")Y?,W/8O --N@N0WTG&3!CR-2KSL44!,Z6$B.KKAA8Y3]]2UHI(3TZ\V MM5]M-+W.VN&?WLQ';SU2^8-2$4]9> M/]*GN;MOGH*M+LC-K%X?&OB6#4JOG99J@,U)+[%!TZ^SR]?ZAOF_ISD(LH?F?M.+#7.Q7UN9/W74R>.9FZ3 >O G@@TCL=7] M(N)IR=$QG;PC1()$LW^576O4DHI)&H@-BM(*TS$ASFZY.,(,*C@L/6WMK;Z& M60YMS,R+W5KX=KPN:.?.[#\JUMRX40'R6>]NE(GW %RM:.58C4S RW(Y(\J9 M&U"5;=<2W.LYQ8![*:&!=4#,!PMVP$"=@^:1\$LB&B2JB\O0$&*& U M4E*;1OB;YZ%K5OY*_I6>_KB@Q5N,7Z$!^JTE>V+ZX M2Y:@S3L!&<<8$ED4%F7"INFK51F<4R\[4'YC3:VD=@YU ](\2#597"$WH(BS M2_AZZ2X2P0;%RE3?NZ0UA!+#>AZ>"0MW1ZUHM+.0.Z,?'DEB@VP_T,(G>*<0 MC3]F]P_L9EQ(98-.[3O'(8'NFZF'R6/%NUS"P$]7E-LV^!]$PC;88_7?Z4RW M"JP"J\!O"?R/I6[_#!AZ,CH@,4Z]K!M(L8^JQN#UJF*$./=7\FW-KPLRM$$! M+OG'V"#!SE/! W>]3S#KLY2#KSSOOO M 8N^;P1^AD1H?SA4U';5[:,3)M\RZ-3347%?K/8WWW)#281O!]6HO<<'[.8D M\:ITNEBBL&0AWD&F4.DPL;Y%1ROJTUV7?$QHW<^/)R)!S8UZ:LX[/GSJ?X'R M?K=VNO=TS,D)R5,[CF4K;LF0W:!A'1*:G.<>OC8\-GW30^6M7I*! J&+T/)> M2G'0I<\!7W0&?/R">R(1&6IL4,C>Q$Z/F<.O7849VDM;V*# N*/NK:?+L1+' M%":._Q %6-@BIM05B#=<\4P&W#I*O)0L@4 E'(6Y**@,LZZ&D:EXJHOF&,6> M0L0#)(SF:A;G ^0S"DL6A2^!@=K^/CN>/X\/_ ML0'8+!%8L4CY[ 0,V;S-LR;]M/&$$LY_[]=W7?\9DJNG0 M%778( W8+I^O;GVS-T+ D^BGD#NID)'OY?[Q,YLSKOQ61\)58!58!7Y' />_ MTZK](]">C)Q^#QEZRASX;,Q@C3*QZ>K^[Y.2E^0*WX^ MF^^\[[U+$CN]/CA>?[CIR[9,Z5L?]5B-<[B W4/RS73QR'O5TS:1? CA(4BR MX?=DD&M=Z9= ,YCJKSIP;&FN8GT).ZO:[&AL(59 MB,6G!Y)Z.*QGR!Z&EUIQ[N?0J5-F%"(.EFV'QQ&P/4H8/3D:A0BX]X]R+4W\ MQH:05B5[6=26MY2:Y;197[B+$L8R@&RI+&!!1F*PP"0LW$D;Q\/Y$3RW6BVZ M]SE;E= 0R&XZ43+>B%0NP# F%+F/ WW$\@4!M-YZC.4VIGJ1*-9"\IEV+;:8 M*MQP?C10M3[TY4]2!_\5"=-C/RZ,3.?4B6@OUD^0[[Z^_'P-PQ1L.T#77E11 M[9+Y,;EQ;B4@,%@>^P2^+=V8FY.,8?X*2O8#2F?^+H9TT%T$U8^1.B' ][UC MC/DJMXQ3A)28- +J]?0XPX$U-5XXHKWHXZ].*V[.,S'%TW7BV* 143LV*"/N MC!^U9ZPKPQ$2:HRD/FIA@TQ5>H,(1RC/F?_N,]DJL JL K\]\+^7AOU+H/50 MM)+$JYI;1Y;@F]2R9.2T#)_7V1P[T=0^,&LR/BH:7?"P)#39[-2[6!G;H6 M MV;J+V;O#IVK)8D^EI$TO[ XXLZ%V=\A# 9[V2MFS!]^)"YC->X(9,@,9LNL0 MT"_?\764SZ=B"S"[LCW;I97.X]_22]!IE\\KW+\9&[-'6YL?NS4V]MZCRM," M4CGR4U;=B.YRL\,4I_W*Z\^IF#1=2[YR/7+D3$ 3_V,C1LN1MZ6G61DI09/H M/Y!W#8_WL$%USB,"ET5+4N&Q?M\J?N0^[I& F"DUP#8%Z$?(Y_]Q-MZP4#JI M.HT-0N6PNAL9.<7Z6C4/1J8;3A@P"VR8J.:A\J6"'ANK@-%%%E)@;KST?M&; MK,U[#)]^&S@F?"]S2^8ZI^-R6@:H6OT&7)IHFFR^CM2-)>.KB!"IB%-7=;:O M-ZAXN %R0WBTT]3$WN J0L69ZE>(%X1( =&TUG9X:#\9H9(YAL]< H3-;23\ MKSZC61Z)2$(64*WM EJ"F9Y(CX&_?/7+"7'&P$9AGV^-A:,S!=N5/S[>ZR& M=1_5B.,NXON7S.RB^5 0<'URKYLC-9?O()LI)]7 M,5B;(F)D. N90=:G-7] QX:^AYN][)(-MDM&Q^_O3XS==;1>#!F=T M9B*]ZCZD"SN@@(M1HG MMY_4;5*6[Z>AM"^G>BA-2O&Z\_T+$=&V/1:=CQMS-TO@[W>#J[M'O/3FA1_X M-9N!&R03 H=_=HS[=VI\TIX4%QAI,_"$S,HNIN(TIG!IGOSTL2UEU?GJ$D*N MQ.YCZZTO'>^C7D[<1TC?FC,B=?KP'V9=VJ^=2\PIF3N9@F.("]-$YMCYA,7* MT2GB*^?WU?VWP&29A1#DX33C8C8H@K?A<#&]A(55E2N=#EM*>N)HT>KC#-MD MZSUK.(GML[MQ[,B0];O:ME-J!_97U(HY%S-*O<^5X>UK%@.3,5\CT'.W]9LG M<4<[KCQU$%D*1G7),2K&,U1WI:IJ?Y@=X>FR],3"YXYZ;&MREL]]V9W;*LL& ME=I^,1)^-!->5[_QUHV;&9J\'5.-+CD]4C/W]NO$M D?88Q>$:@=22QRVA,' M.]U?4QO X@\H!^PE\\O@US+QF4@.#R0P.52+@;*$ A)H'KP"?+S7A\0&"5&S M+XR/ _XG&]14_C1 F8HSDLK"TM%5/,L9=G^N_DL6\TSE :W+;(W_8&=2LAP9 MU$89:W,J$\"V '%[W%$=-\]@F\9<=T(%%:OEKC_VON=JUC75S;+MT*KP4#9H M/.3!9>)LD\].1X/%Z'<"*X*U=R>[(4^=T=]*_>?+%\_-Q,<\>2, MS*0=F(64L%$JQ4M"%#-LF)LVX!=R<0QF>Z5?/^L]X7=I?ZP"J\ J\-L"_W?J MM/\!<'1*/:>@,'1ONO/4)#:@5UET:+/YHQZOV"W#>W.TF^USBI6' C59_$'= MV8WJ>0\=/&U[7&Y+7Z!O>#?.89+V(5%2#:*2Z5!.U8HD5K((BK B%K:6P@__ M4+^GGK+_1L'D[O#/ _IY'_7Q-Z2>FD>\*!HU>?;,'A6["C!,W)].CRC[)G>/W5@ ]8*[W0Q+]9T2#\Y)5#$>(372H,7EXKYO%QEM"MUQ4CB/E&/A M7:<\#U2?]+QK+]ZI%-]C7V8@J*ZI=7OR6WGY(%_ARP7UKH32J<1P5']6#!OD M9:\T.ZKE4-QI>=6\+D,ORI:8W<0&'7X&D>HD2H:TE9 ))3A+(K'<)IU'%\NB M< -@TVNRV"#\7V8J@&45T)XDX<]!"23=-^OC7&F W22/<58E-0WHF!8S_]*?FIAI_*Y*YG9@M/)W@.XD;\.%FRA4N9\H-!SH8#$J!^]8_ M?M9. M\CZ!(JO>#RDQAA@VO@X(W50;P$RZ@%X*:#_@\]25HC8 9UVLQ9&WO4\8%C"J MG(*,"OV[SYFKP"JP"OSVP'\_^NW_*=!RP-KPP6UKPZ@'>_QW[@Z@\'*^>2Z= M4]QB[E;I+@K!Q ;>%R D[V=<;"PIT#KQFN>^:*K._G+,GCRS<(<[:WO$'\$V M+\IJ2U9W.RN[[6_3=' ?TNYW^RFO#H(W(9/1YSU*OPS9/;E]8EZ]:D&T919M M*-/#!DTGE,EK]PYJ:'AF>AP[ [OF:-5;K161?,?I8OE"U]'*0Q?0CPT"7F72 MWH1[A)TD>@SMN$)H54H_9XLD2+YE@["HW'="&&7EMZ7!N!,GV*"0!-H&V#5L M(R.+Y>2.ZC6\0S-6PAXY47Z'-4NQ"%_8J7)AMVA*1J380X&HE,?&K;D9S+#)TD5MP*7YUA7:0,9-YJ7SB0GK&H7<"B0L)72[(O?#= M^>Y17K34T?14^P/I!V][R:;*]D?$IL3;?G^U)W[CPY)C\9NRU_HAG@E%M1X3 M#:@("0TU]!>-V4T! P*S*3%.&:1-@#W&FG[M@8P-^970Z$3=@&&5@9N0_^* MHB*&V08$ "R"K=[P9D'Z$.2)L8K6<<7;^X3RHJX;ZC]-=3@XG/SA>7F$IKY( MH&WCHM ^GX\Y1EN*I-35(H3V!&UKLW52.T'W48VN;.VI#\F*CS'=>:P:11<" M(76D6G:S07^H/[\1=D6P#O?$F F]>U;XCN#YC_QKW;_6 @6:#L<>-"*-OYX& MWV6#7#0$&)J=C;L>HM?-I"$YDU0S&-D5ML,][7H+U(KRAW+*9] MM^MQ\@HJ?KDBU[Y!/J9'4:M"0+:VU.OEFALL&20Z3*@W*_P.;[-58!58!7YK MX/^1N.W_$G#G72!_B7] 3C,]6!KTX20_&Q3>9^9>-^)!V3PE>^&ZJ8%8R<%H MM2CI(%"+X7G'SY,3+\X-E9(Q6]+MQ&1N6893YEZ%5F7DC";M>E M4-XYB>MD-S9H3\+S[NHVX_EV!A&A&/DJR>NHX2389F+<16O@X2;QZKSBVR,! M^XI3[T&R+PPB"NCI9=WZ2@#39-F9+>X-ODE47(PX&TG!$OU-$*SJZ-5WX(L7<@^J2A3BJ MI#,G\:7TS./7)K]_[E3-O3&U0=';I;3&::B@7?_,ZUUT\>HC=<9C=S;;?$9I MU'@41LRU<2_J %#QR@ZXI]6[?KJT],D]Y@B33-,'U24@\0R!?7=88;?DK M00ZH=%/E6 M%%<#LZRT-5@N&2:&%2B8>(/$=]N M4K74/(+D]1:$/FO_4>+OO#84"(Y+@R1I=Z#N)%QWY'&U0&6S0;DLR4=BURDA MU4A^[0YD)QLDH,4&;0M)_S;D^M+"U\^>47[FV2XM :7HC^7)=@<3=^+&/?4G MNK1-$NV@:[BR[L3 *)NS4BY7=?Z_]N[\'0H$C /XE$J2;*[(,3E2&L>3'=HF M,[,ES["2,(RC(=>&#(J9/(,9:JTEC"-W.:(&XZ;&$9.UC#-7KG&4B'4,*^.8 M>^M_L,_Z87[]_/P^SWL\S_=YN4?PG!5,F;S:V&0.T7^N(UNJZ;?V.\4.K1C$ M'_DDX TPB?S":.ZCR6(:.6N1H-].8EA9.WKJ)H#+0?<]++@6E=8$QE++_WU; M$8$(1+#O88_2='L)0ZC0573R>*@O;D$(F)AT"<>P)Y&[T(_4C2L9TB!?G8H; M ;\J%6C_]>0I#?;!!3WMU#7G;#[X$\^\W9IY2.U9G&\^44;A_$RI.;P.Z_AM M2'(TP[,Y]4-$#?HK;-)*&P%'MG6;+>IC,18]38(,Z-6N^2K:!KDDDU M)R;6.OKO7Y^:#<-M@CBQO&(A(,ETFW6^=M%%YSS59Q!H,T7K3A "E*#(L:#P MVVS9 7N9MBGH)=H;/7"P$62A9OQ8":X9V-Y)^+:5(N!,"JIW6-8C9+2M='% 1^/D@%B" 3AI'T+J=SBKY--414_^)_/JX6[XV>&"QA--=AC5_IH?P1?)*37IP,^9*Y*T M&<_63(2B$&"O2S!'\(",'@F>\LO@=]_?RDWA7;PO10>5OU,!5K'$>9H3;54M MWKR;$U*GTE6'OYH6_9,62[:-CR!Z>;IW_;(B> 4)UJ3NBJT.9ZT12.E4RV*"R'7NXT.KKXM(;RR[>D)(Y]YH1/,_- 1AZYB: M^T_ T4_G$^61GW.Q>LFKXCCS"SK+FA;YN4K(HJJ^XY$4D(YZ6M2AH(A5F2+# M[).CK6<^A)@VY;&]PL^MGT39USGA$06CT2 M;/2^!/3W!8,MDW&N///91B\7K:#\*EE\-F-+?,*!A-QJ+A^ M1QWS;*GG2KD"8TF^_U,JB]'R&"T&9!6Q]&H6H+G;3^26%04*3/A=+(@M.ZB> MK/4[(@X9^B66<5DCV4DK\3I&/S'!X^B91T?K8>V*&H6% ^/%G2N4[^\.EN[R MR(V4=6(.O4.U[.D.?6"=V3V/2V%MB_JLYT6_K4W/D.)(G^/]^"ES-V5ZUF=#%!TB"O3.SIGS5Z"XK ME9M25>]G.7@1BS(K\G_YP?^K]P,0.2MXEC_\RP^_WG^ ^(?_^:__[;_]\_\! MX?]^\^4C>%>PU9/(E^#M0I"EX.!KMGP$?^>B_ /(1?$$_EXL_LA>"(3_6KWT MMGC^OL@>'I<@\ )O_[>+OU&/!XAY'O29#"&*$P()HP0R&J$D)3[EOG?U\#<_ MQ+&(<0)Q%'&( II PJ,(8ADE:83\E-.T:G2>Y7_\3?]!22F 4BXOJ[_^RP^/ MR^7SWW[ZZ>O7KW_]1A?SOQ:+AY\"SPM_6C_]0_/XMX/GOX;5TWZ:IC]5O]T\ M6F;''E3-^C_][U\^WK%'\41@EI=+DC/=09G]K:S^\6/!R++"_*Q)!C^QG ML<@*?KIZ+];\]+H0\WNQ\L=AI54N9:BG] M6$OY3Z2=WDHZP#"5>I^&DK&+DP_#2;NO>('X5[@5C<7BUQ_4.]S M/M:WN^GJ8M'=2SS49U$LR7R$SV+;34ODN?Z'C^JGIAO=4 >95OTTU-T257Q; MBIR+FBUWF@89_Y=/L[=BL219_EXI5GP7XA?Q1,5B%I"8$1YS& N2 MJ,7+CR!!%,$$8<%2#\6*6+D19K!9L MN[X]S8\M6FJ]TBL<_BDG3Z)\)LT+2DYM"M2B_VLC)%A+^<\_;77I!>%\!&#F MXV("?J]%_/\N!HO*8%5L!UAYMIP*A;[.!3, (>:BO1S4%NC M7AQZ%=%TO/G3P9W>/9"'>*#.2ORV>GD5>5M_!]6*A!D_H[^+- M]^TCG\EW_4_77\F"O__'*EM^OU$F[J+Z?LK;Y:-8W#^2_/99-U'^K)I8EC=Y MO4S.?.QS$08$4AFE$)$X@JE0G!]+)D)/>'Z:L)G:D-#B'&N.+;K-;&HKX&XR M5?*I/=B/I=:O_(L9X8P^Y-T=#2'E3J@Z72'S0 7($: J"(MP;AK(9.DI!7FC4@_:6[_ M2:T36:].K]3_RBM<(<[M::K>.]I3=Y,M% MEI<9^XW,5V*&.6=Q[#$8QQQ#% D$<>I)B!A6BQMFL4@CDVV!:#K3;& M'?9;7JJUZU.1%\]BH432K;/B2;S_IF44LP!SP?PDA2%A,42^%T#,$(4I(BP) M8T92+[!9([J[FQS15R9J5HD(?A2UD'^Y KE8VA'_&93-V'LX[!Q3< U;6U)P MTV#8"'MZ"VC-GF:H#$F!9WHAJL[%'PU5S,T&RN3.=[0N?B7GQ;OE&J_#%+XC3V?$4J"',"D><32'D<0^:'Q*>A MHAA*K.Q02P&FQCK7;)F]Z-UR(<'71G1 &%NLR-S2WK0="D,STB' KJW#1G2- M;2,\6$L/-N*#WRL%@-8 5"H,X/>]%+U!K3A;&<8USGHB=&!S]6VG'_$IP^XI M6U8>@>M(8"B( M)![&:FMNM?VVZWYJI->2'B@S%^S(;\=ZEN-@QGGNT'5][-<%+-C*KCC/!=OU MPVU(KK.48%2FZX?./L_U;*4?RS54>I/+8O%4;6(_9KFX68JG,AN K(97PT$ MG6-RZHV:-0\9X#$DZ71U-RK#&.B]3R)$"6Y'&RLPFR1R5K'9L\U]*" Q,'Z?[&YL_SFI^A$#.O]./0=ZL M2L5%9:E,'IKE%3E]$:QXR+/_%/R&JQXRF>E-W76IYD]YS?ZQRA:"*[-HO>=3 M1I'ZW>I)\'>*6!;JE_?D6^N7,YFD/L$)AS(B J)$N[R#)($>\8F?L@1YW&I? MYE[DJ;'96DJP)-_ ?+W7MB.Q$0;:C JG-7R."76M+&AI>P6V^H*VPJ#6&*Q5 MKK:7+;U H_45V'P02O'V$\,1]'BC-"3-CR#UJ(O%>*.PO^2,V'//4Q&Q>,G8 M)F(Z8I*A1!FW09!"A*5:8Q!*812EGN $IRCF5D<>[=:GMAPTPH&%>!%Y1^"$ M 6Z^3"(+;3%P_7 M!S<-$,/%X7=J/.AARTX'XYZD'-/MX)CDZ$-3B\__391+1>5-4.7?A;ZLJPA< M34/R(*J(RW=D*3Z0;-%$-X9!P#C6\2JII\QXF4*2I@PF >(>3T+U/SE*=./0 MFDV-WK^(N:BBZ'YEK- M]?WI2B2MUT(\*M6R%U%'I7TLRG(O3(DS%,Y*F0$2-> M% BKHX(+Y9G:BJR%+O**/ NI(\?6*H&BXE+65@K,E3Y]P\KZ#9_A"CO>H+A> M%UM!9RU=FI5M1YM-H*Q6Z"\CQ:%=A*^;L+1^(KU2E-I%^)T.6KNL63MF9L4J M7RZ^S]Y^F@48A[Z0(4R)#L<-"%8_Q0)Z"8]"&DK)<6)"KMLF)\>/CUE.S"BO MA4LW:_73UC'QO/VWFT_7ES/&H6[;25^N9WTIV%\?BI>?FH?K2=_\97^^MQH< M9*K">=4=^8S=QJDP'=TLU\VI+JK[[^?Z;6+"L%)\7VK&2Y=G3ZDF95DPG MKG@0M[DVI'XABS_$LMYSAHAQ/X@C* 7U()+(@YBF.MN8+P46GN\CHVLV@T@S MM>E:Z0.*2B'P4-\0%XU*X%GK!)YJI;3WH=$*J&>EWO<]58J!E\[MGX,A[::+ MT0?*M8E3C5&MR_H6_UH;4*D#&GW 5B%PF]=[\UJG,UMT!V-DD;AFS+$:*:9?(?/JN?)Z MM7PL%OJ8=T8Q9QXE#)(H%!"1(((T\!/H2\Z]-/%2C_NCN/S/RSJU-78K*2!: M@Q*0C:Q %@N0E>5*)P<%/V8Y&#>/C\'(._;9#SN>T_?"U_I6[HKM=U&K#+8Z M3\"9;CXPDW"/&XC[YW!XF^,^F O;HLL>.[BW15ZNGK0GI5R'FD0I)I@@2"3V M(4)2+R8\@A'U."-)Z/$8FR?-W&]^:OS?$M F'>0!:@:[GHNP<.TPV4KBW2R8)Y_J9T!_%&4IQ$<= M@5I.\'LMJ9M3)0-$AC3%NKH;U90RT'O?%#)YI1]' MK".8/V2YWK.]+&LSOOL@FD0^U.C9ON]#==+C-&YN 7912N M%K6K]O=WQ1/)-U%= (GS ^6>:!C/Q1.Z=]@>ZHV6W:'^MF]S[#+^L0XVNJ.("PY2SE0>)%C,#$CQ%$ M(A:08#^%89R$21 C3E*KI(ZF'4]M5G^\N7YS\_'F_N;]';C^] [/^_?KVY_W=+WX7I0!@Z,AS Z]JKT;IIKF^>-U=' M?E^+.J13PQ*=03TD0$D!/D0Q1)! M*E,*@SCPOE'B""6/WU9$.IL:UZX2)F[S@JM,G"\?-,0P-?%D7(N.8S@X2>=]?#HJ% M/^M"<$;R:-F!9.?1ZD"@TZ=U[+WQO%H=4N_XM;J>N^Q\KK[$M9MGZ)-8SA+) M.$?*YN0!Y1"Q((98^%)?QF(B8:GT(Z/8(\/^ID9R0^2/.P>QW8G= , Y/[=K M,&LND.YE6KL"GSIJUO0^P3N#BXMSO%-=OLIIWAG]3YWIG7OM\NRZZQ/<6ZD/ M=&=Q%$O/#R@4ZC^*1B(*L3*.%,:>C,/ BP2/^^;6W>UJ:ERRFR*6Z]/M=2A[ M_ZRZ>^B:<( "@FTH&X2ZAX'PU4ZW;W>7BV9[G&MNU+IGGC# MCBRXR&9O5XJ$\N6'K&1D_N^"+-[G7*?WF(4^3A(/>U D.A@ $0I)RA!DU/?# ME'E>((SB![LZF1I!-'*"6E"@)05*U"ISD!E#=$+:S0U# >68%7IA9,P))B!T M7#A7KRLD_%3_ /4/+0+H;'J4J6^BW'K2&SW;SS:X4?O+_"';)$!5UL;[;VR^ MTO4D?RX*_C6;SV>,IK'GT0C&D2X('$0"=> MQ+QXUIL/P1[S8EX\?.]1\-$(;S.[86@4'7/%5MPF/W2U]="5'QN9P5KH 8M MVF TI&%AU.^H)H8-$OO&AM6[E^]1WA;YBU@L=7^5&>W3D'LTP-#W=$$TA&-( M(B2@3#Q$/!%[<4#[;E+V^IH:Z^R:W6PK[% [EGVL[;[5=RPF]N[8MIU[I6:]ZMV2M3H U2RECQ(\2Z#'$(8IU 5G"?!B$ M<8S\F#.9R-FR6)*Y&7$\460<@*3 M%'EJAF,*"24<^J'@,DQ2M3\)+6\IM)J?FC70$M Z)K^-6O=TOAP+YSN);1+H MWG<4VGA8WU'HBES1>&(^@97%-IOC7U%X8C$1ZXH''O*WHOZ/E_J M0$7.U9B6GXM2+?K_;_;\MN!"EW>) A:G,$$T@DC9(9#*"$.!0N1Y22HC873+ MLKN;J=%6+2EH1+T"M;! 20NTN.;.U YDS[M3A\'+,;7UAB0N\JAV- MC^97/:]@V[-J\/3%=R(:[^TLBI5)$D01#)(DU&%I'J0ABZ&G_C6FC%*J;U6: M[T@.NYC:AN1>]P%8#/%TFQ3\_T,[5UOB5FDQ3.TB]Y DY#G^3E(+GV1Q[@XZ!JV1D8!G5$GNAJ M7"=DM[X'#L@SC_<]O1#/)./OO^G8=W&=UWGYZ\.2]7*ERX[1T$LA(WX"$54_ MI;$(((E)B!(9)2)-[4XQSO8Y.8*H10:BEKF^GM>4'FD,!%+);WN><1Y]TW.- M03%U?KY1P]F(6Z%9EPY9'[ .;E)8 #3LDZ69+$T([TI MJ&;# /L*NB.#-^(ARW-]O/&&S.N$S-,LNVCQ#=$TB2/B)= /)8BX]3_R_UL=CMN)/0=0)F13C5>K

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end

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